1	Pharmacological	JJ	O	pharmacological	amod	2	SENT_1	[p1l7t361r364b411],
2	research	NN	O	research	_	0	SENT_1	[p1l99t427r363b479],

1	ELSEVIER	NNP	ORGANIZATION	ELSEVIER	_	0	SENT_2	[p1l6t493r225b527],
2	Pharmacological	JJ	ORGANIZATION	pharmacological	amod	3	SENT_2	[p1l777t504r999b534],
3	Research	NNP	ORGANIZATION	Research	dep	1	SENT_2	[p1l1074t504r1195b527],
4	55	CD	NUMBER	55	number	5	SENT_2	[p1l1271t504r1301b527],
5	(	CD	NUMBER	(	num	6	SENT_2	[p1l1379t504r1464b533],
6	2007	CD	DATE	2007	dep	3	SENT_2	[p1l1379t504r1464b533],
7	)	CD	NUMBER	)	num	8	SENT_2	[p1l1379t504r1464b533],
8	310-317	CD	NUMBER	310-317	dep	1	SENT_2	[p1l1541t504r1655b527],

1	wvvw.elsevier.com/locate/yphrs	NNS	O	wvvw.elsevier.com/locate/yphrs	_	0	SENT_3	[p1l1737t605r2154b635],

1	Tolerability	NN	O	tolerability	nsubjpass	6	SENT_4	[p1l193t710r518b774],
2	of	IN	O	of	_	0	SENT_4	[p1l539t710r600b759],
3	statins	NNS	O	statin	prep_of	1	SENT_4	[p1l617t710r792b759],
4	is	VBZ	O	be	auxpass	6	SENT_4	[p1l813t710r856b759],
5	not	RB	O	not	neg	6	SENT_4	[p1l878t717r967b759],
6	linked	VBN	O	link	_	0	SENT_4	[p1l986t710r1160b759],
7	to	TO	O	to	_	0	SENT_4	[p1l1179t717r1231b759],
8	CYP450	NN	O	cyp450	nn	9	SENT_4	[p1l1252t710r1492b759],
9	polymorphisms	NNS	O	polymorphism	prep_to	6	SENT_4	[p1l1511t710r1964b774],
10	,	,	O	,	_	0	SENT_4	[p1l1511t710r1964b774],

1	but	CC	O	but	dep	2	SENT_5	[p1l244t792r333b841],
2	reduced	VBN	O	reduce	_	0	SENT_5	[p1l351t792r573b841],
3	CYP2D6	NN	O	cyp2d6	nn	4	SENT_5	[p1l593t792r848b842],
4	metabolism	NN	O	metabolism	dobj	2	SENT_5	[p1l869t792r1197b841],
5	improves	VBZ	O	improve	rcmod	4	SENT_5	[p1l1216t792r1473b856],
6	Cholesteraemic	JJ	MISC	cholesteraemic	amod	7	SENT_5	[p1l1495t792r1914b841],
7	response	NN	O	response	dobj	5	SENT_5	[p1l537t890r783b938],
8	to	TO	O	to	_	0	SENT_5	[p1l802t882r854b923],
9	simvastatin	NN	O	simvastatin	prep_to	5	SENT_5	[p1l877t874r1193b923],
10	and	CC	O	and	_	0	SENT_5	[p1l1214t874r1313b923],
11	ﬂuvastatin	NN	O	ﬂuvastatin	prep_to	5	SENT_5	[p1l1333t874r1622b924],

1	Piergiorgio	NNP	PERSON	Piergiorgio	nn	2	SENT_6	[p1l403t989r642b1038],
2	Zuccaro	NNP	PERSON	Zuccaro	_	0	SENT_6	[p1l658t990r833b1027],
3	a	DT	O	a	det	39	SENT_6	[p1l842t987r872b1034],
4	,	,	O	,	_	0	SENT_6	[p1l842t987r872b1034],
5	Giuliana	NNP	PERSON	Giuliana	nn	6	SENT_6	[p1l890t989r1075b1027],
6	Mombellib	NNP	PERSON	Mombellib	dep	23	SENT_6	[p1l1088t978r1341b1034],
7	,	,	O	,	_	0	SENT_6	[p1l1088t978r1341b1034],
8	Laura	NNP	PERSON	Laura	nn	9	SENT_6	[p1l1358t990r1483b1027],
9	Calabresib	NNP	PERSON	Calabresib	appos	6	SENT_6	[p1l1498t978r1741b1033],
10	,	,	O	,	_	0	SENT_6	[p1l1498t978r1741b1033],
11	Damiano	NNP	PERSON	Damiano	nn	12	SENT_6	[p1l441t1051r637b1089],
12	Baldassarreb	NNP	PERSON	Baldassarreb	appos	6	SENT_6	[p1l652t1040r944b1096],
13	,	,	O	,	_	0	SENT_6	[p1l652t1040r944b1096],
14	Ilaria	NNP	PERSON	Ilaria	nn	15	SENT_6	[p1l961t1051r1074b1089],
15	Palmi	NNP	PERSON	Palmi	appos	6	SENT_6	[p1l1088t1051r1211b1089],
16	3	CD	NUMBER	3	dep	15	SENT_6	[p1l1221t1049r1251b1096],
17	,	,	O	,	_	0	SENT_6	[p1l1221t1049r1251b1096],
18	Cesare	NNP	PERSON	Cesare	nn	20	SENT_6	[p1l1268t1051r1413b1089],
19	R.	NNP	PERSON	R.	nn	20	SENT_6	[p1l1428t1052r1473b1089],
20	Sirtorib	NNP	PERSON	Sirtorib	appos	6	SENT_6	[p1l1492t1040r1689b1089],
21	**	NN	O	**	dep	23	SENT_6	[p1l1492t1040r1689b1089],
22	3	CD	NUMBER	3	num	21	SENT_6	[p1l440t1133r450b1145],
23	Department	NNP	ORGANIZATION	Department	dep	36	SENT_6	[p1l458t1135r618b1164],
24	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l626t1134r656b1164],
25	Drug	NNP	ORGANIZATION	Drug	nn	26	SENT_6	[p1l659t1135r729b1164],
26	Research	NNP	ORGANIZATION	Research	prep_of	23	SENT_6	[p1l738t1134r859b1158],
27	and	CC	ORGANIZATION	and	_	0	SENT_6	[p1l868t1134r919b1158],
28	Evaluation	NN	ORGANIZATION	evaluation	prep_of	23	SENT_6	[p1l926t1134r1077b1162],
29	,	,	O	,	_	0	SENT_6	[p1l926t1134r1077b1162],
30	Italian	JJ	O	italian	amod	32	SENT_6	[p1l1088t1134r1176b1158],
31	National	NNP	ORGANIZATION	National	nn	32	SENT_6	[p1l1185t1134r1302b1158],
32	Institute	NNP	ORGANIZATION	Institute	appos	28	SENT_6	[p1l1310t1135r1418b1158],
33	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1428t1134r1458b1164],
34	Health	NNP	ORGANIZATION	Health	prep_of	32	SENT_6	[p1l1461t1134r1556b1161],
35	,	,	O	,	_	0	SENT_6	[p1l1461t1134r1556b1161],
36	Rome	NNP	LOCATION	Rome	dep	39	SENT_6	[p1l1568t1135r1648b1161],
37	,	,	O	,	_	0	SENT_6	[p1l1568t1135r1648b1161],
38	Italy	NNP	LOCATION	Italy	nn	39	SENT_6	[p1l1660t1134r1721b1164],
39	b	NN	O	b	dep	2	SENT_6	[p1l433t1169r445b1187],
40	Center	NNP	PERSON	Center	nn	43	SENT_6	[p1l455t1176r544b1200],
41	E.	NNP	PERSON	E.	nn	43	SENT_6	[p1l551t1176r577b1199],
42	Grossi	NNP	PERSON	Grossi	nn	43	SENT_6	[p1l590t1176r675b1200],
43	Paoletti	NNP	PERSON	Paoletti	dep	2	SENT_6	[p1l684t1175r791b1203],
44	,	,	O	,	_	0	SENT_6	[p1l684t1175r791b1203],
45	Department	NNP	ORGANIZATION	Department	appos	43	SENT_6	[p1l803t1176r962b1206],
46	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l971t1176r1001b1206],
47	Pharmacological	JJ	ORGANIZATION	pharmacological	amod	48	SENT_6	[p1l1004t1176r1234b1206],
48	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	45	SENT_6	[p1l1243t1176r1362b1203],
49	,	,	O	,	_	0	SENT_6	[p1l1243t1176r1362b1203],
50	University	NNP	ORGANIZATION	University	appos	43	SENT_6	[p1l1377t1176r1511b1206],
51	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1521t1176r1551b1206],
52	Milano	NNP	ORGANIZATION	Milano	nn	54	SENT_6	[p1l1553t1175r1655b1203],
53	,	,	O	,	_	0	SENT_6	[p1l1553t1175r1655b1203],
54	Italy	NNP	LOCATION	Italy	prep_of	50	SENT_6	[p1l1666t1176r1727b1206],

1	Accepted	JJ	O	accepted	_	0	SENT_7	[p1l900t1217r1025b1247],
2	18	CD	DATE	18	dep	1	SENT_7	[p1l1037t1217r1065b1240],
3	December	NNP	DATE	December	tmod	2	SENT_7	[p1l1075t1217r1211b1240],
4	2006	CD	DATE	2006	num	3	SENT_7	[p1l1220t1217r1285b1240],

1	Abstract	JJ	O	abstract	_	0	SENT_8	[p1l6t1363r145b1390],

1	Statin	NN	O	statin	nn	2	SENT_9	[p1l45t1436r130b1462],
2	therapy	NN	O	therapy	nsubj	9	SENT_9	[p1l147t1436r263b1470],
3	,	,	O	,	_	0	SENT_9	[p1l147t1436r263b1470],
4	although	IN	O	although	mark	7	SENT_9	[p1l283t1436r412b1470],
5	generally	RB	O	generally	advmod	7	SENT_9	[p1l430t1436r567b1470],
6	well	RB	O	well	advmod	7	SENT_9	[p1l585t1436r648b1462],
7	tolerated	VBD	O	tolerate	dep	2	SENT_9	[p1l666t1436r804b1467],
8	,	,	O	,	_	0	SENT_9	[p1l666t1436r804b1467],
9	leads	VBZ	O	lead	_	0	SENT_9	[p1l822t1436r897b1462],
10	not	RB	O	not	neg	11	SENT_9	[p1l915t1440r963b1462],
11	infrequently	RB	O	infrequently	amod	20	SENT_9	[p1l980t1436r1161b1470],
12	to	TO	O	to	_	0	SENT_9	[p1l1179t1440r1207b1462],
13	signiﬁcant	JJ	O	signiﬁcant	amod	17	SENT_9	[p1l1226t1436r1380b1470],
14	subjective	JJ	O	subjective	amod	17	SENT_9	[p1l1398t1436r1546b1470],
15	and	CC	O	and	_	0	SENT_9	[p1l1564t1436r1616b1462],
16	at	IN	O	at	conj_and	14	SENT_9	[p1l1635t1440r1661b1462],
17	times	NNS	O	time	prep_to	11	SENT_9	[p1l1677t1436r1757b1462],
18	objective	JJ	O	objective	amod	20	SENT_9	[p1l1775t1436r1909b1470],
19	adverse	JJ	O	adverse	amod	20	SENT_9	[p1l1928t1436r2039b1462],
20	effects	NNS	O	effect	nsubj	21	SENT_9	[p1l2058t1436r2154b1462],
21	(	VBP	O	(	ccomp	9	SENT_9	[p1l6t1481r101b1513],
22	AEs	NNS	O	ae	dobj	21	SENT_9	[p1l6t1481r101b1513],
23	)	CD	NUMBER	)	dep	22	SENT_9	[p1l6t1481r101b1513],
24	,	,	O	,	_	0	SENT_9	[p1l6t1481r101b1513],
25	mainly	RB	O	mainly	advmod	22	SENT_9	[p1l113t1481r216b1515],
26	of	IN	O	of	_	0	SENT_9	[p1l227t1481r260b1507],
27	a	DT	O	a	det	29	SENT_9	[p1l269t1489r284b1507],
28	muscular	JJ	O	muscular	amod	29	SENT_9	[p1l294t1481r431b1507],
29	nature	NN	O	nature	prep_of	22	SENT_9	[p1l441t1485r541b1507],
30	.	.	O	.	_	0	SENT_9	[p1l441t1485r541b1507],

1	The	DT	O	the	det	3	SENT_10	[p1l554t1481r611b1507],
2	genetic	JJ	O	genetic	amod	3	SENT_10	[p1l622t1481r728b1515],
3	background	NN	O	background	nsubj	9	SENT_10	[p1l739t1481r915b1515],
4	of	IN	O	of	_	0	SENT_10	[p1l927t1481r959b1507],
5	these	DT	O	these	det	6	SENT_10	[p1l967t1481r1042b1507],
6	AEs	NNS	O	ae	prep_of	3	SENT_10	[p1l1054t1481r1116b1507],
7	is	VBZ	O	be	cop	9	SENT_10	[p1l1128t1481r1151b1507],
8	not	RB	O	not	neg	9	SENT_10	[p1l1163t1485r1210b1507],
9	clear	JJ	O	clear	_	0	SENT_10	[p1l1221t1481r1293b1507],
10	and	CC	O	and	_	0	SENT_10	[p1l1304t1481r1356b1507],
11	possibly	RB	O	possibly	advmod	13	SENT_10	[p1l1367t1481r1490b1515],
12	side	JJ	O	side	amod	13	SENT_10	[p1l1502t1481r1560b1507],
13	effects	NNS	O	effect	nsubjpass	20	SENT_10	[p1l1572t1481r1668b1507],
14	and	CC	O	and	_	0	SENT_10	[p1l1681t1481r1733b1507],
15	lipid	NN	O	lipid	nn	17	SENT_10	[p1l1744t1481r1811b1515],
16	lowering	NN	O	lowering	nn	17	SENT_10	[p1l1822t1481r1953b1515],
17	efﬁcacy	NN	O	efﬁcacy	nsubjpass	20	SENT_10	[p1l1964t1481r2080b1515],
18	may	MD	O	may	aux	20	SENT_10	[p1l2091t1489r2154b1515],
19	be	VB	O	be	auxpass	20	SENT_10	[p1l6t1526r40b1553],
20	linked	VBN	O	link	conj_and	9	SENT_10	[p1l54t1526r154b1553],
21	.	.	O	.	_	0	SENT_10	[p1l54t1526r154b1553],

1	Aim	NNP	O	Aim	nsubj	8	SENT_11	[p1l168t1526r234b1553],
2	of	IN	O	of	_	0	SENT_11	[p1l248t1526r281b1553],
3	the	DT	O	the	det	4	SENT_11	[p1l293t1526r337b1553],
4	study	NN	O	study	prep_of	1	SENT_11	[p1l353t1526r431b1561],
5	was	VBD	O	be	aux	8	SENT_11	[p1l447t1535r502b1553],
6	a	DT	O	a	det	8	SENT_11	[p1l518t1535r534b1553],
7	detailed	JJ	O	detailed	amod	8	SENT_11	[p1l548t1526r665b1553],
8	evaluation	NN	O	evaluation	conj_and	8	SENT_11	[p1l680t1526r832b1553],
9	of	IN	O	of	_	0	SENT_11	[p1l847t1526r879b1553],
10	CYP450	NN	O	cyp450	nn	15	SENT_11	[p1l892t1526r1019b1553],
11	and	CC	O	and	_	0	SENT_11	[p1l1035t1526r1087b1553],
12	apolipoprotein	NN	O	apolipoprotein	nn	15	SENT_11	[p1l1102t1526r1318b1561],
13	E	NN	O	e	nn	15	SENT_11	[p1l1332t1527r1354b1553],
14	gene	NN	O	gene	nn	15	SENT_11	[p1l1369t1535r1438b1561],
15	polymorphisms	NNS	O	polymorphism	prep_of	8	SENT_11	[p1l1452t1526r1683b1561],
16	in	IN	O	in	_	0	SENT_11	[p1l1699t1526r1727b1553],
17	two	CD	NUMBER	two	num	19	SENT_11	[p1l1742t1530r1796b1553],
18	large	JJ	O	large	amod	19	SENT_11	[p1l1811t1526r1884b1561],
19	series	NN	O	series	prep_in	8	SENT_11	[p1l1899t1526r1981b1553],
20	of	IN	O	of	_	0	SENT_11	[p1l1997t1526r2029b1553],
21	age-sex	JJ	O	age-sex	amod	23	SENT_11	[p1l2043t1535r2154b1561],
22	matched	VBN	O	match	amod	23	SENT_11	[p1l6t1571r132b1598],
23	patients	NNS	O	patient	prep_of	19	SENT_11	[p1l143t1571r258b1605],
24	with	IN	O	with	_	0	SENT_11	[p1l270t1571r336b1597],
25	and	CC	O	and	_	0	SENT_11	[p1l349t1571r401b1597],
26	without	IN	O	without	_	0	SENT_11	[p1l414t1571r528b1597],
27	muscular	JJ	O	muscular	amod	29	SENT_11	[p1l540t1571r677b1597],
28	side	JJ	O	side	amod	29	SENT_11	[p1l689t1571r747b1597],
29	effects	NNS	O	effect	prep_with	8	SENT_11	[p1l761t1571r857b1597],
30	to	TO	O	to	_	0	SENT_11	[p1l870t1575r898b1597],
31	statins	NNS	O	statin	prep_to	8	SENT_11	[p1l912t1571r1013b1597],
32	.	.	O	.	_	0	SENT_11	[p1l912t1571r1013b1597],

1	In	IN	O	in	_	0	SENT_12	[p1l1028t1572r1058b1597],
2	a	DT	O	a	det	4	SENT_12	[p1l1071t1579r1087b1597],
3	Clinical	JJ	MISC	clinical	amod	4	SENT_12	[p1l1099t1571r1216b1597],
4	Institution	NNP	MISC	Institution	prep_in	15	SENT_12	[p1l1229t1571r1382b1597],
5	specialised	VBN	O	specialise	partmod	4	SENT_12	[p1l1395t1571r1557b1605],
6	in	IN	O	in	_	0	SENT_12	[p1l1569t1571r1598b1597],
7	lipid-lipoprotein	JJ	O	lipid-lipoprotein	amod	8	SENT_12	[p1l1611t1571r1855b1605],
8	disorders	NNS	O	disorder	prep_in	5	SENT_12	[p1l1867t1571r2011b1602],
9	,	,	O	,	_	0	SENT_12	[p1l1867t1571r2011b1602],
10	50	CD	NUMBER	50	num	11	SENT_12	[p1l2025t1571r2061b1597],
11	statin	NN	O	statin	nsubjpass	15	SENT_12	[p1l2075t1571r2154b1597],
12	treated	VBN	O	treat	partmod	11	SENT_12	[p1l6t1616r107b1642],
13	patients	NNS	O	patient	dobj	12	SENT_12	[p1l120t1616r235b1650],
14	were	VBD	O	be	auxpass	15	SENT_12	[p1l250t1624r321b1642],
15	selected	VBN	O	select	_	0	SENT_12	[p1l335t1616r462b1647],
16	,	,	O	,	_	0	SENT_12	[p1l335t1616r462b1647],
17	with	IN	O	with	_	0	SENT_12	[p1l478t1616r544b1642],
18	subjective	JJ	O	subjective	amod	22	SENT_12	[p1l560t1616r708b1650],
19	or	CC	O	or	_	0	SENT_12	[p1l724t1624r754b1642],
20	objective	JJ	O	objective	conj_or	18	SENT_12	[p1l769t1616r903b1650],
21	statin-associated	JJ	O	statin-associated	amod	22	SENT_12	[p1l920t1616r1165b1642],
22	myopathy	NN	O	myopathy	prep_with	15	SENT_12	[p1l1179t1616r1334b1650],
23	,	,	O	,	_	0	SENT_12	[p1l1179t1616r1334b1650],
24	evaluated	VBN	O	evaluate	partmod	22	SENT_12	[p1l1351t1616r1491b1642],
25	using	VBG	O	use	xcomp	24	SENT_12	[p1l1506t1616r1586b1650],
26	standardized	JJ	O	standardized	amod	27	SENT_12	[p1l1603t1616r1789b1642],
27	forms	NNS	O	form	dobj	25	SENT_12	[p1l1804t1616r1898b1642],
28	.	.	O	.	_	0	SENT_12	[p1l1804t1616r1898b1642],

1	These	DT	O	these	nsubj	3	SENT_13	[p1l1915t1616r2003b1642],
2	were	VBD	O	be	cop	3	SENT_13	[p1l2019t1624r2090b1642],
3	sex	NN	O	sex	_	0	SENT_13	[p1l2107t1624r2154b1642],
4	and	CC	O	and	_	0	SENT_13	[p1l6t1661r58b1688],
5	age	NN	O	age	conj_and	3	SENT_13	[p1l73t1670r123b1696],
6	matched	VBN	O	match	partmod	3	SENT_13	[p1l138t1661r264b1688],
7	with	IN	O	with	_	0	SENT_13	[p1l278t1661r344b1688],
8	50	CD	NUMBER	50	num	10	SENT_13	[p1l359t1661r395b1688],
9	statin-treated	JJ	O	statin-treated	amod	10	SENT_13	[p1l409t1661r602b1688],
10	patients	NNS	O	patient	prep_with	6	SENT_13	[p1l615t1661r730b1696],
11	from	IN	O	from	_	0	SENT_13	[p1l745t1661r817b1688],
12	the	DT	O	the	det	14	SENT_13	[p1l830t1661r875b1688],
13	same	JJ	O	same	amod	14	SENT_13	[p1l890t1670r964b1688],
14	Clinic	NNP	O	Clinic	prep_from	6	SENT_13	[p1l979t1661r1077b1693],
15	,	,	O	,	_	0	SENT_13	[p1l979t1661r1077b1693],
16	without	IN	O	without	_	0	SENT_13	[p1l1092t1661r1206b1688],
17	any	DT	O	any	det	21	SENT_13	[p1l1220t1670r1271b1696],
18	subjective	JJ	O	subjective	amod	21	SENT_13	[p1l1286t1661r1434b1696],
19	or	CC	O	or	_	0	SENT_13	[p1l1449t1670r1479b1688],
20	objective	JJ	O	objective	conj_or	18	SENT_13	[p1l1493t1661r1627b1696],
21	complaints	NNS	O	complaint	prep_without	6	SENT_13	[p1l1641t1661r1811b1696],
22	.	.	O	.	_	0	SENT_13	[p1l1641t1661r1811b1696],

1	DNA	NN	O	dna	nn	2	SENT_14	[p1l1827t1662r1906b1688],
2	samples	NNS	O	sample	nsubjpass	15	SENT_14	[p1l1921t1661r2038b1696],
3	for	IN	O	for	_	0	SENT_14	[p1l2053t1661r2096b1688],
4	the	DT	O	the	det	5	SENT_14	[p1l2110t1661r2154b1688],
5	evaluation	NN	O	evaluation	prep_for	2	SENT_14	[p1l6t1707r159b1733],
6	of	IN	O	of	_	0	SENT_14	[p1l179t1707r211b1733],
7	CYP450	NN	O	cyp450	nn	9	SENT_14	[p1l228t1707r355b1733],
8	genetic	JJ	O	genetic	amod	9	SENT_14	[p1l376t1707r482b1741],
9	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_14	[p1l502t1707r733b1741],
10	and	CC	O	and	_	0	SENT_14	[p1l756t1707r808b1733],
11	apo	NN	O	apo	nn	13	SENT_14	[p1l830t1715r882b1741],
12	E	NN	O	e	nn	13	SENT_14	[p1l904t1708r926b1733],
13	genotypes	NNS	O	genotype	prep_of	5	SENT_14	[p1l947t1711r1097b1741],
14	were	VBD	O	be	auxpass	15	SENT_14	[p1l1120t1715r1191b1733],
15	collected	VBN	O	collect	_	0	SENT_14	[p1l1212t1707r1346b1733],
16	in	IN	O	in	_	0	SENT_14	[p1l1367t1707r1395b1733],
17	order	NN	O	order	prep_in	15	SENT_14	[p1l1417t1707r1496b1733],
18	to	TO	O	to	aux	19	SENT_14	[p1l1516t1711r1544b1733],
19	assess	VB	O	assess	xcomp	15	SENT_14	[p1l1566t1715r1655b1733],
20	correlations	NNS	O	correlation	dobj	19	SENT_14	[p1l1678t1707r1852b1733],
21	with	IN	O	with	_	0	SENT_14	[p1l1874t1707r1940b1733],
22	both	DT	O	both	preconj	24	SENT_14	[p1l1960t1707r2026b1733],
23	genetic	JJ	O	genetic	amod	24	SENT_14	[p1l2048t1707r2154b1741],
24	polymorphisms	NNS	O	polymorphism	prep_with	19	SENT_14	[p1l6t1751r237b1786],
25	and	CC	O	and	_	0	SENT_14	[p1l256t1752r308b1778],
26	AEs	NNS	O	ae	conj_and	24	SENT_14	[p1l325t1752r396b1783],
27	,	,	O	,	_	0	SENT_14	[p1l325t1752r396b1783],
28	as	RB	O	as	_	0	SENT_14	[p1l415t1760r444b1778],
29	well	RB	O	well	_	0	SENT_14	[p1l462t1751r525b1778],
30	as	IN	O	as	_	0	SENT_14	[p1l543t1760r571b1778],
31	with	IN	O	with	_	0	SENT_14	[p1l589t1751r655b1778],
32	therapeutic	JJ	O	therapeutic	amod	33	SENT_14	[p1l670t1751r835b1786],
33	efﬁcacy	NN	O	efﬁcacy	prep_with	19	SENT_14	[p1l851t1751r972b1786],
34	.	.	O	.	_	0	SENT_14	[p1l851t1751r972b1786],

1	None	NN	O	none	nsubj	7	SENT_15	[p1l988t1752r1068b1778],
2	of	IN	O	of	_	0	SENT_15	[p1l1084t1751r1116b1778],
3	the	DT	O	the	det	6	SENT_15	[p1l1129t1751r1173b1778],
4	assessed	VBN	O	assess	amod	6	SENT_15	[p1l1189t1751r1315b1778],
5	CYP450	NN	O	cyp450	nn	6	SENT_15	[p1l1329t1751r1457b1778],
6	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_15	[p1l1472t1751r1703b1786],
7	appeared	VBD	O	appear	_	0	SENT_15	[p1l1719t1751r1853b1786],
8	to	TO	O	to	aux	10	SENT_15	[p1l1868t1755r1896b1778],
9	be	VB	O	be	auxpass	10	SENT_15	[p1l1910t1751r1945b1778],
10	related	VBN	O	relate	xcomp	7	SENT_15	[p1l1960t1751r2061b1778],
11	to	TO	O	to	_	0	SENT_15	[p1l2076t1755r2104b1778],
12	an	DT	O	a	det	14	SENT_15	[p1l2120t1760r2154b1778],
13	increased	VBN	O	increase	amod	14	SENT_15	[p1l6t1796r146b1823],
14	incidence	NN	O	incidence	prep_to	10	SENT_15	[p1l162t1796r304b1823],
15	of	IN	O	of	_	0	SENT_15	[p1l321t1796r353b1823],
16	AEs	NNS	O	ae	prep_of	14	SENT_15	[p1l367t1797r438b1823],
17	.	.	O	.	_	0	SENT_15	[p1l367t1797r438b1823],

1	The	DT	O	the	det	3	SENT_16	[p1l456t1796r513b1823],
2	CYPZD6	NN	O	cypzd6	nn	3	SENT_16	[p1l530t1796r665b1823],
3	*	NN	O	*	dep	19	SENT_16	[p1l684t1796r766b1823],
4	1	CD	NUMBER	1	dep	3	SENT_16	[p1l684t1796r766b1823],
5	/	:	O	/	punct	3	SENT_16	[p1l684t1796r766b1823],
6	*	CD	NUMBER	*	dep	3	SENT_16	[p1l684t1796r766b1823],
7	4	CD	NUMBER	4	number	11	SENT_16	[p1l684t1796r766b1823],
8	and	CC	O	and	_	0	SENT_16	[p1l783t1796r835b1823],
9	*	CD	NUMBER	*	num	14	SENT_16	[p1l855t1797r936b1823],
10	4/4	CD	NUMBER	4/4	number	11	SENT_16	[p1l855t1797r936b1823],
11	*	CD	NUMBER	*	num	14	SENT_16	[p1l855t1797r936b1823],
12	poor	JJ	O	poor	amod	14	SENT_16	[p1l956t1805r1025b1831],
13	metabolizer	NN	O	metabolizer	nn	14	SENT_16	[p1l1043t1796r1219b1823],
14	(	NN	O	(	nn	15	SENT_16	[p1l1238t1797r1313b1829],
15	PM	NN	O	pm	dep	6	SENT_16	[p1l1238t1797r1313b1829],
16	)	CD	NUMBER	)	num	17	SENT_16	[p1l1238t1797r1313b1829],
17	status	NN	O	status	nsubjpass	19	SENT_16	[p1l1334t1800r1417b1823],
18	was	VBD	O	be	auxpass	19	SENT_16	[p1l1436t1805r1492b1823],
19	associated	VBN	O	associate	_	0	SENT_16	[p1l1512t1796r1664b1823],
20	to	TO	O	to	_	0	SENT_16	[p1l1683t1800r1710b1823],
21	a	DT	O	a	det	23	SENT_16	[p1l1730t1805r1746b1823],
22	higher	JJR	O	higher	amod	23	SENT_16	[p1l1763t1796r1859b1831],
23	efﬁcacy	NN	O	efﬁcacy	prep_to	19	SENT_16	[p1l1877t1796r1992b1831],
24	of	IN	O	of	_	0	SENT_16	[p1l2012t1796r2044b1823],
25	statins	NNS	O	statin	prep_of	23	SENT_16	[p1l2061t1796r2154b1823],
26	metabolized	VBN	O	metabolize	partmod	25	SENT_16	[p1l6t1842r188b1868],
27	by	IN	O	by	_	0	SENT_16	[p1l206t1842r243b1876],
28	this	DT	O	this	det	29	SENT_16	[p1l262t1842r314b1868],
29	system	NN	O	system	agent	26	SENT_16	[p1l336t1846r438b1876],
30	and	CC	O	and	cc	19	SENT_16	[p1l457t1842r517b1873],
31	,	,	O	,	_	0	SENT_16	[p1l457t1842r517b1873],
32	in	IN	O	in	_	0	SENT_16	[p1l538t1842r566b1868],
33	addition	NN	O	addition	prep_in	45	SENT_16	[p1l586t1842r715b1873],
34	,	,	O	,	_	0	SENT_16	[p1l586t1842r715b1873],
35	the	DT	O	the	det	38	SENT_16	[p1l735t1842r780b1868],
36	apo	NN	O	apo	nn	38	SENT_16	[p1l800t1850r852b1876],
37	E2	NN	O	e2	nn	38	SENT_16	[p1l871t1842r911b1868],
38	genotype	NN	O	genotype	nsubjpass	45	SENT_16	[p1l929t1846r1064b1876],
39	was	VBD	O	be	auxpass	45	SENT_16	[p1l1084t1850r1148b1873],
40	,	,	O	,	_	0	SENT_16	[p1l1084t1850r1148b1873],
41	in	IN	O	in	_	0	SENT_16	[p1l1168t1842r1196b1868],
42	this	DT	O	this	det	43	SENT_16	[p1l1215t1842r1267b1868],
43	series	NN	O	series	prep_in	45	SENT_16	[p1l1288t1842r1379b1873],
44	,	,	O	,	_	0	SENT_16	[p1l1288t1842r1379b1873],
45	linked	VBN	O	link	ccomp	19	SENT_16	[p1l1400t1842r1492b1868],
46	to	TO	O	to	_	0	SENT_16	[p1l1510t1846r1538b1868],
47	increased	VBN	O	increase	amod	49	SENT_16	[p1l1557t1842r1698b1868],
48	HDL-C	NN	O	hdl-c	nn	49	SENT_16	[p1l1716t1842r1829b1868],
49	levels	NNS	O	level	prep_to	45	SENT_16	[p1l1848t1842r1932b1868],
50	after	IN	O	after	_	0	SENT_16	[p1l1953t1842r2020b1868],
51	therapy	NN	O	therapy	prep_after	49	SENT_16	[p1l2038t1842r2154b1876],
52	.	.	O	.	_	0	SENT_16	[p1l2038t1842r2154b1876],

1	Patients	NNS	O	patient	nsubjpass	8	SENT_17	[p1l6t1886r122b1913],
2	with	IN	O	with	_	0	SENT_17	[p1l140t1886r205b1913],
3	statin	NN	O	statin	prep_with	1	SENT_17	[p1l223t1886r302b1913],
4	associated	VBN	O	associate	partmod	3	SENT_17	[p1l319t1886r471b1913],
5	myopathy	NN	O	myopathy	dobj	4	SENT_17	[p1l488t1887r636b1921],
6	are	VBP	O	be	auxpass	8	SENT_17	[p1l654t1895r697b1913],
7	not	RB	O	not	neg	8	SENT_17	[p1l714t1891r761b1913],
8	characterized	VBN	O	characterize	_	0	SENT_17	[p1l778t1886r976b1913],
9	by	IN	O	by	_	0	SENT_17	[p1l992t1886r1029b1921],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_17	[p1l1044t1886r1227b1921],
11	different	JJ	O	different	amod	12	SENT_17	[p1l1243t1886r1370b1913],
12	genotypes	NNS	O	genotype	agent	8	SENT_17	[p1l1386t1890r1536b1921],
13	for	IN	O	for	_	0	SENT_17	[p1l1553t1886r1596b1913],
14	the	DT	O	the	det	15	SENT_17	[p1l1611t1886r1655b1913],
15	CYP450s	NN	O	cyp450	prep_for	12	SENT_17	[p1l1672t1886r1813b1913],
16	responsible	JJ	O	responsible	amod	15	SENT_17	[p1l1830t1886r1999b1921],
17	for	IN	O	for	_	0	SENT_17	[p1l2015t1886r2059b1913],
18	statin	NN	O	statin	nn	19	SENT_17	[p1l2075t1886r2154b1913],
19	metabolism	NN	O	metabolism	prep_for	16	SENT_17	[p1l6t1931r187b1957],
20	.	.	O	.	_	0	SENT_17	[p1l6t1931r187b1957],

1	On	IN	O	on	_	0	SENT_18	[p1l201t1931r245b1958],
2	the	DT	O	the	det	4	SENT_18	[p1l257t1931r302b1957],
3	other	JJ	O	other	amod	4	SENT_18	[p1l315t1931r391b1957],
4	hand	NN	O	hand	prep_on	10	SENT_18	[p1l402t1931r482b1962],
5	,	,	O	,	_	0	SENT_18	[p1l402t1931r482b1962],
6	CYP2D6	NN	O	cyp2d6	nn	8	SENT_18	[p1l496t1931r631b1958],
7	PM	NN	O	pm	nn	8	SENT_18	[p1l643t1932r696b1957],
8	status	NN	O	status	nsubjpass	10	SENT_18	[p1l710t1935r792b1957],
9	is	VBZ	O	be	auxpass	10	SENT_18	[p1l805t1931r828b1957],
10	associated	VBN	O	associate	_	0	SENT_18	[p1l842t1931r994b1957],
11	to	TO	O	to	_	0	SENT_18	[p1l1006t1935r1033b1957],
12	an	DT	O	a	det	14	SENT_18	[p1l1046t1939r1080b1957],
13	increased	VBN	O	increase	amod	14	SENT_18	[p1l1092t1931r1233b1958],
14	efﬁcacy	NN	O	efﬁcacy	prep_to	10	SENT_18	[p1l1243t1931r1358b1965],
15	of	IN	O	of	_	0	SENT_18	[p1l1369t1931r1401b1958],
16	statins	NNS	O	statin	prep_of	14	SENT_18	[p1l1410t1931r1503b1958],
17	metabolized	VBN	O	metabolize	partmod	16	SENT_18	[p1l1514t1931r1696b1958],
18	by	IN	O	by	_	0	SENT_18	[p1l1705t1931r1742b1965],
19	this	DT	O	this	det	20	SENT_18	[p1l1753t1931r1805b1958],
20	system	NN	O	system	agent	17	SENT_18	[p1l1817t1935r1926b1965],
21	.	.	O	.	_	0	SENT_18	[p1l1817t1935r1926b1965],

1	©	RB	O	©	dep	2	SENT_19	[p1l6t1976r32b2002],
2	2007	CD	DATE	2007	_	0	SENT_19	[p1l43t1976r116b2002],
3	Published	VBN	O	publish	partmod	2	SENT_19	[p1l127t1976r274b2002],
4	by	IN	O	by	_	0	SENT_19	[p1l284t1976r320b2010],
5	Elsevier	NNP	ORGANIZATION	Elsevier	nn	6	SENT_19	[p1l330t1976r452b2002],
6	Ltd.	NNP	ORGANIZATION	Ltd.	agent	3	SENT_19	[p1l461t1976r520b2002],
7	.	.	O	.	_	0	SENT_19	[p1l461t1976r520b2002],

1	Keywords	NNPS	O	Keywords	_	0	SENT_20	[p1l6t2055r144b2085],
2	:	:	O	:	_	0	SENT_20	[p1l6t2055r144b2085],
3	Statins	NNS	O	statin	dep	1	SENT_20	[p1l164t2055r261b2082],
4	;	:	O	;	_	0	SENT_20	[p1l164t2055r261b2082],
5	Muscle	NN	O	muscle	nn	6	SENT_20	[p1l271t2055r368b2078],
6	toxicity	NN	O	toxicity	dep	3	SENT_20	[p1l377t2055r486b2085],
7	;	:	O	;	_	0	SENT_20	[p1l377t2055r486b2085],
8	CYP450	NN	O	cyp450	dep	3	SENT_20	[p1l497t2055r618b2082],
9	;	:	O	;	_	0	SENT_20	[p1l497t2055r618b2082],
10	Enzyme	NN	O	enzyme	nn	11	SENT_20	[p1l628t2056r736b2085],
11	polymophisms	NNS	O	polymophism	dep	8	SENT_20	[p1l745t2055r948b2085],
12	;	:	O	;	_	0	SENT_20	[p1l745t2055r948b2085],
13	Cholesteraemic	JJ	O	cholesteraemic	amod	14	SENT_20	[p1l959t2055r1164b2079],
14	response	NN	O	response	dep	3	SENT_20	[p1l1173t2062r1297b2085],
15	;	:	O	;	_	0	SENT_20	[p1l1173t2062r1297b2085],
16	Apo	NN	O	apo	nn	19	SENT_20	[p1l1307t2055r1363b2085],
17	E	NN	O	e	nn	19	SENT_20	[p1l1372t2056r1392b2078],
18	allele	NN	O	allele	nn	19	SENT_20	[p1l1402t2055r1472b2078],
19	variants	NNS	O	variant	dep	14	SENT_20	[p1l1482t2055r1584b2078],

1	1	LS	NUMBER	1	_	0	SENT_21	[p1l12t2282r67b2342],
2	.	.	O	.	_	0	SENT_21	[p1l12t2282r67b2342],

1	Introduction	NN	O	introduction	_	0	SENT_22	[p1l114t2282r575b2343],

1	3	LS	NUMBER	3	_	0	SENT_23	[p1l112t2487r1456b2564],
2	.	.	O	.	_	0	SENT_23	[p1l112t2487r1456b2564],

1	—	NN	O	—	_	0	SENT_24	[p1l112t2487r1456b2564],
2	.	.	O	.	_	0	SENT_24	[p1l112t2487r1456b2564],

1	Hydroxy-3	NN	O	hydroxy-3	_	0	SENT_25	[p1l112t2487r1456b2564],
2	.	.	O	.	_	0	SENT_25	[p1l112t2487r1456b2564],

1	—	NN	O	—	_	0	SENT_26	[p1l112t2487r1456b2564],
2	.	.	O	.	_	0	SENT_26	[p1l112t2487r1456b2564],

1	methylg1utaryl	NN	O	methylg1utaryl	_	0	SENT_27	[p1l112t2487r1456b2564],
2	.	.	O	.	_	0	SENT_27	[p1l112t2487r1456b2564],

1	—	NN	O	—	_	0	SENT_28	[p1l112t2487r1456b2564],
2	.	.	O	.	_	0	SENT_28	[p1l112t2487r1456b2564],

1	coenzyme	NN	O	coenzyme	nn	2	SENT_29	[p1l112t2487r1456b2564],
2	A	NN	O	a	_	0	SENT_29	[p1l1554t2487r1613b2545],
3	(	CD	NUMBER	(	num	4	SENT_29	[p1l1713t2487r2151b2560],
4	HMG	NN	O	hmg	dep	2	SENT_29	[p1l1713t2487r2151b2560],
5	.	.	O	.	_	0	SENT_29	[p1l1713t2487r2151b2560],

1	—	NN	O	—	_	0	SENT_30	[p1l1713t2487r2151b2560],
2	.	.	O	.	_	0	SENT_30	[p1l1713t2487r2151b2560],

1	CoA	NN	O	coa	nsubj	15	SENT_31	[p1l1713t2487r2151b2560],
2	)	CD	NUMBER	)	num	4	SENT_31	[p1l1713t2487r2151b2560],
3	reductase	NN	O	reductase	nn	4	SENT_31	[p1l7t2589r327b2649],
4	inhibitors	NNS	O	inhibitor	dep	1	SENT_31	[p1l380t2589r702b2649],
5	(	VBP	O	(	_	0	SENT_31	[p1l760t2589r1027b2663],
6	statins	NNS	O	statin	dobj	5	SENT_31	[p1l760t2589r1027b2663],
7	)	CD	NUMBER	)	nsubj	11	SENT_31	[p1l760t2589r1027b2663],
8	are	VBP	O	be	cop	11	SENT_31	[p1l1085t2608r1184b2649],
9	very	RB	O	very	advmod	10	SENT_31	[p1l1238t2608r1385b2666],
10	effective	JJ	O	effective	amod	11	SENT_31	[p1l1439t2589r1728b2649],
11	cholesterol	NN	O	cholesterol	rcmod	6	SENT_31	[p1l1782t2589r2153b2649],
12	lowering	VBG	O	lower	partmod	11	SENT_31	[p1l8t2691r305b2768],
13	medications	NNS	O	medication	dobj	12	SENT_31	[p1l326t2691r734b2750],
14	and	CC	O	and	_	0	SENT_31	[p1l758t2691r878b2750],
15	are	VBP	O	be	conj_and	5	SENT_31	[p1l899t2709r999b2750],
16	among	IN	O	among	_	0	SENT_31	[p1l1021t2709r1248b2768],
17	the	DT	O	the	det	22	SENT_31	[p1l1269t2691r1371b2750],
18	most	RBS	O	most	advmod	20	SENT_31	[p1l1391t2700r1556b2750],
19	widely	RB	O	widely	advmod	20	SENT_31	[p1l1576t2691r1804b2768],
20	used	VBN	O	use	amod	22	SENT_31	[p1l1825t2691r1980b2750],
21	drug	NN	O	drug	nn	22	SENT_31	[p1l2000t2691r2152b2768],
22	classes	NNS	O	class	prep_among	15	SENT_31	[p1l8t2793r259b2853],
23	.	.	O	.	_	0	SENT_31	[p1l8t2793r259b2853],

1	The	DT	O	the	det	2	SENT_32	[p1l283t2793r413b2853],
2	reason	NN	O	reason	nsubj	10	SENT_32	[p1l432t2812r653b2853],
3	for	IN	O	for	_	0	SENT_32	[p1l673t2793r772b2853],
4	this	DT	O	this	det	6	SENT_32	[p1l789t2793r909b2853],
5	clinical	JJ	O	clinical	amod	6	SENT_32	[p1l931t2793r1179b2853],
6	success	NN	O	success	prep_for	2	SENT_32	[p1l1202t2812r1450b2853],
7	is	VBZ	O	be	cop	10	SENT_32	[p1l1472t2793r1524b2853],
8	a	DT	O	a	det	10	SENT_32	[p1l1548t2812r1583b2853],
9	large	JJ	O	large	amod	10	SENT_32	[p1l1602t2793r1768b2870],
10	experience	NN	O	experience	_	0	SENT_32	[p1l1788t2793r2153b2870],
11	witnessing	VBG	O	witness	partmod	10	SENT_32	[p1l8t2895r369b2972],
12	effectiveness	NN	O	effectiveness	dobj	11	SENT_32	[p1l390t2895r824b2955],
13	and	CC	O	and	_	0	SENT_32	[p1l847t2895r966b2955],
14	safety	NN	O	safety	dobj	11	SENT_32	[p1l987t2895r1185b2972],
15	as	IN	O	as	mark	19	SENT_32	[p1l1206t2914r1271b2955],
16	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_32	[p1l1293t2895r1786b2955],
17	preventive	JJ	O	preventive	amod	18	SENT_32	[p1l1802t2895r2153b2972],
18	agents	NNS	O	agent	nsubj	19	SENT_32	[p1l9t3005r221b3073],
19	[	VBP	O	[	advcl	11	SENT_32	[p1l266t2996r437b3068],
20	1,2	CD	NUMBER	1,2	number	21	SENT_32	[p1l266t2996r437b3068],
21	]	CD	NUMBER	]	dobj	19	SENT_32	[p1l266t2996r437b3068],
22	.	.	O	.	_	0	SENT_32	[p1l266t2996r437b3068],

1	While	IN	O	while	mark	9	SENT_33	[p1l477t2996r702b3066],
2	,	,	O	,	_	0	SENT_33	[p1l477t2996r702b3066],
3	in	IN	O	in	dep	9	SENT_33	[p1l742t2996r806b3054],
4	general	JJ	O	general	pobj	3	SENT_33	[p1l844t2996r1109b3073],
5	,	,	O	,	_	0	SENT_33	[p1l844t2996r1109b3073],
6	large	JJ	O	large	amod	8	SENT_33	[p1l1149t2996r1315b3073],
7	scale	NN	O	scale	nn	8	SENT_33	[p1l1355t2996r1520b3055],
8	trials	NNS	O	trial	nsubj	9	SENT_33	[p1l1557t2995r1723b3055],
9	support	VBP	O	support	advcl	20	SENT_33	[p1l1765t3005r2016b3073],
10	the	DT	O	the	det	12	SENT_33	[p1l2051t2996r2153b3055],
11	excellent	JJ	O	excellent	amod	12	SENT_33	[p1l8t3099r313b3159],
12	tolerability	NN	O	tolerability	dobj	9	SENT_33	[p1l358t3099r729b3176],
13	of	IN	O	of	_	0	SENT_33	[p1l778t3099r851b3159],
14	statins	NNS	O	statin	prep_of	12	SENT_33	[p1l895t3099r1125b3170],
15	,	,	O	,	_	0	SENT_33	[p1l895t3099r1125b3170],
16	daily	JJ	SET	daily	amod	17	SENT_33	[p1l1176t3099r1343b3176],
17	practice	NN	O	practice	nsubjpass	20	SENT_33	[p1l1389t3099r1657b3176],
18	is	VBZ	O	be	auxpass	20	SENT_33	[p1l1704t3099r1757b3159],
19	frequently	RB	O	frequently	advmod	20	SENT_33	[p1l1806t3099r2153b3176],
20	hampered	VBN	O	hamper	_	0	SENT_33	[p1l7t3201r342b3278],
21	by	IN	O	by	_	0	SENT_33	[p1l379t3201r463b3278],
22	reports	NNS	O	report	agent	20	SENT_33	[p1l501t3210r734b3278],
23	by	IN	O	by	_	0	SENT_33	[p1l774t3201r857b3278],
24	the	DT	O	the	det	25	SENT_33	[p1l897t3201r999b3261],
25	patients	NNS	O	patient	agent	20	SENT_33	[p1l1037t3201r1299b3278],
26	of	IN	O	of	_	0	SENT_33	[p1l1341t3201r1427b3271],
27	,	,	O	,	_	0	SENT_33	[p1l1341t3201r1427b3271],
28	particularly	RB	O	particularly	dep	31	SENT_33	[p1l1468t3201r1872b3278],
29	,	,	O	,	_	0	SENT_33	[p1l1468t3201r1872b3278],
30	muscle	NN	O	muscle	nn	31	SENT_33	[p1l1914t3201r2153b3261],
31	symptoms	NNS	O	symptom	prep_of	25	SENT_33	[p1l10t3310r353b3379],
32	during	IN	O	during	_	0	SENT_33	[p1l384t3302r602b3379],
33	therapy	NN	O	therapy	prep_during	20	SENT_33	[p1l631t3302r883b3379],
34	[	CD	NUMBER	[	number	35	SENT_33	[p1l917t3301r1110b3374],
35	3	CD	NUMBER	3	num	36	SENT_33	[p1l917t3301r1110b3374],
36	—	NN	O	—	dep	33	SENT_33	[p1l917t3301r1110b3374],
37	5	CD	NUMBER	5	num	38	SENT_33	[p1l917t3301r1110b3374],
38	]	NN	O	]	dep	36	SENT_33	[p1l917t3301r1110b3374],
39	.	.	O	.	_	0	SENT_33	[p1l917t3301r1110b3374],

1	These	DT	O	these	nsubj	4	SENT_34	[p1l1142t3302r1343b3361],
2	are	VBP	O	be	cop	4	SENT_34	[p1l1372t3320r1472b3361],
3	mainly	RB	O	mainly	advmod	4	SENT_34	[p1l1500t3302r1733b3379],
4	cramps	NNS	O	cramp	_	0	SENT_34	[p1l1762t3320r2003b3379],
5	and	CC	O	and	advmod	4	SENT_34	[p1l2034t3302r2154b3361],

1	*	NN	O	*	_	0	SENT_35	[p1l55t3580r76b3605],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_35	[p1l110t3583r512b3645],
3	author	NN	O	author	dobj	2	SENT_35	[p1l533t3583r705b3631],
4	at	IN	O	at	_	0	SENT_35	[p1l723t3590r783b3631],
5	:	:	O	:	_	0	SENT_35	[p1l723t3590r783b3631],
6	Center	NNP	O	Center	nn	9	SENT_35	[p1l807t3583r987b3631],
7	E.	NNP	PERSON	E.	nn	9	SENT_35	[p1l1003t3584r1057b3631],
8	Grossi	NNP	PERSON	Grossi	nn	9	SENT_35	[p1l1080t3583r1254b3631],
9	Paoletti	NNP	PERSON	Paoletti	prep_at	2	SENT_35	[p1l1273t3583r1493b3639],
10	,	,	O	,	_	0	SENT_35	[p1l1273t3583r1493b3639],
11	Department	NNP	O	Department	appos	9	SENT_35	[p1l1513t3584r1834b3645],
12	of	IN	O	of	_	0	SENT_35	[p1l1852t3582r1911b3631],
13	Pharrna	NNP	O	Pharrna	dep	15	SENT_35	[p1l1924t3583r2152b3631],
14	—	CD	NUMBER	—	num	13	SENT_35	[p1l1924t3583r2152b3631],
15	cological	JJ	O	cological	amod	16	SENT_35	[p1l8t3667r255b3730],
16	Sciences	NNPS	O	Sciences	prep_of	11	SENT_35	[p1l278t3667r528b3724],
17	,	,	O	,	_	0	SENT_35	[p1l278t3667r528b3724],
18	University	NNP	ORGANIZATION	University	appos	9	SENT_35	[p1l550t3667r833b3730],
19	of	IN	ORGANIZATION	of	_	0	SENT_35	[p1l855t3667r914b3716],
20	Milano	NNP	ORGANIZATION	Milano	prep_of	18	SENT_35	[p1l930t3667r1140b3724],
21	,	,	O	,	_	0	SENT_35	[p1l930t3667r1140b3724],
22	Via	NNP	O	Via	nn	23	SENT_35	[p1l1163t3668r1257b3716],
23	Balzaretti	NNP	O	Balzaretti	appos	9	SENT_35	[p1l1276t3668r1539b3716],
24	9	CD	NUMBER	9	num	23	SENT_35	[p1l1561t3668r1607b3724],
25	,	,	O	,	_	0	SENT_35	[p1l1561t3668r1607b3724],
26	20133	CD	NUMBER	20133	num	23	SENT_35	[p1l1631t3668r1795b3716],
27	Milan	NNP	LOCATION	Milan	nn	29	SENT_35	[p1l1819t3667r1995b3724],
28	,	,	O	,	_	0	SENT_35	[p1l1819t3667r1995b3724],
29	Italy	NNP	LOCATION	Italy	dep	23	SENT_35	[p1l2018t3668r2150b3730],
30	.	.	O	.	_	0	SENT_35	[p1l2018t3668r2150b3730],

1	Tel.	NNP	O	Tel.	_	0	SENT_36	[p1l7t3751r123b3799],
2	:	:	O	:	_	0	SENT_36	[p1l7t3751r123b3799],
3	+39 02 50318303	CD	NUMBER	+39 02 50318303	dep	1	SENT_36	[p1l356t3751r643b3807],[p1l147t3752r250b3799],
4	;	:	O	;	_	0	SENT_36	[p1l356t3751r643b3807],
5	fax	NN	O	fax	dep	1	SENT_36	[p1l664t3751r763b3799],
6	:	:	O	:	_	0	SENT_36	[p1l664t3751r763b3799],
7	+39 02 50319900	CD	NUMBER	+39 02 50319900	dep	5	SENT_36	[p1l997t3751r1280b3800],[p1l787t3752r890b3800],
8	.	.	O	.	_	0	SENT_36	[p1l997t3751r1280b3800],

1	E-mail	NN	O	e-mail	nn	2	SENT_37	[p2l111t22r297b70],
2	address	NN	O	address	_	0	SENT_37	[p2l315t21r541b70],
3	:	:	O	:	_	0	SENT_37	[p2l315t21r541b70],
4	cesare.sirtori@unimi.it	NN	O	cesare.sirtori@unimi.it	dep	2	SENT_37	[p2l565t22r1191b70],
5	(	CD	NUMBER	(	num	8	SENT_37	[p2l1210t22r1351b81],
6	C.R.	NNP	PERSON	C.R.	nn	8	SENT_37	[p2l1210t22r1351b81],
7	Sirtori	NNP	PERSON	Sirtori	nn	8	SENT_37	[p2l1375t21r1582b81],
8	)	NN	O	)	dep	4	SENT_37	[p2l1375t21r1582b81],
9	.	.	O	.	_	0	SENT_37	[p2l1375t21r1582b81],

1	1043-6618	CD	DURATION	1043-6618	_	0	SENT_38	[p2l14t206r352b263],
2	/	:	O	/	punct	1	SENT_38	[p2l14t206r352b263],
3	$	$	MONEY	$	nsubj	5	SENT_38	[p2l14t206r352b263],
4	—	CD	MONEY	—	num	3	SENT_38	[p2l371t239r407b243],
5	see	VBP	O	see	dep	1	SENT_38	[p2l426t224r509b257],
6	front	JJ	O	front	amod	7	SENT_38	[p2l528t209r660b257],
7	matter	NN	O	matter	nsubj	9	SENT_38	[p2l678t216r851b257],
8	©	CD	NUMBER	©	num	9	SENT_38	[p2l870t210r918b258],
9	2007	CD	DATE	2007	xcomp	5	SENT_38	[p2l939t210r1070b258],
10	Published	VBN	O	publish	partmod	9	SENT_38	[p2l1091t209r1359b257],
11	by	IN	O	by	_	0	SENT_38	[p2l1377t209r1443b271],
12	Elsevier	NNP	ORGANIZATION	Elsevier	nn	13	SENT_38	[p2l1462t209r1684b257],
13	Ltd.	NNP	ORGANIZATION	Ltd.	agent	10	SENT_38	[p2l1701t209r1808b257],
14	doi	FW	O	doi	dep	13	SENT_38	[p2l8t294r862b356],
15	:10.1016	CD	NUMBER	:10.1016	dep	14	SENT_38	[p2l8t294r862b356],
16	/	:	O	/	punct	18	SENT_38	[p2l8t294r862b356],
17	j.	NN	O	j.	nn	18	SENT_38	[p2l8t294r862b356],
18	phrs	NNS	O	phr	dep	15	SENT_38	[p2l8t294r862b356],
19	.2006.12.009	CD	NUMBER	.2006.12.009	dep	18	SENT_38	[p2l8t294r862b356],

1	stiffness	NN	O	stiffness	_	0	SENT_39	[p2l11t509r305b579],
2	,	,	O	,	_	0	SENT_39	[p2l11t509r305b579],
3	at	IN	O	at	dep	1	SENT_39	[p2l337t518r395b569],
4	times	NNS	O	time	nsubj	10	SENT_39	[p2l421t509r601b569],
5	requiring	VBG	O	require	pcomp	3	SENT_39	[p2l629t509r938b586],
6	analgesic	JJ	O	analgesic	amod	7	SENT_39	[p2l968t509r1278b586],
7	treatment	NN	O	treatment	dobj	5	SENT_39	[p2l1307t518r1627b569],
8	and	CC	O	and	_	0	SENT_39	[p2l1654t509r1773b569],
9	frequently	RB	O	frequently	advmod	10	SENT_39	[p2l1800t509r2146b586],
10	leading	VBG	O	lead	conj_and	5	SENT_39	[p2l8t610r255b687],
11	to	TO	O	to	_	0	SENT_39	[p2l294t619r357b669],
12	drug	NN	O	drug	nn	13	SENT_39	[p2l398t610r549b687],
13	withdrawal	NN	O	withdrawal	prep_to	10	SENT_39	[p2l589t610r966b669],
14	[	CD	NUMBER	[	number	15	SENT_39	[p2l1011t610r1118b682],
15	6	CD	NUMBER	6	num	16	SENT_39	[p2l1011t610r1118b682],
16	]	NN	O	]	dobj	5	SENT_39	[p2l1011t610r1118b682],
17	.	.	O	.	_	0	SENT_39	[p2l1011t610r1118b682],

1	The	DT	O	the	det	3	SENT_40	[p2l1161t610r1291b669],
2	ﬁrst	NN	O	ﬁrst	nn	3	SENT_40	[p2l1331t610r1461b669],
3	report	NN	O	report	nsubj	7	SENT_40	[p2l1497t619r1700b687],
4	of	IN	O	of	_	0	SENT_40	[p2l1738t609r1811b669],
5	a	DT	O	a	det	6	SENT_40	[p2l1846t628r1881b669],
6	patient	NN	O	patient	prep_of	3	SENT_40	[p2l1917t610r2148b687],
7	requiring	VBG	O	require	dep	22	SENT_40	[p2l7t713r316b790],
8	hospitalization	NN	O	hospitalization	dobj	7	SENT_40	[p2l357t713r856b790],
9	for	IN	O	for	_	0	SENT_40	[p2l897t713r995b773],
10	myopathy	NN	O	myopathy	prep_for	8	SENT_40	[p2l1034t713r1370b790],
11	with	IN	O	with	_	0	SENT_40	[p2l1412t713r1561b773],
12	normal	JJ	O	normal	amod	14	SENT_40	[p2l1601t713r1839b773],
13	creatine	NN	O	creatine	nn	14	SENT_40	[p2l1881t713r2146b773],
14	phosphokinase	NN	O	phosphokinase	prep_with	7	SENT_40	[p2l7t815r510b892],
15	(	CD	NUMBER	(	num	18	SENT_40	[p2l537t815r751b888],
16	CPK	NNP	ORGANIZATION	CPK	nn	18	SENT_40	[p2l537t815r751b888],
17	)	NN	O	)	nn	18	SENT_40	[p2l537t815r751b888],
18	levels	NNS	O	level	nsubjpass	22	SENT_40	[p2l777t815r968b875],
19	has	VBZ	O	have	aux	22	SENT_40	[p2l993t815r1102b875],
20	been	VBN	O	be	auxpass	22	SENT_40	[p2l1126t815r1286b875],
21	recently	RB	DATE	recently	advmod	22	SENT_40	[p2l1309t815r1580b892],
22	published	VBN	O	publish	_	0	SENT_40	[p2l1603t815r1933b892],
23	[	NN	O	[	nn	25	SENT_40	[p2l1962t817r2070b887],
24	7	CD	NUMBER	7	num	25	SENT_40	[p2l1962t817r2070b887],
25	]	NN	O	]	dobj	22	SENT_40	[p2l1962t817r2070b887],
26	.	.	O	.	_	0	SENT_40	[p2l1962t817r2070b887],

1	Although	IN	O	although	mark	6	SENT_41	[p2l110t916r429b993],
2	very	RB	O	very	advmod	3	SENT_41	[p2l463t934r610b993],
3	recently	RB	DATE	recently	advmod	6	SENT_41	[p2l644t916r916b993],
4	it	PRP	O	it	nsubjpass	6	SENT_41	[p2l951t916r997b975],
5	was	VBD	O	be	auxpass	6	SENT_41	[p2l1031t934r1158b975],
6	indicated	VBN	O	indicate	advcl	34	SENT_41	[p2l1194t916r1504b975],
7	[	NN	O	[	nn	9	SENT_41	[p2l1544t916r1629b988],
8	8	CD	NUMBER	8	num	9	SENT_41	[p2l1544t916r1629b988],
9	]	NN	O	]	dobj	6	SENT_41	[p2l1544t916r1629b988],
10	that	IN	O	that	complm	17	SENT_41	[p2l1669t916r1796b975],
11	the	DT	O	the	det	12	SENT_41	[p2l1829t916r1930b975],
12	statin	NN	O	statin	nsubj	17	SENT_41	[p2l1968t916r2147b975],
13	associated	VBN	O	associate	partmod	12	SENT_41	[p2l10t1019r355b1079],
14	myopathy	NN	O	myopathy	dobj	13	SENT_41	[p2l372t1019r709b1096],
15	most	RBS	O	most	advmod	16	SENT_41	[p2l727t1028r891b1079],
16	frequently	RB	O	frequently	advmod	13	SENT_41	[p2l908t1019r1254b1096],
17	results	VBZ	O	result	ccomp	6	SENT_41	[p2l1271t1019r1489b1079],
18	in	IN	O	in	_	0	SENT_41	[p2l1509t1019r1573b1078],
19	full	JJ	O	full	amod	20	SENT_41	[p2l1591t1019r1706b1079],
20	resolution	NN	O	resolution	prep_in	17	SENT_41	[p2l1723t1019r2061b1079],
21	of	IN	O	of	_	0	SENT_41	[p2l2079t1019r2152b1079],
22	muscle	NN	O	muscle	nn	23	SENT_41	[p2l8t1121r246b1180],
23	pain	NN	O	pain	prep_of	20	SENT_41	[p2l273t1121r418b1198],
24	upon	IN	O	upon	_	0	SENT_41	[p2l446t1139r614b1198],
25	discontinuation	NN	O	discontinuation	prep_upon	17	SENT_41	[p2l643t1121r1164b1180],
26	of	IN	O	of	_	0	SENT_41	[p2l1193t1121r1266b1180],
27	therapy	NN	O	therapy	prep_of	25	SENT_41	[p2l1288t1121r1552b1198],
28	,	,	O	,	_	0	SENT_41	[p2l1288t1121r1552b1198],
29	still	RB	O	still	advmod	34	SENT_41	[p2l1586t1121r1708b1180],
30	these	DT	O	these	det	31	SENT_41	[p2l1736t1121r1908b1180],
31	symptoms	NNS	O	symptom	nsubj	34	SENT_41	[p2l1940t1139r2144b1198, p2l8t1232r169b1283],
32	are	VBP	O	be	cop	34	SENT_41	[p2l208t1242r308b1283],
33	particularly	RB	O	particularly	advmod	34	SENT_41	[p2l342t1223r732b1300],
34	disturbing	JJ	O	disturbing	_	0	SENT_41	[p2l769t1223r1129b1300],
35	,	,	O	,	_	0	SENT_41	[p2l769t1223r1129b1300],
36	also	RB	O	also	advmod	44	SENT_41	[p2l1169t1223r1301b1283],
37	because	IN	O	because	dep	44	SENT_41	[p2l1336t1223r1604b1283],
38	the	DT	O	the	det	39	SENT_41	[p2l1639t1223r1741b1283],
39	absence	NN	O	absence	nsubj	44	SENT_41	[p2l1778t1223r2043b1283],
40	of	IN	O	of	_	0	SENT_41	[p2l2079t1223r2153b1283],
41	laboratory	NN	O	laboratory	nn	42	SENT_41	[p2l8t1325r354b1402],
42	changes	NNS	O	change	prep_of	39	SENT_41	[p2l376t1325r645b1402],
43	may	MD	O	may	aux	44	SENT_41	[p2l668t1344r811b1402],
44	lead	VB	O	lead	ccomp	34	SENT_41	[p2l833t1325r972b1385],
45	to	TO	O	to	_	0	SENT_41	[p2l992t1334r1055b1385],
46	physician	NN	O	physician	poss	48	SENT_41	[p2l1076t1325r1455b1402],
47	’s	POS	O	’s	_	0	SENT_41	[p2l1076t1325r1455b1402],
48	skepticism	NN	O	skepticism	prep_to	44	SENT_41	[p2l1481t1325r1855b1402],
49	.	.	O	.	_	0	SENT_41	[p2l1481t1325r1855b1402],

1	Clinical	JJ	O	clinical	amod	2	SENT_42	[p2l1881t1325r2147b1385],
2	studies	NNS	O	study	nsubj	3	SENT_42	[p2l11t1426r240b1485],
3	have	VBP	O	have	ccomp	10	SENT_42	[p2l257t1426r431b1496],
4	,	,	O	,	_	0	SENT_42	[p2l257t1426r431b1496],
5	on	IN	O	on	_	0	SENT_42	[p2l451t1444r532b1485],
6	the	DT	O	the	det	8	SENT_42	[p2l548t1426r649b1485],
7	other	JJ	O	other	amod	8	SENT_42	[p2l666t1426r839b1485],
8	hand	NN	O	hand	prep_on	10	SENT_42	[p2l852t1426r1034b1496],
9	,	,	O	,	_	0	SENT_42	[p2l852t1426r1034b1496],
10	suggested	VBD	O	suggest	_	0	SENT_42	[p2l1056t1426r1386b1503],
11	that	IN	O	that	complm	17	SENT_42	[p2l1401t1426r1527b1485],
12	muscle	NN	O	muscle	nn	14	SENT_42	[p2l1542t1426r1780b1485],
13	lipid	NN	O	lipid	nn	14	SENT_42	[p2l1796t1426r1950b1503],
14	accumulation	NN	O	accumulation	nsubjpass	17	SENT_42	[p2l1967t1444r2144b1485, p2l8t1529r308b1589],
15	may	MD	O	may	aux	17	SENT_42	[p2l326t1548r469b1606],
16	be	VB	O	be	auxpass	17	SENT_42	[p2l487t1529r566b1589],
17	observed	VBN	O	observe	ccomp	10	SENT_42	[p2l585t1529r887b1589],
18	in	IN	O	in	_	0	SENT_42	[p2l905t1529r969b1588],
19	biopsies	NNS	O	biopsy	prep_in	17	SENT_42	[p2l985t1529r1261b1606],
20	from	IN	O	from	_	0	SENT_42	[p2l1281t1529r1445b1589],
21	patients	NNS	O	patient	prep_from	19	SENT_42	[p2l1461t1529r1722b1606],
22	with	IN	O	with	_	0	SENT_42	[p2l1742t1529r1891b1589],
23	muscle	NN	O	muscle	nn	24	SENT_42	[p2l1908t1529r2146b1589],
24	symptoms	NNS	O	symptom	prep_with	21	SENT_42	[p2l11t1640r353b1708],
25	without	IN	O	without	_	0	SENT_42	[p2l380t1631r638b1691],
26	CPK	NN	ORGANIZATION	cpk	nn	27	SENT_42	[p2l662t1631r825b1691],
27	rises	NNS	O	rise	prep_without	17	SENT_42	[p2l847t1631r999b1691],
28	during	IN	O	during	_	0	SENT_42	[p2l1026t1631r1243b1708],
29	statin	NN	O	statin	nn	30	SENT_42	[p2l1272t1631r1450b1691],
30	therapy	NN	O	therapy	prep_during	17	SENT_42	[p2l1474t1631r1725b1708],
31	[	CD	NUMBER	[	num	30	SENT_42	[p2l1756t1631r1970b1703],
32	9,10	CD	NUMBER	9,10	num	33	SENT_42	[p2l1756t1631r1970b1703],
33	]	NN	O	]	nsubj	10	SENT_42	[p2l1756t1631r1970b1703],
34	.	.	O	.	_	0	SENT_42	[p2l1756t1631r1970b1703],

1	This	DT	O	this	det	2	SENT_43	[p2l1998t1631r2145b1691],
2	ﬁnding	NN	O	ﬁnding	nsubjpass	14	SENT_43	[p2l9t1732r264b1809],
3	,	,	O	,	_	0	SENT_43	[p2l9t1732r264b1809],
4	i.e.	FW	O	i.e.	appos	2	SENT_43	[p2l291t1732r388b1791],
5	lipid	NN	O	lipid	nn	6	SENT_43	[p2l416t1732r570b1809],
6	droplets	NNS	O	droplet	dep	4	SENT_43	[p2l594t1732r862b1809],
7	inside	IN	O	inside	_	0	SENT_43	[p2l888t1732r1088b1791],
8	the	DT	O	the	det	10	SENT_43	[p2l1112t1732r1213b1791],
9	muscle	NN	O	muscle	nn	10	SENT_43	[p2l1237t1732r1475b1791],
10	ﬁbers	NNS	O	ﬁbers	prep_inside	6	SENT_43	[p2l1500t1732r1703b1802],
11	,	,	O	,	_	0	SENT_43	[p2l1500t1732r1703b1802],
12	is	VBZ	O	be	auxpass	14	SENT_43	[p2l1729t1732r1782b1791],
13	Well	UH	O	well	attr	14	SENT_43	[p2l1808t1732r1951b1792],
14	complemented	VBN	O	complement	_	0	SENT_43	[p2l1975t1750r2144b1791, p2l7t1835r360b1912],
15	by	IN	O	by	_	0	SENT_43	[p2l390t1835r473b1912],
16	a	DT	O	a	det	18	SENT_43	[p2l507t1854r542b1895],
17	recent	JJ	O	recent	amod	18	SENT_43	[p2l572t1844r779b1895],
18	report	NN	O	report	agent	14	SENT_43	[p2l809t1844r1011b1912],
19	indicating	VBG	O	indicate	partmod	18	SENT_43	[p2l1042t1835r1378b1912],
20	that	IN	O	that	complm	34	SENT_43	[p2l1411t1835r1537b1895],
21	respiratory	JJ	O	respiratory	amod	24	SENT_43	[p2l1567t1835r1933b1912],
22	chain	NN	O	chain	nn	24	SENT_43	[p2l1966t1835r2147b1895],
23	enzyme	NN	O	enzyme	nn	24	SENT_43	[p2l9t1955r270b2014],
24	activities	NNS	O	activity	nsubjpass	34	SENT_43	[p2l296t1937r595b1997],
25	in	IN	O	in	_	0	SENT_43	[p2l621t1937r685b1996],
26	the	DT	O	the	det	27	SENT_43	[p2l709t1937r810b1996],
27	muscle	NN	O	muscle	prep_in	24	SENT_43	[p2l835t1937r1073b1996],
28	of	IN	O	of	_	0	SENT_43	[p2l1099t1937r1172b1996],
29	patients	NNS	O	patient	prep_of	27	SENT_43	[p2l1190t1937r1451b2014],
30	taking	VBG	O	take	partmod	29	SENT_43	[p2l1477t1937r1686b2014],
31	major	JJ	O	major	amod	32	SENT_43	[p2l1712t1937r1909b2014],
32	statins	NNS	O	statin	dobj	30	SENT_43	[p2l1935t1937r2145b1996],
33	are	VBP	O	be	auxpass	34	SENT_43	[p2l10t2058r109b2099],
34	reduced	VBN	O	reduce	ccomp	19	SENT_43	[p2l125t2039r410b2110],
35	,	,	O	,	_	0	SENT_43	[p2l125t2039r410b2110],
36	and	CC	O	and	_	0	SENT_43	[p2l431t2039r551b2099],
37	so	RB	O	so	advmod	39	SENT_43	[p2l569t2058r638b2099],
38	are	VBP	O	be	cop	39	SENT_43	[p2l657t2058r756b2099],
39	ubiquinone	JJ	O	ubiquinone	ccomp	19	SENT_43	[p2l772t2039r1152b2116],
40	concentrations	NNS	O	concentration	nsubj	41	SENT_43	[p2l1169t2039r1660b2099],
41	[	VBP	O	[	ccomp	39	SENT_43	[p2l1684t2040r1739b2111],
42	1	CD	NUMBER	1	number	43	SENT_43	[p2l1684t2040r1739b2111],
43	1	CD	NUMBER	1	num	44	SENT_43	[p2l1757t2040r1834b2111],
44	]	NN	O	]	dobj	41	SENT_43	[p2l1757t2040r1834b2111],
45	.	.	O	.	_	0	SENT_43	[p2l1757t2040r1834b2111],

1	As	IN	O	as	_	0	SENT_44	[p2l1854t2040r1944b2099],
2	a	DT	O	a	det	4	SENT_44	[p2l1964t2058r1999b2099],
3	partial	JJ	O	partial	amod	4	SENT_44	[p2l2013t2058r2144b2116, p2l8t2141r114b2201],
4	conﬁrmation	NN	O	conﬁrmation	prep_as	13	SENT_44	[p2l143t2141r592b2211],
5	,	,	O	,	_	0	SENT_44	[p2l143t2141r592b2211],
6	Phillips	NNP	PERSON	Phillips	nsubj	13	SENT_44	[p2l623t2141r878b2218],
7	et	FW	O	et	nn	9	SENT_44	[p2l909t2150r969b2201],
8	al.	FW	O	al.	nn	9	SENT_44	[p2l997t2141r1071b2201],
9	[	FW	O	[	dep	6	SENT_44	[p2l1109t2141r1236b2213],
10	12	CD	NUMBER	12	num	11	SENT_44	[p2l1109t2141r1236b2213],
11	]	NN	O	]	npadvmod	12	SENT_44	[p2l1109t2141r1236b2213],
12	also	RB	O	also	advmod	9	SENT_44	[p2l1272t2141r1404b2201],
13	noted	VBD	O	note	_	0	SENT_44	[p2l1433t2141r1620b2201],
14	abnormal	JJ	O	abnormal	amod	15	SENT_44	[p2l1649t2141r1965b2201],
15	lipid	NN	O	lipid	dobj	13	SENT_44	[p2l1993t2141r2147b2218],

1	P.	FW	PERSON	p.	nn	4	SENT_45	[p2l322t2294r343b2317],
2	Zuccaro	FW	PERSON	zuccaro	nn	4	SENT_45	[p2l354t2294r463b2317],
3	er	FW	O	er	nn	4	SENT_45	[p2l473t2297r497b2317],
4	al.	FW	O	al.	_	0	SENT_45	[p2l505t2293r535b2317],
5	/	:	O	/	punct	7	SENT_45	[p2l545t2293r560b2317],
6	Pharmacological	JJ	O	pharmacological	amod	7	SENT_45	[p2l564t2293r795b2323],
7	Research	NN	O	research	dep	4	SENT_45	[p2l802t2293r924b2317],
8	55	CD	NUMBER	55	number	9	SENT_45	[p2l934t2293r966b2316],
9	(	CD	NUMBER	(	num	10	SENT_45	[p2l976t2293r1062b2322],
10	2007	CD	DATE	2007	dep	7	SENT_45	[p2l976t2293r1062b2322],
11	)	CD	NUMBER	)	num	12	SENT_45	[p2l976t2293r1062b2322],
12	310-31	CD	NUMBER	310-31	dep	10	SENT_45	[p2l1072t2293r1168b2316],
13	7	CD	NUMBER	7	num	14	SENT_45	[p2l1174t2293r1189b2317],
14	311	CD	NUMBER	311	dep	4	SENT_45	[p2l1792t2293r1837b2317],

1	oxidation	NN	O	oxidation	nsubj	8	SENT_46	[p2l9t2428r328b2487],
2	in	IN	O	in	_	0	SENT_46	[p2l362t2428r426b2487],
3	patients	NNS	O	patient	prep_in	1	SENT_46	[p2l460t2428r721b2505],
4	with	IN	O	with	_	0	SENT_46	[p2l759t2428r907b2488],
5	myotoxicity	NN	O	myotoxicity	prep_with	3	SENT_46	[p2l942t2428r1363b2505],
6	,	,	O	,	_	0	SENT_46	[p2l942t2428r1363b2505],
7	possibly	RB	O	possibly	advmod	8	SENT_46	[p2l1400t2428r1682b2505],
8	predisposing	VBG	O	predispose	_	0	SENT_46	[p2l1716t2428r2149b2505],
9	them	PRP	O	they	dobj	8	SENT_46	[p2l8t2530r177b2590],
10	to	TO	O	to	_	0	SENT_46	[p2l200t2539r262b2590],
11	the	DT	O	the	det	12	SENT_46	[p2l287t2530r389b2590],
12	symptoms	NNS	O	symptom	prep_to	8	SENT_46	[p2l416t2539r777b2607],
13	.	.	O	.	_	0	SENT_46	[p2l416t2539r777b2607],

1	Evaluation	NN	O	evaluation	nsubj	17	SENT_47	[p2l110t2632r475b2692],
2	of	IN	O	of	_	0	SENT_47	[p2l519t2632r592b2692],
3	statins	NNS	O	statin	prep_of	1	SENT_47	[p2l633t2632r843b2692],
4	in	IN	O	in	_	0	SENT_47	[p2l889t2632r953b2691],
5	terms	NNS	O	term	prep_in	3	SENT_47	[p2l996t2641r1181b2692],
6	of	IN	O	of	_	0	SENT_47	[p2l1228t2632r1301b2692],
7	their	PRP$	O	they	poss	9	SENT_47	[p2l1339t2632r1494b2692],
8	cytochrome	NN	O	cytochrome	nn	9	SENT_47	[p2l1537t2632r1934b2709],
9	P450	NN	O	p450	prep_of	5	SENT_47	[p2l1977t2632r2149b2692],
10	(	CD	NUMBER	(	num	12	SENT_47	[p2l11t2733r353b2806],
11	CYP450	NN	O	cyp450	nn	12	SENT_47	[p2l11t2733r353b2806],
12	)	NN	O	)	tmod	3	SENT_47	[p2l11t2733r353b2806],
13	associated	VBN	O	associate	partmod	12	SENT_47	[p2l393t2733r739b2792],
14	metabolism	NN	O	metabolism	dobj	13	SENT_47	[p2l775t2733r1170b2792],
15	have	VBP	O	have	aux	17	SENT_47	[p2l1204t2733r1360b2792],
16	clearly	RB	O	clearly	advmod	17	SENT_47	[p2l1397t2733r1624b2810],
17	suggested	VBN	O	suggest	_	0	SENT_47	[p2l1663t2733r1994b2810],
18	differences	NNS	O	difference	dobj	17	SENT_47	[p2l2030t2733r2147b2792, p2l9t2836r287b2896],
19	in	IN	O	in	_	0	SENT_47	[p2l328t2836r391b2895],
20	metabolic	JJ	O	metabolic	prep_in	17	SENT_47	[p2l430t2836r762b2896],
21	handling	VBG	O	handle	dep	17	SENT_47	[p2l801t2836r1096b2913],
22	[	CD	NUMBER	[	number	23	SENT_47	[p2l1141t2836r1419b2908],
23	13	CD	NUMBER	13	dobj	21	SENT_47	[p2l1141t2836r1419b2908],
24	—	CD	NUMBER	—	num	26	SENT_47	[p2l1141t2836r1419b2908],
25	15	CD	NUMBER	15	num	26	SENT_47	[p2l1141t2836r1419b2908],
26	]	NN	O	]	dep	23	SENT_47	[p2l1141t2836r1419b2908],
27	.	.	O	.	_	0	SENT_47	[p2l1141t2836r1419b2908],

1	Different	JJ	O	different	amod	2	SENT_48	[p2l1462t2836r1770b2896],
2	genotypes	NNS	O	genotype	nsubj	4	SENT_48	[p2l1808t2845r2148b2913],
3	can	MD	O	can	aux	4	SENT_48	[p2l9t2957r124b2998],
4	inﬂuence	VB	O	inﬂuence	ccomp	24	SENT_48	[p2l152t2938r461b2998],
5	therapeutic	JJ	O	therapeutic	amod	6	SENT_48	[p2l490t2938r865b3015],
6	efﬁcacy	NN	O	efﬁcacy	dobj	4	SENT_48	[p2l895t2938r1170b3015],
7	,	,	O	,	_	0	SENT_48	[p2l895t2938r1170b3015],
8	so	RB	O	so	advmod	16	SENT_48	[p2l1205t2957r1274b2998],
9	that	IN	O	that	dep	16	SENT_48	[p2l1303t2938r1431b2998],
10	in	IN	O	in	_	0	SENT_48	[p2l1457t2938r1522b2997],
11	subjects	NNS	O	subject	prep_in	16	SENT_48	[p2l1552t2938r1819b3015],
12	homozygous	JJ	O	homozygous	amod	15	SENT_48	[p2l1849t2938r2147b3015, p2l9t3057r165b3116],
13	for	IN	O	for	_	0	SENT_48	[p2l197t3038r295b3098],
14	detrimental	JJ	O	detrimental	prep_for	12	SENT_48	[p2l325t3039r709b3098],
15	alleles	NNS	O	allele	nsubj	16	SENT_48	[p2l741t3039r952b3098],
16	(	VBP	O	(	advcl	4	SENT_48	[p2l987t3039r1180b3112],
17	PM	NN	O	pm	nn	18	SENT_48	[p2l987t3039r1180b3112],
18	)	NN	O	)	dobj	16	SENT_48	[p2l987t3039r1180b3112],
19	,	,	O	,	_	0	SENT_48	[p2l987t3039r1180b3112],
20	plasma	NN	O	plasma	nn	21	SENT_48	[p2l1212t3039r1453b3116],
21	concentrations	NNS	O	concentration	nsubj	24	SENT_48	[p2l1483t3039r1974b3098],
22	may	MD	O	may	aux	24	SENT_48	[p2l2006t3057r2149b3116],
23	potentially	RB	O	potentially	advmod	24	SENT_48	[p2l7t3142r369b3219],
24	increase	VB	O	increase	_	0	SENT_48	[p2l392t3142r668b3202],
25	compared	VBN	O	compare	_	0	SENT_48	[p2l691t3142r1024b3219],
26	with	IN	O	with	prepc_compared_with	24	SENT_48	[p2l1045t3142r1194b3202],
27	the	DT	O	the	det	29	SENT_48	[p2l1216t3142r1317b3202],
28	mean	JJ	O	mean	amod	29	SENT_48	[p2l1339t3161r1521b3202],
29	effects	NNS	O	effect	pobj	24	SENT_48	[p2l1544t3142r1763b3202],
30	in	IN	O	in	_	0	SENT_48	[p2l1787t3142r1851b3201],
31	the	DT	O	the	det	32	SENT_48	[p2l1873t3142r1974b3202],
32	population	NN	O	population	prep_in	29	SENT_48	[p2l1995t3161r2147b3219, p2l8t3244r259b3303],
33	.	.	O	.	_	0	SENT_48	[p2l1995t3161r2147b3219, p2l8t3244r259b3303],

1	With	IN	O	with	_	0	SENT_49	[p2l283t3244r449b3304],
2	the	DT	O	the	det	3	SENT_49	[p2l470t3244r571b3303],
3	exception	NN	O	exception	prep_with	18	SENT_49	[p2l593t3244r920b3321],
4	of	IN	O	of	_	0	SENT_49	[p2l942t3244r1015b3303],
5	pravastatin	NN	O	pravastatin	prep_of	3	SENT_49	[p2l1029t3244r1415b3321],
6	,	,	O	,	_	0	SENT_49	[p2l1029t3244r1415b3321],
7	which	WDT	O	which	nsubjpass	9	SENT_49	[p2l1440t3244r1645b3303],
8	is	VBZ	O	be	auxpass	9	SENT_49	[p2l1666t3244r1719b3303],
9	transformed	VBN	O	transform	rcmod	5	SENT_49	[p2l1741t3244r2151b3303],
10	enzymatically	RB	O	enzymatically	advmod	9	SENT_49	[p2l9t3346r483b3423],
11	in	IN	O	in	_	0	SENT_49	[p2l522t3346r585b3405],
12	the	DT	O	the	det	14	SENT_49	[p2l624t3346r725b3406],
13	liver	NN	O	liver	nn	14	SENT_49	[p2l763t3346r915b3406],
14	cytosol	NN	O	cytosol	prep_in	9	SENT_49	[p2l953t3346r1212b3423],
15	,	,	O	,	_	0	SENT_49	[p2l953t3346r1212b3423],
16	all	DT	O	all	det	17	SENT_49	[p2l1255t3346r1336b3406],
17	statins	NNS	O	statin	nsubj	18	SENT_49	[p2l1378t3346r1588b3406],
18	undergo	VBP	O	undergo	_	0	SENT_49	[p2l1627t3346r1902b3423],
19	extensive	JJ	O	extensive	amod	21	SENT_49	[p2l1942t3355r2147b3406, p2l11t3448r139b3508],
20	microsomal	JJ	O	microsomal	amod	21	SENT_49	[p2l172t3448r571b3508],
21	metabolism	NN	O	metabolism	dobj	18	SENT_49	[p2l603t3448r999b3508],
22	by	IN	O	by	_	0	SENT_49	[p2l1029t3448r1113b3525],
23	the	DT	O	the	det	26	SENT_49	[p2l1145t3448r1247b3508],
24	CYP45O	NN	O	cyp45o	nn	26	SENT_49	[p2l1281t3448r1570b3508],
25	isozyme	NN	O	isozyme	nn	26	SENT_49	[p2l1603t3448r1883b3525],
26	system	NN	O	system	prep_by	18	SENT_49	[p2l1919t3457r2151b3525],
27	[	CD	NUMBER	[	number	28	SENT_49	[p2l14t3551r164b3623],
28	15	CD	NUMBER	15	num	29	SENT_49	[p2l14t3551r164b3623],
29	]	NN	O	]	dep	18	SENT_49	[p2l14t3551r164b3623],
30	.	.	O	.	_	0	SENT_49	[p2l14t3551r164b3623],

1	Aim	NNP	O	Aim	nsubj	6	SENT_50	[p2l110t3653r260b3712],
2	of	IN	O	of	_	0	SENT_50	[p2l306t3653r379b3713],
3	the	DT	O	the	det	5	SENT_50	[p2l420t3653r521b3713],
4	present	JJ	DATE	present	amod	5	SENT_50	[p2l566t3662r812b3730],
5	study	NN	O	study	prep_of	1	SENT_50	[p2l859t3653r1038b3730],
6	was	VBD	O	be	_	0	SENT_50	[p2l1085t3672r1211b3713],
7	to	TO	O	to	aux	8	SENT_50	[p2l1259t3662r1322b3713],
8	investigate	VB	O	investigate	xcomp	6	SENT_50	[p2l1369t3653r1731b3730],
9	differences	NNS	O	difference	dobj	8	SENT_50	[p2l1778t3653r2148b3713],
10	in	IN	O	in	_	0	SENT_50	[p3l8t19r72b78],
11	the	DT	O	the	det	13	SENT_50	[p3l131t19r233b79],
12	genetic	JJ	O	genetic	amod	13	SENT_50	[p3l294t19r535b96],
13	pattern	NN	O	pattern	prep_in	8	SENT_50	[p3l594t28r830b96],
14	between	IN	O	between	_	0	SENT_50	[p3l888t19r1170b79],
15	a	DT	O	a	det	16	SENT_50	[p3l1231t38r1266b79],
16	group	NN	O	group	prep_between	13	SENT_50	[p3l1326t38r1520b96],
17	of	IN	O	of	_	0	SENT_50	[p3l1581t19r1654b79],
18	statin	NN	O	statin	nn	19	SENT_50	[p3l1711t19r2151b79],
19	—	NN	O	—	prep_of	16	SENT_50	[p3l1711t19r2151b79],
20	treated	VBN	O	treat	partmod	19	SENT_50	[p3l1711t19r2151b79],
21	patients	NNS	O	patient	dobj	20	SENT_50	[p3l7t120r269b197],
22	with	IN	O	with	_	0	SENT_50	[p3l310t120r458b179],
23	muscle	NN	O	muscle	nn	24	SENT_50	[p3l497t120r735b179],
24	complaints	NNS	O	complaint	prep_with	20	SENT_50	[p3l775t120r1143b197],
25	requiring	VBG	O	require	partmod	24	SENT_50	[p3l1183t120r1492b197],
26	dose	NN	O	dose	nn	27	SENT_50	[p3l1533t120r1685b179],
27	reduction	NN	O	reduction	dobj	25	SENT_50	[p3l1723t120r2043b179],
28	or	CC	O	or	_	0	SENT_50	[p3l2083t138r2152b179],
29	outright	JJ	O	outright	amod	30	SENT_50	[p3l9t223r277b300],
30	withdrawal	NN	O	withdrawal	conj_or	27	SENT_50	[p3l325t223r702b283],
31	from	IN	O	from	_	0	SENT_50	[p3l752t223r916b283],
32	therapy	NN	O	therapy	prep_from	27	SENT_50	[p3l963t223r1214b300],
33	and	CC	O	and	_	0	SENT_50	[p3l1266t223r1385b283],
34	a	DT	O	a	det	35	SENT_50	[p3l1435t242r1470b283],
35	group	NN	O	group	conj_and	32	SENT_50	[p3l1518t242r1712b300],
36	of	IN	O	of	_	0	SENT_50	[p3l1763t223r1837b283],
37	age	NN	O	age	nn	39	SENT_50	[p3l1881t242r2150b300],
38	—	CD	NUMBER	—	num	39	SENT_50	[p3l1881t242r2150b300],
39	sex	NN	O	sex	prep_of	32	SENT_50	[p3l1881t242r2150b300],
40	matched	JJ	O	matched	amod	41	SENT_50	[p3l8t325r295b384],
41	patients	NNS	O	patient	dep	32	SENT_50	[p3l329t325r591b402],
42	with	IN	O	with	_	0	SENT_50	[p3l629t325r778b385],
43	comparable	JJ	O	comparable	amod	44	SENT_50	[p3l814t325r1208b402],
44	cholesterolaemic	JJ	O	cholesterolaemic	amod	48	SENT_50	[p3l1245t325r1817b384],
45	response	NN	O	response	nn	48	SENT_50	[p3l1854t343r2150b402],
46	[	NN	O	[	nn	48	SENT_50	[p3l14t427r142b499],
47	16	CD	NUMBER	16	num	48	SENT_50	[p3l14t427r142b499],
48	]	NN	O	]	prep_with	41	SENT_50	[p3l14t427r142b499],
49	but	CC	O	but	_	0	SENT_50	[p3l186t427r293b487],
50	free	JJ	O	free	dep	32	SENT_50	[p3l332t427r461b487],
51	of	IN	O	of	_	0	SENT_50	[p3l503t427r576b487],
52	clinical	JJ	O	clinical	amod	53	SENT_50	[p3l611t427r858b487],
53	symptoms	NNS	O	symptom	prep_of	27	SENT_50	[p3l901t436r1262b504],
54	.	.	O	.	_	0	SENT_50	[p3l901t436r1262b504],

1	Availability	NN	O	availability	nsubj	6	SENT_51	[p3l1306t427r1701b504],
2	of	IN	O	of	_	0	SENT_51	[p3l1743t427r1816b487],
3	this	DT	O	this	det	4	SENT_51	[p3l1850t427r1969b487],
4	data	NNS	O	datum	prep_of	1	SENT_51	[p3l2011t427r2151b487],
5	also	RB	O	also	advmod	6	SENT_51	[p3l10t529r142b589],
6	allowed	VBD	O	allow	_	0	SENT_51	[p3l185t529r449b589],
7	to	TO	O	to	aux	8	SENT_51	[p3l489t538r552b589],
8	test	VB	O	test	xcomp	6	SENT_51	[p3l593t538r710b589],
9	the	DT	O	the	det	12	SENT_51	[p3l750t529r851b589],
10	previously	RB	DATE	previously	advmod	11	SENT_51	[p3l891t529r1246b606],
11	reported	VBN	O	report	amod	12	SENT_51	[p3l1286t529r1569b606],
12	hypothesis	NN	O	hypothesis	dobj	8	SENT_51	[p3l1608t529r1968b606],
13	[	IN	O	[	_	0	SENT_51	[p3l2017t530r2144b601],
14	17	CD	NUMBER	17	num	15	SENT_51	[p3l2017t530r2144b601],
15	]	NN	O	]	prep_[	8	SENT_51	[p3l2017t530r2144b601],
16	that	WDT	O	that	nsubj	17	SENT_51	[p3l8t631r135b690],
17	statin	VBP	O	statin	rcmod	15	SENT_51	[p3l193t631r372b690],
18	tolerability	NN	O	tolerability	nsubjpass	21	SENT_51	[p3l428t631r798b708],
19	may	MD	O	may	aux	21	SENT_51	[p3l855t649r999b708],
20	be	VB	O	be	auxpass	21	SENT_51	[p3l1054t631r1133b690],
21	linked	VBN	O	link	ccomp	17	SENT_51	[p3l1190t631r1400b690],
22	to	TO	O	to	_	0	SENT_51	[p3l1456t640r1519b690],
23	cholesterolaemic	JJ	O	cholesterolaemic	amod	24	SENT_51	[p3l1577t631r2149b690],
24	response	NN	O	response	prep_to	21	SENT_51	[p3l7t727r321b784],
25	.	.	O	.	_	0	SENT_51	[p3l7t727r321b784],

1	2	LS	NUMBER	2	_	0	SENT_52	[p3l8t913r68b974],
2	.	.	O	.	_	0	SENT_52	[p3l8t913r68b974],

1	Subjects	NNS	O	subject	_	0	SENT_53	[p3l116t913r419b990],
2	and	CC	O	and	_	0	SENT_53	[p3l444t914r578b974],
3	methods	NNS	O	method	conj_and	1	SENT_53	[p3l601t914r906b974],

1	2	LS	NUMBER	2	_	0	SENT_54	[p3l8t1118r126b1178],
2	.	.	O	.	_	0	SENT_54	[p3l8t1118r126b1178],
3	]	SYM	O	]	dep	1	SENT_54	[p3l8t1118r126b1178],

1	.	.	O	.	_	0	SENT_55	[p3l8t1118r126b1178],

1	Patients	NNS	O	patient	_	0	SENT_56	[p3l177t1120r448b1178],
2	and	CC	O	and	_	0	SENT_56	[p3l472t1118r601b1178],
3	sample	NN	O	sample	nn	4	SENT_56	[p3l621t1118r858b1194],
4	collection	NN	O	collection	conj_and	1	SENT_56	[p3l884t1118r1215b1178],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_57	[p3l110t1322r374b1382],
2	were	VBD	O	be	auxpass	3	SENT_57	[p3l414t1341r576b1382],
3	recruited	VBN	O	recruit	_	0	SENT_57	[p3l612t1322r914b1382],
4	among	IN	O	among	_	0	SENT_57	[p3l952t1341r1179b1399],
5	those	DT	O	those	nsubj	16	SENT_57	[p3l1216t1322r1394b1382],
6	attending	VBG	O	attend	prepc_among	3	SENT_57	[p3l1432t1322r1744b1399],
7	the	DT	O	the	det	9	SENT_57	[p3l1782t1322r1884b1382],
8	Centro	NNP	ORGANIZATION	Centro	nn	9	SENT_57	[p3l1922t1323r2149b1382],
9	Universitario	NNP	ORGANIZATION	Universitario	dobj	6	SENT_57	[p3l8t1424r450b1484],
10	per	IN	O	per	_	0	SENT_57	[p3l480t1442r589b1501],
11	lo	NNP	O	lo	nn	14	SENT_57	[p3l618t1424r681b1483],
12	Studio	NNP	O	Studio	nn	14	SENT_57	[p3l714t1424r931b1484],
13	delle	FW	O	delle	nn	14	SENT_57	[p3l963t1424r1124b1483],
14	Dislipidemie	NNP	O	Dislipidemie	prep_per	9	SENT_57	[p3l1155t1424r1610b1501],
15	,	,	O	,	_	0	SENT_57	[p3l1155t1424r1610b1501],
16	examining	VBG	O	examine	conj_and	6	SENT_57	[p3l1645t1424r1998b1501],
17	and	CC	O	and	_	0	SENT_57	[p3l2031t1424r2151b1483],
18	following	VBG	O	follow	conj_and	6	SENT_57	[p3l9t1525r334b1602],
19	patients	NNS	O	patient	dobj	18	SENT_57	[p3l368t1525r629b1602],
20	with	IN	O	with	_	0	SENT_57	[p3l666t1525r814b1585],
21	lipid	NN	O	lipid	nn	24	SENT_57	[p3l848t1525r1404b1602],
22	—	NN	O	—	nn	24	SENT_57	[p3l848t1525r1404b1602],
23	lipoprotein	NN	O	lipoprotein	nn	24	SENT_57	[p3l848t1525r1404b1602],
24	disorders	NNS	O	disorder	prep_with	18	SENT_57	[p3l1439t1525r1766b1595],
25	,	,	O	,	_	0	SENT_57	[p3l1439t1525r1766b1595],
26	frequently	RB	O	frequently	advmod	18	SENT_57	[p3l1803t1524r2149b1602],

1	Table	NNP	O	Table	nn	4	SENT_58	[p3l8t1756r156b1803],
2	1	CD	NUMBER	1	num	1	SENT_58	[p3l181t1757r201b1803],
3	Baseline	NN	O	baseline	nn	4	SENT_58	[p3l8t1839r240b1886],
4	characteristics	NNS	O	characteristic	nsubj	7	SENT_58	[p3l260t1839r646b1886],
5	of	IN	O	of	_	0	SENT_58	[p3l667t1839r725b1886],
6	patients	NNS	O	patient	prep_of	4	SENT_58	[p3l739t1839r948b1900],
7	associated	VBN	O	associate	_	0	SENT_58	[p3l9t2054r355b2113],
8	with	IN	O	with	_	0	SENT_58	[p3l373t2054r523b2114],
9	cardiovascular	JJ	O	cardiovascular	amod	10	SENT_58	[p3l541t2054r1033b2114],
10	diseases	NNS	O	disease	prep_with	7	SENT_58	[p3l1050t2054r1343b2113],
11	.	.	O	.	_	0	SENT_58	[p3l1050t2054r1343b2113],

1	Some	DT	O	some	det	3	SENT_59	[p3l1368t2054r1557b2114],
2	120-150	CD	NUMBER	120-150	num	3	SENT_59	[p3l1584t2054r1871b2114],
3	patients	NNS	O	patient	nsubjpass	5	SENT_59	[p3l1889t2054r2151b2131],
4	are	VBP	O	be	auxpass	5	SENT_59	[p3l9t2175r108b2216],
5	examined	VBN	O	examine	_	0	SENT_59	[p3l133t2156r461b2216],
6	each	DT	SET	each	det	7	SENT_59	[p3l484t2156r638b2216],
7	week	NN	SET	week	tmod	5	SENT_59	[p3l662t2156r857b2227],
8	,	,	O	,	_	0	SENT_59	[p3l662t2156r857b2227],
9	among	IN	O	among	_	0	SENT_59	[p3l886t2175r1112b2233],
10	which	WDT	O	which	prep_among	5	SENT_59	[p3l1137t2156r1343b2216],
11	8-10	CD	NUMBER	8-10	num	13	SENT_59	[p3l1370t2157r1534b2216],
12	new	JJ	O	new	amod	13	SENT_59	[p3l1558t2175r1695b2216],
13	cases	NNS	O	case	dep	5	SENT_59	[p3l1720t2175r1914b2216],
14	.	.	O	.	_	0	SENT_59	[p3l1720t2175r1914b2216],

1	One	CD	NUMBER	one	num	3	SENT_60	[p3l111t2259r248b2318],
2	hundred	CD	NUMBER	hundred	num	3	SENT_60	[p3l289t2258r567b2318],
3	patients	NNS	O	patient	nsubjpass	8	SENT_60	[p3l606t2258r868b2335],
4	treated	VBN	O	treat	partmod	3	SENT_60	[p3l910t2258r1141b2318],
5	with	IN	O	with	_	0	SENT_60	[p3l1181t2258r1330b2318],
6	statins	NNS	O	statin	prep_with	4	SENT_60	[p3l1374t2258r1584b2318],
7	were	VBD	O	be	auxpass	8	SENT_60	[p3l1627t2277r1790b2318],
8	recruited	VBN	O	recruit	_	0	SENT_60	[p3l1830t2258r2148b2318],
9	.	.	O	.	_	0	SENT_60	[p3l1830t2258r2148b2318],

1	Characteristics	NNS	O	characteristic	nsubjpass	3	SENT_61	[p3l8t2360r509b2420],
2	are	VBP	O	be	auxpass	3	SENT_61	[p3l544t2378r643b2419],
3	reported	VBN	O	report	_	0	SENT_61	[p3l674t2360r957b2437],
4	in	IN	O	in	_	0	SENT_61	[p3l987t2360r1051b2419],
5	Table	NNP	O	Table	prep_in	3	SENT_61	[p3l1082t2360r1266b2419],
6	1	CD	NUMBER	1	num	5	SENT_61	[p3l1306t2360r1355b2419],
7	.	.	O	.	_	0	SENT_61	[p3l1306t2360r1355b2419],

1	Of	IN	O	of	_	0	SENT_62	[p3l1391t2360r1483b2420],
2	these	DT	O	these	prep_of	5	SENT_62	[p3l1508t2360r1699b2430],
3	,	,	O	,	_	0	SENT_62	[p3l1508t2360r1699b2430],
4	50	CD	NUMBER	50	appos	2	SENT_62	[p3l1735t2360r1816b2420],
5	had	VBD	O	have	_	0	SENT_62	[p3l1847t2360r1968b2419],
6	clinical	JJ	O	clinical	amod	7	SENT_62	[p3l2000t2360r2150b2419, p3l7t2462r127b2522],
7	symptoms	NNS	O	symptom	dobj	5	SENT_62	[p3l159t2471r502b2539],
8	of	IN	O	of	_	0	SENT_62	[p3l534t2462r607b2522],
9	muscle	NN	O	muscle	nn	10	SENT_62	[p3l630t2462r869b2522],
10	pain	NN	O	pain	prep_of	7	SENT_62	[p3l896t2462r1042b2539],
11	as	IN	O	as	advmod	12	SENT_62	[p3l1072t2481r1137b2522],
12	assessed	VBN	O	assess	dep	10	SENT_62	[p3l1169t2462r1455b2522],
13	with	IN	O	with	_	0	SENT_62	[p3l1483t2462r1632b2522],
14	a	DT	O	a	det	19	SENT_62	[p3l1662t2481r1697b2522],
15	standardized	JJ	O	standardized	amod	19	SENT_62	[p3l1727t2462r2153b2522],
16	medical	JJ	O	medical	amod	19	SENT_62	[p3l7t2564r274b2624],
17	record	NN	O	record	nn	19	SENT_62	[p3l294t2564r511b2624],
18	review	NN	O	review	nn	19	SENT_62	[p3l531t2564r756b2624],
19	form	NN	O	form	prep_with	12	SENT_62	[p3l779t2564r960b2634],
20	,	,	O	,	_	0	SENT_62	[p3l779t2564r960b2634],
21	as	IN	O	as	_	0	SENT_62	[p3l986t2583r1050b2624],
22	described	VBN	O	describe	dep	10	SENT_62	[p3l1075t2564r1399b2624],
23	previously	RB	DATE	previously	advmod	22	SENT_62	[p3l1418t2564r1774b2641],
24	by	IN	O	by	_	0	SENT_62	[p3l1794t2564r1878b2641],
25	Hansen	NNP	PERSON	Hansen	prep_by	22	SENT_62	[p3l1899t2566r2153b2624],
26	et	FW	O	et	nn	28	SENT_62	[p3l8t2674r67b2724],
27	al.	FW	O	al.	nn	28	SENT_62	[p3l101t2665r176b2724],
28	[	FW	O	[	dobj	12	SENT_62	[p3l220t2665r328b2737],
29	8	CD	NUMBER	8	num	30	SENT_62	[p3l220t2665r328b2737],
30	]	NN	O	]	nsubj	5	SENT_62	[p3l220t2665r328b2737],
31	.	.	O	.	_	0	SENT_62	[p3l220t2665r328b2737],

1	This	DT	O	this	_	0	SENT_63	[p3l366t2665r513b2724],
2	recorded	VBN	O	record	partmod	1	SENT_63	[p3l548t2665r862b2724],
3	:	:	O	:	_	0	SENT_63	[p3l548t2665r862b2724],
4	pain	NN	O	pain	conj_or	1	SENT_63	[p3l901t2665r1046b2742],
5	at	IN	O	at	_	0	SENT_63	[p3l1082t2674r1141b2724],
6	the	DT	O	the	det	8	SENT_63	[p3l1173t2665r1274b2724],
7	upper	JJ	O	upper	amod	8	SENT_63	[p3l1308t2683r1502b2742],
8	girth	NN	O	girth	prep_at	4	SENT_63	[p3l1535t2665r1693b2742],
9	after	IN	O	after	_	0	SENT_63	[p3l1728t2665r1881b2724],
10	limited	JJ	O	limited	amod	11	SENT_63	[p3l1914t2665r2153b2724],
11	effort	NN	O	effort	prep_after	8	SENT_63	[p3l8t2768r212b2839],
12	;	:	O	;	_	0	SENT_63	[p3l8t2768r212b2839],
13	pain	NN	O	pain	conj_or	1	SENT_63	[p3l243t2768r389b2845],
14	to	TO	O	to	_	0	SENT_63	[p3l418t2777r481b2828],
15	the	DT	O	the	det	17	SENT_63	[p3l511t2768r613b2828],
16	lower	JJR	O	lower	amod	17	SENT_63	[p3l642t2768r833b2828],
17	limbs	NNS	O	limb	prep_to	13	SENT_63	[p3l861t2768r1046b2828],
18	after	IN	O	after	_	0	SENT_63	[p3l1079t2768r1232b2828],
19	minimal	JJ	O	minimal	amod	20	SENT_63	[p3l1260t2768r1541b2828],
20	effort	NN	O	effort	prep_after	17	SENT_63	[p3l1572t2768r1774b2839],
21	,	,	O	,	_	0	SENT_63	[p3l1572t2768r1774b2839],
22	e.	FW	O	e.	nn	23	SENT_63	[p3l1807t2787r1858b2828],
23	g.	FW	O	g.	conj_or	1	SENT_63	[p3l1866t2787r1922b2845],
24	uphill	JJ	O	uphill	amod	23	SENT_63	[p3l1956t2768r2152b2845],
25	or	CC	O	or	_	0	SENT_63	[p3l8t2888r77b2929],
26	protracted	JJ	O	protracted	amod	27	SENT_63	[p3l95t2870r440b2947],
27	walking	NN	O	walking	conj_or	1	SENT_63	[p3l461t2870r731b2947],
28	or	CC	O	or	_	0	SENT_63	[p3l754t2888r823b2929],
29	running	VBG	O	run	conj_or	27	SENT_63	[p3l842t2870r1125b2947],
30	;	:	O	;	_	0	SENT_63	[p3l842t2870r1125b2947],
31	diffuse	JJ	O	diffuse	amod	32	SENT_63	[p3l1151t2870r1382b2929],
32	muscle	NN	O	muscle	dep	1	SENT_63	[p3l1403t2870r1642b2929],
33	pain	NN	O	pain	dep	32	SENT_63	[p3l1662t2870r1825b2947],
34	.	.	O	.	_	0	SENT_63	[p3l1662t2870r1825b2947],

1	Of	IN	O	of	_	0	SENT_64	[p3l1851t2870r1943b2930],
2	these	DT	O	these	prep_of	5	SENT_64	[p3l1959t2870r2149b2940],
3	,	,	O	,	_	0	SENT_64	[p3l1959t2870r2149b2940],
4	eight	CD	NUMBER	eight	nsubj	5	SENT_64	[p3l8t2972r176b3049],
5	had	VBD	O	have	_	0	SENT_64	[p3l201t2972r322b3032],
6	increases	NNS	O	increase	dobj	5	SENT_64	[p3l348t2972r656b3032],
7	of	IN	O	of	_	0	SENT_64	[p3l685t2972r759b3032],
8	CPK	NNP	ORGANIZATION	CPK	prep_of	6	SENT_64	[p3l780t2973r960b3043],
9	,	,	O	,	_	0	SENT_64	[p3l780t2973r960b3043],
10	>	JJR	O	>	appos	8	SENT_64	[p3l991t2972r1244b3032],
11	3	CD	NUMBER	3	num	13	SENT_64	[p3l991t2972r1244b3032],
12	—	NN	O	—	nn	13	SENT_64	[p3l991t2972r1244b3032],
13	fo1d	NN	O	fo1d	dep	10	SENT_64	[p3l991t2972r1244b3032],
14	versus	CC	O	versus	_	0	SENT_64	[p3l1270t2991r1482b3032],
15	normal	JJ	O	normal	conj_versus	6	SENT_64	[p3l1510t2972r1749b3032],
16	and	CC	O	and	_	0	SENT_64	[p3l1777t2972r1897b3032],
17	1	CD	NUMBER	1	npadvmod	18	SENT_64	[p3l1930t2973r1955b3031],
18	>	JJR	O	>	conj_versus	6	SENT_64	[p3l1980t2987r2024b3031],
19	10fold	JJ	O	10fold	amod	15	SENT_64	[p3l2049t2973r2150b3032, p3l7t3074r143b3134],
20	versus	CC	O	versus	prep	15	SENT_64	[p3l170t3093r382b3134],
21	normal	JJ	O	normal	dep	20	SENT_64	[p3l413t3074r669b3134],
22	.	.	O	.	_	0	SENT_64	[p3l413t3074r669b3134],

1	The	DT	O	the	det	3	SENT_65	[p3l701t3074r831b3134],
2	comparative	JJ	O	comparative	amod	3	SENT_65	[p3l861t3074r1275b3151],
3	series	NN	O	series	nsubj	8	SENT_65	[p3l1307t3074r1494b3134],
4	of	IN	O	of	_	0	SENT_65	[p3l1525t3074r1598b3134],
5	50	CD	NUMBER	50	num	6	SENT_65	[p3l1622t3074r1703b3134],
6	patients	NNS	O	patient	prep_of	3	SENT_65	[p3l1731t3074r1993b3151],
7	was	VBD	O	be	cop	8	SENT_65	[p3l2024t3093r2151b3134],
8	comparable	JJ	O	comparable	_	0	SENT_65	[p3l8t3176r402b3253],
9	for	IN	O	for	_	0	SENT_65	[p3l438t3176r536b3235],
10	age	NN	O	age	nn	15	SENT_65	[p3l573t3194r705b3253],
11	,	,	O	,	_	0	SENT_65	[p3l573t3194r705b3253],
12	sex	NN	O	sex	nn	15	SENT_65	[p3l747t3194r853b3235],
13	and	CC	O	and	_	0	SENT_65	[p3l891t3176r1011b3235],
14	lipid	NN	O	lipid	nn	15	SENT_65	[p3l1046t3176r1200b3253],
15	levels	NNS	O	level	prep_for	8	SENT_65	[p3l1236t3176r1426b3236],
16	without	IN	O	without	_	0	SENT_65	[p3l1465t3176r1724b3236],
17	any	DT	O	any	dep	19	SENT_65	[p3l1760t3194r1877b3253],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_65	[p3l1916t3176r2150b3253, p3l8t3287r148b3338],
19	subjective	JJ	O	subjective	prep_without	8	SENT_65	[p3l167t3278r504b3355],
20	or	CC	O	or	_	0	SENT_65	[p3l523t3297r592b3338],
21	objective	JJ	O	objective	amod	22	SENT_65	[p3l609t3278r915b3355],
22	disturbances	NNS	O	disturbance	conj_or	19	SENT_65	[p3l933t3278r1354b3338],
23	during	IN	O	during	_	0	SENT_65	[p3l1375t3278r1593b3355],
24	statin	NN	O	statin	nn	25	SENT_65	[p3l1615t3278r1794b3338],
25	treatment	NN	O	treatment	prep_during	8	SENT_65	[p3l1812t3287r2148b3338],
26	.	.	O	.	_	0	SENT_65	[p3l1812t3287r2148b3338],

1	Among	IN	O	among	_	0	SENT_66	[p3l7t3381r259b3457],
2	the	DT	O	the	det	4	SENT_66	[p3l280t3380r381b3440],
3	recruited	VBN	O	recruit	amod	4	SENT_66	[p3l400t3380r702b3440],
4	patients	NNS	O	patient	prep_among	7	SENT_66	[p3l720t3380r1002b3457],
5	,	,	O	,	_	0	SENT_66	[p3l720t3380r1002b3457],
6	11	CD	NUMBER	11	nsubj	7	SENT_66	[p3l1033t3381r1100b3439],
7	reported	VBD	O	report	_	0	SENT_66	[p3l1126t3380r1409b3457],
8	side	JJ	O	side	amod	9	SENT_66	[p3l1431t3380r1563b3440],
9	effects	NNS	O	effect	dobj	7	SENT_66	[p3l1583t3380r1803b3440],
10	to	TO	O	to	aux	11	SENT_66	[p3l1824t3389r1887b3440],
11	pravas	VB	O	prava	xcomp	7	SENT_66	[p3l1907t3399r2150b3457],
12	—	CD	NUMBER	—	num	13	SENT_66	[p3l1907t3399r2150b3457],
13	tatin	NN	O	tatin	dobj	11	SENT_66	[p3l7t3481r174b3551],
14	,	,	O	,	_	0	SENT_66	[p3l7t3481r174b3551],
15	known	VBN	O	know	partmod	13	SENT_66	[p3l198t3481r427b3540],
16	to	TO	O	to	aux	17	SENT_66	[p3l448t3489r511b3540],
17	undergo	VB	O	undergo	xcomp	15	SENT_66	[p3l534t3481r809b3558],
18	minimal	JJ	O	minimal	amod	20	SENT_66	[p3l832t3481r1113b3540],
19	metabolic	JJ	O	metabolic	amod	20	SENT_66	[p3l1135t3481r1468b3540],
20	handling	NN	O	handling	dobj	17	SENT_66	[p3l1491t3481r1804b3558],
21	.	.	O	.	_	0	SENT_66	[p3l1491t3481r1804b3558],

1	However	RB	O	however	advmod	6	SENT_67	[p3l1830t3482r2150b3551],
2	,	,	O	,	_	0	SENT_67	[p3l1830t3482r2150b3551],
3	it	PRP	O	it	nsubjpass	6	SENT_67	[p3l7t3584r53b3644],
4	was	VBD	O	be	auxpass	6	SENT_67	[p3l76t3603r203b3644],
5	not	RB	O	not	neg	6	SENT_67	[p3l229t3593r337b3644],
6	desired	VBN	O	desire	_	0	SENT_67	[p3l360t3584r604b3644],
7	to	TO	O	to	_	0	SENT_67	[p3l627t3593r690b3644],
8	bias	NN	O	bias	prep_to	6	SENT_67	[p3l713t3584r847b3644],
9	the	DT	O	the	det	10	SENT_67	[p3l873t3584r975b3644],
10	collection	NN	O	collection	nsubj	13	SENT_67	[p3l1000t3584r1333b3644],
11	of	IN	O	of	_	0	SENT_67	[p3l1357t3584r1431b3644],
12	cases	NNS	O	case	prep_of	10	SENT_67	[p3l1450t3603r1624b3644],
13	(	VBP	O	(	rcmod	8	SENT_67	[p3l1653t3584r1780b3657],
14	the	DT	O	the	det	16	SENT_67	[p3l1653t3584r1780b3657],
15	evaluating	VBG	O	evaluate	amod	16	SENT_67	[p3l1805t3584r2152b3661],
16	laboratory	NN	O	laboratory	nsubj	19	SENT_67	[p3l7t3686r354b3763],
17	was	VBD	O	be	cop	19	SENT_67	[p3l377t3704r504b3746],
18	not	RB	O	not	neg	19	SENT_67	[p3l528t3695r636b3745],
19	aware	JJ	O	aware	ccomp	13	SENT_67	[p3l658t3704r855b3746],
20	of	IN	O	of	_	0	SENT_67	[p3l878t3686r952b3745],
21	the	DT	O	the	det	22	SENT_67	[p3l968t3686r1069b3745],
22	identity	NN	O	identity	prep_of	19	SENT_67	[p3l1091t3686r1349b3763],
23	of	IN	O	of	_	0	SENT_67	[p3l1373t3686r1446b3745],
24	treatments	NNS	O	treatment	prep_of	22	SENT_67	[p3l1462t3687r1841b3759],
25	)	CD	NUMBER	)	dep	24	SENT_67	[p3l1462t3687r1841b3759],
26	and	CC	O	and	cc	25	SENT_67	[p3l1867t3686r2004b3756],
27	,	,	O	,	_	0	SENT_67	[p3l1867t3686r2004b3756],
28	further	RB	O	further	advmod	19	SENT_67	[p3l2029t3686r2150b3745, p4l7t19r152b90],
29	,	,	O	,	_	0	SENT_67	[p3l2029t3686r2150b3745, p4l7t19r152b90],

1	this	DT	O	this	det	2	SENT_68	[p4l184t19r303b79],
2	inclusion	NN	O	inclusion	nsubj	3	SENT_68	[p4l334t19r645b79],
3	allowed	VBD	O	allow	_	0	SENT_68	[p4l676t19r940b79],
4	a	DT	O	a	det	7	SENT_68	[p4l970t38r1005b79],
5	more	RBR	O	more	advmod	6	SENT_68	[p4l1034t38r1206b79],
6	complete	JJ	O	complete	amod	7	SENT_68	[p4l1236t19r1545b96],
7	evaluation	NN	O	evaluation	dobj	3	SENT_68	[p4l1576t19r1924b79],
8	of	IN	O	of	_	0	SENT_68	[p4l1954t19r2027b79],
9	the	DT	O	the	det	10	SENT_68	[p4l2051t19r2152b79],
10	inﬂuence	NN	O	inﬂuence	prep_of	7	SENT_68	[p4l7t121r316b181],
11	of	IN	O	of	_	0	SENT_68	[p4l342t121r415b181],
12	apo	NN	O	apo	nn	14	SENT_68	[p4l435t140r553b198],
13	E	NN	O	e	nn	14	SENT_68	[p4l577t123r627b180],
14	polymorphism	NN	O	polymorphism	prep_of	10	SENT_68	[p4l650t121r1147b198],
15	on	IN	O	on	_	0	SENT_68	[p4l1170t140r1252b181],
16	response	NN	O	response	nn	18	SENT_68	[p4l1275t140r1572b198],
17	(	CD	NUMBER	(	num	18	SENT_68	[p4l1598t121r1808b195],
18	Table	NNP	O	Table	prep_on	3	SENT_68	[p4l1598t121r1808b195],
19	2	CD	NUMBER	2	number	20	SENT_68	[p4l1834t122r1918b195],
20	)	CD	NUMBER	)	dep	18	SENT_68	[p4l1834t122r1918b195],
21	.	.	O	.	_	0	SENT_68	[p4l1834t122r1918b195],

1	Exclusion	NN	MISC	exclusion	nn	2	SENT_69	[p4l109t222r448b281],
2	criteria	NNS	O	criterion	nsubj	3	SENT_69	[p4l485t222r724b282],
3	were	VBD	O	be	_	0	SENT_69	[p4l760t241r940b282],
4	:	:	O	:	_	0	SENT_69	[p4l760t241r940b282],
5	chronic	JJ	O	chronic	amod	7	SENT_69	[p4l983t222r1234b281],
6	liver	NN	O	liver	nn	7	SENT_69	[p4l1272t222r1424b282],
7	disease	NN	O	disease	nsubj	17	SENT_69	[p4l1459t222r1720b292],
8	,	,	O	,	_	0	SENT_69	[p4l1459t222r1720b292],
9	alcoholism	NN	O	alcoholism	appos	7	SENT_69	[p4l1762t222r2149b292],
10	,	,	O	,	_	0	SENT_69	[p4l1762t222r2149b292],
11	renal	JJ	O	renal	amod	12	SENT_69	[p4l6t325r174b385],
12	disease	NN	O	disease	appos	7	SENT_69	[p4l214t325r476b396],
13	,	,	O	,	_	0	SENT_69	[p4l214t325r476b396],
14	serious	JJ	O	serious	amod	16	SENT_69	[p4l520t325r755b385],
15	atherosclerotic	JJ	O	atherosclerotic	amod	16	SENT_69	[p4l797t325r1294b385],
16	disease	NN	O	disease	appos	7	SENT_69	[p4l1335t325r1577b385],
17	limiting	VBG	O	limit	parataxis	3	SENT_69	[p4l1617t325r1883b402],
18	patient	NN	O	patient	nn	19	SENT_69	[p4l1922t325r2154b402],
19	motility	NN	O	motility	dobj	17	SENT_69	[p4l7t427r287b504],
20	,	,	O	,	_	0	SENT_69	[p4l7t427r287b504],
21	malignant	JJ	O	malignant	amod	22	SENT_69	[p4l315t427r655b504],
22	disease	NN	O	disease	conj_and	19	SENT_69	[p4l679t427r922b487],
23	at	IN	O	at	_	0	SENT_69	[p4l949t436r1008b487],
24	any	DT	O	any	det	25	SENT_69	[p4l1033t446r1150b504],
25	stage	NN	O	stage	prep_at	22	SENT_69	[p4l1179t436r1367b504],
26	,	,	O	,	_	0	SENT_69	[p4l1179t436r1367b504],
27	insulin	NN	O	insulin	npadvmod	28	SENT_69	[p4l1395t427r1625b487],
28	dependent	JJ	O	dependent	amod	29	SENT_69	[p4l1651t427r1999b504],
29	diabetes	NN	O	diabetes	conj_and	19	SENT_69	[p4l2023t427r2150b487, p4l6t528r178b587],
30	as	RB	O	as	_	0	SENT_69	[p4l207t546r272b587],
31	well	RB	O	well	_	0	SENT_69	[p4l300t528r444b587],
32	as	IN	O	as	_	0	SENT_69	[p4l472t546r537b587],
33	multiple	JJ	O	multiple	amod	34	SENT_69	[p4l565t528r846b605],
34	associations	NNS	O	association	conj_and	19	SENT_69	[p4l874t528r1280b587],
35	with	IN	O	with	_	0	SENT_69	[p4l1308t528r1457b587],
36	drugs	NNS	O	drug	prep_with	34	SENT_69	[p4l1484t528r1668b605],
37	and	CC	O	and	_	0	SENT_69	[p4l1698t528r1817b587],
38	CYP3A4	NN	O	cyp3a4	nn	39	SENT_69	[p4l1843t528r2152b588],
39	inhibitors	NNS	O	inhibitor	nsubj	40	SENT_69	[p4l7t631r329b691],
40	(	VBP	O	(	conj_and	3	SENT_69	[p4l388t631r591b705],
41	azole	NN	O	azole	nn	42	SENT_69	[p4l388t631r591b705],
42	antifungals	NNS	O	antifungal	nsubj	52	SENT_69	[p4l648t631r1040b708],
43	,	,	O	,	_	0	SENT_69	[p4l648t631r1040b708],
44	grapefruit	NN	O	grapefruit	nn	45	SENT_69	[p4l1099t631r1433b708],
45	juice	NN	O	juice	appos	42	SENT_69	[p4l1479t631r1667b708],
46	,	,	O	,	_	0	SENT_69	[p4l1479t631r1667b708],
47	dihydropyridine	NN	O	dihydropyridine	nn	49	SENT_69	[p4l1726t631r2150b708, p4l8t733r151b792],
48	calcium	NN	O	calcium	nn	49	SENT_69	[p4l187t733r456b792],
49	antagonists	NNS	O	antagonist	appos	42	SENT_69	[p4l491t733r889b810],
50	,	,	O	,	_	0	SENT_69	[p4l491t733r889b810],
51	others	NNS	O	other	appos	42	SENT_69	[p4l929t733r1179b806],
52	)	VBP	O	)	ccomp	40	SENT_69	[p4l929t733r1179b806],
53	.	.	O	.	_	0	SENT_69	[p4l929t733r1179b806],

1	Each	DT	O	each	det	2	SENT_70	[p4l1218t733r1387b792],
2	patient	NN	O	patient	nsubjpass	5	SENT_70	[p4l1421t733r1653b810],
3	was	VBD	O	be	auxpass	5	SENT_70	[p4l1688t751r1815b793],
4	carefully	RB	O	carefully	advmod	5	SENT_70	[p4l1853t733r2152b810],
5	informed	VBN	O	inform	_	0	SENT_70	[p4l7t835r318b895],
6	and	CC	O	and	_	0	SENT_70	[p4l359t835r478b895],
7	signed	VBN	O	sign	conj_and	5	SENT_70	[p4l521t835r739b912],
8	a	DT	O	a	det	10	SENT_70	[p4l780t854r815b895],
9	consent	NN	O	consent	nn	10	SENT_70	[p4l855t844r1113b895],
10	form	NN	O	form	dobj	5	SENT_70	[p4l1153t835r1317b895],
11	for	IN	O	for	_	0	SENT_70	[p4l1356t835r1455b895],
12	the	DT	O	the	det	13	SENT_70	[p4l1493t835r1595b895],
13	study	NN	O	study	prep_for	5	SENT_70	[p4l1638t835r1817b912],
14	that	WDT	O	that	nsubjpass	16	SENT_70	[p4l1857t835r1984b895],
15	was	VBD	O	be	auxpass	16	SENT_70	[p4l2024t854r2151b895],
16	approved	VBN	O	approve	rcmod	13	SENT_70	[p4l9t937r320b1014],
17	by	IN	O	by	_	0	SENT_70	[p4l332t937r416b1014],
18	the	DT	O	the	det	21	SENT_70	[p4l431t937r532b997],
19	Internal	JJ	ORGANIZATION	internal	amod	21	SENT_70	[p4l547t937r810b997],
20	Review	NNP	ORGANIZATION	Review	nn	21	SENT_70	[p4l824t937r1078b997],
21	Board	NNP	ORGANIZATION	Board	agent	16	SENT_70	[p4l1093t937r1316b997],
22	.	.	O	.	_	0	SENT_70	[p4l1093t937r1316b997],

1	From	IN	O	from	_	0	SENT_71	[p4l1334t939r1518b997],
2	each	DT	O	each	det	3	SENT_71	[p4l1533t937r1686b997],
3	patient	NN	O	patient	prep_from	9	SENT_71	[p4l1699t937r1931b1014],
4	4.5	CD	NUMBER	4.5	num	5	SENT_71	[p4l1944t937r2044b997],
5	ml	NN	O	ml	nsubjpass	16	SENT_71	[p4l2065t937r2152b996],
6	of	IN	O	of	_	0	SENT_71	[p4l8t1039r81b1098],
7	blood	NN	O	blood	prep_of	5	SENT_71	[p4l100t1039r294b1098],
8	were	VBD	O	be	auxpass	9	SENT_71	[p4l320t1057r482b1099],
9	drawn	VBN	O	draw	_	0	SENT_71	[p4l509t1039r718b1099],
10	in	IN	O	in	_	0	SENT_71	[p4l744t1039r808b1098],
11	the	DT	O	the	det	12	SENT_71	[p4l834t1039r935b1098],
12	presence	NN	O	presence	prep_in	9	SENT_71	[p4l961t1057r1257b1116],
13	of	IN	O	of	_	0	SENT_71	[p4l1284t1039r1358b1098],
14	EDTA	NN	O	edta	prep_of	12	SENT_71	[p4l1378t1039r1595b1098],
15	and	CC	O	and	_	0	SENT_71	[p4l1623t1039r1742b1098],
16	kept	VBD	O	keep	conj_and	9	SENT_71	[p4l1767t1039r1913b1116],
17	frozen	VBN	O	freeze	dep	16	SENT_71	[p4l1937t1039r2153b1098],
18	until	IN	O	until	_	0	SENT_71	[p4l6t1140r161b1200],
19	DNA	NN	O	dna	nn	20	SENT_71	[p4l184t1141r364b1200],
20	extraction	NN	O	extraction	prep_until	17	SENT_71	[p4l388t1140r742b1200],
21	.	.	O	.	_	0	SENT_71	[p4l388t1140r742b1200],

1	Simvastatin	NNP	O	Simvastatin	nn	6	SENT_72	[p4l736t1292r890b1316],
2	Fluvastatin	NNP	O	Fluvastatin	nn	6	SENT_72	[p4l1002t1292r1148b1316],
3	Pravastatin	NNP	O	Pravastatin	nn	6	SENT_72	[p4l1269t1292r1414b1316],
4	Atorvastatin	NNP	O	Atorvastatin	nn	6	SENT_72	[p4l1536t1292r1698b1316],
5	Rosuvastatin	NNP	O	Rosuvastatin	nn	6	SENT_72	[p4l1820t1292r1990b1316],
6	Total	NNP	O	Total	_	0	SENT_72	[p4l2088t1292r2154b1316],

1	Demographic	JJ	MISC	demographic	_	0	SENT_73	[p4l6t1374r362b1434],
2	and	CC	O	and	_	0	SENT_73	[p4l383t1374r476b1420],
3	clinical	JJ	O	clinical	amod	4	SENT_73	[p4l494t1374r686b1420],
4	characteristics	NNS	O	characteristic	conj_and	1	SENT_73	[p4l705t1374r1078b1420],

1	Sex	NN	O	sex	_	0	SENT_74	[p4l74t1457r168b1503],

1	Women	NNS	O	woman	dep	10	SENT_75	[p4l137t1539r340b1585],
2	(	CD	PERCENT	(	num	3	SENT_75	[p4l360t1538r453b1595],
3	%	NN	PERCENT	%	dep	1	SENT_75	[p4l360t1538r453b1595],
4	)	CD	NUMBER	)	number	5	SENT_75	[p4l360t1538r453b1595],
5	11	CD	NUMBER	11	dep	3	SENT_75	[p4l1294t1539r1346b1584],
6	(	NN	O	(	dep	10	SENT_75	[p4l1372t1538r1526b1595],
7	45.8	CD	NUMBER	45.8	num	6	SENT_75	[p4l1372t1538r1526b1595],
8	)	CD	NUMBER	)	num	10	SENT_75	[p4l1372t1538r1526b1595],
9	5	CD	NUMBER	5	num	10	SENT_75	[p4l1819t1538r1846b1585],
10	(	NN	O	(	dep	18	SENT_75	[p4l1870t1539r2023b1595],
11	83.3	CD	NUMBER	83.3	number	12	SENT_75	[p4l1870t1539r2023b1595],
12	)	CD	NUMBER	)	num	13	SENT_75	[p4l1870t1539r2023b1595],
13	Men	NN	O	man	dep	10	SENT_75	[p4l138t1621r257b1666],
14	(	CD	PERCENT	(	num	15	SENT_75	[p4l277t1620r371b1677],
15	%	NN	PERCENT	%	dep	13	SENT_75	[p4l277t1620r371b1677],
16	)	CD	NUMBER	)	number	17	SENT_75	[p4l277t1620r371b1677],
17	13	CD	NUMBER	13	num	15	SENT_75	[p4l1294t1621r1348b1667],
18	(	NN	O	(	dep	20	SENT_75	[p4l1372t1620r1526b1677],
19	54.2	CD	NUMBER	54.2	num	18	SENT_75	[p4l1372t1620r1526b1677],
20	)	NN	O	)	dep	22	SENT_75	[p4l1372t1620r1526b1677],
21	1	CD	NUMBER	1	num	20	SENT_75	[p4l1824t1621r1843b1666],
22	(	CD	NUMBER	(	dep	24	SENT_75	[p4l1870t1620r2023b1677],
23	16.7	CD	NUMBER	16.7	num	24	SENT_75	[p4l1870t1620r2023b1677],
24	)	NN	O	)	_	0	SENT_75	[p4l1870t1620r2023b1677],

1	Age	NNP	O	Age	nsubj	3	SENT_76	[p4l72t1744r180b1804],
2	(	CD	NUMBER	(	num	1	SENT_76	[p4l201t1744r362b1801],
3	mean	VB	O	mean	_	0	SENT_76	[p4l201t1744r362b1801],
4	:1	CD	NUMBER	:1	dobj	3	SENT_76	[p4l377t1745r422b1789],
5	:	:	O	:	_	0	SENT_76	[p4l377t1745r422b1789],
6	S.D.	NNP	LOCATION	S.D.	nn	7	SENT_76	[p4l438t1744r588b1801],
7	)	NNP	O	)	dep	4	SENT_76	[p4l438t1744r588b1801],
8	,	,	O	,	_	0	SENT_76	[p4l438t1744r588b1801],
9	year	NN	DURATION	year	appos	7	SENT_76	[p4l609t1758r722b1804],
10	63.7	CD	NUMBER	63.7	number	11	SENT_76	[p4l1289t1744r1399b1790],
11	:1	CD	NUMBER	:1	dep	9	SENT_76	[p4l1417t1745r1462b1789],
12	:	:	O	:	_	0	SENT_76	[p4l1417t1745r1462b1789],
13	7.1	CD	NUMBER	7.1	number	14	SENT_76	[p4l1477t1744r1552b1790],
14	63.1	CD	NUMBER	63.1	dep	9	SENT_76	[p4l1819t1744r1926b1790],
15	ﬂ	NN	O	ﬂ	dep	14	SENT_76	[p4l1947t1745r1992b1789],
16	:	:	O	:	_	0	SENT_76	[p4l1947t1745r1992b1789],
17	6.3	CD	NUMBER	6.3	num	18	SENT_76	[p4l2008t1744r2084b1790],
18	Age	NNP	O	Age	dep	9	SENT_76	[p4l72t1826r180b1886],
19	(	CD	NUMBER	(	num	18	SENT_76	[p4l201t1826r385b1886],
20	range	NN	O	range	nn	22	SENT_76	[p4l201t1826r385b1886],
21	)	CD	NUMBER	)	num	22	SENT_76	[p4l201t1826r385b1886],
22	year	NN	NUMBER	year	dep	18	SENT_76	[p4l405t1840r519b1886],
23	48-73	CD	NUMBER	48-73	num	24	SENT_76	[p4l1287t1826r1448b1872],
24	56-70	CD	NUMBER	56-70	dep	18	SENT_76	[p4l1819t1825r1981b1872],

1	TC	NN	O	tc	nn	4	SENT_77	[p4l6t1921r88b1967],
2	(	CD	NUMBER	(	num	4	SENT_77	[p4l109t1921r211b1980],
3	mg	NN	O	mg	nn	4	SENT_77	[p4l109t1921r211b1980],
4	dl	NN	O	dl	_	0	SENT_77	[p4l225t1908r361b1977],
5	‘	NN	O	‘	dep	4	SENT_77	[p4l225t1908r361b1977],
6	1	CD	NUMBER	1	number	7	SENT_77	[p4l225t1908r361b1977],
7	)	CD	NUMBER	)	dep	5	SENT_77	[p4l225t1908r361b1977],
8	298.5	CD	NUMBER	298.5	number	9	SENT_77	[p4l1288t1920r1431b1967],
9	:1:45.4	CD	TIME	:1:45.4	dep	4	SENT_77	[p4l1450t1920r1623b1967],
10	301.6:1:61.6	CD	NUMBER	301.6:1:61.6	num	11	SENT_77	[p4l1820t1920r2153b1967],
11	LDL	NN	O	ldl	dep	9	SENT_77	[p4l6t2003r197b2049],
12	.	.	O	.	_	0	SENT_77	[p4l6t2003r197b2049],

1	—	NN	O	—	_	0	SENT_78	[p4l6t2003r197b2049],
2	.	.	O	.	_	0	SENT_78	[p4l6t2003r197b2049],

1	C	NN	O	c	nn	4	SENT_79	[p4l6t2003r197b2049],
2	(	CD	NUMBER	(	num	4	SENT_79	[p4l219t2003r320b2062],
3	mg	NN	O	mg	nn	4	SENT_79	[p4l219t2003r320b2062],
4	dl	NN	O	dl	_	0	SENT_79	[p4l335t1990r471b2060],
5	‘	NN	O	‘	dep	4	SENT_79	[p4l335t1990r471b2060],
6	1	CD	NUMBER	1	number	7	SENT_79	[p4l335t1990r471b2060],
7	)	CD	NUMBER	)	num	9	SENT_79	[p4l335t1990r471b2060],
8	217.6	CD	NUMBER	217.6	number	9	SENT_79	[p4l1288t2002r1434b2049],
9	:1	CD	NUMBER	:1	dep	5	SENT_79	[p4l1450t2003r1495b2048],
10	:	:	O	:	_	0	SENT_79	[p4l1450t2003r1495b2048],
11	44.4	CD	NUMBER	44.4	number	12	SENT_79	[p4l1509t2003r1623b2049],
12	221.2	CD	NUMBER	221.2	dep	5	SENT_79	[p4l1819t2003r1964b2049],
13	:1	CD	NUMBER	:1	dep	12	SENT_79	[p4l1980t2003r2025b2048],
14	:	:	O	:	_	0	SENT_79	[p4l1980t2003r2025b2048],
15	64.7	CD	NUMBER	64.7	dep	5	SENT_79	[p4l2041t2002r2151b2049],
16	HDL	NN	O	hdl	dep	15	SENT_79	[p4l6t2085r205b2131],
17	.	.	O	.	_	0	SENT_79	[p4l6t2085r205b2131],

1	—	NN	O	—	_	0	SENT_80	[p4l6t2085r205b2131],
2	.	.	O	.	_	0	SENT_80	[p4l6t2085r205b2131],

1	C	NN	O	c	nn	4	SENT_81	[p4l6t2085r205b2131],
2	(	CD	NUMBER	(	num	4	SENT_81	[p4l226t2085r328b2144],
3	mg	NN	O	mg	nn	4	SENT_81	[p4l226t2085r328b2144],
4	(	NN	O	(	_	0	SENT_81	[p4l342t2072r478b2141],
5	11-1	CD	NUMBER	11-1	num	6	SENT_81	[p4l342t2072r478b2141],
6	)	CD	NUMBER	)	dep	4	SENT_81	[p4l342t2072r478b2141],
7	52.7	CD	NUMBER	52.7	number	8	SENT_81	[p4l1289t2084r1399b2131],
8	:1	CD	NUMBER	:1	dep	6	SENT_81	[p4l1417t2085r1462b2130],
9	:	:	O	:	_	0	SENT_81	[p4l1417t2085r1462b2130],
10	13.0	CD	NUMBER	13.0	number	11	SENT_81	[p4l1483t2085r1590b2131],
11	54.7	CD	NUMBER	54.7	dep	6	SENT_81	[p4l1819t2084r1930b2131],
12	:1	CD	NUMBER	:1	dep	11	SENT_81	[p4l1947t2085r1992b2130],
13	:	:	O	:	_	0	SENT_81	[p4l1947t2085r1992b2130],
14	12.8	CD	NUMBER	12.8	num	15	SENT_81	[p4l2013t2085r2118b2131],
15	TG	NN	O	tg	dep	6	SENT_81	[p4l6t2167r93b2213],
16	(	CD	NUMBER	(	num	19	SENT_81	[p4l112t2167r214b2226],
17	mg	NN	O	mg	nn	19	SENT_81	[p4l112t2167r214b2226],
18	dl	NN	O	dl	nn	19	SENT_81	[p4l228t2154r365b2223],
19	‘	NN	O	‘	dep	15	SENT_81	[p4l228t2154r365b2223],
20	1	CD	NUMBER	1	number	21	SENT_81	[p4l228t2154r365b2223],
21	)	CD	NUMBER	)	num	23	SENT_81	[p4l228t2154r365b2223],
22	144.2	CD	NUMBER	144.2	number	23	SENT_81	[p4l1294t2167r1434b2213],
23	:1	CD	NUMBER	:1	dep	19	SENT_81	[p4l1450t2167r1495b2212],
24	:	:	O	:	_	0	SENT_81	[p4l1450t2167r1495b2212],
25	59.4	CD	NUMBER	59.4	number	26	SENT_81	[p4l1511t2166r1623b2213],
26	129.2	CD	NUMBER	129.2	dep	6	SENT_81	[p4l1824t2167r1964b2213],
27	:1	CD	NUMBER	:1	num	29	SENT_81	[p4l1980t2167r2025b2212],
28	:	:	O	:	_	0	SENT_81	[p4l1980t2167r2025b2212],
29	77.2	CD	NUMBER	77.2	dep	26	SENT_81	[p4l2040t2167r2153b2213],

1	Patients	NNS	O	patient	dep	8	SENT_82	[p4l6t2290r211b2336],
2	with	IN	O	with	_	0	SENT_82	[p4l231t2290r346b2336],
3	hypercholesterolaemia	NN	O	hypercholesterolaemia	prep_with	1	SENT_82	[p4l364t2290r961b2350],
4	(	CD	PERCENT	(	num	5	SENT_82	[p4l980t2290r1073b2347],
5	%	NN	PERCENT	%	dep	8	SENT_82	[p4l980t2290r1073b2347],
6	)	CD	NUMBER	)	number	7	SENT_82	[p4l980t2290r1073b2347],
7	19	CD	NUMBER	19	num	8	SENT_82	[p4l1294t2290r1350b2337],
8	(	NN	O	(	dep	22	SENT_82	[p4l1372t2290r1526b2347],
9	79.2	CD	NUMBER	79.2	number	10	SENT_82	[p4l1372t2290r1526b2347],
10	)	CD	NUMBER	)	num	15	SENT_82	[p4l1372t2290r1526b2347],
11	5	CD	NUMBER	5	num	15	SENT_82	[p4l1819t2290r1846b2337],
12	(	NN	O	(	nn	15	SENT_82	[p4l1870t2290r2023b2347],
13	83.3	CD	NUMBER	83.3	number	14	SENT_82	[p4l1870t2290r2023b2347],
14	)	CD	NUMBER	)	num	15	SENT_82	[p4l1870t2290r2023b2347],
15	Patients	NNS	O	patient	npadvmod	8	SENT_82	[p4l6t2372r211b2418],
16	with	IN	O	with	_	0	SENT_82	[p4l231t2372r346b2418],
17	hypercholesterolaemia	NN	O	hypercholesterolaemia	prep_with	8	SENT_82	[p4l364t2372r961b2432],
18	and	CC	O	and	_	0	SENT_82	[p4l979t2372r1072b2418],
19	5	CD	NUMBER	5	num	20	SENT_82	[p4l1289t2372r1316b2419],
20	(	CD	NUMBER	(	prep_with	8	SENT_82	[p4l1339t2372r1493b2429],
21	20.8	CD	NUMBER	20.8	num	22	SENT_82	[p4l1339t2372r1493b2429],
22	)	NN	O	)	_	0	SENT_82	[p4l1339t2372r1493b2429],
23	1	CD	NUMBER	1	number	24	SENT_82	[p4l1824t2372r1843b2418],
24	(	CD	NUMBER	(	dep	22	SENT_82	[p4l1870t2372r2023b2429],
25	16.7	CD	NUMBER	16.7	num	26	SENT_82	[p4l1870t2372r2023b2429],
26	)	NN	O	)	dep	24	SENT_82	[p4l1870t2372r2023b2429],

1	hypertriglyceridaemia	NN	O	hypertriglyceridaemia	_	0	SENT_83	[p4l71t2454r654b2514],
2	(	CD	PERCENT	(	num	3	SENT_83	[p4l673t2454r766b2511],
3	%	NN	PERCENT	%	dep	1	SENT_83	[p4l673t2454r766b2511],
4	)	CD	NUMBER	)	dep	1	SENT_83	[p4l673t2454r766b2511],

1	Medical	JJ	O	medical	amod	2	SENT_84	[p4l6t2536r220b2582],
2	history	NN	O	history	_	0	SENT_84	[p4l238t2536r420b2596],

1	Myocardial	JJ	O	myocardial	amod	2	SENT_85	[p4l71t2618r374b2678],
2	infartion	NN	O	infartion	dep	11	SENT_85	[p4l393t2618r618b2664],
3	(	CD	PERCENT	(	num	4	SENT_85	[p4l638t2618r731b2675],
4	%	NN	PERCENT	%	dep	2	SENT_85	[p4l638t2618r731b2675],
5	)	CD	NUMBER	)	number	6	SENT_85	[p4l638t2618r731b2675],
6	3	CD	NUMBER	3	num	7	SENT_85	[p4l1289t2618r1316b2665],
7	(	NN	O	(	dep	4	SENT_85	[p4l1339t2618r1493b2675],
8	12.5	CD	NUMBER	12.5	num	9	SENT_85	[p4l1339t2618r1493b2675],
9	)	NN	O	)	dep	11	SENT_85	[p4l1339t2618r1493b2675],
10	1	CD	NUMBER	1	num	11	SENT_85	[p4l1824t2618r1843b2664],
11	(	CD	NUMBER	(	dep	18	SENT_85	[p4l1870t2618r2023b2675],
12	16.7	CD	NUMBER	16.7	number	13	SENT_85	[p4l1870t2618r2023b2675],
13	)	CD	NUMBER	)	dep	11	SENT_85	[p4l1870t2618r2023b2675],
14	Peripheral	JJ	O	peripheral	amod	16	SENT_85	[p4l72t2700r341b2760],
15	vascular	JJ	O	vascular	amod	16	SENT_85	[p4l360t2700r577b2746],
16	disease	NN	O	disease	dep	13	SENT_85	[p4l595t2700r783b2746],
17	(	CD	PERCENT	(	num	18	SENT_85	[p4l804t2700r896b2757],
18	%	NN	PERCENT	%	dep	28	SENT_85	[p4l804t2700r896b2757],
19	)	CD	NUMBER	)	num	22	SENT_85	[p4l804t2700r896b2757],
20	o	NN	O	o	nn	22	SENT_85	[p4l1288t2700r1319b2747],
21	(	NN	O	(	nn	22	SENT_85	[p4l1339t2700r1410b2757],
22	o	NN	O	o	dep	18	SENT_85	[p4l1339t2700r1410b2757],
23	)	CD	NUMBER	)	number	24	SENT_85	[p4l1339t2700r1410b2757],
24	1	CD	NUMBER	1	num	25	SENT_85	[p4l1824t2700r1843b2746],
25	(	NN	O	(	dep	22	SENT_85	[p4l1870t2700r2023b2757],
26	16.7	CD	NUMBER	16.7	number	27	SENT_85	[p4l1870t2700r2023b2757],
27	)	CD	NUMBER	)	num	25	SENT_85	[p4l1870t2700r2023b2757],
28	Angina	NNP	ORGANIZATION	Angina	dep	38	SENT_85	[p4l72t2782r266b2842],
29	(	CD	PERCENT	(	num	30	SENT_85	[p4l285t2782r378b2839],
30	%	NN	PERCENT	%	dep	28	SENT_85	[p4l285t2782r378b2839],
31	)	CD	NUMBER	)	number	32	SENT_85	[p4l285t2782r378b2839],
32	3	CD	NUMBER	3	num	30	SENT_85	[p4l1289t2783r1316b2829],
33	(	NN	O	(	nn	36	SENT_85	[p4l1339t2782r1493b2839],
34	12.5	CD	NUMBER	12.5	num	36	SENT_85	[p4l1339t2782r1493b2839],
35	)	NN	O	)	nn	36	SENT_85	[p4l1339t2782r1493b2839],
36	o	NN	O	o	dep	30	SENT_85	[p4l1818t2782r1849b2829],
37	(	CD	NUMBER	(	num	38	SENT_85	[p4l1870t2783r1941b2839],
38	o	NN	O	o	dep	45	SENT_85	[p4l1870t2783r1941b2839],
39	)	CD	NUMBER	)	num	40	SENT_85	[p4l1870t2783r1941b2839],
40	Hypertension	NN	O	hypertension	dep	38	SENT_85	[p4l72t2864r426b2924],
41	(	CD	PERCENT	(	num	42	SENT_85	[p4l446t2864r539b2921],
42	%	NN	PERCENT	%	dep	40	SENT_85	[p4l446t2864r539b2921],
43	)	CD	NUMBER	)	number	44	SENT_85	[p4l446t2864r539b2921],
44	8	CD	NUMBER	8	num	42	SENT_85	[p4l1290t2865r1317b2911],
45	(	NN	O	(	dep	49	SENT_85	[p4l1339t2865r1493b2921],
46	33.3	CD	NUMBER	33.3	num	45	SENT_85	[p4l1339t2865r1493b2921],
47	)	CD	NUMBER	)	num	49	SENT_85	[p4l1339t2865r1493b2921],
48	5	CD	NUMBER	5	num	49	SENT_85	[p4l1819t2864r1846b2911],
49	(	NN	O	(	dep	54	SENT_85	[p4l1870t2865r2023b2921],
50	83.3	CD	NUMBER	83.3	number	51	SENT_85	[p4l1870t2865r2023b2921],
51	)	CD	NUMBER	)	dep	49	SENT_85	[p4l1870t2865r2023b2921],
52	Diabetes	NNP	O	Diabetes	dep	51	SENT_85	[p4l72t2946r300b2992],
53	(	CD	PERCENT	(	num	54	SENT_85	[p4l322t2946r415b3003],
54	%	NN	PERCENT	%	dep	62	SENT_85	[p4l322t2946r415b3003],
55	)	CD	NUMBER	)	number	56	SENT_85	[p4l322t2946r415b3003],
56	2	CD	NUMBER	2	dep	54	SENT_85	[p4l1288t2947r1318b2992],
57	(	NN	O	(	nn	60	SENT_85	[p4l1339t2947r1460b3003],
58	8.3	CD	NUMBER	8.3	num	60	SENT_85	[p4l1339t2947r1460b3003],
59	)	NN	O	)	nn	60	SENT_85	[p4l1339t2947r1460b3003],
60	o	NN	O	o	dep	56	SENT_85	[p4l1818t2946r1849b2993],
61	(	CD	NUMBER	(	num	62	SENT_85	[p4l1870t2947r1941b3003],
62	o	NN	O	o	dep	63	SENT_85	[p4l1870t2947r1941b3003],
63	)	CD	NUMBER	)	_	0	SENT_85	[p4l1870t2947r1941b3003],

1	Adverse	JJ	O	adverse	amod	2	SENT_86	[p4l6t3070r223b3116],
2	events	NNS	O	event	_	0	SENT_86	[p4l242t3077r404b3116],

1	Patients	NNS	O	patient	dep	6	SENT_87	[p4l72t3151r276b3197],
2	with	IN	O	with	_	0	SENT_87	[p4l297t3151r413b3197],
3	AEs	NNS	O	ae	prep_with	1	SENT_87	[p4l430t3151r541b3197],
4	13	CD	NUMBER	13	dep	6	SENT_87	[p4l1294t3151r1348b3197],
5	5	CD	NUMBER	5	num	6	SENT_87	[p4l1819t3150r1846b3197],
6	Patients	NNS	O	patient	dep	10	SENT_87	[p4l72t3232r277b3278],
7	without	IN	O	without	_	0	SENT_87	[p4l297t3232r497b3278],
8	AEs	NNS	O	ae	prep_without	6	SENT_87	[p4l514t3232r625b3278],
9	11	CD	NUMBER	11	num	10	SENT_87	[p4l1294t3232r1346b3277],
10	1	CD	NUMBER	1	_	0	SENT_87	[p4l1824t3232r1843b3277],

1	Values	NNS	O	value	nsubj	10	SENT_88	[p5l6t1526r93b1550],
2	are	VBP	O	be	cop	3	SENT_88	[p5l106t1533r145b1550],
3	numbers	NNS	O	number	_	0	SENT_88	[p5l158t1526r270b1550],
4	of	IN	O	of	_	0	SENT_88	[p5l284t1526r312b1550],
5	each	DT	O	each	det	6	SENT_88	[p5l323t1526r383b1550],
6	group	NN	O	group	prep_of	3	SENT_88	[p5l395t1534r479b1557],
7	,	,	O	,	_	0	SENT_88	[p5l395t1534r479b1557],
8	range	NN	O	range	appos	6	SENT_88	[p5l492t1534r565b1557],
9	or	CC	O	or	_	0	SENT_88	[p5l577t1534r605b1550],
10	mean	VB	O	mean	conj_or	3	SENT_88	[p5l617t1534r687b1550],
11	:1	CD	NUMBER	:1	dobj	10	SENT_88	[p5l699t1526r722b1550],
12	:	:	O	:	_	0	SENT_88	[p5l699t1526r722b1550],
13	S.D.	NNP	O	S.D.	dep	10	SENT_88	[p5l734t1526r800b1554],
14	;	:	O	;	_	0	SENT_88	[p5l734t1526r800b1554],
15	TC	NNP	O	TC	dep	13	SENT_88	[p5l814t1526r862b1554],
16	,	,	O	,	_	0	SENT_88	[p5l814t1526r862b1554],
17	total	JJ	O	total	amod	18	SENT_88	[p5l876t1526r933b1550],
18	cholesterol	NN	O	cholesterol	appos	15	SENT_88	[p5l946t1526r1099b1554],
19	;	:	O	;	_	0	SENT_88	[p5l946t1526r1099b1554],
20	LDL	NN	O	ldl	dep	13	SENT_88	[p5l1112t1526r1216b1554],
21	.	.	O	.	_	0	SENT_88	[p5l1112t1526r1216b1554],

1	—	NN	O	—	_	0	SENT_89	[p5l1112t1526r1216b1554],
2	.	.	O	.	_	0	SENT_89	[p5l1112t1526r1216b1554],

1	C	NN	O	c	_	0	SENT_90	[p5l1112t1526r1216b1554],
2	,	,	O	,	_	0	SENT_90	[p5l1112t1526r1216b1554],
3	LDL	NN	O	ldl	nn	4	SENT_90	[p5l1230t1527r1294b1550],
4	cholesterol	NN	O	cholesterol	appos	1	SENT_90	[p5l1306t1526r1459b1554],
5	;	:	O	;	_	0	SENT_90	[p5l1306t1526r1459b1554],
6	HDL	NNP	O	HDL	dep	1	SENT_90	[p5l1472t1526r1580b1554],
7	.	.	O	.	_	0	SENT_90	[p5l1472t1526r1580b1554],

1	—	NN	O	—	_	0	SENT_91	[p5l1472t1526r1580b1554],
2	.	.	O	.	_	0	SENT_91	[p5l1472t1526r1580b1554],

1	C	NN	O	c	_	0	SENT_92	[p5l1472t1526r1580b1554],
2	,	,	O	,	_	0	SENT_92	[p5l1472t1526r1580b1554],
3	HDL	NN	O	hdl	nn	4	SENT_92	[p5l1593t1527r1661b1550],
4	cholesterol	NN	O	cholesterol	appos	1	SENT_92	[p5l1674t1526r1826b1554],
5	;	:	O	;	_	0	SENT_92	[p5l1674t1526r1826b1554],
6	TG	NN	O	tg	dep	1	SENT_92	[p5l1840t1526r1890b1554],
7	,	,	O	,	_	0	SENT_92	[p5l1840t1526r1890b1554],
8	triglycerides	NNS	O	triglyceride	appos	6	SENT_92	[p5l1904t1526r2077b1557],
9	;	:	O	;	_	0	SENT_92	[p5l1904t1526r2077b1557],
10	AEs	NNS	O	ae	dep	1	SENT_92	[p5l2091t1527r2154b1554],
11	,	,	O	,	_	0	SENT_92	[p5l2091t1527r2154b1554],
12	adverse	JJ	O	adverse	amod	13	SENT_92	[p5l6t1560r105b1584],
13	events	NNS	O	event	appos	10	SENT_92	[p5l113t1564r202b1584],
14	.	.	O	.	_	0	SENT_92	[p5l113t1564r202b1584],

1	312	CD	NUMBER	312	num	3	SENT_93	[p5l6t1608r54b1632],
2	P.	NNP	PERSON	P.	nn	3	SENT_93	[p5l655t1609r676b1632],
3	Zuccaro	NNP	PERSON	Zuccaro	_	0	SENT_93	[p5l687t1609r796b1632],
4	et	FW	O	et	nn	5	SENT_93	[p5l806t1612r830b1632],
5	al.	FW	O	al.	dep	3	SENT_93	[p5l838t1608r868b1632],
6	/	:	O	/	punct	18	SENT_93	[p5l878t1608r893b1632],
7	Pharmacological	JJ	O	pharmacological	amod	17	SENT_93	[p5l897t1608r1128b1638],
8	Research	NN	O	research	nn	17	SENT_93	[p5l1136t1608r1257b1632],
9	55	CD	NUMBER	55	num	17	SENT_93	[p5l1267t1608r1299b1631],
10	(	CD	NUMBER	(	num	17	SENT_93	[p5l1309t1608r1395b1637],
11	2007	CD	DATE	2007	num	17	SENT_93	[p5l1309t1608r1395b1637],
12	)	CD	NUMBER	)	num	17	SENT_93	[p5l1309t1608r1395b1637],
13	310-31	CD	NUMBER	310-31	num	17	SENT_93	[p5l1405t1608r1501b1631],
14	7	CD	NUMBER	7	num	17	SENT_93	[p5l1507t1608r1522b1632],
15	Table	NNP	O	Table	nn	17	SENT_93	[p5l6t1689r78b1712],
16	2	CD	NUMBER	2	num	17	SENT_93	[p5l88t1689r103b1712],
17	Baseline	NN	O	baseline	dep	18	SENT_93	[p5l6t1729r119b1753],
18	characteristics	NNS	O	characteristic	dep	5	SENT_93	[p5l129t1729r317b1753],
19	of	IN	O	of	_	0	SENT_93	[p5l328t1729r356b1753],
20	patients	NNS	O	patient	prep_of	18	SENT_93	[p5l363t1729r465b1760],
21	with	IN	O	with	_	0	SENT_93	[p5l475t1729r533b1753],
22	and	CC	O	and	_	0	SENT_93	[p5l543t1729r590b1753],
23	without	IN	O	without	_	0	SENT_93	[p5l599t1729r700b1753],
24	AEs	NNS	O	ae	prep_with	5	SENT_93	[p5l709t1730r764b1753],

1	With	IN	O	with	mark	2	SENT_94	[p5l1189t1793r1254b1817],
2	AEs	NNS	O	ae	_	0	SENT_94	[p5l1263t1793r1319b1817],
3	Without	IN	O	without	dep	2	SENT_94	[p5l1982t1793r2090b1817],
4	AEs	NNS	O	ae	pobj	3	SENT_94	[p5l2098t1793r2154b1817],

1	Total	JJ	O	total	amod	2	SENT_95	[p5l6t1857r72b1881],
2	number	NN	O	number	_	0	SENT_95	[p5l82t1857r183b1881],
3	for	IN	O	for	_	0	SENT_95	[p5l192t1857r230b1881],
4	group	NN	O	group	prep_for	2	SENT_95	[p5l239t1865r315b1888],
5	(	CD	PERCENT	(	num	6	SENT_95	[p5l325t1857r372b1886],
6	%	NN	PERCENT	%	dep	4	SENT_95	[p5l325t1857r372b1886],
7	)	CD	NUMBER	)	number	8	SENT_95	[p5l325t1857r372b1886],
8	50	CD	NUMBER	50	num	6	SENT_95	[p5l1178t1857r1264b1886],
9	(	CD	NUMBER	(	number	10	SENT_95	[p5l1178t1857r1264b1886],
10	50	CD	NUMBER	50	num	12	SENT_95	[p5l1178t1857r1264b1886],
11	)	CD	NUMBER	)	number	12	SENT_95	[p5l1178t1857r1264b1886],
12	50	CD	NUMBER	50	dep	6	SENT_95	[p5l1971t1857r2057b1886],
13	(	CD	NUMBER	(	number	14	SENT_95	[p5l1971t1857r2057b1886],
14	50	CD	NUMBER	50	num	12	SENT_95	[p5l1971t1857r2057b1886],
15	)	CD	NUMBER	)	num	16	SENT_95	[p5l1971t1857r2057b1886],
16	Females	NNS	O	female	amod	6	SENT_95	[p5l6t1899r115b1923],
17	28	CD	NUMBER	28	num	19	SENT_95	[p5l1178t1899r1209b1923],
18	27	CD	NUMBER	27	num	19	SENT_95	[p5l1971t1899r2002b1923],
19	Males	NNS	O	male	dep	16	SENT_95	[p5l2012t1899r2092b1923],
20	22	CD	NUMBER	22	number	21	SENT_95	[p5l6t1940r38b1964],
21	23	CD	NUMBER	23	num	24	SENT_95	[p5l799t1940r829b1964],
22	Age	NNP	O	Age	nn	24	SENT_95	[p5l840t1940r894b1971],
23	(	CD	NUMBER	(	num	24	SENT_95	[p5l904t1941r977b1971],
24	year	NN	NUMBER	year	dep	19	SENT_95	[p5l904t1941r977b1971],
25	,	,	O	,	_	0	SENT_95	[p5l904t1941r977b1971],
26	mean	VB	O	mean	dep	29	SENT_95	[p5l987t1948r1058b1964],
27	:1	CD	NUMBER	:1	dobj	26	SENT_95	[p5l1066t1941r1088b1964],
28	:	:	O	:	_	0	SENT_95	[p5l1066t1941r1088b1964],
29	S.D.	NNP	LOCATION	S.D.	appos	19	SENT_95	[p5l1097t1940r1164b1969],
30	)	CD	NUMBER	)	num	29	SENT_95	[p5l1097t1940r1164b1969],
31	61.4	CD	NUMBER	61.4	number	32	SENT_95	[p5l2012t1940r2068b1964],
32	:1	CD	NUMBER	:1	dep	29	SENT_95	[p5l2076t1941r2099b1964],
33	:	:	O	:	_	0	SENT_95	[p5l2076t1941r2099b1964],
34	8.9	CD	NUMBER	8.9	num	35	SENT_95	[p5l2107t1940r2146b1964],
35	61.09	CD	NUMBER	61.09	dep	29	SENT_95	[p5l6t1981r173b2005],
36	:	:	O	:	_	0	SENT_95	[p5l6t1981r173b2005],
37	:9.17	CD	NUMBER	:9.17	num	38	SENT_95	[p5l6t1981r173b2005],
38	TC	NN	O	tc	dep	35	SENT_95	[p5l184t1981r225b2005],
39	(	CD	NUMBER	(	num	41	SENT_95	[p5l236t1975r363b2012],
40	mgdl	NN	O	mgdl	nn	41	SENT_95	[p5l236t1975r363b2012],
41	‘	NN	O	‘	dep	38	SENT_95	[p5l236t1975r363b2012],
42	1	CD	NUMBER	1	number	43	SENT_95	[p5l236t1975r363b2012],
43	)	CD	NUMBER	)	num	44	SENT_95	[p5l236t1975r363b2012],
44	305.24	CD	NUMBER	305.24	dep	41	SENT_95	[p5l1356t1981r1446b2005],
45	:	:	O	:	_	0	SENT_95	[p5l1454t1992r1476b2005],
46	:	:	O	:	_	0	SENT_95	[p5l1454t1992r1476b2005],
47	49.1	CD	NUMBER	49.1	number	48	SENT_95	[p5l1484t1981r1538b2005],
48	326.76	CD	NUMBER	326.76	dep	35	SENT_95	[p5l6t2022r95b2046],
49	:	:	O	:	_	0	SENT_95	[p5l103t2033r126b2046],
50	:	:	O	:	_	0	SENT_95	[p5l103t2033r126b2046],
51	72.69	CD	NUMBER	72.69	dep	2	SENT_95	[p5l133t2022r206b2046],
52	LDL	NN	O	ldl	dep	51	SENT_95	[p5l217t2022r314b2046],
53	.	.	O	.	_	0	SENT_95	[p5l217t2022r314b2046],

1	—	NN	O	—	_	0	SENT_96	[p5l217t2022r314b2046],
2	.	.	O	.	_	0	SENT_96	[p5l217t2022r314b2046],

1	C	NN	O	c	nn	4	SENT_97	[p5l217t2022r314b2046],
2	(	CD	NUMBER	(	num	4	SENT_97	[p5l325t2023r376b2053],
3	mg	NN	O	mg	nn	4	SENT_97	[p5l325t2023r376b2053],
4	dl	NN	O	dl	_	0	SENT_97	[p5l383t2016r452b2051],
5	‘	NN	O	‘	rcmod	4	SENT_97	[p5l383t2016r452b2051],
6	1	CD	NUMBER	1	num	5	SENT_97	[p5l383t2016r452b2051],
7	)	CD	NUMBER	)	number	8	SENT_97	[p5l383t2016r452b2051],
8	215.87	CD	NUMBER	215.87	dep	5	SENT_97	[p5l1389t2022r1478b2046],
9	:	:	O	:	_	0	SENT_97	[p5l1487t2033r1509b2046],
10	:	:	O	:	_	0	SENT_97	[p5l1487t2033r1509b2046],
11	47.2	CD	NUMBER	47.2	number	12	SENT_97	[p5l1517t2022r1574b2046],
12	243.93	CD	NUMBER	243.93	dep	4	SENT_97	[p5l6t2063r94b2087],
13	:	:	O	:	_	0	SENT_97	[p5l104t2074r126b2087],
14	:	:	O	:	_	0	SENT_97	[p5l104t2074r126b2087],
15	72.35	CD	NUMBER	72.35	num	16	SENT_97	[p5l134t2063r206b2087],
16	HDL	NN	O	hdl	dep	4	SENT_97	[p5l217t2063r317b2087],
17	.	.	O	.	_	0	SENT_97	[p5l217t2063r317b2087],

1	—	NN	O	—	_	0	SENT_98	[p5l217t2063r317b2087],
2	.	.	O	.	_	0	SENT_98	[p5l217t2063r317b2087],

1	C	NN	O	c	dep	281	SENT_99	[p5l217t2063r317b2087],
2	(	CD	NUMBER	(	dep	281	SENT_99	[p5l328t2064r379b2094],
3	mg	NN	O	mg	dep	281	SENT_99	[p5l328t2064r379b2094],
4	dl	NN	O	dl	dep	281	SENT_99	[p5l386t2057r455b2092],
5	‘	NN	O	‘	dep	281	SENT_99	[p5l386t2057r455b2092],
6	1	CD	NUMBER	1	dep	281	SENT_99	[p5l386t2057r455b2092],
7	)	CD	NUMBER	)	dep	281	SENT_99	[p5l386t2057r455b2092],
8	51.44	CD	NUMBER	51.44	dep	281	SENT_99	[p5l1389t2063r1462b2087],
9	:1:13.0	CD	TIME	:1:13.0	dep	281	SENT_99	[p5l1470t2063r1557b2087],
10	53.90	CD	NUMBER	53.90	dep	281	SENT_99	[p5l6t2104r110b2128],
11	:	:	O	:	_	0	SENT_99	[p5l6t2104r110b2128],
12	:	:	O	:	_	0	SENT_99	[p5l6t2104r110b2128],
13	13.11	CD	NUMBER	13.11	dep	281	SENT_99	[p5l120t2104r188b2128],
14	TG	NN	O	tg	dep	281	SENT_99	[p5l199t2104r243b2128],
15	(	CD	NUMBER	(	dep	281	SENT_99	[p5l253t2098r380b2135],
16	mgd1	NN	O	mgd1	dep	281	SENT_99	[p5l253t2098r380b2135],
17	‘	NN	O	‘	dep	281	SENT_99	[p5l253t2098r380b2135],
18	1	CD	NUMBER	1	dep	281	SENT_99	[p5l253t2098r380b2135],
19	)	CD	NUMBER	)	dep	281	SENT_99	[p5l253t2098r380b2135],
20	191.41	CD	NUMBER	191.41	dep	281	SENT_99	[p5l1373t2104r1491b2128],
21	:	:	O	:	_	0	SENT_99	[p5l1373t2104r1491b2128],
22	t	NN	O	t	dep	281	SENT_99	[p5l1373t2104r1491b2128],
23	103.7	CD	NUMBER	103.7	dep	281	SENT_99	[p5l1502t2105r1571b2128],
24	144.22	CD	NUMBER	144.22	dep	281	SENT_99	[p5l6t2146r93b2169],
25	:1	CD	NUMBER	:1	dep	281	SENT_99	[p5l101t2146r124b2169],
26	:	:	O	:	_	0	SENT_99	[p5l101t2146r124b2169],
27	72.13	CD	NUMBER	72.13	dep	281	SENT_99	[p5l132t2146r204b2169],
28	Concomitant	JJ	O	concomitant	dep	281	SENT_99	[p5l6t2201r177b2224],
29	therapy	NN	O	therapy	dep	281	SENT_99	[p5l185t2201r283b2231],
30	B-Blockers	NNS	O	b-blocker	dep	281	SENT_99	[p5l41t2242r186b2272],
31	(	CD	PERCENT	(	dep	281	SENT_99	[p5l197t2242r244b2271],
32	%	NN	PERCENT	%	dep	281	SENT_99	[p5l197t2242r244b2271],
33	)	CD	NUMBER	)	dep	281	SENT_99	[p5l197t2242r244b2271],
34	14	CD	NUMBER	14	dep	281	SENT_99	[p5l1180t2242r1209b2265],
35	(	NN	O	(	dep	281	SENT_99	[p5l1219t2242r1296b2271],
36	28.0	CD	NUMBER	28.0	dep	281	SENT_99	[p5l1219t2242r1296b2271],
37	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1219t2242r1296b2271],
38	10	CD	NUMBER	10	dep	281	SENT_99	[p5l1973t2242r2002b2265],
39	(	NN	O	(	dep	281	SENT_99	[p5l2012t2242r2089b2271],
40	20.0	CD	NUMBER	20.0	dep	281	SENT_99	[p5l2012t2242r2089b2271],
41	)	CD	NUMBER	)	dep	281	SENT_99	[p5l2012t2242r2089b2271],
42	Calcium	NN	O	calcium	dep	281	SENT_99	[p5l39t2283r151b2306],
43	channel	NN	O	channel	dep	281	SENT_99	[p5l160t2283r262b2306],
44	antagonists	NNS	O	antagonist	dep	281	SENT_99	[p5l272t2283r419b2313],
45	(	CD	PERCENT	(	dep	281	SENT_99	[p5l430t2283r477b2312],
46	%	NN	PERCENT	%	dep	281	SENT_99	[p5l430t2283r477b2312],
47	)	CD	NUMBER	)	dep	281	SENT_99	[p5l430t2283r477b2312],
48	o	NN	O	o	dep	281	SENT_99	[p5l1177t2283r1192b2306],
49	(	NN	O	(	dep	281	SENT_99	[p5l1202t2283r1238b2312],
50	o	NN	O	o	dep	281	SENT_99	[p5l1202t2283r1238b2312],
51	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1202t2283r1238b2312],
52	1	CD	NUMBER	1	dep	281	SENT_99	[p5l1973t2283r1982b2306],
53	(	NN	O	(	dep	281	SENT_99	[p5l1995t2283r2056b2312],
54	2.0	CD	NUMBER	2.0	dep	281	SENT_99	[p5l1995t2283r2056b2312],
55	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2283r2056b2312],
56	Antiarrhythmic	JJ	O	antiarrhythmic	dep	281	SENT_99	[p5l39t2324r242b2355],
57	drugs	NNS	O	drug	dep	281	SENT_99	[p5l252t2324r324b2355],
58	(	CD	PERCENT	(	dep	281	SENT_99	[p5l335t2324r382b2353],
59	%	NN	PERCENT	%	dep	281	SENT_99	[p5l335t2324r382b2353],
60	)	CD	NUMBER	)	dep	281	SENT_99	[p5l335t2324r382b2353],
61	2	CD	NUMBER	2	dep	281	SENT_99	[p5l1177t2324r1192b2348],
62	(	CD	NUMBER	(	dep	281	SENT_99	[p5l1203t2324r1263b2353],
63	4.0	CD	NUMBER	4.0	dep	281	SENT_99	[p5l1203t2324r1263b2353],
64	)	NN	O	)	dep	281	SENT_99	[p5l1203t2324r1263b2353],
65	1	CD	NUMBER	1	dep	281	SENT_99	[p5l1973t2324r1982b2348],
66	(	NN	O	(	dep	281	SENT_99	[p5l1995t2324r2056b2353],
67	2.0	CD	NUMBER	2.0	dep	281	SENT_99	[p5l1995t2324r2056b2353],
68	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2324r2056b2353],
69	Antiplatelet	JJ	O	antiplatelet	dep	281	SENT_99	[p5l39t2365r195b2396],
70	drugs	NNS	O	drug	dep	281	SENT_99	[p5l204t2365r276b2396],
71	(	CD	PERCENT	(	dep	281	SENT_99	[p5l287t2365r334b2394],
72	%	NN	PERCENT	%	dep	281	SENT_99	[p5l287t2365r334b2394],
73	)	CD	NUMBER	)	dep	281	SENT_99	[p5l287t2365r334b2394],
74	19	CD	NUMBER	19	dep	281	SENT_99	[p5l1180t2365r1208b2389],
75	(	NN	O	(	dep	281	SENT_99	[p5l1219t2365r1297b2394],
76	38.0	CD	NUMBER	38.0	dep	281	SENT_99	[p5l1219t2365r1297b2394],
77	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1219t2365r1297b2394],
78	22	CD	NUMBER	22	dep	281	SENT_99	[p5l1970t2365r2001b2389],
79	(	NN	O	(	dep	281	SENT_99	[p5l2012t2365r2089b2394],
80	44.0	CD	NUMBER	44.0	dep	281	SENT_99	[p5l2012t2365r2089b2394],
81	)	CD	NUMBER	)	dep	281	SENT_99	[p5l2012t2365r2089b2394],
82	Coumarin	NN	O	coumarin	dep	281	SENT_99	[p5l39t2406r171b2430],
83	anticoagulants	NNS	O	anticoagulant	dep	281	SENT_99	[p5l181t2406r370b2437],
84	(	CD	PERCENT	(	dep	281	SENT_99	[p5l381t2406r428b2435],
85	%	NN	PERCENT	%	dep	281	SENT_99	[p5l381t2406r428b2435],
86	)	CD	NUMBER	)	dep	281	SENT_99	[p5l381t2406r428b2435],
87	1	CD	NUMBER	1	dep	281	SENT_99	[p5l1180t2406r1189b2430],
88	(	NN	O	(	dep	281	SENT_99	[p5l1202t2406r1263b2435],
89	2.0	CD	NUMBER	2.0	dep	281	SENT_99	[p5l1202t2406r1263b2435],
90	)	NN	O	)	dep	281	SENT_99	[p5l1202t2406r1263b2435],
91	1	CD	NUMBER	1	dep	281	SENT_99	[p5l1973t2406r1982b2430],
92	(	NN	O	(	dep	281	SENT_99	[p5l1995t2406r2056b2435],
93	2.0	CD	NUMBER	2.0	dep	281	SENT_99	[p5l1995t2406r2056b2435],
94	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2406r2056b2435],
95	Immunosuppressive	JJ	O	immunosuppressive	dep	281	SENT_99	[p5l39t2447r304b2478],
96	agents	NNS	O	agent	dep	281	SENT_99	[p5l314t2451r397b2478],
97	(	CD	PERCENT	(	dep	281	SENT_99	[p5l407t2447r454b2476],
98	%	NN	PERCENT	%	dep	281	SENT_99	[p5l407t2447r454b2476],
99	)	CD	NUMBER	)	dep	281	SENT_99	[p5l407t2447r454b2476],
100	1	CD	NUMBER	1	dep	281	SENT_99	[p5l1180t2447r1189b2471],
101	(	NN	O	(	dep	281	SENT_99	[p5l1202t2447r1263b2476],
102	2.0	CD	NUMBER	2.0	dep	281	SENT_99	[p5l1202t2447r1263b2476],
103	)	NN	O	)	dep	281	SENT_99	[p5l1202t2447r1263b2476],
104	o	NN	O	o	dep	281	SENT_99	[p5l1970t2447r1985b2471],
105	(	CD	NUMBER	(	dep	281	SENT_99	[p5l1995t2447r2031b2476],
106	o	NN	O	o	dep	281	SENT_99	[p5l1995t2447r2031b2476],
107	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2447r2031b2476],
108	ACE-inhibitors	NNS	O	ace-inhibitor	dep	281	SENT_99	[p5l39t2488r241b2512],
109	(	CD	PERCENT	(	dep	281	SENT_99	[p5l252t2488r299b2517],
110	%	NN	PERCENT	%	dep	281	SENT_99	[p5l252t2488r299b2517],
111	)	CD	NUMBER	)	dep	281	SENT_99	[p5l252t2488r299b2517],
112	12	CD	NUMBER	12	dep	281	SENT_99	[p5l1180t2488r1209b2511],
113	(	NN	O	(	dep	281	SENT_99	[p5l1219t2488r1297b2517],
114	24.0	CD	NUMBER	24.0	dep	281	SENT_99	[p5l1219t2488r1297b2517],
115	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1219t2488r1297b2517],
116	8	CD	NUMBER	8	dep	281	SENT_99	[p5l1971t2488r1984b2512],
117	(	NN	O	(	dep	281	SENT_99	[p5l1995t2488r2073b2517],
118	16.0	CD	NUMBER	16.0	dep	281	SENT_99	[p5l1995t2488r2073b2517],
119	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2488r2073b2517],
120	Nitrates	NNS	O	nitrate	dep	281	SENT_99	[p5l39t2529r142b2552],
121	(	CD	PERCENT	(	dep	281	SENT_99	[p5l153t2529r200b2558],
122	%	NN	PERCENT	%	dep	281	SENT_99	[p5l153t2529r200b2558],
123	)	CD	NUMBER	)	dep	281	SENT_99	[p5l153t2529r200b2558],
124	2	CD	NUMBER	2	dep	281	SENT_99	[p5l1177t2529r1192b2552],
125	(	CD	NUMBER	(	dep	281	SENT_99	[p5l1202t2529r1263b2558],
126	4.0	CD	NUMBER	4.0	dep	281	SENT_99	[p5l1202t2529r1263b2558],
127	)	NN	O	)	dep	281	SENT_99	[p5l1202t2529r1263b2558],
128	7	CD	NUMBER	7	dep	281	SENT_99	[p5l1970t2530r1984b2552],
129	(	NN	O	(	dep	281	SENT_99	[p5l1995t2529r2073b2558],
130	14.0	CD	NUMBER	14.0	dep	281	SENT_99	[p5l1995t2529r2073b2558],
131	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2529r2073b2558],
132	Diuretics	NNS	O	diuretic	dep	281	SENT_99	[p5l39t2570r159b2593],
133	(	CD	PERCENT	(	dep	281	SENT_99	[p5l170t2570r217b2599],
134	%	NN	PERCENT	%	dep	281	SENT_99	[p5l170t2570r217b2599],
135	)	CD	NUMBER	)	dep	281	SENT_99	[p5l170t2570r217b2599],
136	8	CD	NUMBER	8	dep	281	SENT_99	[p5l1178t2570r1191b2594],
137	(	NN	O	(	dep	281	SENT_99	[p5l1202t2570r1280b2599],
138	16.0	CD	NUMBER	16.0	dep	281	SENT_99	[p5l1202t2570r1280b2599],
139	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1202t2570r1280b2599],
140	6	CD	NUMBER	6	dep	281	SENT_99	[p5l1970t2570r1985b2594],
141	(	NN	O	(	dep	281	SENT_99	[p5l1995t2570r2073b2599],
142	12.0	CD	NUMBER	12.0	dep	281	SENT_99	[p5l1995t2570r2073b2599],
143	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2570r2073b2599],
144	Antidepressants	NNS	O	antidepressant	dep	281	SENT_99	[p5l39t2611r249b2641],
145	(	CD	PERCENT	(	dep	281	SENT_99	[p5l260t2611r307b2640],
146	%	NN	PERCENT	%	dep	281	SENT_99	[p5l260t2611r307b2640],
147	)	CD	NUMBER	)	dep	281	SENT_99	[p5l260t2611r307b2640],
148	o	NN	O	o	dep	281	SENT_99	[p5l1177t2611r1192b2635],
149	(	NN	O	(	dep	281	SENT_99	[p5l1202t2611r1238b2640],
150	o	NN	O	o	dep	281	SENT_99	[p5l1202t2611r1238b2640],
151	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1202t2611r1238b2640],
152	3	CD	NUMBER	3	dep	281	SENT_99	[p5l1970t2611r1984b2635],
153	(	NN	O	(	dep	281	SENT_99	[p5l1995t2611r2056b2640],
154	6.0	CD	NUMBER	6.0	dep	281	SENT_99	[p5l1995t2611r2056b2640],
155	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2611r2056b2640],
156	Antipsychotic	JJ	O	antipsychotic	dep	281	SENT_99	[p5l39t2652r224b2683],
157	agents	NNS	O	agent	dep	281	SENT_99	[p5l234t2656r317b2683],
158	(	CD	PERCENT	(	dep	281	SENT_99	[p5l328t2652r375b2681],
159	%	NN	PERCENT	%	dep	281	SENT_99	[p5l328t2652r375b2681],
160	)	CD	NUMBER	)	dep	281	SENT_99	[p5l328t2652r375b2681],
161	1	CD	NUMBER	1	dep	281	SENT_99	[p5l1180t2652r1189b2676],
162	(	NN	O	(	dep	281	SENT_99	[p5l1203t2652r1263b2681],
163	2.0	CD	NUMBER	2.0	dep	281	SENT_99	[p5l1203t2652r1263b2681],
164	)	NN	O	)	dep	281	SENT_99	[p5l1203t2652r1263b2681],
165	1	CD	NUMBER	1	dep	281	SENT_99	[p5l1973t2652r1982b2676],
166	(	NN	O	(	dep	281	SENT_99	[p5l1995t2652r2056b2681],
167	2.0	CD	NUMBER	2.0	dep	281	SENT_99	[p5l1995t2652r2056b2681],
168	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2652r2056b2681],
169	Antiseizure	NN	O	antiseizure	dep	281	SENT_99	[p5l39t2693r191b2717],
170	agents	NNS	O	agent	dep	281	SENT_99	[p5l201t2697r283b2724],
171	(	CD	PERCENT	(	dep	281	SENT_99	[p5l294t2693r341b2722],
172	%	NN	PERCENT	%	dep	281	SENT_99	[p5l294t2693r341b2722],
173	)	CD	NUMBER	)	dep	281	SENT_99	[p5l294t2693r341b2722],
174	1	CD	NUMBER	1	dep	281	SENT_99	[p5l1180t2693r1189b2717],
175	(	NN	O	(	dep	281	SENT_99	[p5l1202t2693r1263b2722],
176	2.0	CD	NUMBER	2.0	dep	281	SENT_99	[p5l1202t2693r1263b2722],
177	)	NN	O	)	dep	281	SENT_99	[p5l1202t2693r1263b2722],
178	o	NN	O	o	dep	281	SENT_99	[p5l1970t2693r1985b2717],
179	(	CD	NUMBER	(	dep	281	SENT_99	[p5l1995t2693r2031b2722],
180	o	NN	O	o	dep	281	SENT_99	[p5l1995t2693r2031b2722],
181	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2693r2031b2722],
182	Oral	JJ	O	oral	dep	281	SENT_99	[p5l39t2734r97b2758],
183	hypoglycemic	JJ	O	hypoglycemic	dep	281	SENT_99	[p5l106t2734r293b2765],
184	agents	NNS	O	agent	dep	281	SENT_99	[p5l303t2738r386b2765],
185	(	CD	PERCENT	(	dep	281	SENT_99	[p5l397t2734r444b2763],
186	%	NN	PERCENT	%	dep	281	SENT_99	[p5l397t2734r444b2763],
187	)	CD	NUMBER	)	dep	281	SENT_99	[p5l397t2734r444b2763],
188	o	NN	O	o	dep	281	SENT_99	[p5l1177t2734r1192b2758],
189	(	CD	NUMBER	(	dep	281	SENT_99	[p5l1202t2734r1238b2763],
190	o	NN	O	o	dep	281	SENT_99	[p5l1202t2734r1238b2763],
191	)	NN	O	)	dep	281	SENT_99	[p5l1202t2734r1238b2763],
192	2	CD	NUMBER	2	dep	281	SENT_99	[p5l1970t2734r1985b2758],
193	(	CD	NUMBER	(	dep	281	SENT_99	[p5l1995t2734r2056b2763],
194	4.0	CD	NUMBER	4.0	dep	281	SENT_99	[p5l1995t2734r2056b2763],
195	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2734r2056b2763],
196	Corticosteroids	NNS	O	corticosteroid	dep	281	SENT_99	[p5l39t2775r240b2799],
197	(	CD	PERCENT	(	dep	281	SENT_99	[p5l251t2775r298b2804],
198	%	NN	PERCENT	%	dep	281	SENT_99	[p5l251t2775r298b2804],
199	)	CD	NUMBER	)	dep	281	SENT_99	[p5l251t2775r298b2804],
200	2	CD	NUMBER	2	dep	281	SENT_99	[p5l1177t2775r1192b2798],
201	(	CD	NUMBER	(	dep	281	SENT_99	[p5l1202t2775r1263b2804],
202	4.0	CD	NUMBER	4.0	dep	281	SENT_99	[p5l1202t2775r1263b2804],
203	)	NN	O	)	dep	281	SENT_99	[p5l1202t2775r1263b2804],
204	o	NN	O	o	dep	281	SENT_99	[p5l1970t2775r1985b2799],
205	(	CD	NUMBER	(	dep	281	SENT_99	[p5l1995t2775r2031b2804],
206	o	NN	O	o	dep	281	SENT_99	[p5l1995t2775r2031b2804],
207	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2775r2031b2804],
208	ATH	NN	ORGANIZATION	ath	dep	281	SENT_99	[p5l39t2816r101b2840],
209	antagonists	NNS	O	antagonist	dep	281	SENT_99	[p5l110t2816r258b2847],
210	(	CD	PERCENT	(	dep	281	SENT_99	[p5l269t2816r316b2845],
211	%	NN	PERCENT	%	dep	281	SENT_99	[p5l269t2816r316b2845],
212	)	CD	NUMBER	)	dep	281	SENT_99	[p5l269t2816r316b2845],
213	2	CD	NUMBER	2	dep	281	SENT_99	[p5l1177t2816r1192b2840],
214	(	CD	NUMBER	(	dep	281	SENT_99	[p5l1203t2816r1263b2845],
215	4.0	CD	NUMBER	4.0	dep	281	SENT_99	[p5l1203t2816r1263b2845],
216	)	NN	O	)	dep	281	SENT_99	[p5l1203t2816r1263b2845],
217	3	CD	NUMBER	3	dep	281	SENT_99	[p5l1970t2816r1984b2840],
218	(	NN	O	(	dep	281	SENT_99	[p5l1995t2816r2056b2845],
219	6.0	CD	NUMBER	6.0	dep	281	SENT_99	[p5l1995t2816r2056b2845],
220	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2816r2056b2845],
221	HRT	NN	ORGANIZATION	hrt	dep	281	SENT_99	[p5l39t2858r102b2881],
222	(	CD	PERCENT	(	dep	281	SENT_99	[p5l113t2858r159b2887],
223	%	NN	PERCENT	%	dep	281	SENT_99	[p5l113t2858r159b2887],
224	)	CD	NUMBER	)	dep	281	SENT_99	[p5l113t2858r159b2887],
225	2	CD	NUMBER	2	dep	281	SENT_99	[p5l1177t2858r1192b2881],
226	(	CD	NUMBER	(	dep	281	SENT_99	[p5l1203t2858r1263b2887],
227	4.0	CD	NUMBER	4.0	dep	281	SENT_99	[p5l1203t2858r1263b2887],
228	)	NN	O	)	dep	281	SENT_99	[p5l1203t2858r1263b2887],
229	2	CD	NUMBER	2	dep	281	SENT_99	[p5l1970t2858r1985b2881],
230	(	CD	NUMBER	(	dep	281	SENT_99	[p5l1995t2858r2056b2887],
231	4.0	CD	NUMBER	4.0	dep	281	SENT_99	[p5l1995t2858r2056b2887],
232	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1995t2858r2056b2887],
233	Clinical	JJ	O	clinical	dep	281	SENT_99	[p5l6t2920r110b2943],
234	diagnosis	NN	O	diagnosis	dep	281	SENT_99	[p5l119t2920r243b2950],
235	Primary	JJ	O	primary	dep	281	SENT_99	[p5l40t2961r146b2991],
236	cardiovascular	JJ	O	cardiovascular	dep	281	SENT_99	[p5l155t2961r347b2984],
237	prevention	NN	O	prevention	dep	281	SENT_99	[p5l355t2961r496b2991],
238	(	CD	PERCENT	(	dep	281	SENT_99	[p5l506t2961r553b2990],
239	%	NN	PERCENT	%	dep	281	SENT_99	[p5l506t2961r553b2990],
240	)	CD	NUMBER	)	dep	281	SENT_99	[p5l506t2961r553b2990],
241	35	CD	NUMBER	35	dep	281	SENT_99	[p5l1179t2961r1209b2984],
242	(	NN	O	(	dep	281	SENT_99	[p5l1220t2961r1298b2990],
243	70.0	CD	NUMBER	70.0	dep	281	SENT_99	[p5l1220t2961r1298b2990],
244	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1220t2961r1298b2990],
245	33	CD	NUMBER	33	dep	281	SENT_99	[p5l1972t2961r2002b2984],
246	(	NN	O	(	dep	281	SENT_99	[p5l2013t2961r2091b2990],
247	66.0	CD	NUMBER	66.0	dep	281	SENT_99	[p5l2013t2961r2091b2990],
248	)	CD	NUMBER	)	dep	281	SENT_99	[p5l2013t2961r2091b2990],
249	Secondary	JJ	O	secondary	dep	281	SENT_99	[p5l41t3002r179b3032],
250	cardiovascular	JJ	O	cardiovascular	dep	281	SENT_99	[p5l189t3002r381b3025],
251	prevention	NN	O	prevention	dep	281	SENT_99	[p5l389t3002r529b3032],
252	(	CD	PERCENT	(	dep	281	SENT_99	[p5l539t3002r586b3031],
253	%	NN	PERCENT	%	dep	281	SENT_99	[p5l539t3002r586b3031],
254	)	CD	NUMBER	)	dep	281	SENT_99	[p5l539t3002r586b3031],
255	15	CD	NUMBER	15	dep	281	SENT_99	[p5l1181t3002r1209b3025],
256	(	NN	O	(	dep	281	SENT_99	[p5l1220t3002r1298b3031],
257	30.0	CD	NUMBER	30.0	dep	281	SENT_99	[p5l1220t3002r1298b3031],
258	)	CD	NUMBER	)	dep	281	SENT_99	[p5l1220t3002r1298b3031],
259	17	CD	NUMBER	17	dep	281	SENT_99	[p5l1974t3002r2002b3025],
260	(	NN	O	(	dep	281	SENT_99	[p5l2013t3002r2091b3031],
261	34.0	CD	NUMBER	34.0	dep	281	SENT_99	[p5l2013t3002r2091b3031],
262	)	CD	NUMBER	)	dep	281	SENT_99	[p5l2013t3002r2091b3031],
263	Values	NNS	O	value	dep	281	SENT_99	[p5l6t3065r93b3088],
264	are	VBP	O	be	dep	281	SENT_99	[p5l102t3072r141b3088],
265	numbers	NNS	O	number	dep	281	SENT_99	[p5l148t3065r261b3088],
266	of	IN	O	of	dep	281	SENT_99	[p5l269t3065r298b3088],
267	each	DT	O	each	dep	281	SENT_99	[p5l303t3065r363b3088],
268	group	NN	O	group	dep	281	SENT_99	[p5l370t3072r454b3095],
269	,	,	O	,	_	0	SENT_99	[p5l370t3072r454b3095],
270	or	CC	O	or	dep	281	SENT_99	[p5l463t3072r490b3088],
271	mean	VB	O	mean	dep	281	SENT_99	[p5l496t3072r567b3088],
272	:1	CD	NUMBER	:1	dep	281	SENT_99	[p5l575t3065r598b3088],
273	:	:	O	:	_	0	SENT_99	[p5l575t3065r598b3088],
274	S.D.	NNP	LOCATION	S.D.	dep	281	SENT_99	[p5l606t3065r671b3092],
275	;	:	O	;	_	0	SENT_99	[p5l606t3065r671b3092],
276	TC	NNP	O	TC	dep	281	SENT_99	[p5l680t3065r729b3092],
277	,	,	O	,	_	0	SENT_99	[p5l680t3065r729b3092],
278	total	JJ	O	total	dep	281	SENT_99	[p5l737t3065r795b3088],
279	cholesterol	NN	O	cholesterol	dep	281	SENT_99	[p5l803t3065r955b3092],
280	;	:	O	;	_	0	SENT_99	[p5l803t3065r955b3092],
281	LDL	NN	O	ldl	_	0	SENT_99	[p5l964t3065r1068b3092],
282	.	.	O	.	_	0	SENT_99	[p5l964t3065r1068b3092],

1	—	NN	O	—	_	0	SENT_100	[p5l964t3065r1068b3092],
2	.	.	O	.	_	0	SENT_100	[p5l964t3065r1068b3092],

1	C	NN	O	c	_	0	SENT_101	[p5l964t3065r1068b3092],
2	,	,	O	,	_	0	SENT_101	[p5l964t3065r1068b3092],
3	LDL	NN	O	ldl	nn	4	SENT_101	[p5l1076t3065r1140b3088],
4	cholesterol	NN	O	cholesterol	appos	1	SENT_101	[p5l1147t3065r1300b3092],
5	;	:	O	;	_	0	SENT_101	[p5l1147t3065r1300b3092],
6	HDL	NNP	O	HDL	dep	1	SENT_101	[p5l1309t3065r1416b3092],
7	.	.	O	.	_	0	SENT_101	[p5l1309t3065r1416b3092],

1	—	NN	O	—	_	0	SENT_102	[p5l1309t3065r1416b3092],
2	.	.	O	.	_	0	SENT_102	[p5l1309t3065r1416b3092],

1	C	NN	O	c	_	0	SENT_103	[p5l1309t3065r1416b3092],
2	,	,	O	,	_	0	SENT_103	[p5l1309t3065r1416b3092],
3	HDL	NN	O	hdl	nn	4	SENT_103	[p5l1425t3065r1492b3088],
4	cholesterol	NN	O	cholesterol	appos	1	SENT_103	[p5l1500t3065r1652b3092],
5	;	:	O	;	_	0	SENT_103	[p5l1500t3065r1652b3092],
6	TG	NN	O	tg	dep	1	SENT_103	[p5l1661t3065r1711b3092],
7	,	,	O	,	_	0	SENT_103	[p5l1661t3065r1711b3092],
8	triglycerides	NNS	O	triglyceride	appos	6	SENT_103	[p5l1720t3065r1893b3095],
9	;	:	O	;	_	0	SENT_103	[p5l1720t3065r1893b3095],
10	AEs	NNS	O	ae	dep	1	SENT_103	[p5l1901t3065r1965b3092],
11	,	,	O	,	_	0	SENT_103	[p5l1901t3065r1965b3092],
12	adverse	JJ	O	adverse	amod	13	SENT_103	[p5l1974t3065r2073b3088],
13	events	NNS	O	event	appos	10	SENT_103	[p5l6t3095r191b3143],
14	;	:	O	;	_	0	SENT_103	[p5l6t3095r191b3143],
15	HRT	NNP	ORGANIZATION	HRT	dep	1	SENT_103	[p5l6t3167r146b3222],
16	,	,	O	,	_	0	SENT_103	[p5l6t3167r146b3222],
17	hormone	NN	O	hormone	nn	19	SENT_103	[p5l167t3166r408b3214],
18	replacement	NN	O	replacement	nn	19	SENT_103	[p5l426t3166r760b3228],
19	therapy	NN	O	therapy	appos	15	SENT_103	[p5l777t3166r989b3228],
20	.	.	O	.	_	0	SENT_103	[p5l777t3166r989b3228],

1	2.2	CD	NUMBER	2.2	_	0	SENT_104	[p5l6t3383r124b3442],
2	.	.	O	.	_	0	SENT_104	[p5l6t3383r124b3442],

1	Laboratory	NNP	O	Laboratory	nn	2	SENT_105	[p5l175t3382r562b3458],
2	procedures	NNS	O	procedure	_	0	SENT_105	[p5l578t3382r959b3458],

1	Genomic	JJ	O	genomic	amod	2	SENT_106	[p5l110t3586r418b3646],
2	DNA	NN	O	dna	nsubjpass	4	SENT_106	[p5l448t3587r628b3646],
3	was	VBD	O	be	auxpass	4	SENT_106	[p5l658t3605r785b3646],
4	isolated	VBN	O	isolate	_	0	SENT_106	[p5l816t3586r1080b3646],
5	from	IN	O	from	_	0	SENT_106	[p5l1110t3586r1274b3646],
6	200	CD	NUMBER	200	num	7	SENT_106	[p5l1303t3587r1427b3646],
7	ptl	NN	O	ptl	prep_from	4	SENT_106	[p5l1450t3586r1522b3663],
8	of	IN	O	of	_	0	SENT_106	[p5l1553t3586r1626b3646],
9	blood	NN	O	blood	prep_of	7	SENT_106	[p5l1649t3586r1843b3646],
10	with	IN	O	with	_	0	SENT_106	[p5l1872t3586r2021b3646],
11	the	DT	O	the	det	14	SENT_106	[p5l2050t3586r2152b3646],
12	QIAmp	NN	O	qiamp	nn	14	SENT_106	[p5l8t3689r264b3765],
13	DNA	NN	O	dna	nn	14	SENT_106	[p5l297t3689r477b3748],
14	Mini	NNP	O	Mini	prep_with	9	SENT_106	[p5l509t3688r672b3747],
15	Kit	NN	O	kit	nn	17	SENT_106	[p5l707t3688r813b3748],
16	(	CD	NUMBER	(	num	17	SENT_106	[p5l848t3688r1178b3765],
17	Quiagen	NNP	O	Quiagen	tmod	4	SENT_106	[p5l848t3688r1178b3765],
18	,	,	O	,	_	0	SENT_106	[p5l848t3688r1178b3765],
19	Milan	NNP	LOCATION	Milan	appos	17	SENT_106	[p5l1213t3688r1433b3759],
20	,	,	O	,	_	0	SENT_106	[p5l1213t3688r1433b3759],
21	Italy	NNP	LOCATION	Italy	appos	17	SENT_106	[p5l1469t3688r1649b3765],
22	)	CD	NUMBER	)	num	21	SENT_106	[p5l1469t3688r1649b3765],
23	by	IN	O	by	_	0	SENT_106	[p5l1683t3688r1766b3765],
24	measuring	VBG	O	measure	prepc_by	21	SENT_106	[p5l1800t3688r2151b3765],
25	the	DT	O	the	det	26	SENT_106	[p6l7t19r108b78],
26	absorbance	NN	O	absorbance	dobj	24	SENT_106	[p6l138t19r517b78],
27	at	IN	O	at	_	0	SENT_106	[p6l548t28r606b78],
28	260nm	CD	NUMBER	260nm	num	29	SENT_106	[p6l635t19r883b79],
29	(	CD	NUMBER	(	prep_at	24	SENT_106	[p6l913t19r1145b92],
30	A260	NN	O	a260	nn	31	SENT_106	[p6l913t19r1145b92],
31	)	NN	O	)	dep	17	SENT_106	[p6l913t19r1145b92],
32	.	.	O	.	_	0	SENT_106	[p6l913t19r1145b92],

1	PCRs	NNS	O	pcr	nsubjpass	3	SENT_107	[p6l1177t19r1367b79],
2	were	VBD	O	be	auxpass	3	SENT_107	[p6l1398t37r1560b79],
3	performed	VBN	O	perform	_	0	SENT_107	[p6l1588t19r1942b96],
4	using	VBG	O	use	xcomp	3	SENT_107	[p6l1969t19r2151b96],
5	published	VBN	O	publish	amod	6	SENT_107	[p6l6t121r337b198],
6	methods	NNS	O	method	dobj	4	SENT_107	[p6l370t121r654b181],
7	The	DT	O	the	det	9	SENT_107	[p6l691t121r820b181],
8	PCR	NN	O	pcr	nn	9	SENT_107	[p6l855t122r1014b181],
9	ampliﬁcations	NNS	O	ampliﬁcations	nsubjpass	11	SENT_107	[p6l1049t121r1526b198],
10	were	VBD	O	be	auxpass	11	SENT_107	[p6l1563t140r1725b181],
11	done	VBN	O	do	rcmod	6	SENT_107	[p6l1761t121r1923b181],
12	on	IN	O	on	_	0	SENT_107	[p6l1958t140r2040b181],
13	an	DT	O	a	det	19	SENT_107	[p6l2076t140r2152b181],
14	Applied	NNP	O	Applied	nn	19	SENT_107	[p6l6t223r279b300],
15	Biosystem	NNP	O	Biosystem	nn	19	SENT_107	[p6l302t223r661b300],
16	Gene	NNP	O	Gene	nn	19	SENT_107	[p6l685t223r861b283],
17	Amp	NNP	O	Amp	nn	19	SENT_107	[p6l885t224r1052b300],
18	PCR	NN	O	pcr	nn	19	SENT_107	[p6l1077t223r1236b283],
19	System	NNP	O	System	prep_on	11	SENT_107	[p6l1262t223r1509b300],
20	9700	CD	NUMBER	9700	num	19	SENT_107	[p6l1533t223r1717b284],
21	.	.	O	.	_	0	SENT_107	[p6l1533t223r1717b284],

1	2.2	CD	NUMBER	2.2	_	0	SENT_108	[p6l6t450r124b509],
2	.	.	O	.	_	0	SENT_108	[p6l6t450r124b509],

1	I	PRP	O	I	_	0	SENT_109	[p6l137t450r168b508],
2	.	.	O	.	_	0	SENT_109	[p6l178t499r188b509],

1	CYP3A5	NN	O	cyp3a5	_	0	SENT_110	[p6l245t450r533b510],
2	*	CD	NUMBER	*	num	3	SENT_110	[p6l544t450r616b509],
3	3	CD	NUMBER	3	dep	1	SENT_110	[p6l544t450r616b509],

1	The	DT	O	the	det	2	SENT_111	[p6l109t552r238b612],
2	method	NN	O	method	nsubj	3	SENT_111	[p6l255t552r509b612],
3	described	VBN	O	describe	_	0	SENT_111	[p6l526t552r850b612],
4	by	IN	O	by	_	0	SENT_111	[p6l865t552r948b629],
5	Van	NNP	PERSON	Van	nn	6	SENT_111	[p6l965t554r1096b612],
6	Schaik	NNP	PERSON	Schaik	prep_by	3	SENT_111	[p6l1114t552r1343b612],
7	et	FW	O	et	nn	9	SENT_111	[p6l1359t561r1419b612],
8	al.	FW	O	al.	nn	9	SENT_111	[p6l1435t552r1510b612],
9	[	FW	O	[	dobj	3	SENT_111	[p6l1537t552r1664b624],
10	18	CD	NUMBER	18	num	11	SENT_111	[p6l1537t552r1664b624],
11	]	NN	O	]	nsubjpass	13	SENT_111	[p6l1537t552r1664b624],
12	was	VBD	O	be	auxpass	13	SENT_111	[p6l1687t571r1814b612],
13	followed	VBN	O	follow	parataxis	3	SENT_111	[p6l1833t552r2149b622],
14	,	,	O	,	_	0	SENT_111	[p6l1833t552r2149b622],

1	with	IN	O	with	_	0	SENT_112	[p6l7t653r156b713],
2	minor	JJ	O	minor	amod	3	SENT_112	[p6l179t653r382b712],
3	modiﬁcations	NNS	O	modiﬁcations	pobj	1	SENT_112	[p6l404t653r883b712],
4	.	.	O	.	_	0	SENT_112	[p6l404t653r883b712],

1	2.2.2	CD	NUMBER	2.2.2	_	0	SENT_113	[p6l6t867r188b927],
2	.	.	O	.	_	0	SENT_113	[p6l6t867r188b927],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_114	[p6l245t867r619b927],
2	*	NN	O	*	_	0	SENT_114	[p6l245t867r619b927],
3	2	CD	NUMBER	2	dep	2	SENT_114	[p6l245t867r619b927],
4	and	CC	O	and	_	0	SENT_114	[p6l646t867r775b927],
5	CYP2C9	CD	NUMBER	cyp2c9	dep	2	SENT_114	[p6l799t867r1175b927],
6	*	CD	NUMBER	*	number	7	SENT_114	[p6l799t867r1175b927],
7	3	CD	NUMBER	3	dep	3	SENT_114	[p6l799t867r1175b927],

1	The	DT	O	the	det	2	SENT_115	[p6l109t969r238b1029],
2	methods	NNS	O	method	nsubj	4	SENT_115	[p6l302t969r586b1029],
3	initially	RB	O	initially	advmod	4	SENT_115	[p6l652t969r914b1046],
4	described	VBN	O	describe	_	0	SENT_115	[p6l978t969r1303b1029],
5	by	IN	O	by	_	0	SENT_115	[p6l1364t969r1447b1046],
6	Nasu	NNP	PERSON	Nasu	prep_by	4	SENT_115	[p6l1510t971r1683b1029],
7	et	FW	O	et	dobj	4	SENT_115	[p6l1747t978r1807b1029],
8	al.	FW	O	al.	nn	9	SENT_115	[p6l1871t969r1945b1029],
9	[	FW	O	[	dep	7	SENT_115	[p6l2019t970r2146b1041],
10	19	CD	NUMBER	19	dep	9	SENT_115	[p6l2019t970r2146b1041],
11	]	CD	NUMBER	]	number	12	SENT_115	[p6l2019t970r2146b1041],
12	(	CD	NUMBER	(	num	16	SENT_115	[p6l9t1072r452b1145],
13	CYP2C9	NN	O	cyp2c9	nn	16	SENT_115	[p6l9t1072r452b1145],
14	*	NN	O	*	nn	16	SENT_115	[p6l9t1072r452b1145],
15	2	CD	NUMBER	2	num	16	SENT_115	[p6l9t1072r452b1145],
16	)	NN	O	)	dep	10	SENT_115	[p6l9t1072r452b1145],
17	and	CC	O	and	_	0	SENT_115	[p6l490t1071r610b1131],
18	by	IN	O	by	dep	7	SENT_115	[p6l642t1071r726b1148],
19	SulliVan	NNP	PERSON	SulliVan	pobj	18	SENT_115	[p6l764t1071r1266b1131],
20	.	.	O	.	_	0	SENT_115	[p6l764t1071r1266b1131],

1	—	NN	O	—	_	0	SENT_116	[p6l764t1071r1266b1131],
2	.	.	O	.	_	0	SENT_116	[p6l764t1071r1266b1131],

1	Klose	NNP	PERSON	Klose	nsubjpass	24	SENT_117	[p6l764t1071r1266b1131],
2	et	FW	O	et	dep	1	SENT_117	[p6l1301t1080r1361b1131],
3	al.	FW	O	al.	nn	4	SENT_117	[p6l1396t1071r1470b1131],
4	[	FW	O	[	dep	2	SENT_117	[p6l1515t1072r1643b1143],
5	20	CD	NUMBER	20	number	6	SENT_117	[p6l1515t1072r1643b1143],
6	]	CD	NUMBER	]	num	11	SENT_117	[p6l1515t1072r1643b1143],
7	(	NN	O	(	nn	11	SENT_117	[p6l1686t1072r2149b1145],
8	CYP2C9	NN	O	cyp2c9	nn	11	SENT_117	[p6l1686t1072r2149b1145],
9	*	CD	NUMBER	*	number	10	SENT_117	[p6l1686t1072r2149b1145],
10	3	CD	NUMBER	3	num	11	SENT_117	[p6l1686t1072r2149b1145],
11	)	NN	O	)	dep	4	SENT_117	[p6l1686t1072r2149b1145],
12	,	,	O	,	_	0	SENT_117	[p6l1686t1072r2149b1145],
13	and	CC	O	and	_	0	SENT_117	[p6l8t1173r128b1232],
14	subsequently	RB	O	subsequently	advmod	15	SENT_117	[p6l159t1173r599b1250],
15	Validated	VBN	O	validate	conj_and	2	SENT_117	[p6l629t1173r937b1233],
16	by	IN	O	by	_	0	SENT_117	[p6l964t1173r1047b1250],
17	Yasar	NNP	PERSON	Yasar	prep_by	15	SENT_117	[p6l1078t1174r1267b1232],
18	et	FW	O	et	nn	20	SENT_117	[p6l1295t1182r1355b1232],
19	al.	FW	O	al.	nn	20	SENT_117	[p6l1385t1173r1459b1232],
20	[	FW	O	[	dobj	15	SENT_117	[p6l1499t1173r1626b1245],
21	21	CD	NUMBER	21	num	22	SENT_117	[p6l1499t1173r1626b1245],
22	]	NN	O	]	dep	1	SENT_117	[p6l1499t1173r1626b1245],
23	were	VBD	O	be	auxpass	24	SENT_117	[p6l1662t1191r1824b1233],
24	followed	VBN	O	follow	_	0	SENT_117	[p6l1854t1173r2153b1233],
25	with	IN	O	with	_	0	SENT_117	[p6l7t1275r156b1335],
26	minimal	JJ	O	minimal	amod	27	SENT_117	[p6l179t1275r461b1335],
27	changes	NNS	O	change	prep_with	24	SENT_117	[p6l486t1275r774b1352],
28	.	.	O	.	_	0	SENT_117	[p6l486t1275r774b1352],

1	2.2.3	CD	NUMBER	2.2.3	_	0	SENT_118	[p6l6t1502r188b1561],
2	.	.	O	.	_	0	SENT_118	[p6l6t1502r188b1561],

1	CYP2D6	NN	O	cyp2d6	_	0	SENT_119	[p6l245t1501r625b1562],
2	*	CD	NUMBER	*	number	3	SENT_119	[p6l245t1501r625b1562],
3	3	CD	NUMBER	3	dep	1	SENT_119	[p6l245t1501r625b1562],
4	and	CC	O	and	_	0	SENT_119	[p6l651t1502r780b1562],
5	CYP2D6	CD	NUMBER	cyp2d6	number	6	SENT_119	[p6l804t1501r1186b1562],
6	*	CD	NUMBER	*	dep	1	SENT_119	[p6l804t1501r1186b1562],
7	4	CD	NUMBER	4	dep	1	SENT_119	[p6l804t1501r1186b1562],

1	The	DT	O	the	det	2	SENT_120	[p6l109t1604r238b1664],
2	method	NN	O	method	nsubjpass	12	SENT_120	[p6l272t1604r526b1664],
3	described	VBN	O	describe	partmod	2	SENT_120	[p6l559t1604r883b1664],
4	by	IN	O	by	_	0	SENT_120	[p6l914t1604r998b1681],
5	Mulder	NNP	PERSON	Mulder	agent	3	SENT_120	[p6l1031t1604r1282b1664],
6	et	FW	O	et	nn	8	SENT_120	[p6l1314t1613r1374b1664],
7	al.	FW	O	al.	nn	8	SENT_120	[p6l1407t1604r1481b1664],
8	[	FW	O	[	dobj	3	SENT_120	[p6l1525t1605r1653b1676],
9	17	CD	NUMBER	17	num	10	SENT_120	[p6l1525t1605r1653b1676],
10	]	NN	O	]	dep	2	SENT_120	[p6l1525t1605r1653b1676],
11	was	VBD	O	be	auxpass	12	SENT_120	[p6l1692t1623r1819b1664],
12	followed	VBN	O	follow	_	0	SENT_120	[p6l1854t1604r2153b1664],
13	with	IN	O	with	_	0	SENT_120	[p6l7t1705r156b1765],
14	some	DT	O	some	det	16	SENT_120	[p6l182t1724r356b1765],
15	minor	JJ	O	minor	amod	16	SENT_120	[p6l381t1705r583b1765],
16	modiﬁcations	NNS	O	modiﬁcations	prep_with	12	SENT_120	[p6l605t1705r1084b1765],
17	.	.	O	.	_	0	SENT_120	[p6l605t1705r1084b1765],

1	2.2.4	CD	NUMBER	2.2.4	_	0	SENT_121	[p6l6t1920r188b1979],
2	.	.	O	.	_	0	SENT_121	[p6l6t1920r188b1979],

1	C	NN	O	c	nn	2	SENT_122	[p6l245t1921r299b1980],
2	YP2D6	NN	O	yp2d6	_	0	SENT_122	[p6l303t1919r545b1979],
3	*	CD	NUMBER	*	num	4	SENT_122	[p6l554t1920r627b1979],
4	5	CD	NUMBER	5	dep	2	SENT_122	[p6l554t1920r627b1979],

1	The	DT	O	the	det	2	SENT_123	[p6l109t2022r238b2081],
2	method	NN	O	method	nsubjpass	12	SENT_123	[p6l256t2022r510b2081],
3	described	VBN	O	describe	partmod	2	SENT_123	[p6l526t2022r851b2081],
4	by	IN	O	by	_	0	SENT_123	[p6l865t2022r949b2099],
5	Hersberger	NNP	PERSON	Hersberger	agent	3	SENT_123	[p6l966t2022r1342b2099],
6	et	FW	O	et	nn	8	SENT_123	[p6l1358t2031r1418b2081],
7	al.	FW	O	al.	nn	8	SENT_123	[p6l1435t2022r1509b2081],
8	[	FW	O	[	dobj	3	SENT_123	[p6l1536t2022r1664b2094],
9	22	CD	NUMBER	22	num	10	SENT_123	[p6l1536t2022r1664b2094],
10	]	NN	O	]	dep	2	SENT_123	[p6l1536t2022r1664b2094],
11	was	VBD	O	be	auxpass	12	SENT_123	[p6l1687t2040r1814b2081],
12	followed	VBN	O	follow	_	0	SENT_123	[p6l1833t2022r2148b2082],
13	.	.	O	.	_	0	SENT_123	[p6l1833t2022r2148b2082],

1	2.2.5	CD	NUMBER	2.2.5	_	0	SENT_124	[p6l8t2124r189b2182],
2	.	.	O	.	_	0	SENT_124	[p6l8t2124r189b2182],

1	CYP2D6	NN	O	cyp2d6	_	0	SENT_125	[p6l246t2123r631b2183],
2	*	CD	NUMBER	*	num	3	SENT_125	[p6l246t2123r631b2183],
3	6	CD	NUMBER	6	dep	1	SENT_125	[p6l246t2123r631b2183],

1	The	DT	O	the	det	2	SENT_126	[p6l110t2225r240b2284],
2	method	NN	O	method	nsubjpass	12	SENT_126	[p6l259t2225r513b2284],
3	described	VBN	O	describe	partmod	2	SENT_126	[p6l532t2225r856b2284],
4	by	IN	O	by	_	0	SENT_126	[p6l872t2225r956b2302],
5	Hersberger	NNP	PERSON	Hersberger	agent	3	SENT_126	[p6l975t2225r1351b2302],
6	et	FW	O	et	nn	8	SENT_126	[p6l1369t2234r1429b2284],
7	al.	FW	O	al.	nn	8	SENT_126	[p6l1448t2225r1522b2284],
8	[	FW	O	[	dobj	3	SENT_126	[p6l1551t2225r1679b2297],
9	22	CD	NUMBER	22	num	10	SENT_126	[p6l1551t2225r1679b2297],
10	]	NN	O	]	dep	2	SENT_126	[p6l1551t2225r1679b2297],
11	was	VBD	O	be	auxpass	12	SENT_126	[p6l1704t2243r1831b2284],
12	followed	VBN	O	follow	_	0	SENT_126	[p6l1852t2225r2151b2285],
13	with	IN	O	with	_	0	SENT_126	[p6l9t2326r158b2385],
14	minor	JJ	O	minor	amod	15	SENT_126	[p6l180t2326r383b2385],
15	modiﬁcations	NNS	O	modiﬁcations	prep_with	12	SENT_126	[p6l405t2326r883b2385],
16	.	.	O	.	_	0	SENT_126	[p6l405t2326r883b2385],

1	2.2.6	CD	NUMBER	2.2.6	_	0	SENT_127	[p6l8t2539r189b2598],
2	.	.	O	.	_	0	SENT_127	[p6l8t2539r189b2598],

1	F	NN	O	f	nn	2	SENT_128	[p6l241t2542r296b2597],
2	CYPZD6	NN	O	cypzd6	_	0	SENT_128	[p6l298t2539r598b2599],
3	*	CD	NUMBER	*	num	4	SENT_128	[p6l606t2540r719b2598],
4	2x	NN	O	2x	dep	2	SENT_128	[p6l606t2540r719b2598],

1	The	DT	O	the	det	2	SENT_129	[p6l110t2641r240b2700],
2	method	NN	O	method	nsubjpass	12	SENT_129	[p6l264t2641r517b2700],
3	described	VBN	O	describe	partmod	2	SENT_129	[p6l541t2641r865b2700],
4	by	IN	O	by	_	0	SENT_129	[p6l886t2641r969b2718],
5	Steijns	NNP	O	Steijns	agent	3	SENT_129	[p6l996t2641r1222b2718],
6	et	FW	O	et	nn	8	SENT_129	[p6l1248t2650r1307b2700],
7	al.	FW	O	al.	nn	8	SENT_129	[p6l1331t2641r1406b2700],
8	[	FW	O	[	dobj	3	SENT_129	[p6l1440t2641r1567b2713],
9	23	CD	NUMBER	23	num	10	SENT_129	[p6l1440t2641r1567b2713],
10	]	NN	O	]	dep	2	SENT_129	[p6l1440t2641r1567b2713],
11	was	VBD	O	be	auxpass	12	SENT_129	[p6l1597t2659r1724b2701],
12	followed	VBN	O	follow	_	0	SENT_129	[p6l1750t2641r2064b2701],
13	.	.	O	.	_	0	SENT_129	[p6l1750t2641r2064b2701],

1	2.2.7	CD	NUMBER	2.2.7	_	0	SENT_130	[p6l8t2872r189b2931],
2	.	.	O	.	_	0	SENT_130	[p6l8t2872r189b2931],

1	Apo-E	JJ	O	apo-e	_	0	SENT_131	[p6l236t2873r460b2947],

1	We	PRP	O	we	nsubj	2	SENT_132	[p6l109t2976r219b3034],
2	used	VBD	O	use	_	0	SENT_132	[p6l256t2974r411b3034],
3	the	DT	O	the	det	4	SENT_132	[p6l447t2974r548b3034],
4	method	NN	O	method	dobj	2	SENT_132	[p6l586t2974r839b3034],
5	described	VBN	O	describe	partmod	4	SENT_132	[p6l877t2974r1200b3034],
6	by	IN	O	by	_	0	SENT_132	[p6l1235t2974r1319b3051],
7	Aozaki	NNP	PERSON	Aozaki	agent	5	SENT_132	[p6l1356t2974r1599b3034],
8	et	FW	O	et	nn	10	SENT_132	[p6l1637t2983r1697b3034],
9	al.	FW	O	al.	nn	10	SENT_132	[p6l1735t2974r1809b3034],
10	[	FW	O	[	dobj	5	SENT_132	[p6l1857t2974r2008b3046],
11	24	CD	NUMBER	24	num	12	SENT_132	[p6l1857t2974r2008b3046],
12	]	NN	O	]	dep	4	SENT_132	[p6l1857t2974r2008b3046],
13	,	,	O	,	_	0	SENT_132	[p6l1857t2974r2008b3046],
14	i.e.	FW	O	i.e.	appos	12	SENT_132	[p6l2048t2974r2146b3034],
15	by	IN	O	by	_	0	SENT_132	[p6l7t3075r90b3152],
16	digesting	VBG	O	digest	prepc_by	2	SENT_132	[p6l118t3075r426b3152],
17	the	DT	O	the	det	19	SENT_132	[p6l453t3075r554b3134],
18	PCR	NN	O	pcr	nn	19	SENT_132	[p6l581t3075r740b3135],
19	product	NN	O	product	dobj	16	SENT_132	[p6l765t3075r1025b3152],
20	(	CD	NUMBER	(	number	21	SENT_132	[p6l1052t3075r1160b3148],
21	14	CD	NUMBER	14	num	23	SENT_132	[p6l1052t3075r1160b3148],
22	ul	NN	O	ul	nn	23	SENT_132	[p6l1183t3075r1281b3151],
23	)	NN	O	)	dep	31	SENT_132	[p6l1183t3075r1281b3151],
24	with	IN	O	with	_	0	SENT_132	[p6l1310t3075r1459b3134],
25	the	DT	O	the	det	27	SENT_132	[p6l1485t3075r1587b3134],
26	Hhal	JJ	O	hhal	amod	27	SENT_132	[p6l1613t3075r1781b3134],
27	restriction	NN	O	restriction	prep_with	23	SENT_132	[p6l1806t3075r2150b3134],
28	enzyme	NN	O	enzyme	dep	31	SENT_132	[p6l9t3197r270b3255],
29	(	CD	NUMBER	(	num	28	SENT_132	[p6l290t3179r398b3252],
30	10	CD	NUMBER	10	num	31	SENT_132	[p6l290t3179r398b3252],
31	U	NNP	O	U	dep	44	SENT_132	[p6l415t3179r500b3252],
32	)	CD	NUMBER	)	num	31	SENT_132	[p6l415t3179r500b3252],
33	(	CD	NUMBER	(	num	37	SENT_132	[p6l522t3178r920b3252],
34	Amersham	NNP	ORGANIZATION	Amersham	nn	37	SENT_132	[p6l522t3178r920b3252],
35	Pharmacia	NNP	ORGANIZATION	Pharmacia	nn	37	SENT_132	[p6l936t3178r1294b3238],
36	Biotech	NNP	ORGANIZATION	Biotech	nn	37	SENT_132	[p6l1310t3178r1599b3252],
37	)	NN	O	)	dep	31	SENT_132	[p6l1310t3178r1599b3252],
38	in	IN	O	in	_	0	SENT_132	[p6l1618t3178r1682b3237],
39	total	JJ	O	total	amod	40	SENT_132	[p6l1699t3178r1848b3238],
40	Volumes	NNS	O	volume	prep_in	37	SENT_132	[p6l1866t3178r2148b3238],
41	of	IN	O	of	_	0	SENT_132	[p6l9t3280r82b3340],
42	18	CD	NUMBER	18	num	43	SENT_132	[p6l108t3280r180b3340],
43	ul	NN	O	ul	prep_of	40	SENT_132	[p6l205t3280r277b3356],
44	overnight	JJ	TIME	overnight	dep	16	SENT_132	[p6l302t3280r624b3357],
45	at	IN	O	at	_	0	SENT_132	[p6l648t3289r706b3340],
46	37	CD	NUMBER	37	num	47	SENT_132	[p6l731t3280r865b3340],
47	°	CD	NUMBER	°	prep_at	44	SENT_132	[p6l731t3280r865b3340],
48	.	.	O	.	_	0	SENT_132	[p6l731t3280r865b3340],

1	2.3	CD	NUMBER	2.3	_	0	SENT_133	[p6l8t3511r125b3570],
2	.	.	O	.	_	0	SENT_133	[p6l8t3511r125b3570],

1	Statistical	JJ	O	statistical	amod	2	SENT_134	[p6l178t3511r518b3571],
2	analysis	NN	O	analysis	_	0	SENT_134	[p6l540t3511r816b3587],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_135	[p6l112t3715r443b3775],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_135	[p6l491t3715r759b3792],
3	was	VBD	O	be	auxpass	4	SENT_135	[p6l808t3733r935b3775],
4	performed	VBN	O	perform	_	0	SENT_135	[p6l981t3715r1335b3792],
5	using	VBG	O	use	xcomp	4	SENT_135	[p6l1380t3715r1562b3792],
6	Sigma	NNP	O	Sigma	nsubj	7	SENT_135	[p6l1611t3715r1825b3792],
7	Stat	NN	O	stat	xcomp	5	SENT_135	[p6l1872t3715r2001b3775],
8	3.0	CD	NUMBER	3.0	num	7	SENT_135	[p6l2048t3715r2149b3775],

1	(	RB	O	(	advmod	2	SENT_136	[p7l11t19r355b92],
2	statistical	JJ	O	statistical	amod	3	SENT_136	[p7l11t19r355b92],
3	signiﬁcance	NN	O	signiﬁcance	_	0	SENT_136	[p7l397t19r798b96],
4	at	IN	O	at	_	0	SENT_136	[p7l840t28r898b78],
5	p	NN	O	p	prep_at	3	SENT_136	[p7l928t18r1247b95],
6	<	JJR	O	<	dep	3	SENT_136	[p7l928t18r1247b95],
7	0.05	CD	NUMBER	0.05	num	8	SENT_136	[p7l928t18r1247b95],
8	)	NN	O	)	dep	6	SENT_136	[p7l928t18r1247b95],
9	.	.	O	.	_	0	SENT_136	[p7l928t18r1247b95],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_137	[p7l1293t19r1574b96],
2	were	VBD	O	be	auxpass	3	SENT_137	[p7l1616t37r1778b78],
3	tested	VBN	O	test	_	0	SENT_137	[p7l1818t19r2015b78],
4	for	IN	O	for	_	0	SENT_137	[p7l2053t18r2152b78],
5	homogeneity	NN	O	homogeneity	prep_for	3	SENT_137	[p7l8t122r449b199],
6	of	IN	O	of	_	0	SENT_137	[p7l505t122r578b182],
7	sex	NN	O	sex	prep_of	5	SENT_137	[p7l629t141r754b193],
8	,	,	O	,	_	0	SENT_137	[p7l629t141r754b193],
9	age	NN	O	age	prep_of	5	SENT_137	[p7l812t141r926b199],
10	and	CC	O	and	_	0	SENT_137	[p7l982t122r1102b182],
11	clinical	JJ	O	clinical	amod	12	SENT_137	[p7l1155t122r1402b182],
12	treatment	NN	O	treatment	prep_of	5	SENT_137	[p7l1456t131r1792b182],
13	.	.	O	.	_	0	SENT_137	[p7l1456t131r1792b182],

1	In	IN	O	in	mark	4	SENT_138	[p7l1850t124r1919b181],
2	order	NN	O	order	dep	4	SENT_138	[p7l1974t122r2151b182],
3	to	TO	O	to	aux	4	SENT_138	[p7l8t233r71b283],
4	evaluate	VB	O	evaluate	dep	26	SENT_138	[p7l120t224r396b284],
5	statistical	JJ	O	statistical	amod	6	SENT_138	[p7l446t224r762b283],
6	dependence	NN	O	dependence	dobj	4	SENT_138	[p7l811t224r1209b301],
7	between	IN	O	between	_	0	SENT_138	[p7l1255t224r1538b283],
8	allelic/genotypic	JJ	O	allelic/genotypic	amod	9	SENT_138	[p7l1587t224r2148b301],
9	frequency	NN	O	frequency	prep_between	6	SENT_138	[p7l9t326r344b403],
10	and	CC	O	and	_	0	SENT_138	[p7l373t326r492b386],
11	presence/absence	NN	O	presence/absence	prep_between	6	SENT_138	[p7l516t326r1105b403],
12	of	IN	O	of	_	0	SENT_138	[p7l1133t326r1206b386],
13	adverse	JJ	O	adverse	amod	14	SENT_138	[p7l1228t326r1483b386],
14	effects	NNS	O	effect	prep_of	6	SENT_138	[p7l1510t326r1749b397],
15	,	,	O	,	_	0	SENT_138	[p7l1510t326r1749b397],
16	Chi	NNP	O	Chi	nsubjpass	26	SENT_138	[p7l1780t326r2149b403],
17	—	CD	NUMBER	—	num	16	SENT_138	[p7l1780t326r2149b403],
18	square	JJ	O	square	amod	19	SENT_138	[p7l1780t326r2149b403],
19	test	NN	O	test	dep	16	SENT_138	[p7l8t437r125b488],
20	and	CC	O	and	_	0	SENT_138	[p7l148t428r267b488],
21	Fisher	NNP	PERSON	Fisher	poss	24	SENT_138	[p7l289t428r554b488],
22	’s	POS	O	’s	_	0	SENT_138	[p7l289t428r554b488],
23	exact	JJ	O	exact	amod	24	SENT_138	[p7l580t437r756b488],
24	test	NN	O	test	nsubjpass	26	SENT_138	[p7l777t437r894b488],
25	were	VBD	O	be	auxpass	26	SENT_138	[p7l916t447r1078b488],
26	performed	VBN	O	perform	_	0	SENT_138	[p7l1099t428r1470b505],
27	.	.	O	.	_	0	SENT_138	[p7l1099t428r1470b505],

1	In	IN	O	in	mark	4	SENT_139	[p7l1496t430r1565b487],
2	order	NN	O	order	dep	4	SENT_139	[p7l1588t428r1766b488],
3	to	TO	O	to	aux	4	SENT_139	[p7l1787t437r1850b488],
4	evaluate	VB	O	evaluate	dep	20	SENT_139	[p7l1874t428r2149b488],
5	genetic	JJ	O	genetic	amod	6	SENT_139	[p7l9t529r250b606],
6	polymorphisms	NNS	O	polymorphism	dobj	4	SENT_139	[p7l279t529r806b606],
7	and	CC	O	and	_	0	SENT_139	[p7l839t529r958b588],
8	lipid	NN	O	lipid	nn	10	SENT_139	[p7l987t529r1141b606],
9	lowering	NN	O	lowering	nn	10	SENT_139	[p7l1169t529r1466b606],
10	response	NN	O	response	dobj	4	SENT_139	[p7l1495t547r1791b606],
11	to	TO	O	to	_	0	SENT_139	[p7l1821t538r1884b588],
12	statins	NNS	O	statin	prep_to	4	SENT_139	[p7l1916t529r2147b599],
13	,	,	O	,	_	0	SENT_139	[p7l1916t529r2147b599],
14	Student	NN	O	student	poss	18	SENT_139	[p7l10t632r321b692],
15	’s	POS	O	’s	_	0	SENT_139	[p7l10t632r321b692],
16	t	NN	O	t	nn	18	SENT_139	[p7l376t641r543b692],
17	—	CD	NUMBER	—	num	18	SENT_139	[p7l376t641r543b692],
18	test	NN	O	test	nsubjpass	20	SENT_139	[p7l376t641r543b692],
19	was	VBD	O	be	auxpass	20	SENT_139	[p7l595t651r721b692],
20	performed	VBN	O	perform	_	0	SENT_139	[p7l774t632r1144b709],
21	.	.	O	.	_	0	SENT_139	[p7l774t632r1144b709],

1	Groups	NNS	O	group	_	0	SENT_140	[p7l1202t633r1446b709],
2	not	RB	O	not	neg	3	SENT_140	[p7l1500t641r1608b692],
3	responding	VBG	O	respond	partmod	1	SENT_140	[p7l1658t632r2033b709],
4	to	TO	O	to	_	0	SENT_140	[p7l2086t641r2149b692],
5	Kolmogorov	NNP	PERSON	Kolmogorov	prep_to	3	SENT_140	[p7l10t734r770b811],
6	.	.	O	.	_	0	SENT_140	[p7l10t734r770b811],

1	—	NN	O	—	_	0	SENT_141	[p7l10t734r770b811],
2	.	.	O	.	_	0	SENT_141	[p7l10t734r770b811],

1	Smirnov	NNP	PERSON	Smirnov	_	0	SENT_142	[p7l10t734r770b811],
2	normality	NN	O	normality	nn	3	SENT_142	[p7l805t734r1133b811],
3	test	NN	O	test	nsubjpass	6	SENT_142	[p7l1167t743r1301b804],
4	,	,	O	,	_	0	SENT_142	[p7l1167t743r1301b804],
5	were	VBD	O	be	auxpass	6	SENT_142	[p7l1339t752r1501b794],
6	analysed	VBN	O	analyse	rcmod	1	SENT_142	[p7l1538t734r1832b811],
7	with	IN	O	with	_	0	SENT_142	[p7l1866t734r2015b794],
8	the	DT	O	the	prep_with	6	SENT_142	[p7l2048t734r2149b793],

1	P.	FW	PERSON	p.	nn	4	SENT_143	[p7l321t887r342b910],
2	Zuccaro	FW	PERSON	zuccaro	nn	4	SENT_143	[p7l353t887r462b910],
3	er	FW	O	er	nn	4	SENT_143	[p7l472t890r496b910],
4	al.	FW	O	al.	_	0	SENT_143	[p7l504t886r534b910],
5	/	:	O	/	punct	7	SENT_143	[p7l544t886r559b910],
6	Pharmacological	JJ	O	pharmacological	amod	7	SENT_143	[p7l563t886r794b916],
7	Research	NN	O	research	dep	4	SENT_143	[p7l802t886r923b910],
8	55	CD	NUMBER	55	number	9	SENT_143	[p7l933t886r965b909],
9	(	CD	NUMBER	(	dep	7	SENT_143	[p7l975t886r1061b915],
10	2007	CD	DATE	2007	dep	9	SENT_143	[p7l975t886r1061b915],
11	)	CD	NUMBER	)	num	12	SENT_143	[p7l975t886r1061b915],
12	310-317 313	CD	NUMBER	310-317 313	dep	4	SENT_143	[p7l1791t886r1838b910],[p7l1071t886r1188b910],

1	Mann	NNP	PERSON	Mann	_	0	SENT_144	[p7l8t1021r537b1098],
2	.	.	O	.	_	0	SENT_144	[p7l8t1021r537b1098],

1	—	NN	O	—	_	0	SENT_145	[p7l8t1021r537b1098],
2	.	.	O	.	_	0	SENT_145	[p7l8t1021r537b1098],

1	Whitney	NNP	PERSON	Whitney	nn	3	SENT_146	[p7l8t1021r537b1098],
2	rank	NN	O	rank	nn	3	SENT_146	[p7l576t1021r727b1080],
3	sum	NN	O	sum	nsubj	4	SENT_146	[p7l766t1039r904b1080],
4	test	NN	O	test	_	0	SENT_146	[p7l941t1030r1074b1080],
5	.	.	O	.	_	0	SENT_146	[p7l941t1030r1074b1080],

1	In	IN	O	in	mark	4	SENT_147	[p7l1117t1022r1186b1080],
2	order	NN	O	order	dep	4	SENT_147	[p7l1225t1021r1402b1080],
3	to	TO	O	to	aux	4	SENT_147	[p7l1439t1030r1502b1080],
4	evaluate	VB	O	evaluate	_	0	SENT_147	[p7l1542t1021r1818b1081],
5	CYP450	NN	O	cyp450	nn	8	SENT_147	[p7l1858t1021r2146b1081],
6	isozyme	NN	O	isozyme	nn	8	SENT_147	[p7l8t1122r289b1199],
7	allelic	JJ	O	allelic	amod	8	SENT_147	[p7l323t1122r525b1182],
8	variants	NNS	O	variant	dobj	4	SENT_147	[p7l558t1122r821b1182],
9	and	CC	O	and	_	0	SENT_147	[p7l856t1122r975b1182],
10	lipid	NN	O	lipid	nn	12	SENT_147	[p7l1007t1122r1161b1199],
11	lowering	NN	O	lowering	nn	12	SENT_147	[p7l1192t1122r1489b1199],
12	response	NN	O	response	dobj	4	SENT_147	[p7l1521t1141r1816b1199],
13	to	TO	O	to	_	0	SENT_147	[p7l1848t1131r1911b1182],
14	statin	NN	O	statin	prep_to	4	SENT_147	[p7l1947t1122r2144b1193],
15	,	,	O	,	_	0	SENT_147	[p7l1947t1122r2144b1193],
16	Student	NN	O	student	poss	18	SENT_147	[p7l11t1223r320b1283],
17	’s	POS	O	’s	_	0	SENT_147	[p7l11t1223r320b1283],
18	t-test	NN	O	t-test	appos	14	SENT_147	[p7l361t1232r528b1283],
19	or	CC	O	or	_	0	SENT_147	[p7l564t1242r633b1283],
20	Mann	NNP	PERSON	Mann	conj_or	18	SENT_147	[p7l667t1223r1197b1300],
21	.	.	O	.	_	0	SENT_147	[p7l667t1223r1197b1300],

1	—	NN	O	—	_	0	SENT_148	[p7l667t1223r1197b1300],
2	.	.	O	.	_	0	SENT_148	[p7l667t1223r1197b1300],

1	Whitney	NNP	PERSON	Whitney	nn	3	SENT_149	[p7l667t1223r1197b1300],
2	rank	NN	O	rank	nn	3	SENT_149	[p7l1233t1223r1384b1283],
3	sum	NN	O	sum	nsubj	4	SENT_149	[p7l1422t1242r1560b1283],
4	test	NN	O	test	_	0	SENT_149	[p7l1595t1232r1712b1283],
5	(	NN	O	(	nn	6	SENT_149	[p7l1750t1224r2002b1300],
6	groups	NNS	O	group	dobj	4	SENT_149	[p7l1750t1224r2002b1300],
7	not	RB	O	not	neg	8	SENT_149	[p7l2041t1232r2148b1283],
8	responding	VBG	O	respond	partmod	6	SENT_149	[p7l7t1324r383b1401],
9	to	TO	O	to	_	0	SENT_149	[p7l444t1333r507b1383],
10	Kolmogorov	NNP	PERSON	Kolmogorov	prep_to	8	SENT_149	[p7l570t1324r1329b1401],
11	.	.	O	.	_	0	SENT_149	[p7l570t1324r1329b1401],

1	—	NN	O	—	_	0	SENT_150	[p7l570t1324r1329b1401],
2	.	.	O	.	_	0	SENT_150	[p7l570t1324r1329b1401],

1	Smirnov	NNP	PERSON	Smirnov	nn	4	SENT_151	[p7l570t1324r1329b1401],
2	normality	NN	O	normality	nn	4	SENT_151	[p7l1391t1324r1718b1401],
3	test	NN	O	test	nn	4	SENT_151	[p7l1779t1325r1921b1397],
4	)	NN	O	)	nsubjpass	6	SENT_151	[p7l1779t1325r1921b1397],
5	were	VBD	O	be	auxpass	6	SENT_151	[p7l1985t1342r2146b1384],
6	performed	VBN	O	perform	_	0	SENT_151	[p7l7t1425r377b1502],
7	.	.	O	.	_	0	SENT_151	[p7l7t1425r377b1502],

1	3	LS	NUMBER	3	_	0	SENT_152	[p7l8t1656r68b1716],
2	.	.	O	.	_	0	SENT_152	[p7l8t1656r68b1716],

1	Results	NNS	O	result	_	0	SENT_153	[p7l115t1657r376b1716],

1	3.1	CD	NUMBER	3.1	_	0	SENT_154	[p7l8t1861r125b1920],
2	.	.	O	.	_	0	SENT_154	[p7l8t1861r125b1920],

1	C	NN	O	c	nn	2	SENT_155	[p7l182t1862r236b1920],
2	YP450s	NNS	O	yp450	nsubj	6	SENT_155	[p7l240t1861r491b1920],
3	and	CC	O	and	_	0	SENT_155	[p7l516t1860r645b1920],
4	adverse	JJ	O	adverse	amod	5	SENT_155	[p7l665t1860r924b1920],
5	eﬂects	NNS	O	eﬂects	nsubj	6	SENT_155	[p7l950t1861r1162b1936],
6	(	VBP	O	(	_	0	SENT_155	[p7l1188t1861r1375b1934],
7	AE5	NN	O	ae5	nn	8	SENT_155	[p7l1188t1861r1375b1934],
8	)	NN	O	)	dobj	6	SENT_155	[p7l1188t1861r1375b1934],

1	3.1.1	CD	NUMBER	3.1.1	_	0	SENT_156	[p7l8t2064r189b2123],
2	.	.	O	.	_	0	SENT_156	[p7l8t2064r189b2123],

1	CYP3A5	NN	O	cyp3a5	nn	2	SENT_157	[p7l246t2064r533b2124],
2	genotype	NN	O	genotype	_	0	SENT_157	[p7l555t2075r858b2139],

1	In	IN	O	in	_	0	SENT_158	[p7l110t2167r179b2224],
2	the	DT	O	the	det	5	SENT_158	[p7l207t2165r308b2225],
3	examined	VBN	O	examine	amod	5	SENT_158	[p7l337t2165r664b2225],
4	clinical	JJ	O	clinical	amod	5	SENT_158	[p7l692t2165r938b2225],
5	samples	NNS	O	sample	prep_in	9	SENT_158	[p7l970t2165r1256b2242],
6	,	,	O	,	_	0	SENT_158	[p7l970t2165r1256b2242],
7	73	CD	NUMBER	73	num	8	SENT_158	[p7l1288t2166r1366b2225],
8	patients	NNS	O	patient	nsubj	9	SENT_158	[p7l1397t2165r1658b2242],
9	received	VBD	O	receive	_	0	SENT_158	[p7l1687t2165r1971b2225],
10	simvastatin	NN	O	simvastatin	dobj	9	SENT_158	[p7l2001t2165r2144b2225, p7l9t2266r268b2325],
11	and	CC	O	and	_	0	SENT_158	[p7l318t2266r437b2325],
12	atorvastatin	NN	O	atorvastatin	conj_and	10	SENT_158	[p7l485t2266r893b2336],
13	,	,	O	,	_	0	SENT_158	[p7l485t2266r893b2336],
14	whose	WP$	O	whose	poss	15	SENT_158	[p7l945t2266r1159b2325],
15	metabolism	NN	O	metabolism	nsubjpass	17	SENT_158	[p7l1206t2266r1602b2325],
16	is	VBZ	O	be	auxpass	17	SENT_158	[p7l1648t2266r1701b2325],
17	handled	VBN	O	handle	rcmod	10	SENT_158	[p7l1750t2266r2018b2325],
18	by	IN	O	by	_	0	SENT_158	[p7l2063t2266r2146b2343],
19	CYP3A5	NN	O	cyp3a5	agent	17	SENT_158	[p7l9t2369r313b2429],
20	[	CD	NUMBER	[	number	21	SENT_158	[p7l341t2369r597b2441],
21	25,26	CD	NUMBER	25,26	num	22	SENT_158	[p7l341t2369r597b2441],
22	]	NN	O	]	dep	17	SENT_158	[p7l341t2369r597b2441],
23	.	.	O	.	_	0	SENT_158	[p7l341t2369r597b2441],

1	Among	IN	O	among	_	0	SENT_159	[p7l619t2370r871b2446],
2	these	DT	O	these	prep_among	5	SENT_159	[p7l889t2369r1080b2439],
3	,	,	O	,	_	0	SENT_159	[p7l889t2369r1080b2439],
4	34	CD	NUMBER	34	nsubj	5	SENT_159	[p7l1103t2370r1182b2429],
5	showed	VBD	O	show	_	0	SENT_159	[p7l1203t2369r1456b2429],
6	muscular	JJ	O	muscular	amod	7	SENT_159	[p7l1473t2369r1784b2429],
7	symptoms	NNS	O	symptom	dobj	5	SENT_159	[p7l1803t2378r2145b2446],
8	following	VBG	O	follow	_	0	SENT_159	[p7l9t2471r333b2548],
9	intake	NN	O	intake	prep_following	5	SENT_159	[p7l360t2471r564b2530],
10	of	IN	O	of	_	0	SENT_159	[p7l591t2471r664b2530],
11	the	DT	O	the	det	12	SENT_159	[p7l684t2471r785b2530],
12	statin	NN	O	statin	prep_of	9	SENT_159	[p7l814t2471r1011b2541],
13	,	,	O	,	_	0	SENT_159	[p7l814t2471r1011b2541],
14	whereas	IN	O	whereas	mark	16	SENT_159	[p7l1040t2471r1313b2531],
15	39	CD	NUMBER	39	nsubj	16	SENT_159	[p7l1343t2471r1422b2531],
16	had	VBD	O	have	advcl	5	SENT_159	[p7l1449t2471r1570b2530],
17	no	DT	O	no	det	18	SENT_159	[p7l1595t2489r1676b2530],
18	disturbances	NNS	O	disturbance	dobj	16	SENT_159	[p7l1704t2471r2143b2530],
19	.	.	O	.	_	0	SENT_159	[p7l1704t2471r2143b2530],

1	The	DT	O	the	det	3	SENT_160	[p7l8t2572r138b2631],
2	two	CD	NUMBER	two	num	3	SENT_160	[p7l161t2580r284b2632],
3	groups	NNS	O	group	nsubj	12	SENT_160	[p7l309t2590r534b2649],
4	were	VBD	O	be	cop	12	SENT_160	[p7l560t2590r722b2631],
5	comparable	JJ	O	comparable	amod	12	SENT_160	[p7l746t2572r1139b2649],
6	for	IN	O	for	_	0	SENT_160	[p7l1162t2571r1260b2631],
7	age	NN	O	age	prep_for	5	SENT_160	[p7l1283t2590r1414b2649],
8	,	,	O	,	_	0	SENT_160	[p7l1283t2590r1414b2649],
9	sex	NN	O	sex	prep_for	5	SENT_160	[p7l1444t2590r1550b2631],
10	and	CC	O	and	_	0	SENT_160	[p7l1575t2572r1694b2631],
11	drug	NN	O	drug	prep_for	5	SENT_160	[p7l1717t2572r1869b2649],
12	dosage	NN	O	dosage	_	0	SENT_160	[p7l1893t2572r2143b2649],
13	.	.	O	.	_	0	SENT_160	[p7l1893t2572r2143b2649],

1	In	IN	O	in	_	0	SENT_161	[p7l8t2677r77b2734],
2	the	DT	O	the	det	3	SENT_161	[p7l99t2675r200b2735],
3	group	NN	O	group	prep_in	16	SENT_161	[p7l224t2694r418b2752],
4	of	IN	O	of	_	0	SENT_161	[p7l443t2675r516b2735],
5	patients	NNS	O	patient	prep_of	3	SENT_161	[p7l532t2675r792b2752],
6	with	IN	O	with	_	0	SENT_161	[p7l817t2675r966b2735],
7	AEs	NNS	ORGANIZATION	ae	prep_with	5	SENT_161	[p7l988t2676r1150b2746],
8	,	,	O	,	_	0	SENT_161	[p7l988t2676r1150b2746],
9	4	CD	PERCENT	4	number	10	SENT_161	[p7l1175t2676r1215b2734],
10	(	CD	PERCENT	(	nsubj	16	SENT_161	[p7l1241t2676r1510b2749],
11	11.8	CD	PERCENT	11.8	num	12	SENT_161	[p7l1241t2676r1510b2749],
12	%	NN	PERCENT	%	dep	10	SENT_161	[p7l1241t2676r1510b2749],
13	)	CD	NUMBER	)	dep	10	SENT_161	[p7l1241t2676r1510b2749],
14	were	VBD	O	be	cop	16	SENT_161	[p7l1535t2694r1697b2735],
15	*	CD	NUMBER	*	number	16	SENT_161	[p7l1724t2676r1907b2735],
16	1	CD	NUMBER	1	_	0	SENT_161	[p7l1724t2676r1907b2735],
17	/	:	O	/	punct	19	SENT_161	[p7l1724t2676r1907b2735],
18	*	CD	NUMBER	*	number	19	SENT_161	[p7l1724t2676r1907b2735],
19	3	CD	NUMBER	3	dep	16	SENT_161	[p7l1724t2676r1907b2735],
20	versus	CC	O	versus	prep	19	SENT_161	[p7l1934t2694r2145b2735],
21	10	CD	PERCENT	10	dep	20	SENT_161	[p7l16t2776r90b2836],
22	(	CD	PERCENT	(	number	23	SENT_161	[p7l127t2775r395b2849],
23	25.6	CD	PERCENT	25.6	dep	24	SENT_161	[p7l127t2775r395b2849],
24	%	NN	PERCENT	%	dep	16	SENT_161	[p7l127t2775r395b2849],
25	)	CD	NUMBER	)	npadvmod	16	SENT_161	[p7l127t2775r395b2849],
26	in	IN	O	in	_	0	SENT_161	[p7l432t2776r495b2835],
27	the	DT	O	the	det	29	SENT_161	[p7l529t2776r630b2835],
28	control	NN	O	control	nn	29	SENT_161	[p7l664t2776r902b2835],
29	group	NN	O	group	prep_in	16	SENT_161	[p7l936t2794r1148b2853],
30	.	.	O	.	_	0	SENT_161	[p7l936t2794r1148b2853],

1	The	DT	O	the	det	2	SENT_162	[p7l1186t2776r1316b2835],
2	frequency	NN	O	frequency	_	0	SENT_162	[p7l1350t2776r1685b2853],
3	of	IN	O	of	_	0	SENT_162	[p7l1720t2776r1793b2835],
4	the	DT	O	the	det	5	SENT_162	[p7l1821t2776r1922b2835],
5	*	NN	O	*	prep_of	2	SENT_162	[p7l1960t2776r2143b2836],
6	1	CD	NUMBER	1	num	5	SENT_162	[p7l1960t2776r2143b2836],
7	/	:	O	/	punct	2	SENT_162	[p7l1960t2776r2143b2836],
8	*	CD	NUMBER	*	number	9	SENT_162	[p7l1960t2776r2143b2836],
9	3	CD	NUMBER	3	num	10	SENT_162	[p7l1960t2776r2143b2836],
10	genotype	NN	O	genotype	nsubj	15	SENT_162	[p7l9t2888r317b2956],
11	was	VBD	O	be	cop	15	SENT_162	[p7l347t2898r474b2939],
12	4/34	CD	PERCENT	4/34	number	13	SENT_162	[p7l505t2880r653b2939],
13	(	CD	PERCENT	(	num	15	SENT_162	[p7l686t2880r955b2953],
14	11.8	CD	PERCENT	11.8	num	15	SENT_162	[p7l686t2880r955b2953],
15	%	NN	PERCENT	%	dep	2	SENT_162	[p7l686t2880r955b2953],
16	)	CD	NUMBER	)	rel	35	SENT_162	[p7l686t2880r955b2953],
17	in	IN	O	in	_	0	SENT_162	[p7l986t2879r1050b2938],
18	the	DT	O	the	det	19	SENT_162	[p7l1079t2879r1181b2939],
19	group	NN	O	group	prep_in	16	SENT_162	[p7l1211t2898r1405b2956],
20	of	IN	O	of	_	0	SENT_162	[p7l1437t2879r1510b2939],
21	patients	NNS	O	patient	prep_of	19	SENT_162	[p7l1533t2879r1794b2956],
22	with	IN	O	with	_	0	SENT_162	[p7l1825t2879r1974b2939],
23	AEs	NNS	ORGANIZATION	ae	prep_with	21	SENT_162	[p7l2003t2880r2145b2939],
24	and	CC	O	and	_	0	SENT_162	[p7l10t2981r129b3041],
25	10/39	CD	PERCENT	10/39	prep_of	19	SENT_162	[p7l154t2981r335b3042],
26	(	CD	PERCENT	(	number	27	SENT_162	[p7l357t2981r625b3054],
27	25.6	CD	PERCENT	25.6	num	28	SENT_162	[p7l357t2981r625b3054],
28	%	NN	PERCENT	%	dep	25	SENT_162	[p7l357t2981r625b3054],
29	)	CD	NUMBER	)	nsubj	35	SENT_162	[p7l357t2981r625b3054],
30	in	IN	O	in	_	0	SENT_162	[p7l645t2981r709b3040],
31	the	DT	O	the	det	32	SENT_162	[p7l726t2981r827b3041],
32	group	NN	O	group	prep_in	29	SENT_162	[p7l846t3000r1040b3058],
33	without	IN	O	without	_	0	SENT_162	[p7l1059t2981r1317b3041],
34	complaints	NNS	O	complaint	prep_without	32	SENT_162	[p7l1334t2981r1702b3058],
35	(	VBP	O	(	rcmod	15	SENT_162	[p7l1723t2982r1788b3057],
36	19	CD	NUMBER	19	num	38	SENT_162	[p7l1723t2982r1788b3057],
37	=	JJ	O	=	amod	38	SENT_162	[p7l1807t3006r1850b3029],
38	ns	NNS	O	n	nsubj	39	SENT_162	[p7l1868t2982r1986b3054],
39	)	VBP	O	)	ccomp	35	SENT_162	[p7l1868t2982r1986b3054],
40	.	.	O	.	_	0	SENT_162	[p7l1868t2982r1986b3054],

1	Frequency	NN	O	frequency	_	0	SENT_163	[p7l2007t2983r2144b3041, p7l9t3100r250b3159],
2	of	IN	O	of	_	0	SENT_163	[p7l273t3082r346b3141],
3	the	DT	O	the	det	4	SENT_163	[p7l363t3082r464b3141],
4	*	NN	O	*	prep_of	1	SENT_163	[p7l491t3082r673b3142],
5	3	CD	NUMBER	3	num	4	SENT_163	[p7l491t3082r673b3142],
6	/	:	O	/	punct	1	SENT_163	[p7l491t3082r673b3142],
7	*	CD	NUMBER	*	number	8	SENT_163	[p7l491t3082r673b3142],
8	3	CD	NUMBER	3	num	9	SENT_163	[p7l491t3082r673b3142],
9	genotype	NN	O	genotype	nsubj	21	SENT_163	[p7l701t3090r1008b3159],
10	in	IN	O	in	_	0	SENT_163	[p7l1031t3082r1095b3140],
11	subjects	NNS	O	subject	conj_and	11	SENT_163	[p7l1120t3082r1386b3159],
12	with	IN	O	with	_	0	SENT_163	[p7l1411t3082r1559b3142],
13	and	CC	O	and	_	0	SENT_163	[p7l1583t3082r1702b3141],
14	without	IN	O	without	_	0	SENT_163	[p7l1724t3082r1982b3142],
15	AEs	NNS	O	ae	prep_without	11	SENT_163	[p7l2003t3082r2145b3141],
16	were	VBD	O	be	cop	21	SENT_163	[p7l9t3204r171b3245],
17	88.2	CD	PERCENT	88.2	number	21	SENT_163	[p7l198t3186r408b3245],
18	%	NN	PERCENT	%	dep	21	SENT_163	[p7l198t3186r408b3245],
19	and	CC	O	and	_	0	SENT_163	[p7l438t3185r557b3245],
20	74.4	CD	PERCENT	74.4	conj_and	21	SENT_163	[p7l581t3186r816b3256],
21	%	NN	PERCENT	%	dep	1	SENT_163	[p7l581t3186r816b3256],
22	,	,	O	,	_	0	SENT_163	[p7l581t3186r816b3256],
23	respectively	RB	O	respectively	advmod	21	SENT_163	[p7l842t3185r1246b3262],
24	(	CD	NUMBER	(	num	25	SENT_163	[p7l1274t3186r1339b3261],
25	p	NN	O	p	attr	21	SENT_163	[p7l1274t3186r1339b3261],
26	=	JJ	O	=	dep	25	SENT_163	[p7l1357t3210r1401b3234],
27	ns	FW	O	ns	nn	28	SENT_163	[p7l1418t3186r1537b3259],
28	)	FW	O	)	dobj	26	SENT_163	[p7l1418t3186r1537b3259],
29	.	.	O	.	_	0	SENT_163	[p7l1418t3186r1537b3259],

1	The	DT	O	the	det	2	SENT_164	[p7l1565t3185r1694b3245],
2	frequency	NN	O	frequency	_	0	SENT_164	[p7l1719t3185r2054b3262],
3	of	IN	O	of	_	0	SENT_164	[p7l2080t3185r2153b3245],
4	*	NN	O	*	prep_of	2	SENT_164	[p7l13t3287r195b3347],
5	1	CD	NUMBER	1	num	4	SENT_164	[p7l13t3287r195b3347],
6	/	:	O	/	punct	2	SENT_164	[p7l13t3287r195b3347],
7	*	CD	NUMBER	*	num	8	SENT_164	[p7l13t3287r195b3347],
8	3	CD	NUMBER	3	nsubj	11	SENT_164	[p7l13t3287r195b3347],
9	was	VBD	O	be	cop	11	SENT_164	[p7l226t3306r353b3347],
10	slightly	RB	O	slightly	advmod	11	SENT_164	[p7l384t3287r633b3364],
11	lower	JJR	O	lower	dep	2	SENT_164	[p7l660t3287r850b3347],
12	in	IN	O	in	_	0	SENT_164	[p7l875t3287r939b3346],
13	the	DT	O	the	det	14	SENT_164	[p7l965t3287r1066b3347],
14	group	NN	O	group	prep_in	11	SENT_164	[p7l1094t3306r1287b3364],
15	of	IN	O	of	_	0	SENT_164	[p7l1316t3287r1389b3347],
16	patients	NNS	O	patient	prep_of	14	SENT_164	[p7l1408t3287r1669b3364],
17	with	IN	O	with	_	0	SENT_164	[p7l1698t3287r1846b3347],
18	AEs	NNS	O	ae	prep_with	16	SENT_164	[p7l1872t3288r2014b3347],
19	but	CC	O	but	cc	24	SENT_164	[p7l2041t3287r2148b3347],
20	the	DT	O	the	det	21	SENT_164	[p7l8t3388r109b3447],
21	difference	NN	O	difference	nsubj	24	SENT_164	[p7l138t3387r477b3447],
22	did	VBD	O	do	aux	24	SENT_164	[p7l505t3388r612b3447],
23	not	RB	O	not	neg	24	SENT_164	[p7l638t3397r746b3447],
24	reach	VB	O	reach	ccomp	11	SENT_164	[p7l771t3388r954b3447],
25	statistical	JJ	O	statistical	amod	26	SENT_164	[p7l984t3388r1300b3447],
26	signiﬁcance	NN	O	signiﬁcance	dobj	24	SENT_164	[p7l1330t3388r1748b3465],
27	.	.	O	.	_	0	SENT_164	[p7l1330t3388r1748b3465],

1	Also	RB	O	also	advmod	6	SENT_165	[p7l1779t3388r1937b3447],
2	allele	NN	O	allele	nn	3	SENT_165	[p7l1967t3388r2147b3447],
3	frequencies	NNS	O	frequency	nsubj	6	SENT_165	[p7l9t3491r396b3568],
4	were	VBD	O	be	cop	6	SENT_165	[p7l440t3510r601b3551],
5	approximately	RB	O	approximately	advmod	6	SENT_165	[p7l645t3491r1131b3568],
6	identical	JJ	O	identical	_	0	SENT_165	[p7l1173t3491r1463b3551],
7	in	IN	O	in	_	0	SENT_165	[p7l1504t3491r1568b3550],
8	the	DT	O	the	det	14	SENT_165	[p7l1610t3491r1711b3551],
9	two	CD	NUMBER	two	num	10	SENT_165	[p7l1753t3500r1876b3551],
10	groups	NNS	O	group	dep	11	SENT_165	[p7l1919t3510r2145b3568],
11	(	RB	O	(	amod	14	SENT_165	[p7l11t3592r220b3665],
12	Table	NNP	O	Table	nn	14	SENT_165	[p7l11t3592r220b3665],
13	3	CD	NUMBER	3	amod	14	SENT_165	[p7l247t3592r330b3665],
14	)	NN	O	)	prep_in	6	SENT_165	[p7l247t3592r330b3665],
15	.	.	O	.	_	0	SENT_165	[p7l247t3592r330b3665],

1	Table	NNP	O	Table	_	0	SENT_166	[p8l8t84r155b131],
2	3	CD	NUMBER	3	dep	1	SENT_166	[p8l176t85r203b132],

1	3.1.2	CD	NUMBER	3.1.2	_	0	SENT_167	[p8l7t286r188b345],
2	.	.	O	.	_	0	SENT_167	[p8l7t286r188b345],

1	CYPZC9	NN	O	cypzc9	nn	2	SENT_168	[p8l245t286r538b346],
2	genotype	NN	O	genotype	_	0	SENT_168	[p8l560t297r864b362],

1	In	IN	O	in	_	0	SENT_169	[p8l109t391r178b448],
2	the	DT	O	the	det	4	SENT_169	[p8l209t389r311b449],
3	examined	VBN	O	examine	amod	4	SENT_169	[p8l343t389r671b449],
4	sample	NN	O	sample	prep_in	25	SENT_169	[p8l705t389r941b466],
5	only	RB	O	only	quantmod	6	SENT_169	[p8l973t389r1121b466],
6	32	CD	NUMBER	32	num	7	SENT_169	[p8l1155t390r1235b449],
7	patients	NNS	O	patient	nsubj	25	SENT_169	[p8l1266t389r1548b466],
8	,	,	O	,	_	0	SENT_169	[p8l1266t389r1548b466],
9	18	CD	PERCENT	18	appos	7	SENT_169	[p8l1591t390r1663b449],
10	(	CD	PERCENT	(	number	11	SENT_169	[p8l1700t389r1969b463],
11	56.2	CD	PERCENT	56.2	dep	12	SENT_169	[p8l1700t389r1969b463],
12	%	NN	PERCENT	%	dep	9	SENT_169	[p8l1700t389r1969b463],
13	)	CD	NUMBER	)	advmod	9	SENT_169	[p8l1700t389r1969b463],
14	with	IN	O	with	_	0	SENT_169	[p8l2004t389r2153b449],
15	AEs	NNS	O	ae	prep_with	13	SENT_169	[p8l7t491r149b550],
16	and	CC	O	and	_	0	SENT_169	[p8l176t490r296b550],
17	14	CD	PERCENT	14	number	18	SENT_169	[p8l327t490r401b549],
18	(	CD	PERCENT	(	prep_with	13	SENT_169	[p8l428t490r697b563],
19	43.8	CD	PERCENT	43.8	num	20	SENT_169	[p8l428t490r697b563],
20	%	NN	PERCENT	%	dep	18	SENT_169	[p8l428t490r697b563],
21	)	CD	NUMBER	)	dep	9	SENT_169	[p8l428t490r697b563],
22	without	IN	O	without	_	0	SENT_169	[p8l723t490r982b550],
23	AEs	NNS	O	ae	prep_without	21	SENT_169	[p8l1004t491r1167b560],
24	,	,	O	,	_	0	SENT_169	[p8l1004t491r1167b560],
25	received	VBD	O	receive	_	0	SENT_169	[p8l1192t490r1477b550],
26	statins	NNS	O	statin	dobj	25	SENT_169	[p8l1503t490r1713b550],
27	metabolized	VBN	O	metabolize	partmod	26	SENT_169	[p8l1738t490r2153b550],
28	to	TO	O	to	_	0	SENT_169	[p8l7t602r70b652],
29	a	DT	O	a	det	31	SENT_169	[p8l101t611r136b652],
30	different	JJ	O	different	amod	31	SENT_169	[p8l164t593r453b652],
31	degree	NN	O	degree	prep_to	27	SENT_169	[p8l481t593r703b670],
32	of	IN	O	of	_	0	SENT_169	[p8l733t593r806b652],
33	involvement	NN	O	involvement	prep_of	31	SENT_169	[p8l828t593r1247b652],
34	by	IN	O	by	_	0	SENT_169	[p8l1273t593r1356b670],
35	CYP2C9	NN	O	cyp2c9	nn	37	SENT_169	[p8l1387t593r1689b653],
36	(	CD	NUMBER	(	num	37	SENT_169	[p8l1722t593r2150b666],
37	simvastatin	NN	O	simvastatin	agent	27	SENT_169	[p8l1722t593r2150b666],
38	,	,	O	,	_	0	SENT_169	[p8l1722t593r2150b666],
39	ﬂuvastatin	NN	O	ﬂuvastatin	appos	37	SENT_169	[p8l8t695r376b766],
40	,	,	O	,	_	0	SENT_169	[p8l8t695r376b766],
41	rosuvastatin	NN	O	rosuvastatin	appos	39	SENT_169	[p8l413t695r847b769],
42	)	CD	NUMBER	)	number	43	SENT_169	[p8l413t695r847b769],
43	[	CD	NUMBER	[	dep	41	SENT_169	[p8l891t695r1275b767],
44	13-15	CD	NUMBER	13-15	num	46	SENT_169	[p8l891t695r1275b767],
45	,27	CD	NUMBER	,27	num	46	SENT_169	[p8l891t695r1275b767],
46	]	NN	O	]	dep	43	SENT_169	[p8l891t695r1275b767],
47	.	.	O	.	_	0	SENT_169	[p8l891t695r1275b767],

1	In	IN	O	in	_	0	SENT_170	[p8l1315t697r1384b754],
2	the	DT	O	the	det	3	SENT_170	[p8l1418t695r1520b755],
3	group	NN	O	group	prep_in	18	SENT_170	[p8l1556t714r1750b772],
4	of	IN	O	of	_	0	SENT_170	[p8l1787t695r1861b755],
5	patients	NNS	O	patient	prep_of	3	SENT_170	[p8l1889t695r2151b772],
6	with	IN	O	with	_	0	SENT_170	[p8l7t796r156b856],
7	AEs	NNS	ORGANIZATION	ae	prep_with	5	SENT_170	[p8l195t797r357b866],
8	,	,	O	,	_	0	SENT_170	[p8l195t797r357b866],
9	6	CD	PERCENT	6	num	10	SENT_170	[p8l401t796r438b856],
10	(	NN	PERCENT	(	nsubj	18	SENT_170	[p8l481t796r751b869],
11	33.3	CD	PERCENT	33.3	num	12	SENT_170	[p8l481t796r751b869],
12	%	NN	PERCENT	%	dep	10	SENT_170	[p8l481t796r751b869],
13	)	CD	NUMBER	)	dep	10	SENT_170	[p8l481t796r751b869],
14	had	VBD	O	have	aux	18	SENT_170	[p8l791t796r914b856],
15	at	IN	O	at	advmod	18	SENT_170	[p8l953t805r1012b856],
16	least	JJS	O	least	pobj	15	SENT_170	[p8l1050t796r1204b856],
17	one	CD	NUMBER	one	dep	15	SENT_170	[p8l1243t815r1362b856],
18	mutated	VBN	O	mutate	_	0	SENT_170	[p8l1402t796r1675b856],
19	allele	NN	O	allele	nn	21	SENT_170	[p8l1714t796r1895b856],
20	(	CD	NUMBER	(	num	21	SENT_170	[p8l1937t797r2044b869],
21	*	NN	O	*	dobj	18	SENT_170	[p8l1937t797r2044b869],
22	2	CD	NUMBER	2	dep	21	SENT_170	[p8l1937t797r2044b869],
23	or	CC	O	or	_	0	SENT_170	[p8l2085t815r2154b856],
24	*	CD	NUMBER	*	number	25	SENT_170	[p8l11t898r136b971],
25	3	CD	NUMBER	3	num	26	SENT_170	[p8l11t898r136b971],
26	)	NN	O	)	conj_or	21	SENT_170	[p8l11t898r136b971],
27	,	,	O	,	_	0	SENT_170	[p8l11t898r136b971],
28	whereas	IN	O	whereas	mark	39	SENT_170	[p8l180t898r455b958],
29	in	IN	O	in	_	0	SENT_170	[p8l497t898r561b956],
30	the	DT	O	the	det	32	SENT_170	[p8l601t898r703b957],
31	control	NN	O	control	nn	32	SENT_170	[p8l744t898r982b957],
32	group	NN	O	group	prep_in	39	SENT_170	[p8l1024t916r1219b975],
33	the	DT	O	the	det	34	SENT_170	[p8l1260t898r1361b957],
34	heterozygotes	NNS	O	heterozygote	nsubj	39	SENT_170	[p8l1401t898r1871b975],
35	for	IN	O	for	_	0	SENT_170	[p8l1914t898r2012b957],
36	the	DT	O	the	det	37	SENT_170	[p8l2051t898r2152b957],
37	mutation	NN	O	mutation	prep_for	34	SENT_170	[p8l7t1001r308b1061],
38	were	VBD	O	be	cop	39	SENT_170	[p8l354t1020r516b1061],
39	5	CD	PERCENT	5	advcl	18	SENT_170	[p8l563t1001r599b1061],
40	(	CD	PERCENT	(	number	41	SENT_170	[p8l651t1001r939b1075],
41	35.7	CD	PERCENT	35.7	num	42	SENT_170	[p8l651t1001r939b1075],
42	%	NN	PERCENT	%	dep	39	SENT_170	[p8l651t1001r939b1075],
43	)	CD	NUMBER	)	dep	42	SENT_170	[p8l651t1001r939b1075],
44	.	.	O	.	_	0	SENT_170	[p8l651t1001r939b1075],

1	Patients	NNS	O	patient	nsubj	18	SENT_171	[p8l989t1001r1254b1061],
2	with	IN	O	with	_	0	SENT_171	[p8l1302t1001r1451b1061],
3	homozygous	JJ	O	homozygous	amod	5	SENT_171	[p8l1496t1001r1927b1078],
4	wildtype	JJ	O	wildtype	amod	5	SENT_171	[p8l1975t1001r2150b1061, p8l7t1112r151b1180],
5	genotype	NN	O	genotype	prep_with	1	SENT_171	[p8l192t1112r500b1180],
6	in	IN	O	in	_	0	SENT_171	[p8l540t1103r604b1162],
7	the	DT	O	the	det	8	SENT_171	[p8l643t1103r745b1162],
8	group	NN	O	group	prep_in	5	SENT_171	[p8l786t1121r980b1180],
9	with	IN	O	with	_	0	SENT_171	[p8l1021t1103r1170b1163],
10	AEs	NNS	O	ae	prep_with	8	SENT_171	[p8l1209t1103r1352b1162],
11	and	CC	O	and	_	0	SENT_171	[p8l1395t1103r1514b1162],
12	in	IN	O	in	_	0	SENT_171	[p8l1553t1103r1617b1162],
13	controls	NNS	O	control	prep_in	1	SENT_171	[p8l1657t1103r1947b1173],
14	,	,	O	,	_	0	SENT_171	[p8l1657t1103r1947b1173],
15	were	VBD	O	be	cop	18	SENT_171	[p8l1990t1121r2152b1162],
16	respectively	RB	O	respectively	advmod	18	SENT_171	[p8l6t1205r412b1282],
17	12	CD	PERCENT	12	number	18	SENT_171	[p8l455t1206r529b1264],
18	(	CD	PERCENT	(	_	0	SENT_171	[p8l565t1205r835b1279],
19	66.7	CD	PERCENT	66.7	num	20	SENT_171	[p8l565t1205r835b1279],
20	%	NN	PERCENT	%	dep	18	SENT_171	[p8l565t1205r835b1279],
21	)	CD	NUMBER	)	dep	18	SENT_171	[p8l565t1205r835b1279],
22	and	CC	O	and	_	0	SENT_171	[p8l872t1205r992b1265],
23	9	CD	PERCENT	9	num	24	SENT_171	[p8l1026t1206r1063b1266],
24	(	NN	PERCENT	(	conj_and	18	SENT_171	[p8l1101t1205r1397b1279],
25	623	CD	PERCENT	623	num	26	SENT_171	[p8l1101t1205r1397b1279],
26	%	NN	PERCENT	%	dep	24	SENT_171	[p8l1101t1205r1397b1279],
27	)	CD	NUMBER	)	dep	24	SENT_171	[p8l1101t1205r1397b1279],
28	.	.	O	.	_	0	SENT_171	[p8l1101t1205r1397b1279],

1	By	IN	O	by	_	0	SENT_172	[p8l1435t1207r1531b1282],
2	comparing	VBG	O	compare	prepc_by	20	SENT_172	[p8l1566t1205r1926b1282],
3	genotypic	JJ	O	genotypic	dobj	2	SENT_172	[p8l1962t1224r2150b1282, p8l7t1307r174b1384],
4	as	RB	O	as	_	0	SENT_172	[p8l210t1326r275b1367],
5	well	RB	O	well	_	0	SENT_172	[p8l311t1307r454b1367],
6	as	IN	O	as	_	0	SENT_172	[p8l490t1326r555b1367],
7	allele	NN	O	allele	nn	8	SENT_172	[p8l592t1307r772b1367],
8	frequencies	NNS	O	frequency	conj_and	3	SENT_172	[p8l806t1307r1194b1384],
9	(	RB	O	(	advmod	2	SENT_172	[p8l1232t1307r1442b1380],
10	Table	NNP	O	Table	nn	12	SENT_172	[p8l1232t1307r1442b1380],
11	3	CD	NUMBER	3	num	12	SENT_172	[p8l1478t1307r1542b1380],
12	)	NN	O	)	nsubj	20	SENT_172	[p8l1478t1307r1542b1380],
13	between	IN	O	between	_	0	SENT_172	[p8l1577t1307r1860b1367],
14	the	DT	O	the	det	16	SENT_172	[p8l1893t1307r1994b1367],
15	two	CD	NUMBER	two	num	16	SENT_172	[p8l2028t1316r2152b1367],
16	groups	NNS	O	group	prep_between	12	SENT_172	[p8l8t1427r234b1486],
17	of	IN	O	of	_	0	SENT_172	[p8l259t1409r333b1468],
18	patients	NNS	O	patient	prep_of	16	SENT_172	[p8l347t1409r609b1486],
19	there	RB	O	there	advmod	20	SENT_172	[p8l633t1409r801b1468],
20	appears	VBZ	O	appear	_	0	SENT_172	[p8l824t1427r1079b1486],
21	to	TO	O	to	aux	26	SENT_172	[p8l1102t1418r1165b1468],
22	be	VB	O	be	cop	26	SENT_172	[p8l1187t1409r1265b1468],
23	no	DT	O	no	det	26	SENT_172	[p8l1287t1427r1370b1468],
24	statistically	RB	O	statistically	advmod	25	SENT_172	[p8l1395t1409r1777b1486],
25	signiﬁcant	JJ	O	signiﬁcant	amod	26	SENT_172	[p8l1803t1409r2154b1486],
26	difference	NN	O	difference	xcomp	20	SENT_172	[p8l8t1510r365b1570],
27	.	.	O	.	_	0	SENT_172	[p8l8t1510r365b1570],

1	3.1.3	CD	NUMBER	3.1.3	_	0	SENT_173	[p8l7t1724r188b1784],
2	.	.	O	.	_	0	SENT_173	[p8l7t1724r188b1784],

1	CYP2D6	NN	O	cyp2d6	nn	2	SENT_174	[p8l245t1724r545b1784],
2	genotype	NN	O	genotype	_	0	SENT_174	[p8l565t1735r869b1800],

1	Thirty	CD	NUMBER	thirty	num	2	SENT_175	[p8l109t1826r319b1903],
2	patients	NNS	O	patient	nsubj	3	SENT_175	[p8l349t1826r611b1903],
3	received	VBD	O	receive	_	0	SENT_175	[p8l642t1826r927b1885],
4	statins	NNS	O	statin	dobj	3	SENT_175	[p8l959t1826r1169b1885],
5	whose	WP$	O	whose	poss	6	SENT_175	[p8l1202t1826r1417b1885],
6	metabolism	NN	O	metabolism	nsubj	7	SENT_175	[p8l1447t1826r1844b1885],
7	involves	VBZ	O	involve	rcmod	4	SENT_175	[p8l1873t1826r2151b1885],
8	CYP2D6	NN	O	cyp2d6	nn	10	SENT_175	[p8l8t1929r316b1989],
9	(	CD	NUMBER	(	num	10	SENT_175	[p8l365t1929r775b2003],
10	simvastatin	NN	O	simvastatin	dobj	7	SENT_175	[p8l365t1929r775b2003],
11	and	CC	O	and	_	0	SENT_175	[p8l822t1929r942b1989],
12	ﬂuvastatin	NN	O	ﬂuvastatin	conj_and	10	SENT_175	[p8l988t1929r1363b2002],
13	)	CD	NUMBER	)	number	14	SENT_175	[p8l988t1929r1363b2002],
14	[	CD	NUMBER	[	dep	12	SENT_175	[p8l1417t1929r1802b2001],
15	13-15	CD	NUMBER	13-15	num	17	SENT_175	[p8l1417t1929r1802b2001],
16	,17	CD	NUMBER	,17	num	17	SENT_175	[p8l1417t1929r1802b2001],
17	]	NN	O	]	dep	14	SENT_175	[p8l1417t1929r1802b2001],
18	.	.	O	.	_	0	SENT_175	[p8l1417t1929r1802b2001],

1	Eighteen	CD	NUMBER	eighteen	nsubj	2	SENT_176	[p8l1852t1929r2153b2006],
2	showed	VBD	O	show	_	0	SENT_176	[p8l10t2031r264b2091],
3	AEs	NNS	O	ae	nsubj	7	SENT_176	[p8l302t2031r445b2090],
4	and	CC	O	and	_	0	SENT_176	[p8l488t2031r608b2090],
5	12	CD	NUMBER	12	conj_and	3	SENT_176	[p8l655t2031r728b2090],
6	were	VBD	O	be	cop	7	SENT_176	[p8l769t2049r931b2091],
7	free	JJ	O	free	ccomp	2	SENT_176	[p8l972t2031r1101b2090],
8	of	IN	O	of	_	0	SENT_176	[p8l1142t2031r1215b2090],
9	side	JJ	O	side	amod	10	SENT_176	[p8l1252t2031r1384b2090],
10	effects	NNS	O	effect	prep_of	7	SENT_176	[p8l1424t2031r1663b2090],
11	.	.	O	.	_	0	SENT_176	[p8l1424t2031r1663b2090],

1	In	IN	O	in	_	0	SENT_177	[p8l1707t2032r1776b2090],
2	the	DT	O	the	det	3	SENT_177	[p8l1815t2031r1916b2090],
3	group	NN	O	group	prep_in	9	SENT_177	[p8l1957t2049r2152b2108],
4	with	IN	O	with	_	0	SENT_177	[p8l7t2133r156b2193],
5	AEs	NNS	ORGANIZATION	ae	prep_with	3	SENT_177	[p8l198t2134r361b2204],
6	,	,	O	,	_	0	SENT_177	[p8l198t2134r361b2204],
7	1	CD	NUMBER	1	num	8	SENT_177	[p8l414t2134r439b2192],
8	patient	NN	O	patient	nsubj	9	SENT_177	[p8l487t2133r720b2210],
9	proved	VBD	O	prove	_	0	SENT_177	[p8l759t2133r993b2210],
10	to	TO	O	to	aux	16	SENT_177	[p8l1035t2142r1098b2193],
11	be	VB	O	be	cop	16	SENT_177	[p8l1139t2133r1219b2193],
12	an	DT	O	a	det	16	SENT_177	[p8l1263t2152r1339b2193],
13	ultrarapid	JJ	O	ultrarapid	amod	16	SENT_177	[p8l1381t2133r1711b2210],
14	metabolizer	NN	O	metabolizer	nn	16	SENT_177	[p8l1753t2133r2154b2193],
15	(	NN	O	(	nn	16	SENT_177	[p8l10t2236r188b2308],
16	UM	NN	O	um	xcomp	9	SENT_177	[p8l10t2236r188b2308],
17	,	,	O	,	_	0	SENT_177	[p8l10t2236r188b2308],
18	CYP2D6	NN	O	cyp2d6	nn	19	SENT_177	[p8l236t2235r629b2295],
19	*	NN	O	*	appos	16	SENT_177	[p8l236t2235r629b2295],
20	2	CD	NUMBER	2	dep	19	SENT_177	[p8l236t2235r629b2295],
21	x	CC	O	x	_	0	SENT_177	[p8l657t2254r701b2293],
22	N	NN	O	n	conj_x	9	SENT_177	[p8l728t2236r833b2308],
23	)	NN	O	)	dobj	22	SENT_177	[p8l728t2236r833b2308],
24	.	.	O	.	_	0	SENT_177	[p8l728t2236r833b2308],

1	In	IN	O	in	_	0	SENT_178	[p8l880t2237r949b2294],
2	the	DT	O	the	det	3	SENT_178	[p8l992t2235r1093b2295],
3	group	NN	O	group	prep_in	19	SENT_178	[p8l1138t2254r1332b2312],
4	of	IN	O	of	_	0	SENT_178	[p8l1378t2235r1451b2295],
5	patients	NNS	O	patient	prep_of	3	SENT_178	[p8l1487t2235r1749b2312],
6	with	IN	O	with	_	0	SENT_178	[p8l1795t2235r1944b2295],
7	AEs	NNS	ORGANIZATION	ae	prep_with	5	SENT_178	[p8l1987t2236r2150b2305],
8	,	,	O	,	_	0	SENT_178	[p8l1987t2236r2150b2305],
9	7	CD	PERCENT	7	nsubj	19	SENT_178	[p8l8t2337r44b2395],
10	(	CD	PERCENT	(	number	11	SENT_178	[p8l92t2336r361b2409],
11	41.2	CD	PERCENT	41.2	num	12	SENT_178	[p8l92t2336r361b2409],
12	%	NN	PERCENT	%	dep	9	SENT_178	[p8l92t2336r361b2409],
13	)	CD	NUMBER	)	dep	9	SENT_178	[p8l92t2336r361b2409],
14	had	VBD	O	have	aux	19	SENT_178	[p8l405t2336r527b2395],
15	at	IN	O	at	_	0	SENT_178	[p8l570t2344r629b2395],
16	the	DT	O	the	det	17	SENT_178	[p8l669t2336r771b2395],
17	least	JJS	O	least	prep_at	19	SENT_178	[p8l814t2336r968b2395],
18	one	CD	NUMBER	one	dep	17	SENT_178	[p8l1010t2354r1130b2395],
19	mutated	VBN	O	mutate	_	0	SENT_178	[p8l1172t2336r1445b2395],
20	allele	NN	O	allele	dobj	19	SENT_178	[p8l1488t2336r1687b2406],
21	,	,	O	,	_	0	SENT_178	[p8l1488t2336r1687b2406],
22	whereas	IN	O	whereas	mark	34	SENT_178	[p8l1732t2336r2007b2396],
23	the	DT	O	the	det	26	SENT_178	[p8l2051t2336r2152b2395],
24	remaining	VBG	O	remain	amod	26	SENT_178	[p8l6t2439r349b2516],
25	10	CD	PERCENT	10	number	26	SENT_178	[p8l403t2440r477b2499],
26	(	CD	PERCENT	(	nsubj	34	SENT_178	[p8l525t2439r795b2513],
27	58.8	CD	PERCENT	58.8	number	28	SENT_178	[p8l525t2439r795b2513],
28	%	NN	PERCENT	%	amod	26	SENT_178	[p8l525t2439r795b2513],
29	)	CD	NUMBER	)	dep	26	SENT_178	[p8l525t2439r795b2513],
30	were	VBD	O	be	cop	34	SENT_178	[p8l842t2458r1005b2499],
31	wild	JJ	O	wild	amod	34	SENT_178	[p8l1050t2439r1374b2516],
32	—	NN	O	—	nn	34	SENT_178	[p8l1050t2439r1374b2516],
33	type	NN	O	type	nn	34	SENT_178	[p8l1050t2439r1374b2516],
34	homozygotes	NNS	O	homozygote	advcl	19	SENT_178	[p8l1419t2439r1888b2516],
35	.	.	O	.	_	0	SENT_178	[p8l1419t2439r1888b2516],

1	In	IN	O	in	_	0	SENT_179	[p8l1937t2441r2006b2498],
2	the	DT	O	the	det	4	SENT_179	[p8l2051t2439r2152b2499],
3	control	NN	O	control	nn	4	SENT_179	[p8l8t2541r245b2601],
4	group	NN	O	group	prep_in	12	SENT_179	[p8l290t2560r503b2618],
5	,	,	O	,	_	0	SENT_179	[p8l290t2560r503b2618],
6	6	CD	NUMBER	6	num	7	SENT_179	[p8l551t2541r588b2601],
7	patients	NNS	O	patient	nsubj	12	SENT_179	[p8l631t2541r893b2618],
8	(	IN	O	(	_	0	SENT_179	[p8l940t2541r1210b2614],
9	50.0	CD	PERCENT	50.0	num	10	SENT_179	[p8l940t2541r1210b2614],
10	%	NN	PERCENT	%	prep_(	7	SENT_179	[p8l940t2541r1210b2614],
11	)	CD	NUMBER	)	dep	10	SENT_179	[p8l940t2541r1210b2614],
12	had	VBD	O	have	_	0	SENT_179	[p8l1254t2541r1377b2601],
13	at	IN	O	at	quantmod	15	SENT_179	[p8l1420t2550r1479b2601],
14	least	JJS	O	least	mwe	13	SENT_179	[p8l1520t2541r1676b2601],
15	one	CD	NUMBER	one	dobj	12	SENT_179	[p8l1718t2560r1837b2601],
16	mutated	VBN	O	mutate	partmod	15	SENT_179	[p8l1881t2541r2153b2601],
17	allele	NN	O	allele	nsubj	21	SENT_179	[p8l9t2642r189b2701],
18	and	CC	O	and	_	0	SENT_179	[p8l228t2642r348b2701],
19	the	DT	O	the	conj_and	17	SENT_179	[p8l384t2642r486b2701],
20	remaining	VBG	O	remain	amod	19	SENT_179	[p8l522t2642r866b2719],
21	had	VBD	O	have	ccomp	16	SENT_179	[p8l903t2642r1025b2701],
22	genotype	NN	O	genotype	nn	23	SENT_179	[p8l1063t2650r1372b2719],
23	*	NN	O	*	dobj	21	SENT_179	[p8l1414t2642r1518b2702],
24	1	CD	NUMBER	1	num	23	SENT_179	[p8l1414t2642r1518b2702],
25	/	:	O	/	punct	26	SENT_179	[p8l1414t2642r1518b2702],
26	1	CD	NUMBER	1	dep	15	SENT_179	[p8l1526t2642r1575b2701],
27	.	.	O	.	_	0	SENT_179	[p8l1526t2642r1575b2701],

1	Also	RB	O	also	advmod	6	SENT_180	[p8l1617t2642r1774b2701],
2	allele	NN	O	allele	nn	3	SENT_180	[p8l1814t2642r1995b2701],
3	frequencies	NNS	O	frequency	nsubj	6	SENT_180	[p8l2033t2642r2150b2701, p8l8t2745r301b2822],
4	were	VBD	O	be	cop	6	SENT_180	[p8l358t2764r521b2805],
5	approximately	RB	O	approximately	advmod	6	SENT_180	[p8l578t2745r1066b2822],
6	identical	JJ	O	identical	_	0	SENT_180	[p8l1121t2745r1412b2805],
7	in	IN	O	in	_	0	SENT_180	[p8l1467t2745r1532b2804],
8	the	DT	O	the	det	14	SENT_180	[p8l1586t2745r1688b2805],
9	two	CD	NUMBER	two	num	10	SENT_180	[p8l1743t2754r1867b2805],
10	groups	NNS	O	group	dep	11	SENT_180	[p8l1924t2764r2151b2822],
11	(	RB	O	(	amod	14	SENT_180	[p8l10t2846r220b2919],
12	Table	NNP	O	Table	nn	14	SENT_180	[p8l10t2846r220b2919],
13	3	CD	NUMBER	3	amod	14	SENT_180	[p8l246t2846r330b2919],
14	)	NN	O	)	prep_in	6	SENT_180	[p8l246t2846r330b2919],
15	.	.	O	.	_	0	SENT_180	[p8l246t2846r330b2919],

1	Adverse	JJ	O	adverse	amod	2	SENT_181	[p8l6t2994r115b3017],
2	effects	NNS	O	effect	nsubj	3	SENT_181	[p8l125t2994r211b3017],
3	(	VBP	O	(	_	0	SENT_181	[p8l221t2994r298b3023],
4	AEs	NNS	O	ae	dobj	3	SENT_181	[p8l221t2994r298b3023],
5	)	CD	NUMBER	)	npadvmod	6	SENT_181	[p8l221t2994r298b3023],
6	of	IN	O	of	advmod	4	SENT_181	[p8l308t2994r337b3017],
7	of	IN	O	of	_	0	SENT_181	[p8l344t2994r373b3017],
8	the	DT	O	the	det	9	SENT_181	[p8l380t2994r420b3017],
9	statins	NNS	O	statin	prep_of	4	SENT_181	[p8l430t2994r512b3017],
10	in	IN	O	in	_	0	SENT_181	[p8l522t2994r547b3017],
11	relation	NN	O	relation	prep_in	9	SENT_181	[p8l556t2994r657b3017],
12	to	TO	O	to	_	0	SENT_181	[p8l666t2998r691b3017],
13	the	DT	O	the	det	16	SENT_181	[p8l700t2994r740b3017],
14	different	JJ	O	different	amod	16	SENT_181	[p8l749t2994r862b3017],
15	CYP	NN	O	cyp	nn	16	SENT_181	[p8l871t2994r935b3017],
16	genotypes	NNS	O	genotype	prep_to	3	SENT_181	[p8l944t2998r1077b3024],
17	and	CC	O	and	_	0	SENT_181	[p8l1087t2994r1134b3017],
18	allele	NN	O	allele	nn	19	SENT_181	[p8l1144t2994r1214b3017],
19	variants	NNS	O	variant	conj_and	16	SENT_181	[p8l1223t2994r1326b3017],

1	CYP3A5	NN	O	cyp3a5	nn	4	SENT_182	[p8l175t3056r294b3079],
2	genotype	NN	O	genotype	nn	4	SENT_182	[p8l305t3060r426b3086],
3	Allele	NN	O	allele	nn	4	SENT_182	[p8l722t3056r803b3079],
4	frequency	NN	O	frequency	_	0	SENT_182	[p8l812t3056r943b3086],
5	(	CD	PERCENT	(	num	6	SENT_182	[p8l953t3056r1000b3085],
6	%	NN	PERCENT	%	dep	4	SENT_182	[p8l953t3056r1000b3085],
7	)	CD	NUMBER	)	num	8	SENT_182	[p8l953t3056r1000b3085],
8	*	NN	O	*	dep	6	SENT_182	[p8l2082t3056r2095b3070],
9	1	CD	NUMBER	1	amod	8	SENT_182	[p8l2101t3056r2123b3079],
10	/	:	O	/	punct	4	SENT_182	[p8l2101t3056r2123b3079],
11	*	CD	NUMBER	*	num	12	SENT_182	[p8l2125t3056r2154b3079],
12	3	CD	NUMBER	3	dep	4	SENT_182	[p8l2125t3056r2154b3079],
13	*	NN	O	*	dep	12	SENT_182	[p8l1528t3095r1599b3118],
14	3	CD	NUMBER	3	dep	13	SENT_182	[p8l1528t3095r1599b3118],
15	/	:	O	/	punct	12	SENT_182	[p8l1528t3095r1599b3118],
16	*	CD	NUMBER	*	num	17	SENT_182	[p8l1528t3095r1599b3118],
17	3	CD	NUMBER	3	dep	12	SENT_182	[p8l1528t3095r1599b3118],
18	*	NN	O	*	nn	20	SENT_182	[p8l1801t3095r1814b3109],
19	1	CD	NUMBER	1	num	20	SENT_182	[p8l1820t3095r1829b3118],
20	*	NN	O	*	dep	17	SENT_182	[p8l2125t3095r2154b3118],
21	3	CD	NUMBER	3	dep	20	SENT_182	[p8l2125t3095r2154b3118],

1	Total	JJ	O	total	amod	2	SENT_183	[p8l6t3161r72b3184],
2	number	NN	O	number	nsubj	19	SENT_183	[p8l82t3161r183b3184],
3	of	IN	O	of	_	0	SENT_183	[p8l192t3161r221b3184],
4	patients	NNS	O	patient	prep_of	2	SENT_183	[p8l227t3161r329b3191],
5	14	CD	PERCENT	14	dep	16	SENT_183	[p8l1106t3161r1135b3184],
6	(	CD	PERCENT	(	number	7	SENT_183	[p8l1145t3161r1250b3190],
7	19.2	CD	PERCENT	19.2	num	8	SENT_183	[p8l1145t3161r1250b3190],
8	%	NN	PERCENT	%	dep	5	SENT_183	[p8l1145t3161r1250b3190],
9	)	CD	NUMBER	)	number	10	SENT_183	[p8l1145t3161r1250b3190],
10	59	CD	NUMBER	59	num	11	SENT_183	[p8l1377t3161r1408b3185],
11	(	NN	O	(	dep	8	SENT_183	[p8l1419t3161r1524b3190],
12	80.8	CD	PERCENT	80.8	num	13	SENT_183	[p8l1419t3161r1524b3190],
13	%	NN	PERCENT	%	dep	16	SENT_183	[p8l1419t3161r1524b3190],
14	)	CD	NUMBER	)	num	16	SENT_183	[p8l1419t3161r1524b3190],
15	N.	NNP	O	N.	nn	16	SENT_183	[p8l6t3202r36b3225],
16	pt	NN	O	pt	dep	2	SENT_183	[p8l46t3205r72b3232],
17	with	IN	O	with	_	0	SENT_183	[p8l81t3202r139b3225],
18	AEs	NNS	O	ae	prep_with	16	SENT_183	[p8l148t3202r204b3225],
19	treated	VBN	O	treat	_	0	SENT_183	[p8l213t3202r303b3225],
20	with	IN	O	with	_	0	SENT_183	[p8l313t3202r371b3225],
21	Simvastatin	NN	O	simvastatin	prep_with	19	SENT_183	[p8l539t3202r693b3225],
22	(	CD	NUMBER	(	number	23	SENT_183	[p8l827t3202r919b3231],
23	10-20	CD	NUMBER	10-20	num	28	SENT_183	[p8l827t3202r919b3231],
24	mg	NN	O	mg	nn	28	SENT_183	[p8l925t3202r977b3232],
25	)	NN	O	)	nn	28	SENT_183	[p8l925t3202r977b3232],
26	1	CD	NUMBER	1	number	27	SENT_183	[p8l1106t3202r1116b3225],
27	12 4/68	CD	NUMBER	12 4/68	num	28	SENT_183	[p8l1650t3201r1708b3225],[p8l1380t3202r1409b3225],
28	(	NN	O	(	dobj	19	SENT_183	[p8l1719t3201r1807b3230],
29	5.9	CD	PERCENT	5.9	number	30	SENT_183	[p8l1719t3201r1807b3230],
30	%	NN	PERCENT	%	amod	28	SENT_183	[p8l1719t3201r1807b3230],
31	)	CD	NUMBER	)	number	32	SENT_183	[p8l1719t3201r1807b3230],
32	64/68	CD	NUMBER	64/68	dep	28	SENT_183	[p8l1975t3201r2048b3225],
33	(	NN	O	(	dep	32	SENT_183	[p8l2059t3201r2108b3230],
34	94	CD	NUMBER	94	num	33	SENT_183	[p8l2059t3201r2108b3230],
35	.	.	O	.	_	0	SENT_183	[p8l2059t3201r2108b3230],

1	1	CD	PERCENT	1	num	2	SENT_184	[p8l6t3242r56b3271],
2	%	NN	PERCENT	%	_	0	SENT_184	[p8l6t3242r56b3271],
3	)	CD	NUMBER	)	num	5	SENT_184	[p8l6t3242r56b3271],
4	N.	NNP	O	N.	nn	5	SENT_184	[p8l66t3243r96b3266],
5	pt	NN	O	pt	nsubj	8	SENT_184	[p8l107t3247r133b3273],
6	with	IN	O	with	_	0	SENT_184	[p8l142t3243r200b3266],
7	AEs	NNS	O	ae	prep_with	5	SENT_184	[p8l208t3243r264b3266],
8	treated	VBN	O	treat	rcmod	2	SENT_184	[p8l274t3243r364b3266],
9	with	IN	O	with	_	0	SENT_184	[p8l373t3243r431b3266],
10	Atorvastatin	NN	O	atorvastatin	prep_with	8	SENT_184	[p8l598t3243r761b3266],
11	(	CD	NUMBER	(	number	12	SENT_184	[p8l887t3243r979b3272],
12	10-40	CD	NUMBER	10-40	num	14	SENT_184	[p8l887t3243r979b3272],
13	mg	NN	O	mg	nn	14	SENT_184	[p8l986t3243r1037b3273],
14	)	NN	O	)	nsubj	21	SENT_184	[p8l986t3243r1037b3273],
15	3	CD	NUMBER	3	number	16	SENT_184	[p8l1164t3243r1178b3266],
16	18	CD	NUMBER	18	num	18	SENT_184	[p8l1440t3243r1468b3266],
17	N.	NNP	O	N.	nn	18	SENT_184	[p8l6t3285r36b3308],
18	pt	NN	O	pt	dep	14	SENT_184	[p8l46t3288r72b3315],
19	without	IN	O	without	_	0	SENT_184	[p8l81t3284r182b3308],
20	AEs	NNS	O	ae	prep_without	14	SENT_184	[p8l191t3285r246b3308],
21	treated	VBN	O	treat	rcmod	10	SENT_184	[p8l256t3284r346b3308],
22	with	IN	O	with	_	0	SENT_184	[p8l355t3284r413b3308],
23	Simvastatin	NN	O	simvastatin	prep_with	21	SENT_184	[p8l539t3284r693b3308],
24	(	CD	NUMBER	(	number	25	SENT_184	[p8l827t3284r919b3313],
25	10-20	CD	NUMBER	10-20	num	30	SENT_184	[p8l827t3284r919b3313],
26	mg	NN	O	mg	nn	30	SENT_184	[p8l925t3285r977b3315],
27	)	NN	O	)	nn	30	SENT_184	[p8l925t3285r977b3315],
28	3	CD	NUMBER	3	number	29	SENT_184	[p8l1104t3284r1117b3308],
29	8 10/78	CD	NUMBER	8 10/78	num	30	SENT_184	[p8l1653t3283r1724b3307],[p8l1378t3284r1391b3308],
30	(	NN	O	(	dep	35	SENT_184	[p8l1735t3283r1840b3312],
31	12.8	CD	PERCENT	12.8	num	32	SENT_184	[p8l1735t3283r1840b3312],
32	%	NN	PERCENT	%	dep	30	SENT_184	[p8l1735t3283r1840b3312],
33	)	CD	NUMBER	)	dep	35	SENT_184	[p8l1735t3283r1840b3312],
34	68/78	CD	NUMBER	68/78	num	35	SENT_184	[p8l1974t3283r2047b3307],
35	(	NN	O	(	dep	40	SENT_184	[p8l6t3325r111b3354],
36	87.2	CD	PERCENT	87.2	num	37	SENT_184	[p8l6t3325r111b3354],
37	%	NN	PERCENT	%	dep	35	SENT_184	[p8l6t3325r111b3354],
38	)	CD	NUMBER	)	num	40	SENT_184	[p8l6t3325r111b3354],
39	N.	NNP	O	N.	nn	40	SENT_184	[p8l121t3326r151b3349],
40	pt	NN	O	pt	dep	2	SENT_184	[p8l161t3329r187b3356],
41	without	IN	O	without	_	0	SENT_184	[p8l196t3326r297b3349],
42	AEs	NNS	O	ae	prep_without	40	SENT_184	[p8l305t3326r361b3349],
43	treated	VBN	O	treat	partmod	42	SENT_184	[p8l371t3326r461b3349],
44	with	IN	O	with	_	0	SENT_184	[p8l470t3326r528b3349],
45	Atorvastatin	NN	O	atorvastatin	prep_with	43	SENT_184	[p8l653t3326r816b3349],
46	(	CD	NUMBER	(	num	45	SENT_184	[p8l941t3326r1034b3354],
47	10-60	CD	NUMBER	10-60	num	49	SENT_184	[p8l941t3326r1034b3354],
48	mg	NN	O	mg	nn	49	SENT_184	[p8l1040t3326r1092b3356],
49	)	NN	O	)	tmod	43	SENT_184	[p8l1040t3326r1092b3356],
50	7	CD	NUMBER	7	number	51	SENT_184	[p8l1218t3326r1233b3349],
51	21	CD	NUMBER	21	amod	49	SENT_184	[p8l1492t3326r1521b3349],

1	CYP2C9	NN	O	cyp2c9	nn	4	SENT_185	[p8l1390t3408r1508b3432],
2	genotype	NN	O	genotype	nn	4	SENT_185	[p8l1518t3412r1639b3439],
3	Allele	NN	O	allele	nn	4	SENT_185	[p8l1876t3408r1956b3432],
4	frequency	NN	O	frequency	_	0	SENT_185	[p8l1965t3408r2096b3439],
5	(	CD	PERCENT	(	num	6	SENT_185	[p8l2107t3408r2154b3437],
6	%	NN	PERCENT	%	dep	4	SENT_185	[p8l2107t3408r2154b3437],
7	)	CD	NUMBER	)	num	8	SENT_185	[p8l2107t3408r2154b3437],
8	*	NN	O	*	dep	6	SENT_185	[p8l1100t3482r1173b3505],
9	1	CD	NUMBER	1	amod	8	SENT_185	[p8l1100t3482r1173b3505],
10	/	:	O	/	punct	4	SENT_185	[p8l1100t3482r1173b3505],
11	*	CD	NUMBER	*	num	12	SENT_185	[p8l1100t3482r1173b3505],
12	2	CD	NUMBER	2	dep	4	SENT_185	[p8l1100t3482r1173b3505],
13	*	NN	O	*	dep	12	SENT_185	[p8l1320t3482r1393b3505],
14	1	CD	NUMBER	1	num	13	SENT_185	[p8l1320t3482r1393b3505],
15	/	:	O	/	punct	12	SENT_185	[p8l1320t3482r1393b3505],
16	*	CD	NUMBER	*	num	17	SENT_185	[p8l1320t3482r1393b3505],
17	2	CD	NUMBER	2	dep	12	SENT_185	[p8l1320t3482r1393b3505],
18	or	CC	O	or	_	0	SENT_185	[p8l1402t3489r1430b3505],
19	*	CD	NUMBER	*	num	20	SENT_185	[p8l1440t3482r1511b3505],
20	1	CD	NUMBER	1	conj_or	17	SENT_185	[p8l1440t3482r1511b3505],
21	/	:	O	/	punct	12	SENT_185	[p8l1440t3482r1511b3505],
22	*	CD	NUMBER	*	num	23	SENT_185	[p8l1440t3482r1511b3505],
23	3	CD	NUMBER	3	dep	12	SENT_185	[p8l1440t3482r1511b3505],
24	*	NN	O	*	nn	26	SENT_185	[p8l1586t3482r1613b3505],
25	1	CD	NUMBER	1	num	26	SENT_185	[p8l1586t3482r1613b3505],
26	*	NN	O	*	dep	23	SENT_185	[p8l1856t3482r1886b3505],
27	2	CD	NUMBER	2	number	28	SENT_185	[p8l1856t3482r1886b3505],
28	*	CD	NUMBER	*	num	29	SENT_185	[p8l2125t3482r2154b3505],
29	3	CD	NUMBER	3	dep	26	SENT_185	[p8l2125t3482r2154b3505],

1	Total	JJ	O	total	dep	120	SENT_186	[p9l6t34r72b58],
2	number	NN	O	number	dep	120	SENT_186	[p9l82t34r183b58],
3	of	IN	O	of	dep	120	SENT_186	[p9l192t34r221b58],
4	patients	NNS	O	patient	dep	120	SENT_186	[p9l227t34r329b65],
5	21	CD	PERCENT	21	dep	120	SENT_186	[p9l949t34r978b58],
6	(	CD	PERCENT	(	dep	120	SENT_186	[p9l991t34r1096b63],
7	65.6	CD	PERCENT	65.6	dep	120	SENT_186	[p9l991t34r1096b63],
8	%	NN	PERCENT	%	dep	120	SENT_186	[p9l991t34r1096b63],
9	)	CD	NUMBER	)	dep	120	SENT_186	[p9l991t34r1096b63],
10	11	CD	NUMBER	11	dep	120	SENT_186	[p9l1172t34r1198b58],
11	(	NN	O	(	dep	120	SENT_186	[p9l1211t34r1316b63],
12	34.4	CD	PERCENT	34.4	dep	120	SENT_186	[p9l1211t34r1316b63],
13	%	NN	PERCENT	%	dep	120	SENT_186	[p9l1211t34r1316b63],
14	)	CD	NUMBER	)	dep	120	SENT_186	[p9l1211t34r1316b63],
15	N.	NNP	O	N.	dep	120	SENT_186	[p9l6t76r36b99],
16	pt	NN	O	pt	dep	120	SENT_186	[p9l46t79r72b106],
17	with	IN	O	with	dep	120	SENT_186	[p9l81t76r139b99],
18	AEs	NNS	O	ae	dep	120	SENT_186	[p9l148t76r204b99],
19	treated	VBN	O	treat	dep	120	SENT_186	[p9l213t76r303b99],
20	with	IN	O	with	dep	120	SENT_186	[p9l313t76r371b99],
21	Simvastatin	NN	O	simvastatin	dep	120	SENT_186	[p9l485t76r639b99],
22	(	CD	NUMBER	(	dep	120	SENT_186	[p9l726t76r818b104],
23	10-20	CD	NUMBER	10-20	dep	120	SENT_186	[p9l726t76r818b104],
24	mg	NN	O	mg	dep	120	SENT_186	[p9l825t76r877b106],
25	)	NN	O	)	dep	120	SENT_186	[p9l825t76r877b106],
26	8	CD	NUMBER	8	dep	120	SENT_186	[p9l950t76r963b99],
27	5 30/36	CD	NUMBER	5 30/36	dep	120	SENT_186	[p9l1436t75r1509b98],[p9l1169t76r1183b99],
28	(	NN	O	(	dep	120	SENT_186	[p9l1520t75r1625b104],
29	83.3	CD	PERCENT	83.3	dep	120	SENT_186	[p9l1520t75r1625b104],
30	%	NN	PERCENT	%	dep	120	SENT_186	[p9l1520t75r1625b104],
31	)	CD	NUMBER	)	dep	120	SENT_186	[p9l1520t75r1625b104],
32	5/36	CD	NUMBER	5/36	dep	120	SENT_186	[p9l1705t75r1762b98],
33	(	NN	O	(	dep	120	SENT_186	[p9l1773t75r1878b104],
34	13.9	CD	PERCENT	13.9	dep	120	SENT_186	[p9l1773t75r1878b104],
35	%	NN	PERCENT	%	dep	120	SENT_186	[p9l1773t75r1878b104],
36	)	CD	NUMBER	)	dep	120	SENT_186	[p9l1773t75r1878b104],
37	1/36	CD	NUMBER	1/36	dep	120	SENT_186	[p9l1977t75r2032b98],
38	(	NN	O	(	dep	120	SENT_186	[p9l2042t75r2131b104],
39	2.8	CD	PERCENT	2.8	dep	120	SENT_186	[p9l2042t75r2131b104],
40	%	NN	PERCENT	%	dep	120	SENT_186	[p9l2042t75r2131b104],
41	)	CD	NUMBER	)	dep	120	SENT_186	[p9l2042t75r2131b104],
42	N.	NNP	O	N.	dep	120	SENT_186	[p9l6t117r36b140],
43	pt	NN	O	pt	dep	120	SENT_186	[p9l46t120r72b147],
44	with	IN	O	with	dep	120	SENT_186	[p9l81t117r139b140],
45	AEs	NNS	O	ae	dep	120	SENT_186	[p9l148t117r204b140],
46	treated	VBN	O	treat	dep	120	SENT_186	[p9l213t117r303b140],
47	with	IN	O	with	dep	120	SENT_186	[p9l313t117r371b140],
48	Fluvastatin	NN	O	fluvastatin	dep	120	SENT_186	[p9l484t117r630b140],
49	(	CD	NUMBER	(	dep	120	SENT_186	[p9l727t117r769b145],
50	80	CD	NUMBER	80	dep	120	SENT_186	[p9l727t117r769b145],
51	mg	NN	O	mg	dep	120	SENT_186	[p9l775t117r827b147],
52	)	NN	O	)	dep	120	SENT_186	[p9l775t117r827b147],
53	4	CD	NUMBER	4	dep	120	SENT_186	[p9l949t117r965b140],
54	1	CD	NUMBER	1	dep	120	SENT_186	[p9l1172t117r1182b140],
55	N.	NNP	O	N.	dep	120	SENT_186	[p9l6t158r36b181],
56	pt	NN	O	pt	dep	120	SENT_186	[p9l46t161r72b188],
57	with	IN	O	with	dep	120	SENT_186	[p9l81t158r139b181],
58	AEs	NNS	O	ae	dep	120	SENT_186	[p9l148t158r204b181],
59	treated	VBN	O	treat	dep	120	SENT_186	[p9l213t158r303b181],
60	with	IN	O	with	dep	120	SENT_186	[p9l313t158r371b181],
61	Rosuvastatin	NN	PERSON	rosuvastatin	dep	120	SENT_186	[p9l484t158r654b181],
62	(	CD	NUMBER	(	dep	120	SENT_186	[p9l726t158r818b187],
63	10-20	CD	NUMBER	10-20	dep	120	SENT_186	[p9l726t158r818b187],
64	mg	NN	O	mg	dep	120	SENT_186	[p9l825t158r877b188],
65	)	NN	O	)	dep	120	SENT_186	[p9l825t158r877b188],
66	o	NN	O	o	dep	120	SENT_186	[p9l949t158r964b181],
67	o	NN	O	o	dep	120	SENT_186	[p9l1169t158r1184b181],
68	N.	NNP	O	N.	dep	120	SENT_186	[p9l6t199r36b221],
69	pt	NN	O	pt	dep	120	SENT_186	[p9l46t202r72b228],
70	without	IN	O	without	dep	120	SENT_186	[p9l81t198r182b221],
71	AEs	NNS	O	ae	dep	120	SENT_186	[p9l190t198r246b221],
72	treated	VBN	O	treat	dep	120	SENT_186	[p9l256t198r346b221],
73	with	IN	O	with	dep	120	SENT_186	[p9l355t198r413b221],
74	Simvastatin	NN	O	simvastatin	dep	120	SENT_186	[p9l485t198r640b221],
75	(	CD	NUMBER	(	dep	120	SENT_186	[p9l726t198r818b227],
76	10-20	CD	NUMBER	10-20	dep	120	SENT_186	[p9l726t198r818b227],
77	mg	NN	O	mg	dep	120	SENT_186	[p9l825t198r877b228],
78	)	NN	O	)	dep	120	SENT_186	[p9l825t198r877b228],
79	6	CD	NUMBER	6	dep	120	SENT_186	[p9l949t198r964b221],
80	5 23/28	CD	NUMBER	5 23/28	dep	120	SENT_186	[p9l1435t197r1508b220],[p9l1169t198r1183b221],
81	(	NN	O	(	dep	120	SENT_186	[p9l1520t197r1625b226],
82	82.1	CD	PERCENT	82.1	dep	120	SENT_186	[p9l1520t197r1625b226],
83	%	NN	PERCENT	%	dep	120	SENT_186	[p9l1520t197r1625b226],
84	)	CD	NUMBER	)	dep	120	SENT_186	[p9l1520t197r1625b226],
85	3/28	CD	NUMBER	3/28	dep	120	SENT_186	[p9l1705t197r1761b220],
86	(	NN	O	(	dep	120	SENT_186	[p9l1773t197r1878b226],
87	10.7	CD	PERCENT	10.7	dep	120	SENT_186	[p9l1773t197r1878b226],
88	%	NN	PERCENT	%	dep	120	SENT_186	[p9l1773t197r1878b226],
89	)	CD	NUMBER	)	dep	120	SENT_186	[p9l1773t197r1878b226],
90	2/28	CD	NUMBER	2/28	dep	120	SENT_186	[p9l1975t197r2031b220],
91	(	NN	O	(	dep	120	SENT_186	[p9l2042t197r2131b226],
92	7.2	CD	PERCENT	7.2	dep	120	SENT_186	[p9l2042t197r2131b226],
93	%	NN	PERCENT	%	dep	120	SENT_186	[p9l2042t197r2131b226],
94	)	CD	NUMBER	)	dep	120	SENT_186	[p9l2042t197r2131b226],
95	N.	NNP	O	N.	dep	120	SENT_186	[p9l6t240r36b262],
96	pt	NN	O	pt	dep	120	SENT_186	[p9l46t243r72b269],
97	without	IN	O	without	dep	120	SENT_186	[p9l81t239r182b262],
98	AEs	NNS	O	ae	dep	120	SENT_186	[p9l190t239r246b262],
99	treated	VBN	O	treat	dep	120	SENT_186	[p9l256t239r346b262],
100	with	IN	O	with	dep	120	SENT_186	[p9l355t239r413b262],
101	Fluvastatin	NN	PERSON	fluvastatin	dep	120	SENT_186	[p9l484t239r630b262],
102	(	CD	NUMBER	(	dep	120	SENT_186	[p9l726t239r768b268],
103	80	CD	NUMBER	80	dep	120	SENT_186	[p9l726t239r768b268],
104	mg	NN	O	mg	dep	120	SENT_186	[p9l775t239r827b269],
105	)	NN	O	)	dep	120	SENT_186	[p9l775t239r827b269],
106	1	CD	NUMBER	1	dep	120	SENT_186	[p9l952t239r962b262],
107	o	NN	O	o	dep	120	SENT_186	[p9l1169t239r1184b262],
108	N.	NNP	O	N.	dep	120	SENT_186	[p9l6t281r36b304],
109	pt	NN	O	pt	dep	120	SENT_186	[p9l46t284r72b311],
110	without	IN	O	without	dep	120	SENT_186	[p9l81t280r182b304],
111	AEs	NNS	O	ae	dep	120	SENT_186	[p9l191t280r246b304],
112	treated	VBN	O	treat	dep	120	SENT_186	[p9l256t280r346b304],
113	with	IN	O	with	dep	120	SENT_186	[p9l355t280r413b304],
114	Rosuvastatin	NN	PERSON	rosuvastatin	dep	120	SENT_186	[p9l484t280r654b304],
115	(	CD	NUMBER	(	dep	120	SENT_186	[p9l726t280r818b309],
116	10-20	CD	NUMBER	10-20	dep	120	SENT_186	[p9l726t280r818b309],
117	mg	NN	O	mg	dep	120	SENT_186	[p9l825t280r877b311],
118	)	NN	O	)	dep	120	SENT_186	[p9l825t280r877b311],
119	2	CD	NUMBER	2	dep	120	SENT_186	[p9l949t280r964b304],
120	o	NN	O	o	_	0	SENT_186	[p9l1169t280r1184b304],

1	CYP2D6	NN	O	cyp2d6	nn	4	SENT_187	[p9l1392t363r1512b387],
2	genotype	NN	O	genotype	nn	4	SENT_187	[p9l1522t367r1643b394],
3	Allele	NN	O	allele	nn	4	SENT_187	[p9l1876t363r1956b387],
4	frequency	NN	O	frequency	_	0	SENT_187	[p9l1966t363r2097b394],
5	(	CD	PERCENT	(	num	6	SENT_187	[p9l2107t363r2154b392],
6	%	NN	PERCENT	%	dep	4	SENT_187	[p9l2107t363r2154b392],
7	)	CD	NUMBER	)	num	8	SENT_187	[p9l2107t363r2154b392],
8	*	NN	O	*	dep	6	SENT_187	[p9l1049t430r1119b454],
9	1	CD	NUMBER	1	amod	8	SENT_187	[p9l1049t430r1119b454],
10	/	:	O	/	punct	4	SENT_187	[p9l1049t430r1119b454],
11	*	CD	NUMBER	*	num	12	SENT_187	[p9l1049t430r1119b454],
12	1	CD	NUMBER	1	dep	4	SENT_187	[p9l1049t430r1119b454],
13	*	NN	O	*	dep	12	SENT_187	[p9l1272t430r1345b454],
14	1	CD	NUMBER	1	num	13	SENT_187	[p9l1272t430r1345b454],
15	/	:	O	/	punct	12	SENT_187	[p9l1272t430r1345b454],
16	*	CD	NUMBER	*	num	17	SENT_187	[p9l1272t430r1345b454],
17	4	CD	NUMBER	4	dep	12	SENT_187	[p9l1272t430r1345b454],
18	or	CC	O	or	_	0	SENT_187	[p9l1355t430r1456b454],
19	*	CD	NUMBER	*	num	20	SENT_187	[p9l1355t430r1456b454],
20	4	CD	NUMBER	4	conj_or	17	SENT_187	[p9l1355t430r1456b454],
21	/	:	O	/	punct	12	SENT_187	[p9l1355t430r1456b454],
22	*	CD	NUMBER	*	num	23	SENT_187	[p9l1355t430r1456b454],
23	4	CD	NUMBER	4	dep	12	SENT_187	[p9l1355t430r1456b454],
24	*	NN	O	*	nn	26	SENT_187	[p9l1533t430r1560b454],
25	1	CD	NUMBER	1	num	26	SENT_187	[p9l1533t430r1560b454],
26	*	NN	O	*	dep	23	SENT_187	[p9l1806t430r1836b454],
27	4	CD	NUMBER	4	number	28	SENT_187	[p9l1806t430r1836b454],
28	2	CD	NUMBER	2	num	30	SENT_187	[p9l2078t430r2092b454],
29	X	NN	O	x	nn	30	SENT_187	[p9l2103t437r2120b453],
30	N	NN	O	n	dep	26	SENT_187	[p9l2131t431r2154b454],

1	Total	JJ	O	total	amod	2	SENT_188	[p9l6t494r72b517],
2	number	NN	O	number	dep	8	SENT_188	[p9l82t494r183b517],
3	of	IN	O	of	_	0	SENT_188	[p9l192t494r221b517],
4	patients	NNS	O	patient	prep_of	2	SENT_188	[p9l227t494r329b524],
5	16	CD	PERCENT	16	dep	8	SENT_188	[p9l947t494r976b518],
6	(	CD	PERCENT	(	number	7	SENT_188	[p9l987t494r1092b523],
7	55.2	CD	PERCENT	55.2	num	8	SENT_188	[p9l987t494r1092b523],
8	%	NN	PERCENT	%	dep	16	SENT_188	[p9l987t494r1092b523],
9	)	CD	NUMBER	)	number	10	SENT_188	[p9l987t494r1092b523],
10	13	CD	NUMBER	13	dep	11	SENT_188	[p9l1170t494r1198b518],
11	(	NN	O	(	dep	8	SENT_188	[p9l1210t494r1315b523],
12	44.8	CD	PERCENT	44.8	num	13	SENT_188	[p9l1210t494r1315b523],
13	%	NN	PERCENT	%	dep	8	SENT_188	[p9l1210t494r1315b523],
14	)	CD	NUMBER	)	num	16	SENT_188	[p9l1210t494r1315b523],
15	N.	NNP	O	N.	nn	16	SENT_188	[p9l6t536r36b559],
16	pt	NN	O	pt	_	0	SENT_188	[p9l46t539r72b566],
17	with	IN	O	with	_	0	SENT_188	[p9l81t535r139b559],
18	AEs	NNS	O	ae	prep_with	16	SENT_188	[p9l148t535r204b559],
19	treated	VBN	O	treat	partmod	18	SENT_188	[p9l214t535r303b559],
20	with	IN	O	with	_	0	SENT_188	[p9l312t535r370b559],
21	Simvastatin	NN	O	simvastatin	prep_with	19	SENT_188	[p9l488t535r642b559],
22	(	CD	NUMBER	(	num	21	SENT_188	[p9l718t535r810b564],
23	10-20	CD	NUMBER	10-20	number	25	SENT_188	[p9l718t535r810b564],
24	mg	NN	O	mg	dep	25	SENT_188	[p9l817t535r869b566],
25	)	NN	O	)	amod	21	SENT_188	[p9l817t535r869b566],
26	7	CD	NUMBER	7	number	27	SENT_188	[p9l944t536r959b559],
27	5 30/38	CD	NUMBER	5 30/38	dep	28	SENT_188	[p9l1429t534r1502b558],[p9l1168t535r1181b559],
28	(	NN	O	(	amod	18	SENT_188	[p9l1513t534r1618b563],
29	78.9	CD	PERCENT	78.9	num	30	SENT_188	[p9l1513t534r1618b563],
30	%	NN	PERCENT	%	dep	38	SENT_188	[p9l1513t534r1618b563],
31	)	CD	NUMBER	)	number	32	SENT_188	[p9l1513t534r1618b563],
32	7/38	CD	NUMBER	7/38	num	30	SENT_188	[p9l1701t534r1758b558],
33	(	NN	O	(	prep	30	SENT_188	[p9l1769t534r1875b563],
34	18.4	CD	PERCENT	18.4	num	35	SENT_188	[p9l1769t534r1875b563],
35	%	NN	PERCENT	%	dep	33	SENT_188	[p9l1769t534r1875b563],
36	)	CD	NUMBER	)	dep	38	SENT_188	[p9l1769t534r1875b563],
37	1/38	CD	NUMBER	1/38	num	38	SENT_188	[p9l1977t534r2031b558],
38	(	NN	O	(	dep	73	SENT_188	[p9l2042t534r2131b563],
39	2.7	CD	PERCENT	2.7	num	40	SENT_188	[p9l2042t534r2131b563],
40	%	NN	PERCENT	%	dep	38	SENT_188	[p9l2042t534r2131b563],
41	)	CD	NUMBER	)	num	43	SENT_188	[p9l2042t534r2131b563],
42	N.	NNP	O	N.	nn	43	SENT_188	[p9l6t577r36b600],
43	pt	NN	O	pt	nsubj	73	SENT_188	[p9l46t580r72b607],
44	with	IN	O	with	_	0	SENT_188	[p9l81t576r139b600],
45	AES	NN	ORGANIZATION	ae	prep_with	43	SENT_188	[p9l148t576r204b600],
46	treated	VBN	O	treat	partmod	45	SENT_188	[p9l214t576r303b600],
47	with	IN	O	with	_	0	SENT_188	[p9l312t576r370b600],
48	Fluvastatin	NN	O	fluvastatin	prep_with	46	SENT_188	[p9l487t576r633b600],
49	(	CD	NUMBER	(	number	50	SENT_188	[p9l718t576r760b605],
50	80	CD	NUMBER	80	num	52	SENT_188	[p9l718t576r760b605],
51	mg	NN	O	mg	nn	52	SENT_188	[p9l767t576r819b607],
52	)	NN	O	)	nsubj	59	SENT_188	[p9l767t576r819b607],
53	3	CD	NUMBER	3	number	54	SENT_188	[p9l945t576r958b600],
54	2	CD	NUMBER	2	num	56	SENT_188	[p9l1167t576r1182b600],
55	N.	NNP	O	N.	nn	56	SENT_188	[p9l6t617r36b640],
56	pt	NN	O	pt	dep	52	SENT_188	[p9l46t620r72b647],
57	without	IN	O	without	_	0	SENT_188	[p9l81t617r182b640],
58	AEs	NNS	O	ae	prep_without	52	SENT_188	[p9l190t617r246b640],
59	treated	VBN	O	treat	rcmod	48	SENT_188	[p9l256t617r346b640],
60	with	IN	O	with	_	0	SENT_188	[p9l355t617r413b640],
61	Simvastatin	NN	O	simvastatin	prep_with	59	SENT_188	[p9l488t617r643b640],
62	(	CD	NUMBER	(	number	63	SENT_188	[p9l718t617r810b646],
63	10-20	CD	NUMBER	10-20	num	68	SENT_188	[p9l718t617r810b646],
64	mg	NN	O	mg	nn	68	SENT_188	[p9l817t617r869b647],
65	)	NN	O	)	nn	68	SENT_188	[p9l817t617r869b647],
66	5	CD	NUMBER	5	number	67	SENT_188	[p9l945t617r958b640],
67	6 17/24	CD	NUMBER	6 17/24	num	68	SENT_188	[p9l1431t616r1503b639],[p9l1168t617r1182b640],
68	(	NN	O	(	dobj	59	SENT_188	[p9l1513t616r1618b644],
69	70.8	CD	PERCENT	70.8	num	70	SENT_188	[p9l1513t616r1618b644],
70	%	NN	PERCENT	%	dep	68	SENT_188	[p9l1513t616r1618b644],
71	)	CD	NUMBER	)	number	72	SENT_188	[p9l1513t616r1618b644],
72	7/24	CD	NUMBER	7/24	num	68	SENT_188	[p9l1701t616r1759b639],
73	(	NN	O	(	ccomp	28	SENT_188	[p9l1769t616r1875b644],
74	29.2	CD	PERCENT	29.2	num	75	SENT_188	[p9l1769t616r1875b644],
75	%	NN	PERCENT	%	dobj	73	SENT_188	[p9l1769t616r1875b644],
76	)	CD	NUMBER	)	number	77	SENT_188	[p9l1769t616r1875b644],
77	0/24	CD	NUMBER	0/24	num	75	SENT_188	[p9l1974t616r2032b639],
78	(	NN	O	(	nn	83	SENT_188	[p9l2042t616r2106b644],
79	o	NN	PERCENT	o	nn	83	SENT_188	[p9l2042t616r2106b644],
80	%	NN	PERCENT	%	nn	83	SENT_188	[p9l2042t616r2106b644],
81	)	CD	NUMBER	)	num	83	SENT_188	[p9l2042t616r2106b644],
82	N.	NNP	O	N.	nn	83	SENT_188	[p9l2116t617r2146b640],
83	pt	NN	O	pt	dep	75	SENT_188	[p9l6t662r32b688],
84	without	IN	O	without	_	0	SENT_188	[p9l41t658r141b681],
85	AEs	NNS	O	ae	prep_without	83	SENT_188	[p9l150t658r206b681],
86	treated	VBN	O	treat	partmod	85	SENT_188	[p9l215t658r305b681],
87	with	IN	O	with	_	0	SENT_188	[p9l315t658r373b681],
88	Fluvastatin	NN	PERSON	fluvastatin	prep_with	86	SENT_188	[p9l447t658r593b681],
89	(	CD	NUMBER	(	number	90	SENT_188	[p9l677t658r720b687],
90	80	CD	NUMBER	80	num	94	SENT_188	[p9l677t658r720b687],
91	mg	NN	O	mg	nn	94	SENT_188	[p9l726t658r778b688],
92	)	NN	O	)	nn	94	SENT_188	[p9l726t658r778b688],
93	1	CD	NUMBER	1	num	94	SENT_188	[p9l906t658r916b681],
94	o	NN	O	o	dep	88	SENT_188	[p9l1127t658r1142b681],

1	314	CD	NUMBER	314	num	3	SENT_189	[p9l322t783r370b807],
2	P.	NNP	PERSON	P.	nn	3	SENT_189	[p9l971t784r992b807],
3	Zuccaro	NNP	PERSON	Zuccaro	_	0	SENT_189	[p9l1003t784r1112b807],
4	et	FW	O	et	nn	5	SENT_189	[p9l1122t787r1146b807],
5	al.	FW	O	al.	dep	3	SENT_189	[p9l1154t783r1184b807],
6	/	:	O	/	punct	3	SENT_189	[p9l1194t783r1209b807],
7	Pharmacological	JJ	O	pharmacological	amod	8	SENT_189	[p9l1213t783r1444b813],
8	Research	NN	O	research	dep	3	SENT_189	[p9l1452t783r1573b807],
9	55	CD	NUMBER	55	number	10	SENT_189	[p9l1583t783r1615b806],
10	(	CD	NUMBER	(	num	12	SENT_189	[p9l1625t783r1711b812],
11	2007	CD	DATE	2007	number	12	SENT_189	[p9l1625t783r1711b812],
12	)	CD	NUMBER	)	dep	8	SENT_189	[p9l1625t783r1711b812],
13	310-31	CD	NUMBER	310-31	number	14	SENT_189	[p9l1721t783r1817b806],
14	7	CD	NUMBER	7	num	12	SENT_189	[p9l1823t783r1838b807],

1	3.2	CD	NUMBER	3.2	_	0	SENT_190	[p9l6t918r124b977],
2	.	.	O	.	_	0	SENT_190	[p9l6t918r124b977],

1	C	NN	O	c	nn	2	SENT_191	[p9l181t919r235b978],
2	YP450	NN	O	yp450	_	0	SENT_191	[p9l239t918r460b977],
3	and	CC	O	and	_	0	SENT_191	[p9l482t918r612b978],
4	lipid	NN	O	lipid	nn	5	SENT_191	[p9l634t918r790b994],
5	responses	NNS	O	response	conj_and	2	SENT_191	[p9l812t938r1140b994],

1	3.2	CD	NUMBER	3.2	nsubj	3	SENT_192	[p9l7t1122r188b1182],
2	.	.	O	.	_	0	SENT_192	[p9l7t1122r188b1182],
3	]	SYM	O	]	_	0	SENT_192	[p9l7t1122r188b1182],

1	.	.	O	.	_	0	SENT_193	[p9l7t1122r188b1182],

1	CYP3A5	NN	O	cyp3a5	nn	2	SENT_194	[p9l245t1122r533b1182],
2	genotype	NN	O	genotype	_	0	SENT_194	[p9l555t1133r859b1198],

1	Among	IN	O	among	_	0	SENT_195	[p9l109t1225r361b1302],
2	the	DT	O	the	det	4	SENT_195	[p9l380t1225r481b1284],
3	73	CD	NUMBER	73	num	4	SENT_195	[p9l500t1225r578b1285],
4	patients	NNS	O	patient	prep_among	20	SENT_195	[p9l598t1225r860b1302],
5	who	WP	O	who	nsubj	6	SENT_195	[p9l880t1225r1024b1285],
6	received	VBD	O	receive	rcmod	4	SENT_195	[p9l1041t1225r1326b1285],
7	simvastatin	NN	O	simvastatin	nn	11	SENT_195	[p9l1346t1225r1727b1284],
8	and	CC	O	and	_	0	SENT_195	[p9l1746t1225r1865b1284],
9	atorvas	NN	O	atorva	conj_and	7	SENT_195	[p9l1884t1234r2150b1285],
10	—	CD	NUMBER	—	num	11	SENT_195	[p9l1884t1234r2150b1285],
11	tatin	NN	O	tatin	dobj	6	SENT_195	[p9l6t1327r174b1398],
12	,	,	O	,	_	0	SENT_195	[p9l6t1327r174b1398],
13	both	CC	O	both	dep	6	SENT_195	[p9l202t1327r353b1387],
14	handled	VBN	O	handle	conj	6	SENT_195	[p9l379t1327r648b1387],
15	by	IN	O	by	_	0	SENT_195	[p9l672t1327r756b1404],
16	CYP3A5	NN	O	cyp3a5	prep_by	14	SENT_195	[p9l784t1327r1111b1398],
17	,	,	O	,	_	0	SENT_195	[p9l784t1327r1111b1398],
18	14	CD	NUMBER	14	nsubj	20	SENT_195	[p9l1150t1328r1224b1386],
19	were	VBD	O	be	cop	20	SENT_195	[p9l1251t1346r1414b1387],
20	*	CD	NUMBER	*	_	0	SENT_195	[p9l1445t1328r1651b1398],
21	1	CD	NUMBER	1	dep	20	SENT_195	[p9l1445t1328r1651b1398],
22	/	:	O	/	punct	31	SENT_195	[p9l1445t1328r1651b1398],
23	*	CD	NUMBER	*	num	24	SENT_195	[p9l1445t1328r1651b1398],
24	3	CD	NUMBER	3	nsubj	31	SENT_195	[p9l1445t1328r1651b1398],
25	,	,	O	,	_	0	SENT_195	[p9l1445t1328r1651b1398],
26	the	DT	O	the	det	28	SENT_195	[p9l1680t1327r1782b1387],
27	remaining	VBG	O	remain	amod	28	SENT_195	[p9l1808t1327r2151b1404],
28	59	CD	NUMBER	59	appos	24	SENT_195	[p9l8t1429r87b1490],
29	were	VBD	O	be	cop	31	SENT_195	[p9l116t1448r278b1489],
30	*	CD	NUMBER	*	number	31	SENT_195	[p9l309t1429r513b1489],
31	3	CD	NUMBER	3	dep	20	SENT_195	[p9l309t1429r513b1489],
32	/	:	O	/	punct	31	SENT_195	[p9l309t1429r513b1489],
33	*	CD	NUMBER	*	dep	20	SENT_195	[p9l309t1429r513b1489],
34	3	CD	NUMBER	3	dep	33	SENT_195	[p9l309t1429r513b1489],
35	.	.	O	.	_	0	SENT_195	[p9l309t1429r513b1489],

1	Statistical	JJ	O	statistical	amod	2	SENT_196	[p9l545t1429r877b1489],
2	analysis	NN	O	analysis	nsubj	16	SENT_196	[p9l904t1429r1173b1506],
3	of	IN	O	of	_	0	SENT_196	[p9l1202t1429r1275b1489],
4	lipid	NN	O	lipid	nn	5	SENT_196	[p9l1295t1429r1450b1506],
5	lipoprotein	NN	O	lipoprotein	prep_of	2	SENT_196	[p9l1475t1429r1847b1506],
6	and	CC	O	and	_	0	SENT_196	[p9l1874t1429r1994b1489],
7	percentage	NN	O	percentage	nn	8	SENT_196	[p9l2018t1448r2150b1506, p9l7t1539r264b1607],
8	responses	NNS	O	response	conj_and	5	SENT_196	[p9l280t1548r608b1607],
9	to	TO	O	to	_	0	SENT_196	[p9l627t1539r690b1589],
10	treatment	NN	O	treatment	prep_to	2	SENT_196	[p9l708t1539r1029b1589],
11	in	IN	O	in	_	0	SENT_196	[p9l1044t1530r1108b1588],
12	these	DT	O	these	det	13	SENT_196	[p9l1125t1530r1297b1589],
13	patients	NNS	O	patient	prep_in	10	SENT_196	[p9l1313t1530r1575b1607],
14	did	VBD	O	do	aux	16	SENT_196	[p9l1595t1530r1701b1589],
15	not	RB	O	not	neg	16	SENT_196	[p9l1717t1539r1825b1589],
16	show	VB	O	show	dep	32	SENT_196	[p9l1844t1530r2015b1590],
17	any	DT	O	any	det	19	SENT_196	[p9l2035t1548r2152b1607],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_196	[p9l9t1633r360b1710],
19	differences	NNS	O	difference	dobj	16	SENT_196	[p9l390t1633r761b1693],
20	either	CC	O	either	preconj	16	SENT_196	[p9l793t1633r986b1693],
21	in	IN	O	in	_	0	SENT_196	[p9l1014t1633r1078b1692],
22	baseline	NN	O	baseline	nn	23	SENT_196	[p9l1107t1633r1385b1693],
23	data	NNS	O	datum	prep_in	16	SENT_196	[p9l1416t1633r1556b1693],
24	or	CC	O	or	_	0	SENT_196	[p9l1585t1652r1654b1693],
25	in	IN	O	in	_	0	SENT_196	[p9l1682t1633r1746b1692],
26	therapeutic	JJ	O	therapeutic	amod	27	SENT_196	[p9l1776t1633r2151b1710],
27	responses	NNS	O	response	conj_or	23	SENT_196	[p9l6t1753r334b1812],
28	between	IN	O	between	_	0	SENT_196	[p9l358t1735r641b1795],
29	the	DT	O	the	det	31	SENT_196	[p9l665t1735r766b1794],
30	two	CD	NUMBER	two	num	31	SENT_196	[p9l790t1744r914b1794],
31	groups	NNS	O	group	prep_between	27	SENT_196	[p9l939t1753r1166b1812],
32	(	VBP	O	(	_	0	SENT_196	[p9l1195t1735r1361b1808],
33	data	NNS	O	datum	dobj	32	SENT_196	[p9l1195t1735r1361b1808],
34	not	RB	O	not	neg	35	SENT_196	[p9l1383t1744r1491b1794],
35	shown	VBN	O	show	partmod	33	SENT_196	[p9l1516t1735r1777b1808],
36	)	NN	O	)	nsubj	32	SENT_196	[p9l1516t1735r1777b1808],
37	.	.	O	.	_	0	SENT_196	[p9l1516t1735r1777b1808],

1	3.2.2	CD	NUMBER	3.2.2	_	0	SENT_197	[p9l6t1966r188b2025],
2	.	.	O	.	_	0	SENT_197	[p9l6t1966r188b2025],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_198	[p9l245t1966r538b2026],
2	genotype	NN	O	genotype	_	0	SENT_198	[p9l560t1977r864b2042],

1	Among	IN	O	among	_	0	SENT_199	[p9l109t2069r361b2145],
2	the	DT	O	the	det	4	SENT_199	[p9l381t2068r483b2128],
3	32	CD	NUMBER	32	num	4	SENT_199	[p9l504t2069r583b2128],
4	patients	NNS	O	patient	prep_among	27	SENT_199	[p9l602t2068r864b2145],
5	who	WP	O	who	nsubj	6	SENT_199	[p9l885t2068r1028b2128],
6	received	VBD	O	receive	rcmod	4	SENT_199	[p9l1047t2068r1332b2128],
7	statins	NNS	O	statin	iobj	6	SENT_199	[p9l1353t2068r1563b2128],
8	(	CD	NUMBER	(	num	9	SENT_199	[p9l1586t2068r2014b2142],
9	simvastatin	NN	O	simvastatin	dobj	6	SENT_199	[p9l1586t2068r2014b2142],
10	,	,	O	,	_	0	SENT_199	[p9l1586t2068r2014b2142],
11	ﬂuvastatin	NN	O	ﬂuvastatin	appos	9	SENT_199	[p9l2038t2068r2150b2128, p9l7t2170r285b2240],
12	,	,	O	,	_	0	SENT_199	[p9l2038t2068r2150b2128, p9l7t2170r285b2240],
13	rosuvastatin	NN	O	rosuvastatin	nn	14	SENT_199	[p9l305t2170r739b2243],
14	)	NN	O	)	appos	9	SENT_199	[p9l305t2170r739b2243],
15	partly	RB	O	partly	advmod	18	SENT_199	[p9l758t2170r955b2247],
16	or	CC	O	or	_	0	SENT_199	[p9l975t2189r1044b2230],
17	totally	RB	O	totally	advmod	18	SENT_199	[p9l1060t2170r1275b2247],
18	metabolized	VBN	O	metabolize	partmod	14	SENT_199	[p9l1293t2170r1708b2230],
19	by	IN	O	by	_	0	SENT_199	[p9l1724t2170r1807b2247],
20	CYP2C9	NN	O	cyp2c9	agent	18	SENT_199	[p9l1826t2170r2149b2240],
21	,	,	O	,	_	0	SENT_199	[p9l1826t2170r2149b2240],
22	21	CD	PERCENT	21	appos	9	SENT_199	[p9l8t2271r82b2329],
23	(	CD	PERCENT	(	number	24	SENT_199	[p9l113t2270r383b2344],
24	65.6	CD	PERCENT	65.6	num	25	SENT_199	[p9l113t2270r383b2344],
25	%	NN	PERCENT	%	dep	22	SENT_199	[p9l113t2270r383b2344],
26	)	CD	NUMBER	)	nsubj	27	SENT_199	[p9l113t2270r383b2344],
27	had	VBD	O	have	_	0	SENT_199	[p9l406t2271r528b2330],
28	genotype	NN	O	genotype	nn	29	SENT_199	[p9l549t2279r858b2348],
29	*	NN	O	*	dobj	27	SENT_199	[p9l884t2271r1064b2331],
30	1	CD	NUMBER	1	dep	29	SENT_199	[p9l884t2271r1064b2331],
31	/	:	O	/	punct	30	SENT_199	[p9l884t2271r1064b2331],
32	*	CD	NUMBER	*	number	37	SENT_199	[p9l884t2271r1064b2331],
33	1	CD	NUMBER	1	number	37	SENT_199	[p9l884t2271r1064b2331],
34	and	CC	O	and	_	0	SENT_199	[p9l1094t2271r1214b2330],
35	11	CD	PERCENT	11	num	38	SENT_199	[p9l1242t2271r1310b2329],
36	(	CD	PERCENT	(	number	37	SENT_199	[p9l1341t2271r1611b2344],
37	34.4	CD	PERCENT	34.4	num	38	SENT_199	[p9l1341t2271r1611b2344],
38	%	NN	PERCENT	%	nsubj	40	SENT_199	[p9l1341t2271r1611b2344],
39	)	CD	NUMBER	)	tmod	38	SENT_199	[p9l1341t2271r1611b2344],
40	had	VBD	O	have	dep	30	SENT_199	[p9l1633t2271r1756b2330],
41	at	IN	O	at	quantmod	43	SENT_199	[p9l1778t2280r1837b2330],
42	least	JJS	O	least	mwe	41	SENT_199	[p9l1857t2271r2012b2330],
43	one	CD	NUMBER	one	dobj	40	SENT_199	[p9l2033t2289r2152b2330],
44	mutated	VBN	O	mutate	partmod	43	SENT_199	[p9l7t2374r279b2434],
45	allele	NN	O	allele	nn	64	SENT_199	[p9l300t2374r480b2434],
46	(	CD	NUMBER	(	num	45	SENT_199	[p9l503t2375r713b2447],
47	*	NN	O	*	dep	45	SENT_199	[p9l503t2375r713b2447],
48	1	CD	NUMBER	1	num	47	SENT_199	[p9l503t2375r713b2447],
49	/	:	O	/	punct	52	SENT_199	[p9l503t2375r713b2447],
50	*	CD	NUMBER	*	number	51	SENT_199	[p9l503t2375r713b2447],
51	1	CD	NUMBER	1	num	52	SENT_199	[p9l503t2375r713b2447],
52	n	NN	O	n	dep	47	SENT_199	[p9l740t2395r779b2434],
53	=	JJ	O	=	amod	52	SENT_199	[p9l798t2399r842b2423],
54	8	CD	NUMBER	8	tmod	53	SENT_199	[p9l863t2375r896b2434],
55	and	CC	O	and	_	0	SENT_199	[p9l921t2374r1040b2434],
56	*	CD	NUMBER	*	tmod	53	SENT_199	[p9l1064t2375r1247b2434],
57	1	CD	NUMBER	1	dep	52	SENT_199	[p9l1064t2375r1247b2434],
58	/	:	O	/	punct	52	SENT_199	[p9l1064t2375r1247b2434],
59	*	CD	NUMBER	*	number	60	SENT_199	[p9l1064t2375r1247b2434],
60	3	CD	NUMBER	3	num	61	SENT_199	[p9l1064t2375r1247b2434],
61	n	NN	O	n	dep	45	SENT_199	[p9l1271t2395r1310b2434],
62	=	JJ	O	=	amod	64	SENT_199	[p9l1329t2399r1373b2422],
63	3	CD	NUMBER	3	tmod	62	SENT_199	[p9l1393t2375r1476b2448],
64	)	NN	O	)	dobj	44	SENT_199	[p9l1393t2375r1476b2448],
65	.	.	O	.	_	0	SENT_199	[p9l1393t2375r1476b2448],

1	By	IN	O	by	_	0	SENT_200	[p9l1500t2376r1596b2451],
2	comparing	VBG	O	compare	prepc_by	29	SENT_200	[p9l1617t2374r1978b2451],
3	lipid	NN	O	lipid	nn	4	SENT_200	[p9l1998t2374r2153b2451],
4	changes	NNS	O	change	dobj	2	SENT_200	[p9l7t2476r277b2553],
5	in	IN	O	in	_	0	SENT_200	[p9l309t2476r373b2535],
6	patients	NNS	O	patient	prep_in	2	SENT_200	[p9l402t2476r664b2553],
7	with	IN	O	with	prep	6	SENT_200	[p9l696t2476r845b2536],
8	the	DT	O	the	det	10	SENT_200	[p9l875t2476r976b2535],
9	wt	JJ	O	wt	amod	10	SENT_200	[p9l1007t2485r1091b2535],
10	genotype	NN	O	genotype	dep	7	SENT_200	[p9l1121t2485r1429b2553],
11	(	CD	NUMBER	(	num	10	SENT_200	[p9l1463t2476r1706b2549],
12	*	NN	O	*	dep	10	SENT_200	[p9l1463t2476r1706b2549],
13	1	CD	NUMBER	1	num	12	SENT_200	[p9l1463t2476r1706b2549],
14	/	:	O	/	punct	10	SENT_200	[p9l1463t2476r1706b2549],
15	*	CD	NUMBER	*	number	16	SENT_200	[p9l1463t2476r1706b2549],
16	1	CD	NUMBER	1	dep	10	SENT_200	[p9l1463t2476r1706b2549],
17	)	NN	O	)	dep	16	SENT_200	[p9l1463t2476r1706b2549],
18	and	CC	O	and	_	0	SENT_200	[p9l1740t2476r1860b2535],
19	patients	NNS	O	patient	conj_and	16	SENT_200	[p9l1888t2476r2150b2553],
20	with	IN	O	with	_	0	SENT_200	[p9l7t2578r156b2638],
21	at	IN	O	at	quantmod	23	SENT_200	[p9l173t2587r232b2638],
22	least	JJS	O	least	mwe	21	SENT_200	[p9l246t2578r401b2638],
23	one	CD	NUMBER	one	prep_with	19	SENT_200	[p9l417t2597r536b2638],
24	mutated	VBN	O	mutate	partmod	6	SENT_200	[p9l552t2578r825b2638],
25	allele	NN	O	allele	dobj	24	SENT_200	[p9l842t2578r1040b2649],
26	,	,	O	,	_	0	SENT_200	[p9l842t2578r1040b2649],
27	percent	NN	O	percent	nn	28	SENT_200	[p9l1057t2587r1308b2655],
28	variations	NNS	O	variation	nsubj	29	SENT_200	[p9l1323t2578r1653b2638],
29	showed	VBD	O	show	_	0	SENT_200	[p9l1673t2578r1927b2638],
30	essentially	RB	O	essentially	advmod	32	SENT_200	[p9l1942t2597r2150b2638, p9l6t2680r179b2757],
31	no	DT	O	no	det	32	SENT_200	[p9l197t2699r279b2740],
32	difference	NN	O	difference	nsubj	48	SENT_200	[p9l299t2680r639b2740],
33	for	IN	O	for	_	0	SENT_200	[p9l657t2680r755b2740],
34	total	NN	O	total	prep_for	32	SENT_200	[p9l771t2680r939b2751],
35	,	,	O	,	_	0	SENT_200	[p9l771t2680r939b2751],
36	LDL	NN	O	ldl	nn	37	SENT_200	[p9l959t2682r1169b2751],
37	—	NN	O	—	prep_for	32	SENT_200	[p9l959t2682r1169b2751],
38	,	,	O	,	_	0	SENT_200	[p9l959t2682r1169b2751],
39	and	CC	O	and	_	0	SENT_200	[p9l1192t2680r1312b2740],
40	HDL	NNP	O	HDL	nn	42	SENT_200	[p9l1329t2680r1903b2740],
41	—	CD	NUMBER	—	num	42	SENT_200	[p9l1329t2680r1903b2740],
42	cholesterol	NN	O	cholesterol	prep_for	32	SENT_200	[p9l1329t2680r1903b2740],
43	as	RB	O	as	_	0	SENT_200	[p9l1923t2699r1988b2740],
44	well	RB	O	well	_	0	SENT_200	[p9l2008t2680r2152b2740],
45	as	IN	O	as	_	0	SENT_200	[p9l8t2800r73b2841],
46	for	IN	O	for	_	0	SENT_200	[p9l99t2782r197b2841],
47	triglycerides	NNS	O	triglyceride	prep_for	32	SENT_200	[p9l219t2782r641b2859],
48	(	VBP	O	(	ccomp	29	SENT_200	[p9l669t2782r837b2855],
49	data	NNS	O	datum	dobj	48	SENT_200	[p9l669t2782r837b2855],
50	not	RB	O	not	neg	51	SENT_200	[p9l859t2791r966b2841],
51	shown	VBN	O	show	rcmod	49	SENT_200	[p9l992t2782r1252b2855],
52	)	NN	O	)	dobj	51	SENT_200	[p9l992t2782r1252b2855],
53	.	.	O	.	_	0	SENT_200	[p9l992t2782r1252b2855],

1	3.2.3	CD	NUMBER	3.2.3	_	0	SENT_201	[p9l6t3014r188b3073],
2	.	.	O	.	_	0	SENT_201	[p9l6t3014r188b3073],

1	C	NN	O	c	_	0	SENT_202	[p9l245t3015r299b3074],
2	YP2D6	NN	O	yp2d6	nn	3	SENT_202	[p9l303t3013r545b3073],
3	genotype	NN	O	genotype	dep	1	SENT_202	[p9l564t3025r869b3090],

1	Thirty	CD	NUMBER	thirty	num	2	SENT_203	[p9l109t3116r319b3193],
2	patients	NNS	O	patient	nsubj	3	SENT_203	[p9l352t3116r614b3193],
3	received	VBD	O	receive	_	0	SENT_203	[p9l648t3116r932b3176],
4	statins	NNS	O	statin	iobj	3	SENT_203	[p9l968t3116r1179b3176],
5	(	CD	NUMBER	(	num	6	SENT_203	[p9l1217t3116r1644b3190],
6	simvastatin	NN	O	simvastatin	dobj	3	SENT_203	[p9l1217t3116r1644b3190],
7	,	,	O	,	_	0	SENT_203	[p9l1217t3116r1644b3190],
8	ﬂuvastatin	NN	O	ﬂuvastatin	nn	9	SENT_203	[p9l1682t3116r2057b3190],
9	)	NN	O	)	appos	6	SENT_203	[p9l1682t3116r2057b3190],
10	at	IN	O	at	advmod	13	SENT_203	[p9l2095t3125r2153b3176],
11	least	JJS	O	least	pobj	10	SENT_203	[p9l7t3218r161b3277],
12	partially	RB	O	partially	advmod	13	SENT_203	[p9l190t3218r472b3295],
13	metabolized	VBN	O	metabolize	rcmod	9	SENT_203	[p9l503t3218r918b3277],
14	by	IN	O	by	_	0	SENT_203	[p9l946t3218r1030b3295],
15	CYP2D6	NN	O	cyp2d6	prep_by	13	SENT_203	[p9l1061t3218r1388b3278],
16	.	.	O	.	_	0	SENT_203	[p9l1061t3218r1388b3278],

1	Of	IN	O	of	_	0	SENT_204	[p9l1424t3218r1516b3278],
2	these	DT	O	these	prep_of	9	SENT_204	[p9l1540t3218r1731b3288],
3	,	,	O	,	_	0	SENT_204	[p9l1540t3218r1731b3288],
4	16	CD	PERCENT	16	nsubj	9	SENT_204	[p9l1773t3218r1846b3278],
5	(	CD	PERCENT	(	number	6	SENT_204	[p9l1880t3218r2150b3291],
6	53.3	CD	PERCENT	53.3	num	7	SENT_204	[p9l1880t3218r2150b3291],
7	%	NN	PERCENT	%	dep	4	SENT_204	[p9l1880t3218r2150b3291],
8	)	CD	NUMBER	)	dep	4	SENT_204	[p9l1880t3218r2150b3291],
9	had	VBD	O	have	_	0	SENT_204	[p9l6t3320r128b3379],
10	a	DT	O	a	det	14	SENT_204	[p9l167t3338r202b3379],
11	wt	JJ	O	wt	amod	14	SENT_204	[p9l239t3328r323b3379],
12	genotype	NN	O	genotype	nn	14	SENT_204	[p9l360t3329r669b3397],
13	(	CD	NUMBER	(	num	14	SENT_204	[p9l710t3320r954b3393],
14	*	NN	O	*	dobj	9	SENT_204	[p9l710t3320r954b3393],
15	1	CD	NUMBER	1	dep	9	SENT_204	[p9l710t3320r954b3393],
16	/	:	O	/	punct	15	SENT_204	[p9l710t3320r954b3393],
17	*	CD	NUMBER	*	number	18	SENT_204	[p9l710t3320r954b3393],
18	1	CD	NUMBER	1	num	19	SENT_204	[p9l710t3320r954b3393],
19	)	NN	O	)	nsubj	65	SENT_204	[p9l710t3320r954b3393],
20	whereas	IN	O	whereas	mark	26	SENT_204	[p9l995t3320r1269b3379],
21	13	CD	PERCENT	13	nsubj	26	SENT_204	[p9l1317t3320r1388b3379],
22	(	CD	PERCENT	(	number	23	SENT_204	[p9l1433t3320r1702b3393],
23	43.3	CD	PERCENT	43.3	num	24	SENT_204	[p9l1433t3320r1702b3393],
24	%	NN	PERCENT	%	dep	21	SENT_204	[p9l1433t3320r1702b3393],
25	)	CD	NUMBER	)	dep	21	SENT_204	[p9l1433t3320r1702b3393],
26	had	VBD	O	have	dep	19	SENT_204	[p9l1742t3320r1864b3379],
27	at	IN	O	at	quantmod	29	SENT_204	[p9l1903t3329r1962b3379],
28	least	JJS	O	least	mwe	27	SENT_204	[p9l1999t3320r2153b3379],
29	one	CD	NUMBER	one	dobj	26	SENT_204	[p9l8t3441r127b3482],
30	mutated	VBN	O	mutate	partmod	29	SENT_204	[p9l151t3422r424b3482],
31	allele	NN	O	allele	dobj	30	SENT_204	[p9l448t3422r628b3482],
32	(	CD	NUMBER	(	num	31	SENT_204	[p9l655t3423r891b3495],
33	*	NN	O	*	dep	31	SENT_204	[p9l655t3423r891b3495],
34	1	CD	NUMBER	1	num	33	SENT_204	[p9l655t3423r891b3495],
35	/	:	O	/	punct	37	SENT_204	[p9l655t3423r891b3495],
36	*	CD	NUMBER	*	num	37	SENT_204	[p9l655t3423r891b3495],
37	4	CD	NUMBER	4	dep	33	SENT_204	[p9l655t3423r891b3495],
38	,	,	O	,	_	0	SENT_204	[p9l655t3423r891b3495],
39	n	NN	O	n	dep	33	SENT_204	[p9l918t3443r957b3482],
40	=	JJ	O	=	amod	39	SENT_204	[p9l976t3447r1019b3471],
41	12	CD	NUMBER	12	tmod	40	SENT_204	[p9l1045t3423r1119b3481],
42	and	CC	O	and	_	0	SENT_204	[p9l1145t3422r1265b3482],
43	4	CD	NUMBER	4	conj_and	37	SENT_204	[p9l1287t3423r1455b3492],
44	/	:	O	/	punct	37	SENT_204	[p9l1287t3423r1455b3492],
45	*	CD	NUMBER	*	number	46	SENT_204	[p9l1287t3423r1455b3492],
46	4	CD	NUMBER	4	num	33	SENT_204	[p9l1287t3423r1455b3492],
47	,	,	O	,	_	0	SENT_204	[p9l1287t3423r1455b3492],
48	n	NN	O	n	dobj	30	SENT_204	[p9l1482t3443r1521b3482],
49	=	JJ	O	=	amod	51	SENT_204	[p9l1540t3447r1583b3471],
50	1	CD	NUMBER	1	tmod	49	SENT_204	[p9l1609t3423r1688b3495],
51	)	NN	O	)	dep	48	SENT_204	[p9l1609t3423r1688b3495],
52	,	,	O	,	_	0	SENT_204	[p9l1609t3423r1688b3495],
53	and	CC	O	and	_	0	SENT_204	[p9l1716t3422r1836b3482],
54	only	RB	O	only	advmod	56	SENT_204	[p9l1860t3422r2007b3499],
55	one	CD	NUMBER	one	num	56	SENT_204	[p9l2033t3441r2152b3482],
56	patient	NN	O	patient	conj_and	31	SENT_204	[p9l6t3524r237b3601],
57	(	CD	PERCENT	(	number	58	SENT_204	[p9l270t3524r496b3597],
58	3.4	CD	PERCENT	3.4	num	59	SENT_204	[p9l270t3524r496b3597],
59	%	NN	PERCENT	%	dep	56	SENT_204	[p9l270t3524r496b3597],
60	)	CD	NUMBER	)	dep	56	SENT_204	[p9l270t3524r496b3597],
61	was	VBD	O	be	cop	65	SENT_204	[p9l530t3542r657b3584],
62	an	DT	O	a	det	65	SENT_204	[p9l691t3542r768b3583],
63	UM	NN	O	um	nn	65	SENT_204	[p9l798t3525r932b3584],
64	(	CD	NUMBER	(	num	65	SENT_204	[p9l966t3524r1074b3597],
65	*	NN	O	*	dep	15	SENT_204	[p9l966t3524r1074b3597],
66	2	CD	NUMBER	2	dep	65	SENT_204	[p9l966t3524r1074b3597],
67	x	CC	O	x	_	0	SENT_204	[p9l1102t3542r1146b3582],
68	N	NN	O	n	conj_x	65	SENT_204	[p9l1172t3524r1277b3597],
69	)	NN	O	)	dep	68	SENT_204	[p9l1172t3524r1277b3597],
70	.	.	O	.	_	0	SENT_204	[p9l1172t3524r1277b3597],

1	Statistical	JJ	O	statistical	dep	2	SENT_205	[p9l1314t3524r1646b3584],
2	analysis	NN	O	analysis	dep	3	SENT_205	[p9l1678t3524r1947b3601],
3	comparing	VBG	O	compare	dep	14	SENT_205	[p9l1980t3542r2150b3583, p9l6t3626r221b3703],
4	subjects	NNS	O	subject	dobj	3	SENT_205	[p9l255t3626r523b3703],
5	with	IN	O	with	_	0	SENT_205	[p9l556t3626r705b3686],
6	wt	JJ	O	wt	amod	7	SENT_205	[p9l736t3635r819b3686],
7	genotype	NN	O	genotype	prep_with	3	SENT_205	[p9l850t3635r1158b3703],
8	(	CD	NUMBER	(	num	9	SENT_205	[p9l1192t3627r1435b3700],
9	*	NN	O	*	tmod	3	SENT_205	[p9l1192t3627r1435b3700],
10	1	CD	NUMBER	1	dep	9	SENT_205	[p9l1192t3627r1435b3700],
11	/	:	O	/	punct	14	SENT_205	[p9l1192t3627r1435b3700],
12	*	CD	NUMBER	*	number	13	SENT_205	[p9l1192t3627r1435b3700],
13	1	CD	NUMBER	1	num	14	SENT_205	[p9l1192t3627r1435b3700],
14	)	NN	O	)	_	0	SENT_205	[p9l1192t3627r1435b3700],
15	and	CC	O	and	_	0	SENT_205	[p9l1470t3626r1590b3686],
16	patients	NNS	O	patient	conj_and	14	SENT_205	[p9l1619t3626r1881b3703],
17	with	IN	O	with	_	0	SENT_205	[p9l1914t3626r2063b3686],
18	at	IN	O	at	quantmod	20	SENT_205	[p9l2095t3635r2153b3686],
19	least	JJS	O	least	mwe	18	SENT_205	[p9l7t3728r162b3788],
20	one	CD	NUMBER	one	prep_with	16	SENT_205	[p9l199t3747r318b3788],
21	mutated	VBN	O	mutate	partmod	14	SENT_205	[p9l355t3728r628b3788],
22	allele	NN	O	allele	dobj	21	SENT_205	[p9l666t3728r846b3788],
23	(	CD	NUMBER	(	num	22	SENT_205	[p9l887t3728r1021b3801],
24	*	CD	NUMBER	*	number	25	SENT_205	[p9l887t3728r1021b3801],
25	4	CD	NUMBER	4	num	26	SENT_205	[p9l887t3728r1021b3801],
26	)	NN	O	)	dep	22	SENT_205	[p9l887t3728r1021b3801],
27	(	CD	NUMBER	(	num	30	SENT_205	[p9l1063t3728r1273b3801],
28	Table	NNP	O	Table	nn	30	SENT_205	[p9l1063t3728r1273b3801],
29	3	CD	NUMBER	3	num	30	SENT_205	[p9l1313t3729r1377b3801],
30	)	NN	O	)	nsubj	31	SENT_205	[p9l1313t3729r1377b3801],
31	showed	VBD	O	show	rcmod	22	SENT_205	[p9l1420t3728r1673b3788],
32	homogeneity	NN	O	homogeneity	dobj	31	SENT_205	[p9l1709t3728r2152b3805],
33	for	IN	O	for	_	0	SENT_205	[p10l7t19r105b78],
34	age	NN	O	age	prep_for	31	SENT_205	[p10l142t37r274b96],
35	,	,	O	,	_	0	SENT_205	[p10l142t37r274b96],
36	sex	NN	O	sex	conj_and	34	SENT_205	[p10l317t37r442b89],
37	,	,	O	,	_	0	SENT_205	[p10l317t37r442b89],
38	doses	NNS	O	dose	conj_and	34	SENT_205	[p10l482t19r687b89],
39	,	,	O	,	_	0	SENT_205	[p10l482t19r687b89],
40	and	CC	O	and	_	0	SENT_205	[p10l728t19r848b78],
41	basal	JJ	O	basal	amod	43	SENT_205	[p10l882t19r1056b78],
42	lipid	NN	O	lipid	nn	43	SENT_205	[p10l1093t19r1247b96],
43	levels	NNS	O	level	conj_and	34	SENT_205	[p10l1283t19r1493b78],
44	.	.	O	.	_	0	SENT_205	[p10l1283t19r1493b78],

1	Fig	NN	O	fig	_	0	SENT_206	[p10l1534t19r1662b96],
2	.	.	O	.	_	0	SENT_206	[p10l1534t19r1662b96],

1	1	CD	NUMBER	1	nsubj	2	SENT_207	[p10l1711t19r1735b77],
2	reports	VBZ	O	report	_	0	SENT_207	[p10l1779t28r2012b96],
3	the	DT	O	the	det	7	SENT_207	[p10l2050t19r2152b78],
4	LDL	NN	O	ldl	nn	7	SENT_207	[p10l6t121r572b181],
5	—	NN	O	—	nn	7	SENT_207	[p10l6t121r572b181],
6	cholesterol	NN	O	cholesterol	nn	7	SENT_207	[p10l6t121r572b181],
7	reductions	NNS	O	reduction	nsubj	16	SENT_207	[p10l588t121r939b181],
8	found	VBN	O	find	partmod	7	SENT_207	[p10l958t121r1155b181],
9	after	IN	O	after	_	0	SENT_207	[p10l1172t121r1326b181],
10	treatment	NN	O	treatment	prep_after	8	SENT_207	[p10l1341t130r1661b181],
11	with	IN	O	with	_	0	SENT_207	[p10l1677t121r1826b181],
12	CYP2D6	NN	O	cyp2d6	nn	13	SENT_207	[p10l1843t121r2151b181],
13	substrates	NNS	O	substrate	prep_with	8	SENT_207	[p10l9t224r339b283],
14	(	CD	NUMBER	(	num	16	SENT_207	[p10l385t224r1216b297],
15	simvastatin	NN	O	simvastatin	nn	16	SENT_207	[p10l385t224r1216b297],
16	—	NN	O	—	ccomp	2	SENT_207	[p10l385t224r1216b297],
17	ﬂuvastatin	NN	O	ﬂuvastatin	nn	18	SENT_207	[p10l385t224r1216b297],
18	)	NN	O	)	dobj	16	SENT_207	[p10l385t224r1216b297],
19	in	IN	O	in	_	0	SENT_207	[p10l1261t224r1325b283],
20	patients	NNS	O	patient	prep_in	18	SENT_207	[p10l1366t224r1628b301],
21	with	IN	O	with	_	0	SENT_207	[p10l1672t224r1821b284],
22	different	JJ	O	different	prep_with	16	SENT_207	[p10l1864t224r2153b283],

1	Table	NNP	O	Table	_	0	SENT_208	[p10l6t437r154b484],
2	4	CD	NUMBER	4	dep	1	SENT_208	[p10l173t437r205b483],

1	LDL	NN	O	ldl	_	0	SENT_209	[p10l32t1660r84b1814],
2	-	:	O	-	_	0	SENT_209	[p10l32t1660r84b1814],
3	C	NN	O	c	dep	1	SENT_209	[p10l31t1595r84b1641],
4	after	IN	O	after	_	0	SENT_209	[p10l31t1422r84b1571],
5	treatment	NN	O	treatment	prep_after	3	SENT_209	[p10l32t1054r96b1407],
6	(	CD	PERCENT	(	num	7	SENT_209	[p10l32t1054r96b1407],
7	%	NN	PERCENT	%	dep	3	SENT_209	[p10l31t977r84b1030],
8	Va	NNP	O	Va	dep	7	SENT_209	[p10l32t663r84b952],
9	;	:	O	;	_	0	SENT_209	[p10l32t663r84b952],
10	:	:	O	:	_	0	SENT_209	[p10l32t663r84b952],
11	ria	NN	O	rium	dep	1	SENT_209	[p10l32t663r84b952],
12	.	.	O	.	_	0	SENT_209	[p10l32t663r84b952],

1	tioIn	NN	O	tioin	_	0	SENT_210	[p10l32t663r84b952],
2	vs	CC	O	vs	_	0	SENT_210	[p10l127t1669r164b1740],
3	pretreatment	NN	O	pretreatment	conj_vs	1	SENT_210	[p10l115t1226r177b1642],
4	concentration	NN	O	concentration	nn	5	SENT_210	[p10l112t736r177b1208],
5	)	NN	O	)	dep	1	SENT_210	[p10l112t736r177b1208],

1	t	NN	O	t	_	0	SENT_211	[p10l463t1848r589b1894],
2	*	CD	NUMBER	*	dep	1	SENT_211	[p10l463t1848r589b1894],
3	!	.	O	!	_	0	SENT_211	[p10l463t1848r589b1894],

1	4	CD	NUMBER	4	_	0	SENT_212	[p10l463t1848r589b1894],
2	*	CD	NUMBER	*	dep	1	SENT_212	[p10l463t1848r589b1894],
3	or	CC	O	or	_	0	SENT_212	[p10l608t1860r666b1894],
4	4	CD	NUMBER	4	dep	1	SENT_212	[p10l685t1848r811b1894],
5	*	NN	O	*	dep	2	SENT_212	[p10l685t1848r811b1894],
6	!	.	O	!	_	0	SENT_212	[p10l685t1848r811b1894],

1	4	CD	NUMBER	4	num	2	SENT_213	[p10l685t1848r811b1894],
2	*	NN	O	*	_	0	SENT_213	[p10l685t1848r811b1894],
3	1	CD	NUMBER	1	num	4	SENT_213	[p10l1108t1848r1181b1894],
4	*	NN	O	*	dep	2	SENT_213	[p10l1108t1848r1181b1894],
5	!	.	O	!	_	0	SENT_213	[p10l1108t1848r1181b1894],

1	‘	NN	O	‘	_	0	SENT_214	[p10l1108t1848r1181b1894],
2	1	CD	NUMBER	1	number	3	SENT_214	[p10l1197t1850r1219b1894],
3	*	CD	NUMBER	*	num	4	SENT_214	[p10l1231t1850r1250b1870],
4	*	NN	O	*	dep	1	SENT_214	[p10l1674t1850r1727b1894],
5	2	CD	NUMBER	2	dep	1	SENT_214	[p10l1674t1850r1727b1894],
6	x	CC	O	x	_	0	SENT_214	[p10l1748t1860r1779b1894],
7	N	NN	O	n	conj_x	5	SENT_214	[p10l1798t1850r1838b1894],

1	Fig	NN	O	fig	_	0	SENT_215	[p10l7t1994r110b2056],
2	.	.	O	.	_	0	SENT_215	[p10l7t1994r110b2056],

1	1	LS	NUMBER	1	_	0	SENT_216	[p10l139t1994r178b2042],
2	.	.	O	.	_	0	SENT_216	[p10l139t1994r178b2042],

1	LDL	NN	O	ldl	nn	3	SENT_217	[p10l212t1995r343b2041],
2	cholesterol	NN	O	cholesterol	nn	3	SENT_217	[p10l362t1994r659b2042],
3	reductions	NNS	O	reduction	nsubj	12	SENT_217	[p10l678t1994r959b2042],
4	following	VBG	O	follow	_	0	SENT_217	[p10l980t1994r1240b2056],
5	simvastatin	NN	O	simvastatin	prep_following	3	SENT_217	[p10l1263t1994r1883b2051],
6	/	:	O	/	punct	7	SENT_217	[p10l1263t1994r1883b2051],
7	ﬂuvastatin	NN	O	ﬂuvastatin	dep	5	SENT_217	[p10l1263t1994r1883b2051],
8	,	,	O	,	_	0	SENT_217	[p10l1263t1994r1883b2051],
9	CYPZD6	NN	O	cypzd6	nn	10	SENT_217	[p10l1906t1994r2152b2042],
10	substrates	NNS	O	substrate	appos	7	SENT_217	[p10l9t2079r289b2136],
11	,	,	O	,	_	0	SENT_217	[p10l9t2079r289b2136],
12	regulated	VBN	O	regulate	_	0	SENT_217	[p10l313t2079r565b2141],
13	by	IN	O	by	_	0	SENT_217	[p10l586t2079r653b2141],
14	the	DT	O	the	det	16	SENT_217	[p10l676t2079r758b2127],
15	CYP2D6	NN	O	cyp2d6	nn	16	SENT_217	[p10l781t2079r1028b2127],
16	polymorphisms	NNS	O	polymorphism	prep_by	12	SENT_217	[p10l1050t2079r1488b2141],
17	.	.	O	.	_	0	SENT_217	[p10l1050t2079r1488b2141],

1	The	DT	O	the	det	3	SENT_218	[p10l1513t2079r1617b2127],
2	best	JJS	O	best	amod	3	SENT_218	[p10l1639t2079r1750b2127],
3	reduction	NN	O	reduction	nsubjpass	5	SENT_218	[p10l1771t2079r2027b2127],
4	was	VBD	O	be	auxpass	5	SENT_218	[p10l2050t2094r2151b2127],
5	found	VBN	O	find	_	0	SENT_218	[p10l7t2164r165b2212],
6	in	IN	O	in	_	0	SENT_218	[p10l195t2164r246b2211],
7	individuals	NNS	O	individual	prep_in	5	SENT_218	[p10l276t2164r574b2212],
8	with	IN	O	with	_	0	SENT_218	[p10l607t2164r726b2212],
9	impaired	JJ	O	impaired	amod	11	SENT_218	[p10l756t2164r997b2226],
10	CYP2D6	NN	O	cyp2d6	nn	11	SENT_218	[p10l1028t2164r1274b2212],
11	function	NN	O	function	nn	36	SENT_218	[p10l1306t2164r1531b2212],
12	(	CD	NUMBER	(	num	13	SENT_218	[p10l1564t2164r1759b2223],
13	*	NN	O	*	amod	36	SENT_218	[p10l1564t2164r1759b2223],
14	1	CD	NUMBER	1	dep	13	SENT_218	[p10l1564t2164r1759b2223],
15	/	:	O	/	punct	18	SENT_218	[p10l1564t2164r1759b2223],
16	*	CD	NUMBER	*	number	17	SENT_218	[p10l1564t2164r1759b2223],
17	4	CD	NUMBER	4	num	18	SENT_218	[p10l1564t2164r1759b2223],
18	)	NN	O	)	dep	13	SENT_218	[p10l1564t2164r1759b2223],
19	and	CC	O	and	_	0	SENT_218	[p10l1792t2164r1888b2212],
20	the	DT	O	the	det	22	SENT_218	[p10l1918t2164r1999b2212],
21	least	JJS	O	least	amod	22	SENT_218	[p10l2030t2164r2154b2212],
22	reduction	NN	O	reduction	dep	13	SENT_218	[p10l6t2249r263b2297],
23	in	IN	O	in	_	0	SENT_218	[p10l281t2249r333b2296],
24	the	DT	O	the	det	32	SENT_218	[p10l352t2249r433b2297],
25	individual	JJ	O	individual	amod	32	SENT_218	[p10l452t2249r725b2297],
26	with	IN	O	with	_	0	SENT_218	[p10l744t2249r864b2297],
27	the	DT	O	the	det	29	SENT_218	[p10l882t2249r963b2297],
28	UM	NNP	O	UM	nn	29	SENT_218	[p10l982t2250r1090b2297],
29	genotype	NN	O	genotype	prep_with	25	SENT_218	[p10l1110t2256r1357b2311],
30	(	CD	NUMBER	(	num	32	SENT_218	[p10l1379t2249r1598b2308],
31	CYP	NN	O	cyp	nn	32	SENT_218	[p10l1379t2249r1598b2308],
32	*	NN	O	*	prep_in	22	SENT_218	[p10l1379t2249r1598b2308],
33	2	CD	NUMBER	2	dep	18	SENT_218	[p10l1379t2249r1598b2308],
34	x	CC	O	x	cc	33	SENT_218	[p10l1620t2264r1654b2296],
35	N	NN	O	n	nn	36	SENT_218	[p10l1676t2250r1760b2308],
36	)	NN	O	)	prep_with	7	SENT_218	[p10l1676t2250r1760b2308],
37	.	.	O	.	_	0	SENT_218	[p10l1676t2250r1760b2308],

1	CYP2D6	NN	O	cyp2d6	nn	2	SENT_219	[p10l8t2433r316b2493],
2	genotypes	NNS	O	genotype	_	0	SENT_219	[p10l345t2442r705b2510],
3	,	,	O	,	_	0	SENT_219	[p10l345t2442r705b2510],
4	i.e.	FW	O	i.e.	appos	2	SENT_219	[p10l734t2433r832b2493],
5	from	IN	O	from	_	0	SENT_219	[p10l862t2433r1027b2493],
6	the	DT	O	the	det	11	SENT_219	[p10l1051t2433r1153b2493],
7	wild	JJ	O	wild	amod	11	SENT_219	[p10l1180t2433r1329b2493],
8	type	NN	O	type	nn	11	SENT_219	[p10l1355t2442r1499b2510],
9	(	CD	NUMBER	(	num	11	SENT_219	[p10l1528t2434r1589b2507],
10	*	NN	O	*	nn	11	SENT_219	[p10l1528t2434r1589b2507],
11	l	NN	O	l	prep_from	4	SENT_219	[p10l1605t2434r1662b2493],
12	/	:	O	/	punct	15	SENT_219	[p10l1605t2434r1662b2493],
13	1	CD	NUMBER	1	number	14	SENT_219	[p10l1671t2434r1771b2507],
14	*	CD	NUMBER	*	num	15	SENT_219	[p10l1671t2434r1771b2507],
15	)	NN	O	)	dep	11	SENT_219	[p10l1671t2434r1771b2507],
16	to	TO	O	to	dep	15	SENT_219	[p10l1800t2442r1863b2493],
17	the	DT	O	the	det	23	SENT_219	[p10l1890t2433r1992b2493],
18	UM	NNP	O	UM	nn	23	SENT_219	[p10l2018t2435r2152b2493],
19	(	CD	NUMBER	(	num	23	SENT_219	[p10l10t2535r118b2608],
20	*	CD	NUMBER	*	number	21	SENT_219	[p10l10t2535r118b2608],
21	2	CD	NUMBER	2	dep	22	SENT_219	[p10l10t2535r118b2608],
22	x	NN	O	x	dep	23	SENT_219	[p10l145t2554r189b2593],
23	N	NN	O	n	dep	15	SENT_219	[p10l215t2536r320b2608],
24	)	CD	NUMBER	)	dep	15	SENT_219	[p10l215t2536r320b2608],
25	.	.	O	.	_	0	SENT_219	[p10l215t2536r320b2608],

1	All	DT	O	all	det	3	SENT_220	[p10l354t2535r460b2594],
2	ﬂuvastatin	NN	O	ﬂuvastatin	nn	3	SENT_220	[p10l491t2535r841b2595],
3	patients	NNS	O	patient	nsubj	4	SENT_220	[p10l869t2535r1131b2612],
4	received	VBD	O	receive	_	0	SENT_220	[p10l1161t2535r1446b2595],
5	the	DT	O	the	det	6	SENT_220	[p10l1474t2535r1576b2595],
6	drug	NN	O	drug	dobj	4	SENT_220	[p10l1607t2535r1758b2612],
7	in	IN	O	in	_	0	SENT_220	[p10l1789t2535r1853b2594],
8	a	DT	O	a	det	10	SENT_220	[p10l1884t2554r1919b2595],
9	80	CD	NUMBER	80	num	10	SENT_220	[p10l1950t2535r2029b2595],
10	mg	NN	O	mg	prep_in	6	SENT_220	[p10l2046t2554r2152b2612],
11	daily	JJ	SET	daily	amod	12	SENT_220	[p10l8t2637r175b2714],
12	dose	NN	O	dose	tmod	4	SENT_220	[p10l214t2637r367b2696],
13	in	IN	O	in	_	0	SENT_220	[p10l405t2637r469b2696],
14	the	DT	O	the	det	17	SENT_220	[p10l507t2637r609b2696],
15	slow	JJ	O	slow	amod	17	SENT_220	[p10l650t2637r802b2697],
16	release	NN	O	release	nn	17	SENT_220	[p10l841t2637r1075b2696],
17	formulation	NN	O	formulation	prep_in	12	SENT_220	[p10l1114t2637r1531b2696],
18	.	.	O	.	_	0	SENT_220	[p10l1114t2637r1531b2696],

1	In	IN	O	in	mark	4	SENT_221	[p10l1573t2638r1642b2696],
2	order	NN	O	order	dep	4	SENT_221	[p10l1681t2637r1859b2696],
3	to	TO	O	to	aux	4	SENT_221	[p10l1895t2646r1958b2696],
4	have	VB	O	have	dep	14	SENT_221	[p10l1997t2637r2152b2696],
5	comparable	JJ	O	comparable	amod	6	SENT_221	[p10l8t2739r402b2816],
6	data	NNS	O	datum	dobj	4	SENT_221	[p10l433t2739r573b2799],
7	for	IN	O	for	_	0	SENT_221	[p10l602t2739r701b2799],
8	all	DT	O	all	det	10	SENT_221	[p10l731t2739r811b2799],
9	simvastatin	NN	O	simvastatin	nn	10	SENT_221	[p10l845t2739r1226b2799],
10	doses	NNS	O	dose	prep_for	6	SENT_221	[p10l1256t2739r1461b2810],
11	,	,	O	,	_	0	SENT_221	[p10l1256t2739r1461b2810],
12	these	DT	O	these	nsubjpass	14	SENT_221	[p10l1494t2739r1667b2799],
13	were	VBD	O	be	auxpass	14	SENT_221	[p10l1697t2758r1860b2799],
14	brought	VBN	O	bring	dep	43	SENT_221	[p10l1889t2739r2154b2816],
15	to	TO	O	to	_	0	SENT_221	[p10l7t2850r70b2901],
16	a	DT	O	a	det	18	SENT_221	[p10l107t2860r142b2901],
17	uniﬁed	JJ	O	uniﬁed	amod	18	SENT_221	[p10l174t2841r410b2901],
18	dose	NN	O	dose	prep_to	14	SENT_221	[p10l444t2841r597b2901],
19	of	IN	O	of	_	0	SENT_221	[p10l633t2841r706b2901],
20	20	CD	NUMBER	20	num	21	SENT_221	[p10l736t2841r817b2901],
21	mg	NN	O	mg	prep_of	18	SENT_221	[p10l834t2860r959b2918],
22	:	:	O	:	_	0	SENT_221	[p10l834t2860r959b2918],
23	patients	NNS	O	patient	dep	21	SENT_221	[p10l998t2841r1260b2918],
24	who	WP	O	who	nsubj	25	SENT_221	[p10l1296t2841r1440b2901],
25	received	VBD	O	receive	rcmod	23	SENT_221	[p10l1474t2841r1758b2901],
26	40	CD	NUMBER	40	num	27	SENT_221	[p10l1791t2841r1874b2901],
27	mg	NN	O	mg	nsubj	28	SENT_221	[p10l1891t2860r1997b2918],
28	had	VBD	O	have	ccomp	25	SENT_221	[p10l2032t2841r2154b2901],
29	their	PRP$	O	they	poss	33	SENT_221	[p10l7t2942r163b3001],
30	LDL	NN	O	ldl	nn	33	SENT_221	[p10l182t2942r748b3001],
31	—	CD	NUMBER	—	num	33	SENT_221	[p10l182t2942r748b3001],
32	cholesterol	NN	O	cholesterol	nn	33	SENT_221	[p10l182t2942r748b3001],
33	response	NN	O	response	dobj	28	SENT_221	[p10l770t2960r1067b3019],
34	reduced	VBN	O	reduce	partmod	33	SENT_221	[p10l1088t2942r1357b3001],
35	by	IN	O	by	_	0	SENT_221	[p10l1377t2942r1461b3019],
36	6	CD	PERCENT	6	num	37	SENT_221	[p10l1485t2941r1615b3012],
37	%	NN	PERCENT	%	agent	34	SENT_221	[p10l1485t2941r1615b3012],
38	;	:	O	;	_	0	SENT_221	[p10l1485t2941r1615b3012],
39	those	DT	O	those	nsubj	40	SENT_221	[p10l1640t2942r1818b3001],
40	receiving	VBG	O	receive	dep	33	SENT_221	[p10l1839t2942r2152b3019],
41	10	CD	NUMBER	10	num	42	SENT_221	[p10l15t3046r89b3105],
42	mg/day	NN	O	mg/day	dobj	40	SENT_221	[p10l107t3045r359b3122],
43	had	VBD	O	have	_	0	SENT_221	[p10l381t3045r503b3105],
44	their	PRP$	O	they	poss	48	SENT_221	[p10l523t3045r679b3105],
45	LDL	NN	O	ldl	nn	48	SENT_221	[p10l698t3045r1264b3105],
46	—	CD	NUMBER	—	num	48	SENT_221	[p10l698t3045r1264b3105],
47	cholesterol	NN	O	cholesterol	nn	48	SENT_221	[p10l698t3045r1264b3105],
48	response	NN	O	response	dobj	43	SENT_221	[p10l1285t3064r1581b3122],
49	raised	VBN	O	raise	partmod	48	SENT_221	[p10l1602t3045r1805b3105],
50	by	IN	O	by	_	0	SENT_221	[p10l1825t3045r1908b3122],
51	6	CD	PERCENT	6	num	52	SENT_221	[p10l1932t3045r2060b3116],
52	%	NN	PERCENT	%	agent	49	SENT_221	[p10l1932t3045r2060b3116],
53	,	,	O	,	_	0	SENT_221	[p10l1932t3045r2060b3116],
54	as	IN	O	as	mark	55	SENT_221	[p10l2086t3064r2151b3105],
55	suggested	VBN	O	suggest	dep	52	SENT_221	[p10l10t3147r342b3224],
56	by	IN	O	by	_	0	SENT_221	[p10l363t3147r447b3224],
57	Roberts	NNP	PERSON	Roberts	prep_by	55	SENT_221	[p10l471t3147r732b3206],
58	[	CD	NUMBER	[	num	57	SENT_221	[p10l764t3147r914b3219],
59	28	CD	NUMBER	28	num	60	SENT_221	[p10l764t3147r914b3219],
60	]	NN	O	]	nsubj	43	SENT_221	[p10l764t3147r914b3219],
61	.	.	O	.	_	0	SENT_221	[p10l764t3147r914b3219],

1	3.2.4	CD	NUMBER	3.2.4	_	0	SENT_222	[p10l7t3352r188b3411],
2	.	.	O	.	_	0	SENT_222	[p10l7t3352r188b3411],

1	Apo	NN	O	apo	_	0	SENT_223	[p10l236t3352r375b3427],
2	E	NN	O	e	nn	3	SENT_223	[p10l399t3354r453b3410],
3	genotype	NN	O	genotype	dep	1	SENT_223	[p10l473t3363r777b3427],

1	Carriers	NNS	O	carrier	nsubj	14	SENT_224	[p10l110t3453r380b3513],
2	of	IN	O	of	_	0	SENT_224	[p10l398t3453r471b3513],
3	the	DT	O	the	det	6	SENT_224	[p10l481t3453r582b3513],
4	apo	NN	O	apo	nn	6	SENT_224	[p10l600t3472r719b3530],
5	E2	NN	O	e2	nn	6	SENT_224	[p10l735t3453r827b3512],
6	genotype	NN	O	genotype	prep_of	1	SENT_224	[p10l844t3462r1171b3530],
7	,	,	O	,	_	0	SENT_224	[p10l844t3462r1171b3530],
8	as	IN	O	as	_	0	SENT_224	[p10l1192t3472r1257b3513],
9	expectable	JJ	O	expectable	amod	12	SENT_224	[p10l1275t3453r1635b3530],
10	[	NN	O	[	nn	12	SENT_224	[p10l1657t3453r1808b3525],
11	29	CD	NUMBER	29	num	12	SENT_224	[p10l1657t3453r1808b3525],
12	]	NN	O	]	prep_as	1	SENT_224	[p10l1657t3453r1808b3525],
13	,	,	O	,	_	0	SENT_224	[p10l1657t3453r1808b3525],
14	had	VBD	O	have	_	0	SENT_224	[p10l1826t3453r1949b3513],
15	lower	JJR	O	lower	advmod	14	SENT_224	[p10l1964t3453r2154b3513],
16	total	JJ	O	total	amod	20	SENT_224	[p10l7t3555r156b3614],
17	and	CC	O	and	_	0	SENT_224	[p10l191t3555r311b3614],
18	LDL	NN	O	ldl	conj_and	16	SENT_224	[p10l343t3556r507b3613],
19	cholesterol	NN	O	cholesterol	nn	20	SENT_224	[p10l541t3555r911b3614],
20	levels	NNS	O	level	dobj	14	SENT_224	[p10l945t3555r1136b3614],
21	versus	CC	O	versus	prep	20	SENT_224	[p10l1171t3573r1383b3614],
22	the	DT	O	the	det	25	SENT_224	[p10l1419t3555r1520b3614],
23	other	JJ	O	other	amod	25	SENT_224	[p10l1555t3555r1728b3614],
24	three	CD	NUMBER	three	num	25	SENT_224	[p10l1760t3555r1927b3614],
25	genotypes	NNS	O	genotype	dep	21	SENT_224	[p10l1962t3573r2150b3632, p10l7t3666r201b3734],
26	.	.	O	.	_	0	SENT_224	[p10l1962t3573r2150b3632, p10l7t3666r201b3734],

1	The	DT	O	the	det	2	SENT_225	[p10l228t3657r358b3717],
2	difference	NN	O	difference	nsubj	9	SENT_225	[p10l381t3657r739b3728],
3	,	,	O	,	_	0	SENT_225	[p10l381t3657r739b3728],
4	however	RB	O	however	advmod	9	SENT_225	[p10l764t3657r1065b3727],
5	,	,	O	,	_	0	SENT_225	[p10l764t3657r1065b3727],
6	was	VBD	O	be	cop	9	SENT_225	[p10l1091t3676r1218b3717],
7	not	RB	O	not	neg	9	SENT_225	[p10l1242t3666r1350b3717],
8	statistically	RB	O	statistically	advmod	9	SENT_225	[p10l1374t3657r1756b3734],
9	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_225	[p10l1782t3657r2149b3734],
10	.	.	O	.	_	0	SENT_225	[p10l1782t3657r2149b3734],

1	They	PRP	O	they	nsubj	3	SENT_226	[p11l7t19r178b96],
2	also	RB	O	also	advmod	3	SENT_226	[p11l206t19r338b78],
3	experienced	VBD	O	experience	_	0	SENT_226	[p11l365t19r773b96],
4	the	DT	O	the	det	7	SENT_226	[p11l797t19r899b78],
5	most	RBS	O	most	advmod	6	SENT_226	[p11l925t28r1089b78],
6	marked	JJ	O	marked	amod	7	SENT_226	[p11l1113t19r1366b78],
7	reduction	NN	O	reduction	dobj	3	SENT_226	[p11l1390t19r1711b78],
8	of	IN	O	of	_	0	SENT_226	[p11l1736t19r1810b78],
9	both	DT	O	both	det	10	SENT_226	[p11l1828t19r1979b78],
10	total	NN	O	total	prep_of	7	SENT_226	[p11l2004t19r2152b78],

1	Effectiveness	NN	O	effectiveness	_	0	SENT_227	[p11l6t171r181b194],
2	of	IN	O	of	_	0	SENT_227	[p11l191t171r220b194],
3	the	DT	O	the	det	4	SENT_227	[p11l227t171r267b194],
4	statins	NNS	O	statin	prep_of	1	SENT_227	[p11l277t171r359b194],
5	in	IN	O	in	_	0	SENT_227	[p11l369t171r394b194],
6	relation	NN	O	relation	prep_in	4	SENT_227	[p11l403t171r504b194],
7	to	TO	O	to	_	0	SENT_227	[p11l513t174r538b194],
8	the	DT	O	the	det	9	SENT_227	[p11l547t171r587b194],
9	Apo	NN	O	apo	prep_to	1	SENT_227	[p11l596t171r684b201],
10	.	.	O	.	_	0	SENT_227	[p11l596t171r684b201],

1	—	NN	O	—	_	0	SENT_228	[p11l596t171r684b201],
2	.	.	O	.	_	0	SENT_228	[p11l596t171r684b201],

1	E	NN	O	e	nn	2	SENT_229	[p11l596t171r684b201],
2	genotype	NN	O	genotype	_	0	SENT_229	[p11l693t175r814b201],
3	and	CC	O	and	_	0	SENT_229	[p11l824t171r870b194],
4	allele	NN	O	allele	nn	5	SENT_229	[p11l880t171r950b194],
5	frequencies	NNS	O	frequency	conj_and	2	SENT_229	[p11l959t171r1111b201],

1	ApoE-genotype	JJ	O	apoe-genotype	_	0	SENT_230	[p11l479t233r689b264],

1	E2/E3	NN	O	e2/e3	nn	2	SENT_231	[p11l680t298r761b322],
2	E3/E3	NN	O	e3/e3	_	0	SENT_231	[p11l945t298r1025b322],

1	Apo	NN	O	apo	_	0	SENT_232	[p11l1314t233r1402b264],
2	.	.	O	.	_	0	SENT_232	[p11l1314t233r1402b264],

1	—	NN	O	—	_	0	SENT_233	[p11l1314t233r1402b264],
2	.	.	O	.	_	0	SENT_233	[p11l1314t233r1402b264],

1	E	NN	O	e	nn	3	SENT_234	[p11l1314t233r1402b264],
2	allele	NN	O	allele	nn	3	SENT_234	[p11l1412t233r1482b257],
3	frequency	NN	O	frequency	_	0	SENT_234	[p11l1491t233r1622b264],
4	(	CD	PERCENT	(	num	5	SENT_234	[p11l1633t233r1680b262],
5	%	NN	PERCENT	%	dep	3	SENT_234	[p11l1633t233r1680b262],
6	)	CD	NUMBER	)	dep	3	SENT_234	[p11l1633t233r1680b262],

1	E3/E4	NN	O	e3/e4	nn	4	SENT_235	[p11l1193t298r1275b322],
2	or	CC	O	or	_	0	SENT_235	[p11l1285t305r1312b322],
3	E4/E4	NN	O	e4/e4	nn	4	SENT_235	[p11l1320t298r1402b322],
4	s2	NN	O	s2	_	0	SENT_235	[p11l1516t298r1547b322],
5	83	CD	NUMBER	83	num	6	SENT_235	[p11l1803t298r1841b322],
6	84	CD	NUMBER	84	dep	4	SENT_235	[p11l2114t298r2154b322],

1	Number	NN	O	number	_	0	SENT_236	[p11l6t362r115b385],
2	patients	NNS	O	patient	dep	1	SENT_236	[p11l123t362r225b392],
3	for	IN	O	for	_	0	SENT_236	[p11l235t362r273b385],
4	phenotype	NN	O	phenotype	prep_for	2	SENT_236	[p11l282t362r419b392],
5	3	CD	NUMBER	3	num	4	SENT_236	[p11l533t362r546b386],
6	74 3/200	CD	NUMBER	74 3/200	num	7	SENT_236	[p11l1367t361r1441b385],[p11l797t362r829b385],
7	(	NN	O	(	dep	1	SENT_236	[p11l1451t361r1540b390],
8	1.5	CD	PERCENT	1.5	num	9	SENT_236	[p11l1451t361r1540b390],
9	%	NN	PERCENT	%	dep	7	SENT_236	[p11l1451t361r1540b390],
10	)	CD	NUMBER	)	number	11	SENT_236	[p11l1451t361r1540b390],
11	174/200	CD	NUMBER	174/200	num	9	SENT_236	[p11l1656t361r1761b385],
12	(	NN	O	(	dep	1	SENT_236	[p11l1772t361r1852b390],
13	87	CD	PERCENT	87	num	14	SENT_236	[p11l1772t361r1852b390],
14	%	NN	PERCENT	%	rcmod	12	SENT_236	[p11l1772t361r1852b390],
15	)	CD	NUMBER	)	number	16	SENT_236	[p11l1772t361r1852b390],
16	25/200	CD	NUMBER	25/200	num	14	SENT_236	[p11l1965t361r2056b385],
17	;	:	O	;	_	0	SENT_236	[p11l6t402r111b468],
18	1I	CD	NUMBER	1i	dep	14	SENT_236	[p11l6t402r111b468],
19	:	:	O	:	_	0	SENT_236	[p11l6t402r111b468],
20	.	.	O	.	_	0	SENT_236	[p11l6t402r111b468],

1	n5	CD	PERCENT	n5	num	2	SENT_237	[p11l6t402r111b468],
2	%	NN	PERCENT	%	dep	6	SENT_237	[p11l6t402r111b468],
3	)	CD	NUMBER	)	num	4	SENT_237	[p11l6t402r111b468],
4	Women	NNS	O	woman	dep	2	SENT_237	[p11l121t403r223b426],
5	1	CD	NUMBER	1	dep	6	SENT_237	[p11l535t445r545b468],
6	2	CD	NUMBER	2	dep	13	SENT_237	[p11l648t403r663b426],
7	36	CD	NUMBER	36	number	8	SENT_237	[p11l797t444r828b468],
8	1	CD	NUMBER	1	dep	6	SENT_237	[p11l915t403r925b426],
9	15	CD	NUMBER	15	num	11	SENT_237	[p11l1164t403r1191b427],
10	Mean	NN	O	mean	nn	11	SENT_237	[p11l6t486r81b509],
11	age	NN	O	age	dep	8	SENT_237	[p11l91t493r135b516],
12	(	CD	NUMBER	(	num	13	SENT_237	[p11l145t485r239b514],
13	Years	NNS	DURATION	year	_	0	SENT_237	[p11l145t485r239b514],
14	)	VBP	O	)	rcmod	13	SENT_237	[p11l145t485r239b514],
15	52.7	CD	NUMBER	52.7	number	16	SENT_237	[p11l532t485r588b509],
16	:1	CD	NUMBER	:1	dobj	14	SENT_237	[p11l596t486r619b509],
17	:	:	O	:	_	0	SENT_237	[p11l596t486r619b509],
18	17.2	CD	NUMBER	17.2	number	19	SENT_237	[p11l630t485r684b509],
19	60.8	CD	NUMBER	60.8	dep	13	SENT_237	[p11l797t485r852b509],
20	i	FW	O	i	dep	19	SENT_237	[p11l861t486r884b509],
21	9.0	CD	NUMBER	9.0	number	22	SENT_237	[p11l892t485r932b509],
22	62.9	CD	NUMBER	62.9	dep	19	SENT_237	[p11l1045t485r1101b509],
23	:1	CD	NUMBER	:1	num	25	SENT_237	[p11l1109t486r1132b509],
24	:	:	O	:	_	0	SENT_237	[p11l1109t486r1132b509],
25	7.7	CD	NUMBER	7.7	dep	22	SENT_237	[p11l1140t486r1179b509],

1	ApoE-genotype	JJ	O	apoe-genotype	amod	2	SENT_238	[p11l869t568r1078b599],
2	Apo	NN	O	apo	_	0	SENT_238	[p11l1788t568r1876b599],
3	.	.	O	.	_	0	SENT_238	[p11l1788t568r1876b599],

1	—	NN	O	—	_	0	SENT_239	[p11l1788t568r1876b599],
2	.	.	O	.	_	0	SENT_239	[p11l1788t568r1876b599],

1	E	NN	O	e	nn	3	SENT_240	[p11l1788t568r1876b599],
2	allele	NN	O	allele	nn	3	SENT_240	[p11l1886t568r1956b592],
3	frequency	NN	O	frequency	_	0	SENT_240	[p11l1965t568r2096b599],
4	(	CD	PERCENT	(	num	5	SENT_240	[p11l2107t568r2154b597],
5	%	NN	PERCENT	%	dep	3	SENT_240	[p11l2107t568r2154b597],
6	)	CD	NUMBER	)	num	8	SENT_240	[p11l2107t568r2154b597],
7	E2/E3	NN	O	e2/e3	nn	8	SENT_240	[p11l542t633r623b657],
8	E3/E3	NN	O	e3/e3	dep	5	SENT_240	[p11l843t633r924b657],
9	E3/E4	NN	O	e3/e4	nn	13	SENT_240	[p11l1137t633r1219b657],
10	or	CC	O	or	_	0	SENT_240	[p11l1228t640r1255b657],
11	E4/E4	NN	O	e4/e4	nn	13	SENT_240	[p11l1264t633r1346b657],
12	P	NN	O	p	nn	13	SENT_240	[p11l1461t634r1479b657],
13	E2	NN	O	e2	dep	3	SENT_240	[p11l1488t633r1524b657],
14	vs.	CC	O	vs.	prep	13	SENT_240	[p11l1533t640r1568b657],
15	E3	NN	O	e3	nn	21	SENT_240	[p11l1579t633r1614b657],
16	P	NN	O	p	nn	21	SENT_240	[p11l1731t634r1748b657],
17	E3	NN	O	e3	nn	21	SENT_240	[p11l1757t633r1792b657],
18	Vs.	NN	O	v.	nn	21	SENT_240	[p11l1803t640r1838b657],
19	E4	NN	O	e4	nn	21	SENT_240	[p11l1849t633r1885b657],
20	P	NN	O	p	nn	21	SENT_240	[p11l2000t634r2018b657],
21	E2	NN	O	e2	dep	14	SENT_240	[p11l2027t633r2062b657],
22	vs.	CC	O	vs.	prep	21	SENT_240	[p11l2072t640r2107b657],
23	E4	NN	O	e4	nn	26	SENT_240	[p11l2118t633r2154b657],
24	Basal	JJ	O	basal	amod	26	SENT_240	[p11l6t717r158b765],
25	Total	JJ	O	total	amod	26	SENT_240	[p11l177t717r315b765],
26	C	NN	O	c	dep	22	SENT_240	[p11l335t717r378b766],
27	(	CD	NUMBER	(	num	30	SENT_240	[p11l400t717r507b780],
28	mg	NN	O	mg	nn	30	SENT_240	[p11l400t717r507b780],
29	dl	NN	O	dl	nn	30	SENT_240	[p11l522t704r664b777],
30	‘	NN	O	‘	dep	3	SENT_240	[p11l522t704r664b777],
31	1	CD	NUMBER	1	number	32	SENT_240	[p11l522t704r664b777],
32	)	CD	NUMBER	)	num	34	SENT_240	[p11l522t704r664b777],
33	284.7	CD	NUMBER	284.7	number	34	SENT_240	[p11l1160t717r1311b766],
34	:1	CD	NUMBER	:1	dep	30	SENT_240	[p11l1329t718r1375b765],
35	:	:	O	:	_	0	SENT_240	[p11l1329t718r1375b765],
36	56.8	CD	NUMBER	56.8	number	37	SENT_240	[p11l1392t717r1508b766],
37	320.8	CD	NUMBER	320.8	dep	30	SENT_240	[p11l1787t717r1936b766],
38	:1	CD	NUMBER	:1	dep	37	SENT_240	[p11l1954t718r2001b765],
39	:	:	O	:	_	0	SENT_240	[p11l1954t718r2001b765],
40	66.1	CD	NUMBER	66.1	num	42	SENT_240	[p11l2019t717r2130b766],
41	Total	JJ	O	total	amod	42	SENT_240	[p11l6t802r144b850],
42	C	NN	O	c	dep	30	SENT_240	[p11l165t802r207b851],
43	post	NN	O	post	nn	49	SENT_240	[p11l226t809r626b865],
44	—	NN	O	—	nn	49	SENT_240	[p11l226t809r626b865],
45	treatment	NN	O	treatment	nn	49	SENT_240	[p11l226t809r626b865],
46	(	CD	NUMBER	(	num	49	SENT_240	[p11l646t803r752b865],
47	mg	NN	O	mg	nn	49	SENT_240	[p11l646t803r752b865],
48	dl	NN	O	dl	nn	49	SENT_240	[p11l767t789r910b862],
49	‘	NN	O	‘	dep	42	SENT_240	[p11l767t789r910b862],
50	1	CD	NUMBER	1	number	51	SENT_240	[p11l767t789r910b862],
51	)	CD	NUMBER	)	num	53	SENT_240	[p11l767t789r910b862],
52	184.7	CD	NUMBER	184.7	number	53	SENT_240	[p11l1166t802r1311b851],
53	:1	CD	NUMBER	:1	dep	49	SENT_240	[p11l1329t803r1376b850],
54	:	:	O	:	_	0	SENT_240	[p11l1329t803r1376b850],
55	30.7	CD	NUMBER	30.7	number	56	SENT_240	[p11l1393t802r1508b851],
56	248.9	CD	NUMBER	248.9	dep	30	SENT_240	[p11l1786t802r1937b851],
57	:	:	O	:	_	0	SENT_240	[p11l1954t803r2001b850],
58	E	NN	O	e	dep	56	SENT_240	[p11l1954t803r2001b850],
59	46.0	CD	NUMBER	46.0	num	61	SENT_240	[p11l2017t802r2136b851],
60	Mean	NN	O	mean	nn	61	SENT_240	[p11l6t889r162b936],
61	Tota1	NN	O	tota1	dep	58	SENT_240	[p11l181t888r387b936],
62	.	.	O	.	_	0	SENT_240	[p11l181t888r387b936],

1	—	NN	O	—	_	0	SENT_241	[p11l181t888r387b936],
2	.	.	O	.	_	0	SENT_241	[p11l181t888r387b936],

1	C	NN	O	c	nn	2	SENT_242	[p11l181t888r387b936],
2	change	NN	O	change	_	0	SENT_242	[p11l408t887r601b950],
3	(	CD	PERCENT	(	num	4	SENT_242	[p11l623t888r720b947],
4	%	NN	PERCENT	%	dep	2	SENT_242	[p11l623t888r720b947],
5	)	CD	NUMBER	)	number	6	SENT_242	[p11l623t888r720b947],
6	-34.0	CD	NUMBER	-34.0	num	4	SENT_242	[p11l1164t888r1332b936],
7	:1	CD	NUMBER	:1	dep	4	SENT_242	[p11l1348t888r1395b935],
8	:	:	O	:	_	0	SENT_242	[p11l1348t888r1395b935],
9	14.3	CD	NUMBER	14.3	number	10	SENT_242	[p11l1417t888r1527b936],
10	-21.4	CD	NUMBER	-21.4	dep	4	SENT_242	[p11l1790t888r1957b936],
11	:1	CD	NUMBER	:1	dep	10	SENT_242	[p11l1974t888r2021b935],
12	:	:	O	:	_	0	SENT_242	[p11l1974t888r2021b935],
13	14.1	CD	NUMBER	14.1	dep	4	SENT_242	[p11l2043t888r2150b936],
14	Basal	JJ	O	basal	amod	15	SENT_242	[p11l6t971r157b1020],
15	LDL	NN	O	ldl	dep	13	SENT_242	[p11l177t972r377b1020],
16	.	.	O	.	_	0	SENT_242	[p11l177t972r377b1020],

1	—	NN	O	—	_	0	SENT_243	[p11l177t972r377b1020],
2	.	.	O	.	_	0	SENT_243	[p11l177t972r377b1020],

1	C	NN	O	c	nn	3	SENT_244	[p11l177t972r377b1020],
2	(	CD	NUMBER	(	num	3	SENT_244	[p11l400t972r506b1034],
3	mg	NN	O	mg	_	0	SENT_244	[p11l400t972r506b1034],
4	61-1	CD	NUMBER	61-1	number	5	SENT_244	[p11l521t959r664b1031],
5	)	CD	NUMBER	)	num	7	SENT_244	[p11l521t959r664b1031],
6	172.0	CD	NUMBER	172.0	number	7	SENT_244	[p11l1166t972r1313b1020],
7	:1	CD	NUMBER	:1	dep	3	SENT_244	[p11l1329t972r1375b1019],
8	:	:	O	:	_	0	SENT_244	[p11l1329t972r1375b1019],
9	23.1	CD	NUMBER	23.1	number	10	SENT_244	[p11l1392t972r1504b1020],
10	236.1	CD	NUMBER	236.1	dep	3	SENT_244	[p11l1786t971r1932b1020],
11	:1	CD	NUMBER	:1	dep	10	SENT_244	[p11l1954t972r2001b1019],
12	:	:	O	:	_	0	SENT_244	[p11l1954t972r2001b1019],
13	65.6	CD	NUMBER	65.6	dep	3	SENT_244	[p11l2019t971r2135b1020],
14	LDL	NN	O	ldl	dep	13	SENT_244	[p11l6t1057r206b1105],
15	.	.	O	.	_	0	SENT_244	[p11l6t1057r206b1105],

1	—	NN	O	—	_	0	SENT_245	[p11l6t1057r206b1105],
2	.	.	O	.	_	0	SENT_245	[p11l6t1057r206b1105],

1	C	NN	O	c	nn	8	SENT_246	[p11l6t1057r206b1105],
2	post	NN	O	post	nn	8	SENT_246	[p11l226t1064r625b1119],
3	—	NN	O	—	nn	8	SENT_246	[p11l226t1064r625b1119],
4	treatment	NN	O	treatment	nn	8	SENT_246	[p11l226t1064r625b1119],
5	(	CD	NUMBER	(	num	8	SENT_246	[p11l646t1057r752b1119],
6	mg	NN	O	mg	nn	8	SENT_246	[p11l646t1057r752b1119],
7	dl	NN	O	dl	nn	8	SENT_246	[p11l767t1044r909b1116],
8	‘	NN	O	‘	_	0	SENT_246	[p11l767t1044r909b1116],
9	1	CD	NUMBER	1	number	10	SENT_246	[p11l767t1044r909b1116],
10	)	CD	NUMBER	)	num	12	SENT_246	[p11l767t1044r909b1116],
11	100.4	CD	NUMBER	100.4	number	12	SENT_246	[p11l1166t1057r1312b1105],
12	:1	CD	NUMBER	:1	dep	8	SENT_246	[p11l1329t1057r1375b1104],
13	:	:	O	:	_	0	SENT_246	[p11l1329t1057r1375b1104],
14	19.4	CD	NUMBER	19.4	number	15	SENT_246	[p11l1398t1057r1510b1106],
15	166.0	CD	NUMBER	166.0	dep	8	SENT_246	[p11l1792t1056r1938b1105],
16	:1	CD	NUMBER	:1	dep	15	SENT_246	[p11l1954t1057r2001b1104],
17	:	:	O	:	_	0	SENT_246	[p11l1954t1057r2001b1104],
18	45.4	CD	NUMBER	45.4	num	19	SENT_246	[p11l2017t1056r2136b1105],
19	Mean	NN	O	mean	dep	8	SENT_246	[p11l6t1142r162b1189],
20	LDL	NN	O	ldl	dep	19	SENT_246	[p11l180t1142r381b1190],
21	.	.	O	.	_	0	SENT_246	[p11l180t1142r381b1190],

1	—	NN	O	—	_	0	SENT_247	[p11l180t1142r381b1190],
2	.	.	O	.	_	0	SENT_247	[p11l180t1142r381b1190],

1	C	NN	O	c	dep	125	SENT_248	[p11l180t1142r381b1190],
2	change	NN	O	change	dep	125	SENT_248	[p11l402t1141r595b1203],
3	(	CD	PERCENT	(	dep	125	SENT_248	[p11l616t1141r714b1200],
4	%	NN	PERCENT	%	dep	125	SENT_248	[p11l616t1141r714b1200],
5	)	CD	NUMBER	)	dep	125	SENT_248	[p11l616t1141r714b1200],
6	-41.6	CD	NUMBER	-41.6	dep	125	SENT_248	[p11l1164t1141r1331b1190],
7	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l1348t1142r1395b1189],
8	:	:	O	:	_	0	SENT_248	[p11l1348t1142r1395b1189],
9	8.3	CD	NUMBER	8.3	dep	125	SENT_248	[p11l1413t1142r1492b1190],
10	-28.2	CD	NUMBER	-28.2	dep	125	SENT_248	[p11l1790t1142r1957b1189],
11	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l1974t1142r2021b1189],
12	:	:	O	:	_	0	SENT_248	[p11l1974t1142r2021b1189],
13	17.5	CD	NUMBER	17.5	dep	125	SENT_248	[p11l2043t1141r2153b1189],
14	Basal	JJ	O	basal	dep	125	SENT_248	[p11l6t1227r158b1275],
15	HDL-C	NN	O	hdl-c	dep	125	SENT_248	[p11l177t1227r385b1276],
16	(	CD	NUMBER	(	dep	125	SENT_248	[p11l407t1227r514b1290],
17	mg	NN	O	mg	dep	125	SENT_248	[p11l407t1227r514b1290],
18	d1	NN	O	d1	dep	125	SENT_248	[p11l529t1214r672b1287],
19	‘	NN	O	‘	dep	125	SENT_248	[p11l529t1214r672b1287],
20	1	CD	NUMBER	1	dep	125	SENT_248	[p11l529t1214r672b1287],
21	)	CD	NUMBER	)	dep	125	SENT_248	[p11l529t1214r672b1287],
22	42.0	CD	NUMBER	42.0	dep	125	SENT_248	[p11l1159t1227r1278b1276],
23	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l1294t1228r1341b1275],
24	:	:	O	:	_	0	SENT_248	[p11l1294t1228r1341b1275],
25	7.2	CD	NUMBER	7.2	dep	125	SENT_248	[p11l1357t1227r1441b1276],
26	50.8	CD	NUMBER	50.8	dep	125	SENT_248	[p11l1786t1227r1901b1276],
27	:	:	O	:	_	0	SENT_248	[p11l1920t1228r1967b1275],
28	t	NN	O	t	dep	125	SENT_248	[p11l1920t1228r1967b1275],
29	13.0	CD	NUMBER	13.0	dep	125	SENT_248	[p11l1989t1227r2101b1276],
30	HDL-C	NN	O	hdl-c	dep	125	SENT_248	[p11l6t1312r214b1361],
31	post	NN	O	post	dep	125	SENT_248	[p11l234t1320r613b1375],
32	—	NN	O	—	dep	125	SENT_248	[p11l234t1320r613b1375],
33	treatmen	NNS	O	treatman	dep	125	SENT_248	[p11l234t1320r613b1375],
34	(	CD	NUMBER	(	dep	125	SENT_248	[p11l634t1312r741b1375],
35	mg	NN	O	mg	dep	125	SENT_248	[p11l634t1312r741b1375],
36	d1	NN	O	d1	dep	125	SENT_248	[p11l755t1299r920b1372],
37	‘	CD	NUMBER	‘	dep	125	SENT_248	[p11l755t1299r920b1372],
38	1	CD	NUMBER	1	dep	125	SENT_248	[p11l755t1299r920b1372],
39	)	NN	O	)	dep	125	SENT_248	[p11l755t1299r920b1372],
40	t	NN	O	t	dep	125	SENT_248	[p11l755t1299r920b1372],
41	54.7	CD	NUMBER	54.7	dep	125	SENT_248	[p11l1160t1312r1276b1361],
42	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l1294t1313r1341b1360],
43	:	:	O	:	_	0	SENT_248	[p11l1294t1313r1341b1360],
44	11.0	CD	NUMBER	11.0	dep	125	SENT_248	[p11l1363t1312r1476b1361],
45	52.6	CD	NUMBER	52.6	dep	125	SENT_248	[p11l1786t1312r1903b1361],
46	:	:	O	:	_	0	SENT_248	[p11l1920t1313r1967b1360],
47	E	NN	O	e	dep	125	SENT_248	[p11l1920t1313r1967b1360],
48	12.6	CD	NUMBER	12.6	dep	125	SENT_248	[p11l1989t1312r2101b1361],
49	Mean	NN	O	mean	dep	125	SENT_248	[p11l6t1399r162b1446],
50	HDL-C	NN	O	hdl-c	dep	125	SENT_248	[p11l181t1398r389b1446],
51	change	NN	O	change	dep	125	SENT_248	[p11l410t1398r602b1460],
52	(	CD	PERCENT	(	dep	125	SENT_248	[p11l624t1398r722b1457],
53	%	NN	PERCENT	%	dep	125	SENT_248	[p11l624t1398r722b1457],
54	)	CD	NUMBER	)	dep	125	SENT_248	[p11l624t1398r722b1457],
55	30.3	CD	NUMBER	30.3	dep	125	SENT_248	[p11l1161t1398r1275b1446],
56	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l1294t1399r1341b1445],
57	:	:	O	:	_	0	SENT_248	[p11l1294t1399r1341b1445],
58	12.6	CD	NUMBER	12.6	dep	125	SENT_248	[p11l1363t1398r1475b1446],
59	5.5	CD	NUMBER	5.5	dep	125	SENT_248	[p11l1786t1398r1866b1446],
60	:1	NN	O	:1	dep	125	SENT_248	[p11l1885t1399r1932b1445],
61	:	:	O	:	_	0	SENT_248	[p11l1885t1399r1932b1445],
62	19.3	CD	NUMBER	19.3	dep	125	SENT_248	[p11l1955t1398r2064b1447],
63	Basal	JJ	O	basal	dep	125	SENT_248	[p11l6t1482r157b1530],
64	TG	NN	O	tg	dep	125	SENT_248	[p11l177t1482r267b1530],
65	(	CD	NUMBER	(	dep	125	SENT_248	[p11l289t1482r395b1544],
66	mg	NN	O	mg	dep	125	SENT_248	[p11l289t1482r395b1544],
67	dl	NN	O	dl	dep	125	SENT_248	[p11l410t1469r553b1541],
68	‘	NN	O	‘	dep	125	SENT_248	[p11l410t1469r553b1541],
69	1	CD	NUMBER	1	dep	125	SENT_248	[p11l410t1469r553b1541],
70	)	CD	NUMBER	)	dep	125	SENT_248	[p11l410t1469r553b1541],
71	353.3	CD	NUMBER	353.3	dep	125	SENT_248	[p11l1161t1481r1309b1530],
72	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l1329t1482r1375b1529],
73	:	:	O	:	_	0	SENT_248	[p11l1329t1482r1375b1529],
74	232.6	CD	NUMBER	232.6	dep	125	SENT_248	[p11l1392t1481r1544b1530],
75	168.8	CD	NUMBER	168.8	dep	125	SENT_248	[p11l1792t1481r1936b1530],
76	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l1954t1482r2001b1529],
77	:	:	O	:	_	0	SENT_248	[p11l1954t1482r2001b1529],
78	83.2	CD	NUMBER	83.2	dep	125	SENT_248	[p11l2020t1482r2136b1530],
79	TG	NN	O	tg	dep	125	SENT_248	[p11l6t1567r97b1615],
80	post	NN	O	post	dep	125	SENT_248	[p11l115t1574r514b1629],
81	—	NN	O	—	dep	125	SENT_248	[p11l115t1574r514b1629],
82	treatment	NN	O	treatment	dep	125	SENT_248	[p11l115t1574r514b1629],
83	(	CD	NUMBER	(	dep	125	SENT_248	[p11l534t1567r641b1629],
84	mg	NN	O	mg	dep	125	SENT_248	[p11l534t1567r641b1629],
85	dl	NN	O	dl	dep	125	SENT_248	[p11l655t1554r798b1626],
86	‘	NN	O	‘	dep	125	SENT_248	[p11l655t1554r798b1626],
87	1	CD	NUMBER	1	dep	125	SENT_248	[p11l655t1554r798b1626],
88	)	CD	NUMBER	)	dep	125	SENT_248	[p11l655t1554r798b1626],
89	148.0	CD	NUMBER	148.0	dep	125	SENT_248	[p11l1166t1567r1313b1615],
90	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l1329t1567r1375b1614],
91	:	:	O	:	_	0	SENT_248	[p11l1329t1567r1375b1614],
92	88.4	CD	NUMBER	88.4	dep	125	SENT_248	[p11l1394t1567r1510b1615],
93	153.3	CD	NUMBER	153.3	dep	125	SENT_248	[p11l1792t1566r1935b1615],
94	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l1954t1567r2001b1614],
95	:	:	O	:	_	0	SENT_248	[p11l1954t1567r2001b1614],
96	81.8	CD	NUMBER	81.8	dep	125	SENT_248	[p11l2020t1567r2134b1615],
97	Mean	NN	O	mean	dep	125	SENT_248	[p11l6t1652r162b1699],
98	TG	NN	O	tg	dep	125	SENT_248	[p11l181t1651r271b1699],
99	change	NN	O	change	dep	125	SENT_248	[p11l291t1651r484b1713],
100	(	CD	PERCENT	(	dep	125	SENT_248	[p11l505t1651r603b1710],
101	%	NN	PERCENT	%	dep	125	SENT_248	[p11l505t1651r603b1710],
102	)	CD	NUMBER	)	dep	125	SENT_248	[p11l505t1651r603b1710],
103	-49.1	CD	NUMBER	-49.1	dep	125	SENT_248	[p11l1164t1651r1326b1700],
104	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l1348t1652r1395b1699],
105	:	:	O	:	_	0	SENT_248	[p11l1348t1652r1395b1699],
106	30.9	CD	NUMBER	30.9	dep	125	SENT_248	[p11l1412t1652r1528b1700],
107	-5.4	CD	NUMBER	-5.4	dep	125	SENT_248	[p11l1790t1651r1923b1700],
108	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l1939t1652r1986b1699],
109	:	:	O	:	_	0	SENT_248	[p11l1939t1652r1986b1699],
110	33.4	CD	NUMBER	33.4	dep	125	SENT_248	[p11l2004t1651r2120b1700],
111	305.9	CD	NUMBER	305.9	dep	125	SENT_248	[p11l7t1743r173b1798],
112	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l192t1745r244b1796],
113	:	:	O	:	_	0	SENT_248	[p11l192t1745r244b1796],
114	47.5	CD	NUMBER	47.5	dep	125	SENT_248	[p11l261t1743r389b1797],
115	0.421	CD	NUMBER	0.421	dep	125	SENT_248	[p11l750t1741r912b1795],
116	0.125	CD	NUMBER	0.125	dep	125	SENT_248	[p11l1368t1742r1534b1795],
117	0.133	CD	NUMBER	0.133	dep	125	SENT_248	[p11l1986t1742r2151b1795],
118	239.8	CD	NUMBER	239.8	dep	125	SENT_248	[p11l6t1838r171b1892],
119	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l192t1838r244b1890],
120	:	:	O	:	_	0	SENT_248	[p11l192t1838r244b1890],
121	40.2	CD	NUMBER	40.2	dep	125	SENT_248	[p11l261t1838r392b1891],
122	-26.6	CD	NUMBER	-26.6	dep	125	SENT_248	[p11l10t1933r195b1987],
123	:1	CD	NUMBER	:1	dep	125	SENT_248	[p11l213t1934r265b1986],
124	:	:	O	:	_	0	SENT_248	[p11l213t1934r265b1986],
125	14.8	CD	NUMBER	14.8	_	0	SENT_248	[p11l289t1934r411b1987],

1	132.8	CD	NUMBER	132.8	number	2	SENT_249	[p11l12t2739r171b2792],
2	:1	CD	NUMBER	:1	nsubjpass	18	SENT_249	[p11l192t2739r244b2791],
3	:	:	O	:	_	0	SENT_249	[p11l192t2739r244b2791],
4	63.9	CD	NUMBER	63.9	number	5	SENT_249	[p11l263t2738r390b2792],
5	0.041	CD	NUMBER	0.041	num	7	SENT_249	[p11l750t2736r912b2789],
6	0.084	CD	NUMBER	0.084	number	7	SENT_249	[p11l1368t2736r1536b2789],
7	0.029	CD	NUMBER	0.029	dep	2	SENT_249	[p11l1986t2736r2153b2790],
8	116.9	CD	NUMBER	116.9	num	9	SENT_249	[p11l12t2833r173b2887],
9	:1	CD	NUMBER	:1	dep	7	SENT_249	[p11l192t2834r244b2886],
10	:	:	O	:	_	0	SENT_249	[p11l192t2834r244b2886],
11	52.0	CD	NUMBER	52.0	number	12	SENT_249	[p11l262t2833r392b2887],
12	-3.4	CD	NUMBER	-3.4	dep	2	SENT_249	[p11l10t2927r157b2981],
13	:1	CD	NUMBER	:1	dep	12	SENT_249	[p11l175t2928r227b2980],
14	:	:	O	:	_	0	SENT_249	[p11l175t2928r227b2980],
15	34.9	CD	NUMBER	34.9	num	16	SENT_249	[p11l247t2927r374b2981],
16	Data	NNS	O	datum	dep	12	SENT_249	[p11l6t3020r68b3043],
17	are	VBP	O	be	auxpass	18	SENT_249	[p11l78t3027r117b3043],
18	expressed	VBN	O	express	_	0	SENT_249	[p11l126t3020r256b3050],
19	as	IN	O	as	_	0	SENT_249	[p11l265t3027r291b3043],
20	mean	JJ	O	mean	amod	21	SENT_249	[p11l301t3027r372b3043],
21	:1	NN	O	:1	prep_as	18	SENT_249	[p11l379t3020r402b3043],
22	:	:	O	:	_	0	SENT_249	[p11l379t3020r402b3043],
23	S.D.	NNP	O	S.D.	dep	21	SENT_249	[p11l410t3020r466b3043],

1	P.	NNP	PERSON	P.	nn	2	SENT_250	[p11l321t3126r342b3149],
2	Zuccaro	NNP	PERSON	Zuccaro	_	0	SENT_250	[p11l353t3126r462b3149],
3	et	FW	O	et	nn	4	SENT_250	[p11l472t3130r496b3149],
4	al.	FW	O	al.	dep	2	SENT_250	[p11l504t3125r534b3149],
5	/	:	O	/	punct	2	SENT_250	[p11l544t3126r559b3149],
6	Pharmacological	JJ	O	pharmacological	amod	7	SENT_250	[p11l563t3125r794b3155],
7	Research	NN	O	research	dep	2	SENT_250	[p11l802t3125r923b3149],
8	55	CD	NUMBER	55	number	9	SENT_250	[p11l933t3126r965b3149],
9	(	CD	NUMBER	(	num	10	SENT_250	[p11l975t3125r1061b3154],
10	2007	CD	DATE	2007	dep	7	SENT_250	[p11l975t3125r1061b3154],
11	)	CD	NUMBER	)	number	12	SENT_250	[p11l975t3125r1061b3154],
12	310-317	CD	NUMBER	310-317	num	10	SENT_250	[p11l1071t3125r1188b3149],

1	and	CC	O	and	_	0	SENT_251	[p11l15t3260r135b3319],
2	LDL	NN	O	ldl	dep	1	SENT_251	[p11l153t3260r400b3320],
3	.	.	O	.	_	0	SENT_251	[p11l153t3260r400b3320],

1	—	NN	O	—	_	0	SENT_252	[p11l153t3260r400b3320],
2	.	.	O	.	_	0	SENT_252	[p11l153t3260r400b3320],

1	C	NN	O	c	nn	2	SENT_253	[p11l153t3260r400b3320],
2	levels	NNS	O	level	nsubj	3	SENT_253	[p11l421t3260r612b3319],
3	(	VBP	O	(	_	0	SENT_253	[p11l636t3260r1066b3337],
4	respectively	RB	O	respectively	advmod	5	SENT_253	[p11l636t3260r1066b3337],
5	-34	CD	NUMBER	-34	dobj	3	SENT_253	[p11l1093t3260r1235b3320],
6	and	CC	O	and	_	0	SENT_253	[p11l1257t3260r1377b3319],
7	-41.6	CD	PERCENT	-41.6	num	8	SENT_253	[p11l1402t3260r1705b3333],
8	%	NN	PERCENT	%	conj_and	5	SENT_253	[p11l1402t3260r1705b3333],
9	)	CD	NUMBER	)	num	10	SENT_253	[p11l1402t3260r1705b3333],
10	Versus	NNP	O	Versus	dep	8	SENT_253	[p11l1728t3278r1939b3320],
11	lesser	JJR	O	lesser	amod	12	SENT_253	[p11l1961t3260r2154b3319],
12	reductions	NNS	O	reduction	tmod	3	SENT_253	[p11l13t3362r363b3422],
13	in	IN	O	in	_	0	SENT_253	[p11l386t3362r450b3421],
14	the	DT	O	the	det	17	SENT_253	[p11l471t3363r572b3422],
15	other	JJ	O	other	amod	17	SENT_253	[p11l595t3362r768b3422],
16	two	CD	NUMBER	two	num	17	SENT_253	[p11l787t3371r910b3422],
17	genotypes	NNS	O	genotype	prep_in	12	SENT_253	[p11l934t3371r1292b3439],
18	.	.	O	.	_	0	SENT_253	[p11l934t3371r1292b3439],

1	Again	RB	O	again	advmod	7	SENT_254	[p11l1317t3362r1540b3439],
2	,	,	O	,	_	0	SENT_254	[p11l1317t3362r1540b3439],
3	none	NN	O	none	nsubj	7	SENT_254	[p11l1565t3381r1727b3422],
4	of	IN	O	of	_	0	SENT_254	[p11l1750t3362r1823b3422],
5	these	DT	O	these	det	6	SENT_254	[p11l1839t3362r2010b3422],
6	differences	NNS	O	difference	prep_of	3	SENT_254	[p11l2033t3362r2150b3422, p11l14t3464r292b3524],
7	turned	VBD	O	turn	_	0	SENT_254	[p11l319t3464r534b3524],
8	out	RP	O	out	prt	7	SENT_254	[p11l560t3473r666b3524],
9	to	TO	O	to	aux	12	SENT_254	[p11l690t3473r753b3524],
10	be	VB	O	be	cop	12	SENT_254	[p11l777t3464r857b3524],
11	statistically	RB	O	statistically	advmod	12	SENT_254	[p11l885t3464r1266b3541],
12	signiﬁcant	JJ	O	signiﬁcant	xcomp	7	SENT_254	[p11l1294t3464r1660b3541],
13	.	.	O	.	_	0	SENT_254	[p11l1294t3464r1660b3541],

1	Nonertheless	NNP	MISC	Nonertheless	nsubj	9	SENT_255	[p11l1689t3464r2149b3534],
2	,	,	O	,	_	0	SENT_255	[p11l1689t3464r2149b3534],
3	triglyceride	NN	O	triglyceride	nn	4	SENT_255	[p11l13t3566r402b3643],
4	reduction	NN	O	reduction	appos	1	SENT_255	[p11l432t3566r751b3625],
5	in	IN	O	in	_	0	SENT_255	[p11l782t3566r845b3625],
6	the	DT	O	the	det	8	SENT_255	[p11l875t3566r976b3625],
7	E2/E3	NN	O	e2/e3	nn	8	SENT_255	[p11l1006t3566r1212b3626],
8	carriers	NNS	O	carrier	prep_in	4	SENT_255	[p11l1247t3566r1497b3625],
9	reached	VBD	O	reach	_	0	SENT_255	[p11l1528t3566r1791b3625],
10	close	RB	O	close	_	0	SENT_255	[p11l1821t3566r1992b3625],
11	to	TO	O	to	_	0	SENT_255	[p11l2023t3575r2086b3625],
12	a	DT	O	a	det	13	SENT_255	[p11l2118t3584r2153b3625],
13	mean	NN	O	mean	prep_close_to	20	SENT_255	[p11l13t3687r195b3728],
14	of	IN	O	of	_	0	SENT_255	[p11l212t3668r285b3728],
15	50	CD	PERCENT	50	num	16	SENT_255	[p11l296t3668r466b3739],
16	%	NN	PERCENT	%	prep_of	13	SENT_255	[p11l296t3668r466b3739],
17	,	,	O	,	_	0	SENT_255	[p11l296t3668r466b3739],
18	Versus	NNP	O	Versus	appos	16	SENT_255	[p11l485t3687r697b3728],
19	minimal	JJ	O	minimal	amod	20	SENT_255	[p11l714t3668r995b3728],
20	reductions	NNS	O	reduction	dobj	9	SENT_255	[p11l1010t3668r1360b3728],
21	in	IN	O	in	_	0	SENT_255	[p11l1378t3668r1442b3727],
22	the	DT	O	the	det	25	SENT_255	[p11l1457t3668r1558b3728],
23	other	JJ	O	other	amod	25	SENT_255	[p11l1575t3668r1748b3728],
24	two	CD	NUMBER	two	num	25	SENT_255	[p11l1762t3677r1885b3728],
25	groups	NNS	O	group	prep_in	9	SENT_255	[p11l1903t3687r2148b3745],
26	.	.	O	.	_	0	SENT_255	[p11l1903t3687r2148b3745],

1	Exclusion	NN	O	exclusion	nsubj	15	SENT_256	[p12l13t19r351b79],
2	of	IN	O	of	_	0	SENT_256	[p12l370t19r443b79],
3	one	CD	NUMBER	one	num	4	SENT_256	[p12l456t38r574b79],
4	patient	NN	O	patient	prep_of	1	SENT_256	[p12l591t19r823b96],
5	with	IN	O	with	_	0	SENT_256	[p12l840t19r988b79],
6	the	DT	O	the	det	9	SENT_256	[p12l1006t19r1106b79],
7	highest	JJS	O	highest	amod	9	SENT_256	[p12l1124t19r1369b96],
8	triglyceride	NN	O	triglyceride	nn	9	SENT_256	[p12l1385t19r1774b96],
9	level	NN	O	level	prep_with	4	SENT_256	[p12l1792t19r1951b79],
10	in	IN	O	in	_	0	SENT_256	[p12l1969t19r2033b78],
11	the	DT	O	the	det	14	SENT_256	[p12l2050t19r2151b79],
12	E2/E3	NN	O	e2/e3	nn	14	SENT_256	[p12l13t120r219b180],
13	genotype	NN	O	genotype	nn	14	SENT_256	[p12l248t129r556b197],
14	group	NN	O	group	prep_in	9	SENT_256	[p12l581t138r775b197],
15	led	VBD	O	lead	_	0	SENT_256	[p12l800t120r903b179],
16	to	TO	O	to	_	0	SENT_256	[p12l926t129r988b179],
17	the	DT	O	the	det	18	SENT_256	[p12l1013t120r1114b179],
18	loss	NN	O	loss	prep_to	15	SENT_256	[p12l1139t120r1267b179],
19	of	IN	O	of	_	0	SENT_256	[p12l1293t120r1367b179],
20	statistical	JJ	O	statistical	amod	21	SENT_256	[p12l1388t120r1703b179],
21	signiﬁcance	NN	O	signiﬁcance	prep_of	18	SENT_256	[p12l1730t120r2148b197],
22	.	.	O	.	_	0	SENT_256	[p12l1730t120r2148b197],

1	In	IN	O	in	dep	16	SENT_257	[p12l13t225r82b282],
2	View	NNP	O	View	pobj	1	SENT_257	[p12l115t223r275b283],
3	of	IN	O	of	_	0	SENT_257	[p12l310t223r383b283],
4	the	DT	O	the	det	8	SENT_257	[p12l410t223r512b283],
5	very	RB	O	very	advmod	6	SENT_257	[p12l545t242r692b300],
6	high	JJ	O	high	amod	8	SENT_257	[p12l725t223r875b300],
7	mean	NN	O	mean	nn	8	SENT_257	[p12l908t242r1090b283],
8	triglyceridaemia	NN	O	triglyceridaemia	prep_of	2	SENT_257	[p12l1123t223r1678b300],
9	in	IN	O	in	_	0	SENT_257	[p12l1711t223r1774b282],
10	the	DT	O	the	det	13	SENT_257	[p12l1807t223r1909b283],
11	E2/E3	NN	O	e2/e3	nn	13	SENT_257	[p12l1942t224r2148b283],
12	genotype	NN	O	genotype	nn	13	SENT_257	[p12l14t334r322b402],
13	carriers	NNS	O	carrier	prep_in	8	SENT_257	[p12l350t325r619b395],
14	,	,	O	,	_	0	SENT_257	[p12l350t325r619b395],
15	basal	JJ	O	basal	amod	16	SENT_257	[p12l647t325r820b384],
16	HDL	NN	O	hdl	_	0	SENT_257	[p12l847t325r1102b385],
17	.	.	O	.	_	0	SENT_257	[p12l847t325r1102b385],

1	—	NN	O	—	_	0	SENT_258	[p12l847t325r1102b385],
2	.	.	O	.	_	0	SENT_258	[p12l847t325r1102b385],

1	C	NN	O	c	nn	2	SENT_259	[p12l847t325r1102b385],
2	levels	NNS	O	level	nsubj	10	SENT_259	[p12l1130t325r1320b384],
3	were	VBD	O	be	cop	5	SENT_259	[p12l1349t343r1511b385],
4	also	RB	O	also	advmod	5	SENT_259	[p12l1540t325r1671b384],
5	lowest	JJS	O	lowest	_	0	SENT_259	[p12l1698t325r1917b385],
6	in	IN	O	in	_	0	SENT_259	[p12l1942t325r2006b384],
7	this	DT	O	this	det	8	SENT_259	[p12l2032t325r2150b384],
8	group	NN	O	group	prep_in	5	SENT_259	[p12l14t446r208b504],
9	and	CC	O	and	_	0	SENT_259	[p12l243t427r363b487],
10	rose	VBD	O	rise	conj_and	5	SENT_259	[p12l394t446r533b487],
11	about	IN	O	about	_	0	SENT_259	[p12l568t427r753b487],
12	30	CD	PERCENT	30	num	13	SENT_259	[p12l787t428r934b487],
13	%	NN	PERCENT	%	prep_about	10	SENT_259	[p12l787t428r934b487],
14	after	IN	O	after	_	0	SENT_259	[p12l972t427r1126b487],
15	drug	NN	O	drug	nn	16	SENT_259	[p12l1157t427r1309b504],
16	treatment	NN	O	treatment	prep_after	10	SENT_259	[p12l1342t436r1677b487],
17	.	.	O	.	_	0	SENT_259	[p12l1342t436r1677b487],

1	The	DT	O	the	det	2	SENT_260	[p12l1714t427r1843b487],
2	increase	NN	O	increase	nsubj	4	SENT_260	[p12l1876t427r2152b487],
3	was	VBD	O	be	cop	4	SENT_260	[p12l14t548r140b589],
4	maximal	JJ	O	maximal	_	0	SENT_260	[p12l163t529r458b589],
5	for	IN	O	for	_	0	SENT_260	[p12l480t529r578b589],
6	the	DT	O	the	det	8	SENT_260	[p12l597t529r698b589],
7	E2/E3	NN	O	e2/e3	nn	8	SENT_260	[p12l719t529r925b589],
8	carriers	NNS	O	carrier	prep_for	4	SENT_260	[p12l951t529r1221b599],
9	,	,	O	,	_	0	SENT_260	[p12l951t529r1221b599],
10	with	IN	O	with	_	0	SENT_260	[p12l1245t529r1394b589],
11	no	DT	O	no	det	12	SENT_260	[p12l1415t548r1496b589],
12	changes	NNS	O	change	prep_with	4	SENT_260	[p12l1519t529r1788b606],
13	in	IN	O	in	_	0	SENT_260	[p12l1810t529r1874b588],
14	HDL	NNP	O	HDL	prep_in	12	SENT_260	[p12l1895t531r2067b588],
15	in	IN	O	in	_	0	SENT_260	[p12l2088t529r2152b588],
16	the	DT	O	the	det	19	SENT_260	[p12l13t631r115b690],
17	other	JJ	O	other	amod	19	SENT_260	[p12l140t631r312b690],
18	two	CD	NUMBER	two	num	19	SENT_260	[p12l334t640r457b691],
19	groups	NNS	O	group	prep_in	14	SENT_260	[p12l483t649r709b708],
20	(	RB	O	(	dep	21	SENT_260	[p12l737t631r947b704],
21	Table	NNP	O	Table	dep	19	SENT_260	[p12l737t631r947b704],
22	4	CD	NUMBER	4	number	23	SENT_260	[p12l971t631r1056b704],
23	)	CD	NUMBER	)	num	21	SENT_260	[p12l971t631r1056b704],
24	.	.	O	.	_	0	SENT_260	[p12l971t631r1056b704],

1	4	LS	NUMBER	4	_	0	SENT_261	[p12l14t833r73b893],
2	.	.	O	.	_	0	SENT_261	[p12l14t833r73b893],

1	Discussion	NN	O	discussion	_	0	SENT_262	[p12l119t833r500b893],

1	Very	RB	O	very	advmod	2	SENT_263	[p12l115t1039r273b1114],
2	wide	JJ	O	wide	amod	3	SENT_263	[p12l308t1037r470b1097],
3	use	NN	O	use	nsubj	19	SENT_263	[p12l504t1056r615b1097],
4	of	IN	O	of	_	0	SENT_263	[p12l651t1037r724b1097],
5	statins	NNS	O	statin	prep_of	3	SENT_263	[p12l755t1037r965b1097],
6	and	CC	O	and	_	0	SENT_263	[p12l1003t1037r1122b1097],
7	their	PRP$	O	they	poss	9	SENT_263	[p12l1155t1037r1310b1097],
8	unquestionable	JJ	O	unquestionable	amod	9	SENT_263	[p12l1342t1037r1854b1114],
9	efﬁcacy	NN	O	efﬁcacy	prep_of	3	SENT_263	[p12l1890t1037r2151b1114],
10	in	IN	O	in	_	0	SENT_263	[p12l13t1139r77b1198],
11	lipid	NN	O	lipid	nn	12	SENT_263	[p12l104t1139r258b1216],
12	lowering	NN	O	lowering	prep_in	9	SENT_263	[p12l283t1139r580b1216],
13	and	CC	O	and	_	0	SENT_263	[p12l609t1139r728b1198],
14	in	IN	O	in	_	0	SENT_263	[p12l754t1139r818b1198],
15	preventing	VBG	O	prevent	conj_and	12	SENT_263	[p12l843t1139r1200b1216],
16	coronary	JJ	O	coronary	amod	17	SENT_263	[p12l1229t1157r1527b1216],
17	disease	NN	O	disease	dobj	15	SENT_263	[p12l1555t1139r1796b1198],
18	has	VBZ	O	have	aux	19	SENT_263	[p12l1823t1139r1932b1198],
19	led	VBN	O	lead	_	0	SENT_263	[p12l1961t1139r2063b1198],
20	to	TO	O	to	_	0	SENT_263	[p12l2088t1148r2151b1198],
21	an	DT	O	a	det	25	SENT_263	[p12l15t1260r91b1301],
22	approximately	RB	O	approximately	quantmod	23	SENT_263	[p12l116t1241r602b1318],
23	3	CD	PERCENT	3	dep	24	SENT_263	[p12l629t1242r734b1301],
24	%	NN	PERCENT	%	dep	25	SENT_263	[p12l629t1242r734b1301],
25	use	NN	O	use	prep_to	19	SENT_263	[p12l760t1260r890b1312],
26	,	,	O	,	_	0	SENT_263	[p12l760t1260r890b1312],
27	e.	FW	O	e.	nn	28	SENT_263	[p12l917t1260r969b1301],
28	g.	FW	O	g.	appos	25	SENT_263	[p12l976t1260r1033b1318],
29	in	IN	O	in	_	0	SENT_263	[p12l1060t1241r1124b1300],
30	the	DT	O	the	det	33	SENT_263	[p12l1147t1241r1249b1301],
31	adult	JJ	O	adult	amod	33	SENT_263	[p12l1274t1241r1441b1301],
32	UK	NNP	LOCATION	UK	nn	33	SENT_263	[p12l1463t1243r1585b1301],
33	population	NN	O	population	prep_in	28	SENT_263	[p12l1606t1241r1968b1318],
34	[	CD	NUMBER	[	number	35	SENT_263	[p12l1997t1242r2148b1313],
35	30	CD	NUMBER	30	num	36	SENT_263	[p12l1997t1242r2148b1313],
36	]	NN	O	]	dep	28	SENT_263	[p12l1997t1242r2148b1313],
37	.	.	O	.	_	0	SENT_263	[p12l1997t1242r2148b1313],

1	They	PRP	O	they	nsubjpass	5	SENT_264	[p12l13t1343r184b1420],
2	are	VBP	O	be	auxpass	5	SENT_264	[p12l218t1362r317b1403],
3	generally	RB	O	generally	dep	5	SENT_264	[p12l350t1343r662b1420],
4	well	RB	O	well	dep	3	SENT_264	[p12l695t1343r838b1403],
5	tolerated	VBD	O	tolerate	_	0	SENT_264	[p12l870t1343r1183b1413],
6	,	,	O	,	_	0	SENT_264	[p12l870t1343r1183b1413],
7	but	CC	O	but	_	0	SENT_264	[p12l1216t1343r1323b1403],
8	side	JJ	O	side	amod	9	SENT_264	[p12l1357t1343r1488b1403],
9	effects	NNS	O	effect	nsubjpass	20	SENT_264	[p12l1521t1343r1760b1413],
10	,	,	O	,	_	0	SENT_264	[p12l1521t1343r1760b1413],
11	in	IN	O	in	_	0	SENT_264	[p12l1795t1343r1859b1402],
12	particular	JJ	O	particular	prep_in	9	SENT_264	[p12l1889t1343r2149b1420, p12l14t1445r102b1504],
13	of	IN	O	of	_	0	SENT_264	[p12l130t1445r203b1504],
14	the	DT	O	the	det	16	SENT_264	[p12l226t1445r327b1504],
15	muscle	NN	O	muscle	nn	16	SENT_264	[p12l356t1445r594b1504],
16	type	NN	O	type	prep_of	12	SENT_264	[p12l623t1454r785b1522],
17	,	,	O	,	_	0	SENT_264	[p12l623t1454r785b1522],
18	are	VBP	O	be	auxpass	20	SENT_264	[p12l818t1463r917b1504],
19	frequently	RB	O	frequently	advmod	20	SENT_264	[p12l946t1445r1292b1522],
20	reported	VBN	O	report	conj_but	5	SENT_264	[p12l1320t1445r1603b1522],
21	by	IN	O	by	_	0	SENT_264	[p12l1629t1445r1712b1522],
22	patients	NNS	O	patient	agent	20	SENT_264	[p12l1740t1445r2001b1522],
23	and	CC	O	and	_	0	SENT_264	[p12l2033t1445r2153b1504],
24	may	MD	O	may	aux	25	SENT_264	[p12l13t1566r157b1624],
25	result	VB	O	result	conj_and	20	SENT_264	[p12l192t1547r381b1607],
26	in	IN	O	in	_	0	SENT_264	[p12l415t1547r479b1606],
27	reduced	VBN	O	reduce	amod	28	SENT_264	[p12l514t1547r782b1607],
28	compliance	NN	O	compliance	prep_in	25	SENT_264	[p12l818t1547r1206b1624],
29	or	CC	O	or	_	0	SENT_264	[p12l1243t1566r1312b1607],
30	interruption	NN	O	interruption	conj_or	28	SENT_264	[p12l1346t1547r1745b1624],
31	of	IN	O	of	_	0	SENT_264	[p12l1781t1547r1855b1607],
32	therapy	NN	O	therapy	prep_of	28	SENT_264	[p12l1885t1547r2148b1624],
33	.	.	O	.	_	0	SENT_264	[p12l1885t1547r2148b1624],

1	This	DT	O	this	det	2	SENT_265	[p12l13t1649r160b1709],
2	study	NN	O	study	nsubj	3	SENT_265	[p12l194t1649r372b1726],
3	attempted	VBD	O	attempt	_	0	SENT_265	[p12l404t1649r736b1726],
4	to	TO	O	to	aux	5	SENT_265	[p12l764t1658r827b1709],
5	elucidate	VB	O	elucidate	xcomp	3	SENT_265	[p12l858t1649r1161b1709],
6	an	DT	O	a	det	10	SENT_265	[p12l1193t1668r1269b1709],
7	important	JJ	O	important	amod	10	SENT_265	[p12l1298t1649r1627b1726],
8	and	CC	O	and	_	0	SENT_265	[p12l1657t1649r1776b1709],
9	controversial	JJ	O	controversial	amod	10	SENT_265	[p12l1806t1658r2149b1709, p12l16t1750r129b1809],
10	aspect	NN	O	aspect	dobj	5	SENT_265	[p12l151t1758r360b1827],
11	of	IN	O	of	_	0	SENT_265	[p12l380t1749r453b1809],
12	statin	NN	O	statin	nn	14	SENT_265	[p12l470t1750r650b1809],
13	muscle	NN	O	muscle	nn	14	SENT_265	[p12l669t1750r908b1809],
14	toxicity	NN	O	toxicity	prep_of	10	SENT_265	[p12l928t1750r1196b1827],
15	.	.	O	.	_	0	SENT_265	[p12l928t1750r1196b1827],

1	If	IN	O	if	mark	6	SENT_266	[p12l1221t1750r1281b1808],
2	indeed	RB	O	indeed	advmod	4	SENT_266	[p12l1295t1750r1520b1809],
3	this	DT	O	this	det	4	SENT_266	[p12l1540t1750r1658b1809],
4	toxicity	NN	O	toxicity	nsubj	6	SENT_266	[p12l1680t1750r1936b1827],
5	is	VBZ	O	be	cop	6	SENT_266	[p12l1957t1750r2010b1809],
6	due	JJ	O	due	advcl	24	SENT_266	[p12l2033t1750r2152b1809],
7	to	TO	O	to	_	0	SENT_266	[p12l13t1862r76b1913],
8	elevated	JJ	O	elevated	amod	10	SENT_266	[p12l97t1853r373b1913],
9	statin	NN	O	statin	nn	10	SENT_266	[p12l395t1853r574b1913],
10	levels	NNS	O	level	prep_to	6	SENT_266	[p12l592t1853r783b1913],
11	rather	RB	O	rather	_	0	SENT_266	[p12l803t1853r1001b1913],
12	than	IN	O	than	_	0	SENT_266	[p12l1019t1853r1163b1913],
13	to	TO	O	to	_	0	SENT_266	[p12l1182t1862r1244b1913],
14	idiosyncratic	JJ	O	idiosyncratic	amod	15	SENT_266	[p12l1265t1853r1700b1930],
15	vulnerability	NN	O	vulnerability	prep_to	6	SENT_266	[p12l1720t1853r2151b1930],
16	in	IN	O	in	_	0	SENT_266	[p12l13t1955r77b2014],
17	certain	JJ	O	certain	amod	18	SENT_266	[p12l100t1955r328b2014],
18	patients	NNS	O	patient	prep_in	15	SENT_266	[p12l350t1955r631b2032],
19	,	,	O	,	_	0	SENT_266	[p12l350t1955r631b2032],
20	then	RB	O	then	advmod	24	SENT_266	[p12l656t1955r800b2014],
21	patients	NNS	O	patient	nsubj	24	SENT_266	[p12l821t1955r1083b2032],
22	unable	JJ	O	unable	amod	21	SENT_266	[p12l1106t1955r1331b2014],
23	to	TO	O	to	prep	22	SENT_266	[p12l1353t1964r1416b2014],
24	metabolize	VBZ	O	metabolize	dep	35	SENT_266	[p12l1440t1955r1809b2014],
25	statins	NNS	O	statin	dobj	24	SENT_266	[p12l1835t1955r2045b2014],
26	by	IN	O	by	_	0	SENT_266	[p12l2068t1955r2151b2032],
27	way	NN	O	way	prep_by	24	SENT_266	[p12l14t2076r151b2134],
28	of	IN	O	of	_	0	SENT_266	[p12l177t2057r250b2117],
29	the	DT	O	the	det	32	SENT_266	[p12l267t2057r368b2117],
30	appropriate	JJ	O	appropriate	amod	32	SENT_266	[p12l394t2057r776b2134],
31	CYP45O	NN	O	cyp45o	nn	32	SENT_266	[p12l801t2057r1090b2117],
32	isoform	NN	O	isoform	prep_of	27	SENT_266	[p12l1114t2057r1377b2117],
33	should	MD	O	should	aux	35	SENT_266	[p12l1403t2057r1624b2117],
34	be	VB	O	be	auxpass	35	SENT_266	[p12l1646t2057r1725b2117],
35	predisposed	VBN	O	predispose	_	0	SENT_266	[p12l1748t2057r2153b2134],
36	to	TO	O	to	_	0	SENT_266	[p12l13t2168r76b2219],
37	muscle	NN	O	muscle	nn	38	SENT_266	[p12l101t2159r339b2219],
38	toxicity	NN	O	toxicity	prep_to	35	SENT_266	[p12l362t2159r619b2236],
39	[	CD	NUMBER	[	num	38	SENT_266	[p12l650t2160r799b2231],
40	31	CD	NUMBER	31	num	41	SENT_266	[p12l650t2160r799b2231],
41	]	NN	O	]	nsubjpass	35	SENT_266	[p12l650t2160r799b2231],
42	.	.	O	.	_	0	SENT_266	[p12l650t2160r799b2231],

1	AEs	NNS	O	ae	nsubj	4	SENT_267	[p12l115t2261r257b2320],
2	to	TO	O	to	_	0	SENT_267	[p12l289t2270r351b2320],
3	statins	NNS	O	statin	prep_to	1	SENT_267	[p12l385t2261r595b2320],
4	are	VBP	O	be	_	0	SENT_267	[p12l628t2279r727b2320],
5	in	IN	O	in	_	0	SENT_267	[p12l757t2261r821b2320],
6	general	JJ	O	general	prep_in	4	SENT_267	[p12l851t2261r1097b2338],
7	associated	VBN	O	associate	partmod	6	SENT_267	[p12l1129t2261r1475b2320],
8	to	TO	O	to	_	0	SENT_267	[p12l1503t2270r1566b2320],
9	two	CD	NUMBER	two	num	11	SENT_267	[p12l1596t2270r1719b2321],
10	major	JJ	O	major	amod	11	SENT_267	[p12l1750t2261r1947b2338],
11	types	NNS	O	type	prep_to	7	SENT_267	[p12l1975t2270r2150b2338],
12	of	IN	O	of	_	0	SENT_267	[p12l14t2363r88b2423],
13	events	NNS	O	event	prep_of	11	SENT_267	[p12l106t2372r335b2423],
14	:	:	O	:	_	0	SENT_267	[p12l106t2372r335b2423],
15	increased	VBN	O	increase	amod	18	SENT_267	[p12l364t2363r684b2423],
16	hepatic	JJ	O	hepatic	amod	18	SENT_267	[p12l706t2363r948b2440],
17	transaminase	NN	O	transaminase	nn	18	SENT_267	[p12l974t2363r1414b2423],
18	levels	NNS	O	level	dep	13	SENT_267	[p12l1439t2363r1629b2423],
19	and	CC	O	and	_	0	SENT_267	[p12l1656t2363r1776b2423],
20	myopathy	NN	O	myopathy	conj_and	18	SENT_267	[p12l1799t2363r2148b2440],
21	.	.	O	.	_	0	SENT_267	[p12l1799t2363r2148b2440],

1	While	IN	O	while	mark	8	SENT_268	[p12l12t2465r218b2525],
2	increased	VBN	O	increase	amod	3	SENT_268	[p12l248t2465r567b2525],
3	transaminase	NN	O	transaminase	nsubj	8	SENT_268	[p12l595t2465r1036b2525],
4	is	VBZ	O	be	cop	8	SENT_268	[p12l1065t2465r1118b2525],
5	a	DT	O	a	det	8	SENT_268	[p12l1150t2484r1185b2525],
6	relatively	RB	O	relatively	advmod	7	SENT_268	[p12l1212t2465r1527b2542],
7	rare	JJ	O	rare	amod	8	SENT_268	[p12l1556t2484r1686b2525],
8	phenomenon	NN	O	phenomenon	csubj	30	SENT_268	[p12l1715t2465r2152b2542],
9	and	CC	O	and	_	0	SENT_268	[p12l15t2566r135b2625],
10	not	RB	O	not	advmod	8	SENT_268	[p12l164t2574r271b2625],
11	of	IN	O	of	_	0	SENT_268	[p12l302t2566r375b2625],
12	major	JJ	O	major	amod	13	SENT_268	[p12l399t2566r597b2643],
13	importance	NN	O	importance	prep_of	10	SENT_268	[p12l625t2566r1005b2643],
14	in	IN	O	in	_	0	SENT_268	[p12l1036t2566r1099b2624],
15	daily	JJ	SET	daily	amod	16	SENT_268	[p12l1130t2566r1297b2643],
16	practice	NN	O	practice	prep_in	13	SENT_268	[p12l1326t2566r1594b2643],
17	[	CD	NUMBER	[	number	18	SENT_268	[p12l1630t2566r1782b2638],
18	32	CD	NUMBER	32	num	19	SENT_268	[p12l1630t2566r1782b2638],
19	]	NN	O	]	csubj	30	SENT_268	[p12l1630t2566r1782b2638],
20	,	,	O	,	_	0	SENT_268	[p12l1630t2566r1782b2638],
21	myopathy	NN	O	myopathy	nsubj	24	SENT_268	[p12l1815t2566r2151b2643],
22	is	VBZ	O	be	cop	24	SENT_268	[p12l13t2669r66b2729],
23	particularly	RB	O	particularly	advmod	24	SENT_268	[p12l101t2669r490b2746],
24	disturbing	JJ	O	disturbing	dep	19	SENT_268	[p12l526t2669r866b2746],
25	both	CC	O	both	dep	24	SENT_268	[p12l900t2669r1050b2729],
26	for	IN	O	for	_	0	SENT_268	[p12l1084t2669r1182b2729],
27	patients	NNS	O	patient	prep_for	24	SENT_268	[p12l1213t2669r1475b2746],
28	and	CC	O	and	_	0	SENT_268	[p12l1512t2669r1632b2729],
29	physicians	NNS	O	physician	prep_for	24	SENT_268	[p12l1664t2669r2019b2746],
30	[	VBP	O	[	_	0	SENT_268	[p12l2062t2669r2146b2741],
31	6	CD	NUMBER	6	number	32	SENT_268	[p12l2062t2669r2146b2741],
32	]	CD	NUMBER	]	dobj	30	SENT_268	[p12l2062t2669r2146b2741],
33	leading	VBG	O	lead	xcomp	30	SENT_268	[p12l14t2771r279b2848],
34	,	,	O	,	_	0	SENT_268	[p12l14t2771r279b2848],
35	not	RB	O	not	prep	33	SENT_268	[p12l303t2780r410b2830],
36	infrequently	RB	O	infrequently	dep	35	SENT_268	[p12l429t2771r855b2848],
37	,	,	O	,	_	0	SENT_268	[p12l429t2771r855b2848],
38	to	TO	O	to	_	0	SENT_268	[p12l878t2780r941b2830],
39	drug	NN	O	drug	nn	40	SENT_268	[p12l963t2771r1114b2848],
40	withdrawal	NN	O	withdrawal	prep_to	33	SENT_268	[p12l1136t2771r1513b2831],
41	with	IN	O	with	_	0	SENT_268	[p12l1534t2771r1683b2830],
42	the	DT	O	the	det	44	SENT_268	[p12l1702t2771r1803b2830],
43	accompanying	JJ	O	accompanying	amod	44	SENT_268	[p12l1826t2789r2149b2848, p12l13t2873r203b2950],
44	loss	NN	O	loss	prep_with	40	SENT_268	[p12l227t2873r355b2933],
45	of	IN	O	of	_	0	SENT_268	[p12l382t2873r455b2933],
46	beneﬁt	NN	O	beneﬁt	prep_of	44	SENT_268	[p12l472t2873r703b2933],
47	from	IN	O	from	_	0	SENT_268	[p12l726t2873r890b2933],
48	this	DT	O	this	det	51	SENT_268	[p12l912t2873r1031b2933],
49	important	JJ	O	important	amod	51	SENT_268	[p12l1057t2873r1386b2950],
50	drug	NN	O	drug	nn	51	SENT_268	[p12l1409t2873r1561b2950],
51	treatment	NN	O	treatment	prep_from	33	SENT_268	[p12l1585t2882r1905b2933],
52	[	CD	NUMBER	[	number	53	SENT_268	[p12l1934t2874r2149b2945],
53	7,33	CD	NUMBER	7,33	num	54	SENT_268	[p12l1934t2874r2149b2945],
54	]	NN	O	]	dobj	33	SENT_268	[p12l1934t2874r2149b2945],
55	,	,	O	,	_	0	SENT_268	[p12l1934t2874r2149b2945],
56	although	IN	O	although	mark	64	SENT_268	[p12l15t2975r309b3052],
57	the	DT	O	the	det	60	SENT_268	[p12l329t2975r430b3035],
58	long	JJ	O	long	amod	60	SENT_268	[p12l452t2975r600b3052],
59	term	NN	O	term	nn	60	SENT_268	[p12l621t2984r776b3035],
60	severity	NN	O	severity	nsubj	64	SENT_268	[p12l799t2975r1058b3052],
61	of	IN	O	of	_	0	SENT_268	[p12l1081t2975r1154b3035],
62	muscular	JJ	O	muscular	amod	63	SENT_268	[p12l1169t2975r1480b3035],
63	changes	NNS	O	change	prep_of	60	SENT_268	[p12l1500t2975r1769b3052],
64	[	VBP	O	[	dep	54	SENT_268	[p12l1798t2976r1883b3047],
65	8	CD	NUMBER	8	num	66	SENT_268	[p12l1798t2976r1883b3047],
66	]	NN	O	]	nsubj	70	SENT_268	[p12l1798t2976r1883b3047],
67	may	MD	O	may	aux	70	SENT_268	[p12l1909t2994r2053b3052],
68	be	VB	O	be	cop	70	SENT_268	[p12l2073t2975r2152b3035],
69	relatively	RB	O	relatively	advmod	70	SENT_268	[p12l13t3077r328b3154],
70	modest	JJ	O	modest	ccomp	64	SENT_268	[p12l352t3077r612b3136],
71	.	.	O	.	_	0	SENT_268	[p12l352t3077r612b3136],

1	The	DT	O	the	det	2	SENT_269	[p12l115t3179r245b3239],
2	mechanism	NN	O	mechanism	nsubj	11	SENT_269	[p12l279t3179r665b3239],
3	of	IN	O	of	_	0	SENT_269	[p12l699t3179r772b3239],
4	myopathy	NN	O	myopathy	prep_of	2	SENT_269	[p12l801t3179r1137b3256],
5	due	JJ	O	due	_	0	SENT_269	[p12l1173t3179r1292b3239],
6	to	TO	O	to	_	0	SENT_269	[p12l1327t3188r1389b3239],
7	statins	NNS	O	statin	prep_due_to	4	SENT_269	[p12l1427t3179r1637b3239],
8	is	VBZ	O	be	cop	11	SENT_269	[p12l1673t3179r1726b3239],
9	still	RB	O	still	advmod	11	SENT_269	[p12l1765t3179r1887b3239],
10	overall	JJ	O	overall	advmod	11	SENT_269	[p12l1922t3179r2152b3239],
11	unclear	JJ	O	unclear	_	0	SENT_269	[p12l13t3281r273b3341],
12	.	.	O	.	_	0	SENT_269	[p12l13t3281r273b3341],

1	A	DT	O	a	dep	122	SENT_270	[p12l303t3282r362b3340],
2	number	NN	O	number	dep	122	SENT_270	[p12l387t3281r646b3341],
3	of	IN	O	of	dep	122	SENT_270	[p12l670t3281r743b3341],
4	potential	JJ	O	potential	dep	122	SENT_270	[p12l761t3281r1057b3358],
5	risk	NN	O	risk	dep	122	SENT_270	[p12l1081t3281r1209b3341],
6	factors	NNS	O	factor	dep	122	SENT_270	[p12l1233t3281r1458b3341],
7	has	VBZ	O	have	dep	122	SENT_270	[p12l1484t3281r1594b3341],
8	been	VBN	O	be	dep	122	SENT_270	[p12l1620t3281r1779b3341],
9	listed	VBN	O	list	dep	122	SENT_270	[p12l1804t3281r2004b3351],
10	,	,	O	,	_	0	SENT_270	[p12l1804t3281r2004b3351],
11	e.	FW	O	e.	dep	122	SENT_270	[p12l2032t3300r2084b3341],
12	g.	FW	O	g.	dep	122	SENT_270	[p12l2092t3300r2148b3358],
13	advanced	VBN	O	advance	dep	122	SENT_270	[p12l15t3382r331b3441],
14	age	NN	O	age	dep	122	SENT_270	[p12l348t3400r462b3459],
15	(	CD	NUMBER	(	dep	122	SENT_270	[p12l481t3382r895b3459],
16	particularly	RB	O	particularly	dep	122	SENT_270	[p12l481t3382r895b3459],
17	above	IN	O	above	dep	122	SENT_270	[p12l914t3382r1110b3442],
18	80	CD	DURATION	80	dep	122	SENT_270	[p12l1130t3382r1209b3442],
19	years	NNS	NUMBER	year	dep	122	SENT_270	[p12l1226t3400r1401b3459],
20	and	CC	O	and	dep	122	SENT_270	[p12l1421t3382r1540b3441],
21	women	NNS	O	woman	dep	122	SENT_270	[p12l1556t3400r1803b3441],
22	more	JJR	O	more	dep	122	SENT_270	[p12l1819t3400r1991b3441],
23	than	IN	O	than	dep	122	SENT_270	[p12l2008t3382r2152b3441],
24	men	NNS	O	man	dep	122	SENT_270	[p12l13t3485r183b3558],
25	)	CD	NUMBER	)	dep	122	SENT_270	[p12l13t3485r183b3558],
26	and	CC	O	and	dep	122	SENT_270	[p12l216t3484r335b3544],
27	interaction	NN	O	interaction	dep	122	SENT_270	[p12l362t3484r723b3544],
28	with	IN	O	with	dep	122	SENT_270	[p12l752t3484r900b3544],
29	a	DT	O	a	dep	122	SENT_270	[p12l930t3503r965b3544],
30	number	NN	O	number	dep	122	SENT_270	[p12l992t3484r1250b3544],
31	of	IN	O	of	dep	122	SENT_270	[p12l1278t3484r1351b3544],
32	inhibitors	NNS	O	inhibitor	dep	122	SENT_270	[p12l1373t3484r1695b3544],
33	of	IN	O	of	dep	122	SENT_270	[p12l1726t3484r1799b3544],
34	CYP3A4	NN	O	cyp3a4	dep	122	SENT_270	[p12l1822t3485r2149b3555],
35	,	,	O	,	_	0	SENT_270	[p12l1822t3485r2149b3555],
36	e.g.	FW	O	e.g.	dep	122	SENT_270	[p12l14t3605r129b3664],
37	amiodarone	FW	O	amiodarone	dep	122	SENT_270	[p12l168t3587r583b3657],
38	,	,	O	,	_	0	SENT_270	[p12l168t3587r583b3657],
39	verapamil	NN	O	verapamil	dep	122	SENT_270	[p12l619t3587r973b3664],
40	,	,	O	,	_	0	SENT_270	[p12l619t3587r973b3664],
41	diltiazem	NN	O	diltiazem	dep	122	SENT_270	[p12l1010t3587r1341b3657],
42	,	,	O	,	_	0	SENT_270	[p12l1010t3587r1341b3657],
43	nefazodone	NN	O	nefazodone	dep	122	SENT_270	[p12l1377t3587r1784b3657],
44	,	,	O	,	_	0	SENT_270	[p12l1377t3587r1784b3657],
45	grapefruit	NN	O	grapefruit	dep	122	SENT_270	[p12l1820t3587r2153b3664],
46	juice	NN	O	juice	dep	122	SENT_270	[p12l6t3689r194b3766],
47	,	,	O	,	_	0	SENT_270	[p12l6t3689r194b3766],
48	clarithromycin	NN	O	clarithromycin	dep	122	SENT_270	[p12l226t3689r741b3766],
49	,	,	O	,	_	0	SENT_270	[p12l226t3689r741b3766],
50	azole	NN	O	azole	dep	122	SENT_270	[p12l774t3689r949b3749],
51	antifungals	NNS	O	antifungal	dep	122	SENT_270	[p12l979t3689r1351b3766],
52	[	VBP	O	[	dep	122	SENT_270	[p12l1387t3690r1538b3761],
53	34	CD	NUMBER	34	dep	122	SENT_270	[p12l1387t3690r1538b3761],
54	]	CD	NUMBER	]	dep	122	SENT_270	[p12l1387t3690r1538b3761],
55	,	,	O	,	_	0	SENT_270	[p12l1387t3690r1538b3761],
56	or	CC	O	or	dep	122	SENT_270	[p12l1571t3708r1639b3749],
57	also	RB	O	also	dep	122	SENT_270	[p12l1668t3689r1800b3749],
58	inhibitors	NNS	O	inhibitor	dep	122	SENT_270	[p12l1829t3689r2150b3749],
59	of	IN	O	of	dep	122	SENT_270	[p13l14t18r87b78],
60	CYPZC9	NN	O	cypzc9	dep	122	SENT_270	[p13l109t19r410b79],
61	such	JJ	O	such	dep	122	SENT_270	[p13l442t18r593b78],
62	as	IN	O	as	dep	122	SENT_270	[p13l620t37r685b78],
63	diclofenac	NN	O	diclofenac	dep	122	SENT_270	[p13l714t18r1083b89],
64	,	,	O	,	_	0	SENT_270	[p13l714t18r1083b89],
65	tolbutamide	NN	O	tolbutamide	dep	122	SENT_270	[p13l1112t18r1514b78],
66	and	CC	O	and	dep	122	SENT_270	[p13l1542t18r1661b78],
67	others	NNS	O	other	dep	122	SENT_270	[p13l1688t18r1890b78],
68	[	VBP	O	[	dep	122	SENT_270	[p13l1924t19r2052b90],
69	27	CD	NUMBER	27	dep	122	SENT_270	[p13l1924t19r2052b90],
70	]	CD	NUMBER	]	dep	122	SENT_270	[p13l1924t19r2052b90],
71	as	RB	O	as	dep	122	SENT_270	[p13l2085t37r2150b78],
72	well	RB	O	well	dep	122	SENT_270	[p13l14t121r157b181],
73	as	IN	O	as	dep	122	SENT_270	[p13l176t139r241b180],
74	lipid	NN	O	lipid	dep	122	SENT_270	[p13l260t121r414b198],
75	lowering	VBG	O	lower	dep	122	SENT_270	[p13l430t121r727b198],
76	agents	NNS	O	agent	dep	122	SENT_270	[p13l747t130r958b198],
77	such	JJ	O	such	dep	122	SENT_270	[p13l979t121r1130b180],
78	as	IN	O	as	dep	122	SENT_270	[p13l1149t139r1213b180],
79	ﬁbrates	NNS	O	ﬁbrates	dep	122	SENT_270	[p13l1233t121r1498b191],
80	,	,	O	,	_	0	SENT_270	[p13l1233t121r1498b191],
81	preexisting	VBG	O	preexist	dep	122	SENT_270	[p13l1517t121r1891b198],
82	disease	NN	O	disease	dep	122	SENT_270	[p13l1910t121r2152b180],
83	(	NN	O	(	dep	122	SENT_270	[p13l16t223r209b297],
84	renal	JJ	O	renal	dep	122	SENT_270	[p13l16t223r209b297],
85	or	CC	O	or	dep	122	SENT_270	[p13l233t242r302b283],
86	liver	NN	O	liver	dep	122	SENT_270	[p13l324t223r488b294],
87	,	,	O	,	_	0	SENT_270	[p13l324t223r488b294],
88	complicated	JJ	O	complicated	dep	122	SENT_270	[p13l515t223r928b300],
89	diabetes	NN	O	diabetes	dep	122	SENT_270	[p13l951t223r1244b294],
90	,	,	O	,	_	0	SENT_270	[p13l951t223r1244b294],
91	renal	JJ	O	renal	dep	122	SENT_270	[p13l1270t223r1438b283],
92	infection	NN	O	infection	dep	122	SENT_270	[p13l1461t223r1807b297],
93	)	NN	O	)	dep	122	SENT_270	[p13l1461t223r1807b297],
94	,	,	O	,	_	0	SENT_270	[p13l1461t223r1807b297],
95	excessive	JJ	O	excessive	dep	122	SENT_270	[p13l1834t223r2152b283],
96	ethanol	NN	O	ethanol	dep	122	SENT_270	[p13l14t325r261b385],
97	intake	NN	O	intake	dep	122	SENT_270	[p13l287t325r491b385],
98	(	NN	O	(	dep	122	SENT_270	[p13l520t325r901b402],
99	apparently	RB	O	apparently	dep	122	SENT_270	[p13l520t325r901b402],
100	predisposing	VBG	O	predispose	dep	122	SENT_270	[p13l927t325r1359b402],
101	to	TO	O	to	dep	122	SENT_270	[p13l1385t334r1448b385],
102	myopathy	VB	O	myopathy	dep	122	SENT_270	[p13l1475t325r1838b402],
103	)	CD	NUMBER	)	dep	122	SENT_270	[p13l1475t325r1838b402],
104	[	CD	NUMBER	[	dep	122	SENT_270	[p13l1873t325r2000b397],
105	35	CD	NUMBER	35	dep	122	SENT_270	[p13l1873t325r2000b397],
106	]	NN	O	]	dep	122	SENT_270	[p13l1873t325r2000b397],
107	and	CC	O	and	dep	122	SENT_270	[p13l2033t325r2153b385],
108	intensive	JJ	O	intensive	dep	122	SENT_270	[p13l13t426r314b485],
109	physical	JJ	O	physical	dep	122	SENT_270	[p13l339t426r620b503],
110	exercise	NN	O	exercise	dep	122	SENT_270	[p13l647t426r938b496],
111	,	,	O	,	_	0	SENT_270	[p13l647t426r938b496],
112	this	DT	O	this	dep	122	SENT_270	[p13l967t426r1085b485],
113	last	JJ	O	last	dep	122	SENT_270	[p13l1113t426r1229b485],
114	controindicating	JJ	O	controindicating	dep	122	SENT_270	[p13l1254t426r1807b503],
115	statin	NN	O	statin	dep	122	SENT_270	[p13l1837t426r2016b485],
116	use	NN	O	use	dep	122	SENT_270	[p13l2040t444r2152b485],
117	in	IN	O	in	dep	122	SENT_270	[p13l13t529r77b588],
118	professional	JJ	O	professional	dep	122	SENT_270	[p13l100t529r513b606],
119	athletes	NNS	O	athlete	dep	122	SENT_270	[p13l539t529r792b589],
120	[	VBP	O	[	dep	122	SENT_270	[p13l824t529r974b601],
121	36	CD	NUMBER	36	dep	122	SENT_270	[p13l824t529r974b601],
122	]	CD	NUMBER	]	_	0	SENT_270	[p13l824t529r974b601],
123	.	.	O	.	_	0	SENT_270	[p13l824t529r974b601],

1	The	DT	O	the	det	3	SENT_271	[p13l115t631r245b690],
2	molecular	JJ	O	molecular	amod	3	SENT_271	[p13l292t631r631b690],
3	mechanism	NN	O	mechanism	nsubjpass	10	SENT_271	[p13l676t631r1062b690],
4	of	IN	O	of	_	0	SENT_271	[p13l1109t631r1182b690],
5	statin	NN	O	statin	nn	6	SENT_271	[p13l1226t631r1405b690],
6	myopathy	NN	O	myopathy	prep_of	3	SENT_271	[p13l1452t631r1789b708],
7	has	VBZ	O	have	aux	10	SENT_271	[p13l1836t631r1945b690],
8	been	VBN	O	be	auxpass	10	SENT_271	[p13l1993t631r2152b690],
9	directly	RB	O	directly	advmod	10	SENT_271	[p13l14t732r270b809],
10	related	VBN	O	relate	_	0	SENT_271	[p13l302t732r532b791],
11	to	TO	O	to	_	0	SENT_271	[p13l563t740r626b791],
12	chloride	NN	O	chloride	nn	14	SENT_271	[p13l659t732r934b791],
13	(	CD	NUMBER	(	num	14	SENT_271	[p13l969t732r1153b805],
14	Cl	NN	O	cl	prep_to	10	SENT_271	[p13l969t732r1153b805],
15	‘	CD	NUMBER	‘	num	18	SENT_271	[p13l969t732r1153b805],
16	)	NN	O	)	nn	18	SENT_271	[p13l969t732r1153b805],
17	channel	NN	O	channel	nn	18	SENT_271	[p13l1188t732r1449b791],
18	antagonism	NN	O	antagonism	dep	14	SENT_271	[p13l1483t732r1887b809],
19	.	.	O	.	_	0	SENT_271	[p13l1483t732r1887b809],

1	Statins	NNS	O	statin	nsubj	2	SENT_272	[p13l1925t732r2150b792],
2	antagonize	VBP	O	antagonize	_	0	SENT_272	[p13l15t835r379b912],
3	this	DT	O	this	det	4	SENT_272	[p13l409t835r527b895],
4	channel	NN	O	channel	dobj	2	SENT_272	[p13l560t835r821b895],
5	to	TO	O	to	_	0	SENT_272	[p13l851t844r913b895],
6	a	DT	O	a	det	7	SENT_272	[p13l946t854r981b895],
7	concentration	NN	O	concentration	prep_to	2	SENT_272	[p13l1010t835r1470b895],
8	related	JJ	O	related	amod	9	SENT_272	[p13l1498t835r1729b895],
9	extent	NN	O	extent	dep	7	SENT_272	[p13l1759t844r1980b906],
10	,	,	O	,	_	0	SENT_272	[p13l1759t844r1980b906],
11	thus	RB	O	thus	advmod	7	SENT_272	[p13l2013t835r2150b895],
12	leading	VBG	O	lead	partmod	7	SENT_272	[p13l14t937r260b1014],
13	to	TO	O	to	prep	12	SENT_272	[p13l305t946r367b996],
14	potentially	RB	O	potentially	advmod	15	SENT_272	[p13l411t937r773b1014],
15	raised	VBN	O	raise	amod	17	SENT_272	[p13l816t937r1018b996],
16	muscle	NN	O	muscle	nn	17	SENT_272	[p13l1061t937r1299b996],
17	contractility	NN	O	contractility	dobj	12	SENT_272	[p13l1343t937r1771b1014],
18	;	:	O	;	_	0	SENT_272	[p13l1343t937r1771b1014],
19	the	DT	O	the	det	20	SENT_272	[p13l1818t937r1919b996],
20	effect	NN	O	effect	nsubj	22	SENT_272	[p13l1964t937r2153b996],
21	is	VBZ	O	be	cop	22	SENT_272	[p13l13t1039r66b1099],
22	maximal	JJ	O	maximal	parataxis	2	SENT_272	[p13l105t1039r399b1099],
23	with	IN	O	with	_	0	SENT_272	[p13l437t1039r585b1099],
24	lipophilic	JJ	O	lipophilic	amod	25	SENT_272	[p13l622t1039r944b1116],
25	statins	NNS	O	statin	prep_with	22	SENT_272	[p13l985t1039r1195b1099],
26	and	CC	O	and	_	0	SENT_272	[p13l1235t1039r1355b1099],
27	of	IN	O	of	_	0	SENT_272	[p13l1392t1039r1465b1099],
28	a	DT	O	a	det	30	SENT_272	[p13l1498t1058r1533b1099],
29	lesser	JJR	O	lesser	amod	30	SENT_272	[p13l1568t1039r1761b1099],
30	degree	NN	O	degree	prep_of	22	SENT_272	[p13l1797t1039r2018b1116],
31	for	IN	O	for	_	0	SENT_272	[p13l2056t1039r2154b1099],
32	hydrophilic	JJ	O	hydrophilic	amod	33	SENT_272	[p13l13t1141r401b1218],
33	molecules	NNS	O	molecule	prep_for	30	SENT_272	[p13l449t1141r809b1211],
34	,	,	O	,	_	0	SENT_272	[p13l449t1141r809b1211],
35	such	JJ	O	such	_	0	SENT_272	[p13l861t1141r1012b1201],
36	as	IN	O	as	_	0	SENT_272	[p13l1059t1160r1124b1201],
37	pravastatin	NN	O	pravastatin	prep_such_as	30	SENT_272	[p13l1171t1141r1539b1218],
38	[	CD	NUMBER	[	num	37	SENT_272	[p13l1591t1142r1741b1213],
39	37	CD	NUMBER	37	num	40	SENT_272	[p13l1591t1142r1741b1213],
40	]	NN	O	]	dep	22	SENT_272	[p13l1591t1142r1741b1213],
41	.	.	O	.	_	0	SENT_272	[p13l1591t1142r1741b1213],

1	Additional	JJ	O	additional	amod	2	SENT_273	[p13l1791t1141r2152b1201],
2	mechanisms	NNS	O	mechanism	nsubj	8	SENT_273	[p13l13t1242r429b1301],
3	of	IN	O	of	_	0	SENT_273	[p13l479t1242r552b1301],
4	toxicity	NN	O	toxicity	prep_of	2	SENT_273	[p13l593t1242r850b1319],
5	may	MD	O	may	aux	8	SENT_273	[p13l897t1260r1041b1319],
6	be	VB	O	be	cop	8	SENT_273	[p13l1087t1242r1166b1301],
7	the	DT	O	the	det	8	SENT_273	[p13l1213t1242r1314b1301],
8	downregulation	NN	O	downregulation	_	0	SENT_273	[p13l1362t1242r1889b1319],
9	of	IN	O	of	_	0	SENT_273	[p13l1936t1242r2010b1301],
10	the	DT	O	the	det	11	SENT_273	[p13l2050t1242r2152b1301],
11	Na	NN	MISC	na	prep_of	8	SENT_273	[p13l13t1327r337b1403],
12	+	CC	O	+	_	0	SENT_273	[p13l13t1327r337b1403],
13	/	:	O	/	punct	14	SENT_273	[p13l13t1327r337b1403],
14	Ca2	NN	O	ca2	dep	8	SENT_273	[p13l13t1327r337b1403],
15	+	CC	O	+	_	0	SENT_273	[p13l13t1327r337b1403],
16	exchanger	NN	O	exchanger	dep	8	SENT_273	[p13l375t1343r722b1420],
17	described	VBN	O	describe	conj_+	8	SENT_273	[p13l754t1343r1077b1403],
18	with	IN	O	with	_	0	SENT_273	[p13l1109t1343r1258b1403],
19	ﬂuvastatin	NN	O	ﬂuvastatin	prep_with	17	SENT_273	[p13l1292t1343r1640b1403],
20	in	IN	O	in	_	0	SENT_273	[p13l1673t1343r1737b1402],
21	the	DT	O	the	det	23	SENT_273	[p13l1769t1343r1871b1403],
22	rat	NN	O	rat	nn	23	SENT_273	[p13l1903t1352r1992b1403],
23	cardiomyoblast	NN	O	cardiomyoblast	prep_in	17	SENT_273	[p13l2025t1362r2149b1403, p13l14t1446r433b1523],
24	H9C2	NN	O	h9c2	nn	25	SENT_273	[p13l469t1446r668b1507],
25	cells	NNS	O	cell	nsubj	26	SENT_273	[p13l708t1446r858b1506],
26	[	VBP	O	[	rcmod	23	SENT_273	[p13l904t1446r1031b1518],
27	38	CD	NUMBER	38	num	28	SENT_273	[p13l904t1446r1031b1518],
28	]	CD	NUMBER	]	dobj	26	SENT_273	[p13l904t1446r1031b1518],
29	and	CC	O	and	_	0	SENT_273	[p13l1076t1446r1195b1506],
30	the	DT	O	the	det	31	SENT_273	[p13l1232t1446r1333b1506],
31	induction	NN	O	induction	prep_in	17	SENT_273	[p13l1371t1446r1690b1506],
32	of	IN	O	of	_	0	SENT_273	[p13l1729t1446r1802b1506],
33	apoptosis	NN	O	apoptosis	prep_of	31	SENT_273	[p13l1835t1446r2150b1523],
34	due	JJ	O	due	_	0	SENT_273	[p13l9t1550r128b1609],
35	to	TO	O	to	_	0	SENT_273	[p13l152t1559r215b1609],
36	sustained	JJ	O	sustained	amod	39	SENT_273	[p13l243t1550r555b1609],
37	muscle	NN	O	muscle	nn	39	SENT_273	[p13l579t1550r816b1609],
38	cell	NN	O	cell	nn	39	SENT_273	[p13l842t1550r961b1609],
39	Ca2	NN	O	ca2	prep_due_to	31	SENT_273	[p13l986t1534r1146b1610],
40	+	CC	O	+	_	0	SENT_273	[p13l986t1534r1146b1610],
41	transients	NNS	O	transient	conj_+	39	SENT_273	[p13l1175t1550r1516b1620],
42	,	,	O	,	_	0	SENT_273	[p13l1175t1550r1516b1620],
43	leading	VBG	O	lead	partmod	31	SENT_273	[p13l1544t1550r1791b1627],
44	to	TO	O	to	_	0	SENT_273	[p13l1815t1559r1878b1609],
45	calpain	NN	O	calpain	nn	46	SENT_273	[p13l1904t1550r2147b1627],
46	activation	NN	O	activation	prep_to	43	SENT_273	[p13l10t1652r337b1712],
47	[	CD	NUMBER	[	number	48	SENT_273	[p13l366t1653r516b1724],
48	39	CD	NUMBER	39	num	49	SENT_273	[p13l366t1653r516b1724],
49	]	NN	O	]	dep	46	SENT_273	[p13l366t1653r516b1724],
50	.	.	O	.	_	0	SENT_273	[p13l366t1653r516b1724],

1	It	PRP	O	it	nsubjpass	14	SENT_274	[p13l110t1757r161b1815],
2	is	VBZ	O	be	auxpass	4	SENT_274	[p13l181t1755r233b1815],
3	frequently	RB	O	frequently	advmod	4	SENT_274	[p13l257t1755r603b1832],
4	assumed	VBN	O	assume	_	0	SENT_274	[p13l626t1755r915b1815],
5	that	IN	O	that	complm	11	SENT_274	[p13l936t1755r1062b1815],
6	statin	NN	O	statin	nn	8	SENT_274	[p13l1085t1755r1264b1815],
7	muscle	NN	O	muscle	nn	8	SENT_274	[p13l1285t1755r1523b1815],
8	toxicity	NN	O	toxicity	nsubj	11	SENT_274	[p13l1545t1755r1801b1832],
9	should	MD	O	should	aux	11	SENT_274	[p13l1826t1755r2048b1815],
10	be	VB	O	be	cop	11	SENT_274	[p13l2068t1755r2146b1815],
11	dose-related	JJ	O	dose-related	ccomp	4	SENT_274	[p13l9t1857r422b1916],
12	and	CC	O	and	_	0	SENT_274	[p13l442t1857r562b1916],
13	consequently	RB	O	consequently	advmod	14	SENT_274	[p13l581t1857r1026b1934],
14	linked	VBN	O	link	conj_and	4	SENT_274	[p13l1047t1857r1256b1916],
15	to	TO	O	to	_	0	SENT_274	[p13l1276t1866r1338b1916],
16	plasma	NN	O	plasma	nn	18	SENT_274	[p13l1358t1857r1599b1934],
17	drug	NN	O	drug	nn	18	SENT_274	[p13l1618t1857r1769b1934],
18	concentrations	NNS	O	concentration	prep_to	14	SENT_274	[p13l1791t1866r2144b1916, p13l8t1959r169b2019],
19	[	CD	NUMBER	[	num	21	SENT_274	[p13l207t1960r357b2031],
20	ll	NN	O	ll	nn	21	SENT_274	[p13l207t1960r357b2031],
21	]	NN	O	]	dobj	4	SENT_274	[p13l207t1960r357b2031],
22	.	.	O	.	_	0	SENT_274	[p13l207t1960r357b2031],

1	Thus	RB	O	thus	advmod	27	SENT_275	[p13l393t1959r578b2030],
2	,	,	O	,	_	0	SENT_275	[p13l393t1959r578b2030],
3	if	IN	O	if	mark	10	SENT_275	[p13l612t1959r667b2018],
4	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_275	[p13l695t1959r1045b2036],
5	interindividual	JJ	O	interindividual	amod	6	SENT_275	[p13l1075t1959r1570b2019],
6	statin	NN	O	statin	nsubj	10	SENT_275	[p13l1604t1959r1783b2019],
7	metabolic	JJ	O	metabolic	amod	8	SENT_275	[p13l1814t1959r2145b2019],
8	handling	NN	O	handling	dep	6	SENT_275	[p13l7t2061r302b2138],
9	does	VBZ	O	do	aux	10	SENT_275	[p13l324t2061r475b2121],
10	occur	VB	O	occur	advcl	27	SENT_275	[p13l498t2080r698b2131],
11	,	,	O	,	_	0	SENT_275	[p13l498t2080r698b2131],
12	a	DT	O	a	det	14	SENT_275	[p13l723t2080r758b2121],
13	reduced	VBN	O	reduce	amod	14	SENT_275	[p13l775t2061r1044b2121],
14	expression	NN	O	expression	nsubj	27	SENT_275	[p13l1064t2061r1423b2138],
15	of	IN	O	of	_	0	SENT_275	[p13l1444t2061r1518b2121],
16	drug	NN	O	drug	prep_of	14	SENT_275	[p13l1533t2061r1684b2138],
17	metabolizing	VBG	O	metabolize	partmod	14	SENT_275	[p13l1705t2061r2146b2138],
18	enzymes	NNS	O	enzyme	dobj	17	SENT_275	[p13l9t2180r321b2239],
19	,	,	O	,	_	0	SENT_275	[p13l9t2180r321b2239],
20	resulting	VBG	O	result	partmod	17	SENT_275	[p13l350t2162r645b2239],
21	in	IN	O	in	_	0	SENT_275	[p13l672t2162r736b2220],
22	higher	JJR	O	higher	amod	25	SENT_275	[p13l761t2162r978b2239],
23	plasma	NN	O	plasma	nn	25	SENT_275	[p13l1002t2162r1243b2239],
24	drug	NN	O	drug	nn	25	SENT_275	[p13l1269t2162r1420b2239],
25	levels	NNS	O	level	prep_in	20	SENT_275	[p13l1448t2162r1638b2221],
26	should	MD	O	should	aux	27	SENT_275	[p13l1670t2162r1891b2221],
27	lead	VB	O	lead	_	0	SENT_275	[p13l1917t2162r2057b2221],
28	to	TO	O	to	_	0	SENT_275	[p13l2083t2171r2146b2221],
29	enhanced	VBN	O	enhance	amod	30	SENT_275	[p13l9t2265r327b2325],
30	toxicity	NN	O	toxicity	prep_to	27	SENT_275	[p13l359t2265r627b2342],
31	.	.	O	.	_	0	SENT_275	[p13l359t2265r627b2342],

1	Plasma	NN	O	plasma	nn	3	SENT_276	[p13l665t2265r909b2325],
2	statin	NN	O	statin	nn	3	SENT_276	[p13l943t2265r1122b2325],
3	levels	NNS	O	level	nsubj	8	SENT_276	[p13l1155t2265r1345b2325],
4	are	VBP	O	be	aux	8	SENT_276	[p13l1381t2284r1481b2325],
5	generally	RB	O	generally	advmod	8	SENT_276	[p13l1515t2265r1827b2342],
6	not	RB	O	not	neg	8	SENT_276	[p13l1860t2274r1968b2325],
7	very	RB	O	very	advmod	8	SENT_276	[p13l1999t2284r2146b2342],
8	informative	JJ	O	informative	_	0	SENT_276	[p13l8t2367r417b2437],
9	,	,	O	,	_	0	SENT_276	[p13l8t2367r417b2437],
10	since	IN	O	since	mark	13	SENT_276	[p13l458t2367r627b2426],
11	most	JJS	O	most	amod	12	SENT_276	[p13l664t2376r828b2426],
12	statins	NNS	O	statin	nsubj	13	SENT_276	[p13l865t2367r1075b2426],
13	have	VBP	O	have	advcl	8	SENT_276	[p13l1112t2367r1268b2426],
14	a	DT	O	a	det	19	SENT_276	[p13l1306t2385r1341b2426],
15	very	RB	O	very	advmod	16	SENT_276	[p13l1375t2385r1522b2444],
16	short	JJ	O	short	amod	19	SENT_276	[p13l1561t2367r1727b2426],
17	elimination	NN	O	elimination	nn	19	SENT_276	[p13l1763t2367r2147b2426],
18	half	NN	O	half	nn	19	SENT_276	[p13l7t2469r143b2529],
19	life	NN	O	life	dobj	13	SENT_276	[p13l157t2469r288b2540],
20	;	:	O	;	_	0	SENT_276	[p13l157t2469r288b2540],
21	the	DT	O	the	det	22	SENT_276	[p13l311t2469r412b2529],
22	case	NN	O	case	nsubj	25	SENT_276	[p13l432t2488r575b2529],
23	may	MD	O	may	aux	25	SENT_276	[p13l595t2488r738b2546],
24	be	VB	O	be	cop	25	SENT_276	[p13l757t2469r836b2529],
25	different	JJ	O	different	parataxis	8	SENT_276	[p13l856t2469r1144b2529],
26	for	IN	O	for	_	0	SENT_276	[p13l1163t2469r1261b2529],
27	statins	NNS	O	statin	prep_for	25	SENT_276	[p13l1282t2469r1491b2529],
28	with	IN	O	with	_	0	SENT_276	[p13l1513t2469r1662b2529],
29	a	DT	O	a	det	33	SENT_276	[p13l1683t2488r1718b2529],
30	longer	JJR	O	longer	amod	33	SENT_276	[p13l1736t2469r1952b2546],
31	elimination	NN	O	elimination	nn	33	SENT_276	[p13l1970t2469r2144b2529, p13l8t2571r242b2631],
32	half	NN	O	half	nn	33	SENT_276	[p13l269t2571r405b2631],
33	life	NN	O	life	prep_with	27	SENT_276	[p13l427t2571r538b2631],
34	(	CD	NUMBER	(	num	35	SENT_276	[p13l569t2571r1004b2644],
35	atorvastatin	NN	O	atorvastatin	tmod	25	SENT_276	[p13l569t2571r1004b2644],
36	,	,	O	,	_	0	SENT_276	[p13l569t2571r1004b2644],
37	rosuvastatin	NN	O	rosuvastatin	nn	38	SENT_276	[p13l1035t2571r1487b2644],
38	)	NN	O	)	appos	35	SENT_276	[p13l1035t2571r1487b2644],
39	.	.	O	.	_	0	SENT_276	[p13l1035t2571r1487b2644],

1	While	IN	O	while	mark	21	SENT_277	[p13l1518t2571r1724b2631],
2	preliminary	JJ	O	preliminary	amod	3	SENT_277	[p13l1752t2571r2146b2648],
3	ﬁndings	NNS	O	ﬁndings	nsubj	21	SENT_277	[p13l9t2673r277b2750],
4	from	IN	O	from	_	0	SENT_277	[p13l309t2673r473b2732],
5	our	PRP$	O	we	poss	6	SENT_277	[p13l502t2691r613b2732],
6	group	NN	O	group	prep_from	3	SENT_277	[p13l642t2691r836b2750],
7	attempting	VBG	O	attempt	partmod	6	SENT_277	[p13l868t2673r1226b2750],
8	to	TO	O	to	aux	9	SENT_277	[p13l1256t2682r1319b2732],
9	correlate	VB	O	correlate	xcomp	7	SENT_277	[p13l1350t2673r1644b2732],
10	drug	NN	O	drug	nn	11	SENT_277	[p13l1675t2673r1826b2750],
11	levels	NNS	O	level	dobj	9	SENT_277	[p13l1856t2673r2047b2733],
12	of	IN	O	of	_	0	SENT_277	[p13l2079t2673r2152b2732],
13	atorvastatirﬂrosuvastatin	NN	O	atorvastatirﬂrosuvastatin	prep_of	11	SENT_277	[p13l10t2775r832b2835],
14	with	IN	O	with	_	0	SENT_277	[p13l867t2775r1016b2835],
15	reported	VBN	O	report	amod	16	SENT_277	[p13l1049t2775r1332b2852],
16	toxicity	NN	O	toxicity	prep_with	9	SENT_277	[p13l1366t2775r1622b2852],
17	have	VBP	O	have	aux	21	SENT_277	[p13l1657t2775r1812b2835],
18	not	RB	O	not	neg	21	SENT_277	[p13l1848t2784r1955b2835],
19	been	VBN	O	be	cop	21	SENT_277	[p13l1987t2775r2147b2835],
20	particularly	RB	O	particularly	advmod	21	SENT_277	[p13l7t2877r396b2954],
21	informative	JJ	O	informative	advcl	31	SENT_277	[p13l422t2877r830b2947],
22	,	,	O	,	_	0	SENT_277	[p13l422t2877r830b2947],
23	in	IN	O	in	_	0	SENT_277	[p13l858t2877r922b2936],
24	a	DT	O	a	det	27	SENT_277	[p13l949t2896r984b2937],
25	very	RB	O	very	advmod	26	SENT_277	[p13l1008t2896r1153b2954],
26	recent	JJ	O	recent	amod	27	SENT_277	[p13l1178t2886r1386b2937],
27	report	NN	O	report	prep_in	21	SENT_277	[p13l1408t2886r1628b2954],
28	,	,	O	,	_	0	SENT_277	[p13l1408t2886r1628b2954],
29	myopathy	NN	O	myopathy	nsubjpass	31	SENT_277	[p13l1656t2877r1992b2954],
30	was	VBD	O	be	auxpass	31	SENT_277	[p13l2018t2896r2145b2937],
31	related	VBN	O	relate	_	0	SENT_277	[p13l7t2978r237b3037],
32	to	TO	O	to	_	0	SENT_277	[p13l252t2987r315b3037],
33	an	DT	O	a	det	36	SENT_277	[p13l333t2996r410b3037],
34	increased	VBN	O	increase	amod	36	SENT_277	[p13l425t2978r744b3037],
35	systemic	JJ	O	systemic	amod	36	SENT_277	[p13l762t2978r1053b3055],
36	exposure	NN	O	exposure	prep_to	31	SENT_277	[p13l1071t2996r1373b3055],
37	to	TO	O	to	_	0	SENT_277	[p13l1388t2986r1451b3037],
38	the	DT	O	the	det	41	SENT_277	[p13l1468t2978r1569b3037],
39	metabolites	NNS	O	metabolite	nn	41	SENT_277	[p13l1585t2978r1973b3037],
40	atorvastatin	NN	O	atorvastatin	nn	41	SENT_277	[p13l1992t2987r2144b3037, p13l8t3081r268b3141],
41	lactone	NN	O	lactone	prep_to	36	SENT_277	[p13l296t3081r538b3141],
42	and	CC	O	and	_	0	SENT_277	[p13l569t3081r688b3141],
43	p-hydroxyatorvastatin	NN	O	p-hydroxyatorvastatin	conj_and	36	SENT_277	[p13l714t3081r1461b3158],
44	[	CD	NUMBER	[	number	45	SENT_277	[p13l1495t3082r1645b3153],
45	40	CD	NUMBER	40	num	46	SENT_277	[p13l1495t3082r1645b3153],
46	]	NN	O	]	dep	43	SENT_277	[p13l1495t3082r1645b3153],
47	.	.	O	.	_	0	SENT_277	[p13l1495t3082r1645b3153],

1	In	IN	O	in	_	0	SENT_278	[p13l1677t3083r1746b3140],
2	the	DT	O	the	det	4	SENT_278	[p13l1774t3081r1875b3141],
3	present	JJ	DATE	present	amod	4	SENT_278	[p13l1902t3090r2148b3158],
4	series	NN	O	series	prep_in	10	SENT_278	[p13l11t3183r197b3242],
5	of	IN	O	of	_	0	SENT_278	[p13l222t3183r295b3242],
6	atorvastatin	NN	O	atorvastatin	nn	8	SENT_278	[p13l313t3183r703b3242],
7	treated	JJ	O	treated	amod	8	SENT_278	[p13l724t3183r954b3242],
8	patients	NNS	O	patient	prep_of	4	SENT_278	[p13l974t3183r1234b3260],
9	there	EX	O	there	expl	10	SENT_278	[p13l1258t3183r1425b3242],
10	was	VBD	O	be	_	0	SENT_278	[p13l1448t3201r1574b3243],
11	no	DT	O	no	det	12	SENT_278	[p13l1598t3201r1679b3242],
12	evidence	NN	O	evidence	nsubj	10	SENT_278	[p13l1703t3183r1999b3243],
13	of	IN	O	of	_	0	SENT_278	[p13l2022t3183r2095b3242],
14	a	DT	O	a	det	15	SENT_278	[p13l2113t3201r2148b3242],
15	difference	NN	O	difference	prep_of	12	SENT_278	[p13l9t3284r348b3343],
16	in	IN	O	in	_	0	SENT_278	[p13l371t3284r435b3342],
17	CYP3A5	NN	O	cyp3a5	nn	19	SENT_278	[p13l459t3284r764b3344],
18	carrier	NN	O	carrier	nn	19	SENT_278	[p13l792t3284r1012b3343],
19	status	NN	O	status	prep_in	15	SENT_278	[p13l1037t3293r1242b3343],
20	.	.	O	.	_	0	SENT_278	[p13l1037t3293r1242b3343],

1	From	IN	O	from	_	0	SENT_279	[p13l109t3388r293b3446],
2	the	DT	O	the	det	4	SENT_279	[p13l317t3386r418b3446],
3	present	JJ	DATE	present	amod	4	SENT_279	[p13l444t3395r689b3463],
4	investigation	NN	O	investigation	prep_from	7	SENT_279	[p13l713t3386r1163b3463],
5	,	,	O	,	_	0	SENT_279	[p13l713t3386r1163b3463],
6	it	PRP	O	it	nsubj	7	SENT_279	[p13l1192t3386r1238b3446],
7	appears	VBZ	O	appear	_	0	SENT_279	[p13l1265t3405r1518b3463],
8	that	IN	O	that	complm	23	SENT_279	[p13l1545t3386r1672b3446],
9	the	DT	O	the	det	10	SENT_279	[p13l1696t3386r1797b3446],
10	incidence	NN	O	incidence	nsubj	23	SENT_279	[p13l1824t3386r2146b3446],
11	of	IN	O	of	_	0	SENT_279	[p13l9t3488r82b3547],
12	myopathy	NN	O	myopathy	prep_of	10	SENT_279	[p13l97t3488r447b3565],
13	,	,	O	,	_	0	SENT_279	[p13l97t3488r447b3565],
14	both	DT	O	both	det	15	SENT_279	[p13l469t3488r620b3547],
15	CPK	NN	ORGANIZATION	cpk	appos	10	SENT_279	[p13l641t3488r804b3548],
16	associated	VBN	O	associate	partmod	15	SENT_279	[p13l825t3488r1171b3547],
17	and	CC	O	and	_	0	SENT_279	[p13l1193t3488r1312b3547],
18	non	JJ	O	non	appos	10	SENT_279	[p13l1332t3506r1457b3547],
19	associated	VBN	O	associate	partmod	18	SENT_279	[p13l1479t3488r1843b3558],
20	,	,	O	,	_	0	SENT_279	[p13l1479t3488r1843b3558],
21	does	VBZ	O	do	dep	23	SENT_279	[p13l1867t3488r2018b3547],
22	not	RB	O	not	neg	23	SENT_279	[p13l2040t3497r2148b3547],
23	signiﬁcantly	JJ	O	signiﬁcantly	ccomp	7	SENT_279	[p13l11t3590r425b3667],
24	differ	VBP	O	differ	ccomp	23	SENT_279	[p13l457t3590r642b3650],
25	in	IN	O	in	_	0	SENT_279	[p13l670t3590r734b3649],
26	the	DT	O	the	det	27	SENT_279	[p13l764t3590r865b3650],
27	carriers	NNS	O	carrier	prep_in	24	SENT_279	[p13l897t3590r1146b3650],
28	of	IN	O	of	_	0	SENT_279	[p13l1180t3590r1253b3650],
29	the	DT	O	the	det	32	SENT_279	[p13l1277t3590r1378b3650],
30	major	JJ	O	major	amod	32	SENT_279	[p13l1409t3590r1607b3667],
31	CYP450	NN	O	cyp450	nn	32	SENT_279	[p13l1636t3590r1925b3650],
32	genotypes	NNS	O	genotype	prep_of	27	SENT_279	[p13l1956t3609r2144b3667, p13l8t3701r203b3769],
33	,	,	O	,	_	0	SENT_279	[p13l1956t3609r2144b3667, p13l8t3701r203b3769],
34	in	IN	O	in	_	0	SENT_279	[p13l230t3692r294b3751],
35	particular	JJ	O	particular	prep_in	23	SENT_279	[p13l316t3692r642b3769],
36	as	IN	O	as	mark	37	SENT_279	[p13l665t3711r730b3752],
37	relates	VBZ	O	relate	dep	35	SENT_279	[p13l754t3692r972b3752],
38	to	TO	O	to	_	0	SENT_279	[p13l998t3701r1061b3752],
39	CYP3A5	NN	O	cyp3a5	prep_to	37	SENT_279	[p13l1086t3692r1412b3762],
40	,	,	O	,	_	0	SENT_279	[p13l1086t3692r1412b3762],
41	2D6	NN	O	2d6	prep_to	37	SENT_279	[p13l1440t3692r1601b3762],
42	,	,	O	,	_	0	SENT_279	[p13l1440t3692r1601b3762],
43	and	CC	O	and	_	0	SENT_279	[p13l1630t3692r1749b3752],
44	2C9	NN	O	2c9	prep_to	37	SENT_279	[p13l1773t3692r1928b3753],
45	.	.	O	.	_	0	SENT_279	[p13l1773t3692r1928b3753],

1	Some	DT	O	some	det	2	SENT_280	[p13l1958t3692r2146b3752],
2	borderline	NN	O	borderline	nsubj	4	SENT_280	[p14l7t19r354b78],
3	higher	JJR	O	higher	amod	4	SENT_280	[p14l379t19r596b96],
4	incidence	NN	O	incidence	_	0	SENT_280	[p14l619t19r942b78],
5	of	IN	O	of	_	0	SENT_280	[p14l968t19r1041b78],
6	toxicity	NN	O	toxicity	prep_of	4	SENT_280	[p14l1060t19r1316b96],
7	was	VBD	O	be	auxpass	8	SENT_280	[p14l1342t37r1469b78],
8	found	VBN	O	find	rcmod	4	SENT_280	[p14l1496t19r1692b78],
9	with	IN	O	with	_	0	SENT_280	[p14l1716t19r1865b78],
10	speciﬁc	NN	O	speciﬁc	nn	11	SENT_280	[p14l1892t19r2145b96],
11	genotypes	NNS	O	genotype	prep_with	8	SENT_280	[p14l9t131r348b199],
12	e.g.	FW	O	e.g.	nn	14	SENT_280	[p14l376t141r491b199],
13	*	FW	O	*	dep	14	SENT_280	[p14l526t123r708b182],
14	3	CD	NUMBER	3	advmod	8	SENT_280	[p14l526t123r708b182],
15	/	:	O	/	punct	17	SENT_280	[p14l526t123r708b182],
16	*	CD	NUMBER	*	number	17	SENT_280	[p14l526t123r708b182],
17	3	CD	NUMBER	3	dep	4	SENT_280	[p14l526t123r708b182],
18	for	IN	O	for	_	0	SENT_280	[p14l738t122r836b182],
19	CYP3A5	NN	O	cyp3a5	prep_for	17	SENT_280	[p14l861t122r1186b182],
20	.	.	O	.	_	0	SENT_280	[p14l861t122r1186b182],

1	These	DT	O	these	det	4	SENT_281	[p14l1216t122r1416b182],
2	last	JJ	O	last	amod	4	SENT_281	[p14l1442t122r1559b182],
3	ﬁndings	NNS	O	ﬁndings	nn	4	SENT_281	[p14l1584t122r1852b199],
4	contrast	NN	O	contrast	_	0	SENT_281	[p14l1881t131r2148b182],
5	with	IN	O	with	_	0	SENT_281	[p14l8t223r157b283],
6	those	DT	O	those	prep_with	4	SENT_281	[p14l181t223r357b282],
7	of	IN	O	of	_	0	SENT_281	[p14l383t223r456b282],
8	Fiegenbaum	NNP	PERSON	Fiegenbaum	prep_of	6	SENT_281	[p14l473t223r892b300],
9	et	FW	O	et	nn	11	SENT_281	[p14l915t232r975b282],
10	al.	FW	O	al.	nn	11	SENT_281	[p14l999t223r1073b282],
11	[	FW	O	[	dep	8	SENT_281	[p14l1108t223r1259b295],
12	25	CD	NUMBER	25	num	13	SENT_281	[p14l1108t223r1259b295],
13	]	NN	O	]	dep	11	SENT_281	[p14l1108t223r1259b295],
14	,	,	O	,	_	0	SENT_281	[p14l1108t223r1259b295],
15	suggesting	VBG	O	suggest	partmod	13	SENT_281	[p14l1289t223r1647b300],
16	that	IN	O	that	complm	21	SENT_281	[p14l1671t223r1798b282],
17	this	DT	O	this	det	18	SENT_281	[p14l1820t223r1939b282],
18	allele	NN	O	allele	nsubjpass	21	SENT_281	[p14l1967t223r2146b282],
19	is	VBZ	O	be	auxpass	21	SENT_281	[p14l8t326r60b386],
20	signiﬁcantly	RB	O	signiﬁcantly	advmod	21	SENT_281	[p14l84t326r498b403],
21	associated	VBN	O	associate	ccomp	15	SENT_281	[p14l520t326r866b386],
22	with	IN	O	with	_	0	SENT_281	[p14l885t326r1034b386],
23	a	DT	O	a	det	25	SENT_281	[p14l1054t345r1089b386],
24	higher	JJR	O	higher	amod	25	SENT_281	[p14l1106t326r1323b403],
25	incidence	NN	O	incidence	prep_with	21	SENT_281	[p14l1341t326r1664b386],
26	of	IN	O	of	_	0	SENT_281	[p14l1684t326r1757b386],
27	side	JJ	O	side	amod	28	SENT_281	[p14l1774t326r1905b386],
28	effects	NNS	O	effect	prep_of	25	SENT_281	[p14l1926t326r2145b386],
29	to	TO	O	to	_	0	SENT_281	[p14l8t437r71b488],
30	simvastatin	NN	O	simvastatin	prep_to	21	SENT_281	[p14l96t428r493b488],
31	.	.	O	.	_	0	SENT_281	[p14l96t428r493b488],

1	Their	PRP$	O	they	poss	3	SENT_282	[p14l519t428r702b488],
2	patient	NN	O	patient	nn	3	SENT_282	[p14l721t428r952b505],
3	series	NN	O	series	nsubj	8	SENT_282	[p14l975t428r1162b488],
4	was	VBD	O	be	cop	8	SENT_282	[p14l1186t447r1332b499],
5	,	,	O	,	_	0	SENT_282	[p14l1186t447r1332b499],
6	however	RB	O	however	dep	8	SENT_282	[p14l1356t428r1656b498],
7	,	,	O	,	_	0	SENT_282	[p14l1356t428r1656b498],
8	small	JJ	O	small	_	0	SENT_282	[p14l1684t428r1862b488],
9	and	CC	O	and	_	0	SENT_282	[p14l1886t428r2006b488],
10	statistical	JJ	O	statistical	amod	11	SENT_282	[p14l2029t437r2144b488, p14l8t530r232b589],
11	signiﬁcance	NN	O	signiﬁcance	nsubj	16	SENT_282	[p14l263t530r663b607],
12	might	MD	O	might	aux	16	SENT_282	[p14l691t530r888b607],
13	be	VB	O	be	cop	16	SENT_282	[p14l914t530r993b589],
14	a	DT	O	a	det	16	SENT_282	[p14l1022t548r1057b589],
15	chance	NN	O	chance	nn	16	SENT_282	[p14l1085t530r1317b589],
16	ﬁnding	NN	O	ﬁnding	conj_and	8	SENT_282	[p14l1346t530r1601b607],
17	.	.	O	.	_	0	SENT_282	[p14l1346t530r1601b607],

1	The	DT	O	the	det	4	SENT_283	[p14l1633t530r1762b589],
2	apparently	RB	O	apparently	advmod	4	SENT_283	[p14l1792t530r2146b607],
3	increased	VBN	O	increase	amod	4	SENT_283	[p14l8t632r327b692],
4	incidence	NN	O	incidence	nsubj	26	SENT_283	[p14l356t632r679b692],
5	of	IN	O	of	_	0	SENT_283	[p14l710t632r783b692],
6	AEs	NNS	O	ae	prep_of	4	SENT_283	[p14l806t633r949b692],
7	in	IN	O	in	_	0	SENT_283	[p14l980t632r1044b691],
8	carriers	NNS	O	carrier	prep_in	6	SENT_283	[p14l1074t632r1323b692],
9	of	IN	O	of	_	0	SENT_283	[p14l1356t632r1429b692],
10	the	DT	O	the	det	11	SENT_283	[p14l1453t632r1554b692],
11	*	NN	O	*	prep_of	8	SENT_283	[p14l1588t633r1767b692],
12	1	CD	NUMBER	1	num	11	SENT_283	[p14l1588t633r1767b692],
13	/	:	O	/	punct	16	SENT_283	[p14l1588t633r1767b692],
14	*	CD	NUMBER	*	number	15	SENT_283	[p14l1588t633r1767b692],
15	1	CD	NUMBER	1	num	16	SENT_283	[p14l1588t633r1767b692],
16	genotypes	NNS	O	genotype	dep	11	SENT_283	[p14l1805t641r2145b709],
17	for	IN	O	for	_	0	SENT_283	[p14l8t733r106b793],
18	both	DT	O	both	det	19	SENT_283	[p14l124t733r274b793],
19	CYP2D6	NN	O	cyp2d6	prep_for	16	SENT_283	[p14l296t733r603b793],
20	and	CC	O	and	_	0	SENT_283	[p14l627t733r746b793],
21	CYPZC9	NN	O	cypzc9	conj_and	11	SENT_283	[p14l767t733r1089b803],
22	,	,	O	,	_	0	SENT_283	[p14l767t733r1089b803],
23	did	VBD	O	do	aux	26	SENT_283	[p14l1113t733r1220b793],
24	not	RB	O	not	neg	26	SENT_283	[p14l1239t742r1347b793],
25	instead	RB	O	instead	advmod	26	SENT_283	[p14l1367t733r1606b793],
26	reach	VB	O	reach	_	0	SENT_283	[p14l1625t733r1807b793],
27	statistical	JJ	O	statistical	amod	28	SENT_283	[p14l1831t733r2146b793],
28	signiﬁcance	NN	O	signiﬁcance	dobj	26	SENT_283	[p14l11t835r428b912],
29	.	.	O	.	_	0	SENT_283	[p14l11t835r428b912],

1	Even	RB	O	even	advmod	9	SENT_284	[p14l462t836r634b895],
2	if	IN	O	if	dep	9	SENT_284	[p14l665t835r720b893],
3	a	DT	O	a	det	6	SENT_284	[p14l747t853r782b894],
4	larger	JJR	O	larger	amod	6	SENT_284	[p14l811t835r1007b912],
5	patients	NNS	O	patient	nn	6	SENT_284	[p14l1034t835r1296b912],
6	database	NN	O	database	nsubj	9	SENT_284	[p14l1329t835r1618b894],
7	could	MD	O	could	aux	9	SENT_284	[p14l1649t835r1836b894],
8	possibly	RB	O	possibly	advmod	9	SENT_284	[p14l1865t835r2146b912],
9	lead	VB	O	lead	advcl	29	SENT_284	[p14l8t938r148b998],
10	to	TO	O	to	_	0	SENT_284	[p14l169t947r232b998],
11	the	DT	O	the	det	12	SENT_284	[p14l255t938r356b998],
12	identiﬁcation	NN	O	identiﬁcation	prep_to	9	SENT_284	[p14l378t938r825b998],
13	of	IN	O	of	_	0	SENT_284	[p14l847t938r921b998],
14	an	DT	O	a	det	16	SENT_284	[p14l939t957r1015b998],
15	increased	VBN	O	increase	amod	16	SENT_284	[p14l1037t938r1356b998],
16	risk	NN	O	risk	prep_of	12	SENT_284	[p14l1376t938r1504b998],
17	of	IN	O	of	_	0	SENT_284	[p14l1525t938r1599b998],
18	myopathy	NN	O	myopathy	prep_of	16	SENT_284	[p14l1615t938r1952b1015],
19	associated	VBN	O	associate	partmod	18	SENT_284	[p14l1976t957r2144b998, p14l9t1040r209b1099],
20	with	IN	O	with	_	0	SENT_284	[p14l233t1040r382b1099],
21	these	DT	O	these	det	22	SENT_284	[p14l406t1040r578b1099],
22	genotypes	NNS	O	genotype	prep_with	19	SENT_284	[p14l604t1049r963b1117],
23	,	,	O	,	_	0	SENT_284	[p14l604t1049r963b1117],
24	the	DT	O	the	det	25	SENT_284	[p14l991t1040r1092b1099],
25	ﬁnding	NN	O	ﬁnding	nsubj	29	SENT_284	[p14l1118t1040r1354b1117],
26	would	MD	O	would	aux	29	SENT_284	[p14l1380t1040r1590b1100],
27	probably	RB	O	probably	advmod	29	SENT_284	[p14l1613t1040r1913b1117],
28	not	RB	O	not	neg	29	SENT_284	[p14l1938t1049r2046b1099],
29	be	VB	O	be	_	0	SENT_284	[p14l2068t1040r2146b1099],
30	of	IN	O	of	_	0	SENT_284	[p14l9t1142r82b1202],
31	major	JJ	O	major	amod	33	SENT_284	[p14l100t1142r298b1219],
32	clinical	JJ	O	clinical	amod	33	SENT_284	[p14l320t1142r567b1202],
33	interest	NN	O	interest	prep_of	29	SENT_284	[p14l591t1142r856b1202],
34	.	.	O	.	_	0	SENT_284	[p14l591t1142r856b1202],

1	This	DT	O	this	det	2	SENT_285	[p14l110t1244r257b1304],
2	study	NN	O	study	nsubj	3	SENT_285	[p14l298t1244r476b1321],
3	allowed	VBD	O	allow	_	0	SENT_285	[p14l516t1244r779b1304],
4	thus	RB	O	thus	advmod	3	SENT_285	[p14l815t1244r953b1304],
5	to	TO	O	to	aux	6	SENT_285	[p14l991t1253r1054b1304],
6	evaluate	VB	O	evaluate	xcomp	3	SENT_285	[p14l1093t1244r1368b1304],
7	a	DT	O	a	det	9	SENT_285	[p14l1407t1263r1442b1304],
8	large	JJ	O	large	amod	9	SENT_285	[p14l1477t1244r1643b1321],
9	population	NN	O	population	dobj	6	SENT_285	[p14l1679t1244r2042b1321],
10	of	IN	O	of	_	0	SENT_285	[p14l2079t1244r2152b1304],
11	statin	NN	O	statin	nn	13	SENT_285	[p14l11t1346r190b1405],
12	treated	JJ	O	treated	amod	13	SENT_285	[p14l207t1346r437b1405],
13	patients	NNS	O	patient	prep_of	9	SENT_285	[p14l453t1346r714b1423],
14	with	IN	O	with	prep	13	SENT_285	[p14l735t1346r883b1406],
15	well	RB	O	well	pcomp	14	SENT_285	[p14l901t1346r1045b1406],
16	documented	VBN	O	document	partmod	13	SENT_285	[p14l1064t1346r1477b1405],
17	subjective	JJ	O	subjective	amod	22	SENT_285	[p14l1497t1346r1832b1423],
18	or	CC	O	or	_	0	SENT_285	[p14l1851t1364r1920b1405],
19	obj	JJ	O	obj	conj_or	17	SENT_285	[p14l1938t1346r2037b1423],
20	ective	JJ	O	ective	amod	22	SENT_285	[p14l2046t1364r2144b1405, p14l8t1448r129b1508],
21	muscular	JJ	O	muscular	amod	22	SENT_285	[p14l159t1448r471b1508],
22	AEs	NNS	O	ae	dobj	16	SENT_285	[p14l499t1449r660b1508],
23	.	.	O	.	_	0	SENT_285	[p14l499t1449r660b1508],

1	While	IN	O	while	mark	13	SENT_286	[p14l693t1448r899b1508],
2	the	DT	O	the	det	3	SENT_286	[p14l929t1448r1031b1508],
3	number	NN	O	number	nsubj	13	SENT_286	[p14l1061t1448r1320b1508],
4	of	IN	O	of	_	0	SENT_286	[p14l1349t1448r1423b1508],
5	patients	NNS	O	patient	prep_of	3	SENT_286	[p14l1446t1448r1707b1525],
6	treated	VBN	O	treat	partmod	5	SENT_286	[p14l1739t1448r1968b1508],
7	with	IN	O	with	_	0	SENT_286	[p14l1998t1448r2147b1508],
8	each	DT	O	each	det	9	SENT_286	[p14l9t1550r162b1610],
9	statin	NN	O	statin	prep_with	6	SENT_286	[p14l195t1550r374b1610],
10	may	MD	O	may	aux	13	SENT_286	[p14l405t1569r548b1627],
11	seem	VB	O	seem	cop	13	SENT_286	[p14l583t1569r753b1610],
12	relatively	RB	O	relatively	advmod	13	SENT_286	[p14l783t1550r1098b1627],
13	small	JJ	O	small	advcl	18	SENT_286	[p14l1133t1550r1329b1620],
14	,	,	O	,	_	0	SENT_286	[p14l1133t1550r1329b1620],
15	it	PRP	O	it	nsubjpass	18	SENT_286	[p14l1364t1550r1410b1610],
16	should	MD	O	should	aux	18	SENT_286	[p14l1443t1550r1665b1610],
17	be	VB	O	be	auxpass	18	SENT_286	[p14l1694t1550r1772b1610],
18	noted	VBN	O	note	_	0	SENT_286	[p14l1804t1550r1991b1610],
19	that	IN	O	that	complm	23	SENT_286	[p14l2021t1550r2148b1610],
20	statins	NNS	O	statin	nsubjpass	23	SENT_286	[p14l11t1650r221b1710],
21	must	MD	O	must	aux	23	SENT_286	[p14l264t1660r428b1710],
22	be	VB	O	be	auxpass	23	SENT_286	[p14l467t1651r545b1710],
23	grouped	VBN	O	group	ccomp	18	SENT_286	[p14l588t1651r864b1728],
24	into	IN	O	into	_	0	SENT_286	[p14l904t1651r1033b1710],
25	molecules	NNS	O	molecule	prep_into	23	SENT_286	[p14l1075t1651r1415b1710],
26	handled	VBN	O	handle	partmod	25	SENT_286	[p14l1457t1651r1725b1710],
27	by	IN	O	by	_	0	SENT_286	[p14l1765t1651r1848b1728],
28	speciﬁc	NN	O	speciﬁc	nn	29	SENT_286	[p14l1892t1651r2145b1728],
29	CYPS	NN	O	cyp	agent	26	SENT_286	[p14l9t1755r224b1825],
30	;	:	O	;	_	0	SENT_286	[p14l9t1755r224b1825],
31	it	PRP	O	it	nsubj	34	SENT_286	[p14l261t1754r307b1814],
32	is	VBZ	O	be	cop	34	SENT_286	[p14l339t1754r392b1814],
33	thus	RB	O	thus	advmod	34	SENT_286	[p14l427t1754r565b1814],
34	evident	JJ	O	evident	parataxis	18	SENT_286	[p14l601t1754r847b1814],
35	that	IN	O	that	complm	42	SENT_286	[p14l879t1754r1006b1814],
36	a	DT	O	a	det	38	SENT_286	[p14l1039t1773r1075b1814],
37	signiﬁcant	JJ	O	signiﬁcant	amod	38	SENT_286	[p14l1110t1754r1460b1831],
38	number	NN	O	number	nsubjpass	42	SENT_286	[p14l1492t1754r1751b1814],
39	of	IN	O	of	_	0	SENT_286	[p14l1784t1754r1857b1814],
40	patients	NNS	O	patient	prep_of	38	SENT_286	[p14l1884t1754r2145b1831],
41	were	VBD	O	be	auxpass	42	SENT_286	[p14l8t1873r170b1915],
42	treated	VBN	O	treat	ccomp	34	SENT_286	[p14l206t1855r436b1914],
43	with	IN	O	with	prep	42	SENT_286	[p14l472t1855r638b1925],
44	,	,	O	,	_	0	SENT_286	[p14l472t1855r638b1925],
45	e.g.	FW	O	e.g.	dep	49	SENT_286	[p14l677t1873r793b1932],
46	CYP2D6	NN	O	cyp2d6	nn	49	SENT_286	[p14l834t1855r1141b1915],
47	or	CC	O	or	_	0	SENT_286	[p14l1179t1873r1248b1914],
48	CYP3A5	NN	O	cyp3a5	conj_or	46	SENT_286	[p14l1283t1854r1587b1915],
49	substrates	NNS	O	substrate	dep	34	SENT_286	[p14l1630t1855r1977b1914],
50	.	.	O	.	_	0	SENT_286	[p14l1630t1855r1977b1914],

1	The	DT	O	the	det	2	SENT_287	[p14l2017t1855r2146b1914],
2	study	NN	O	study	nsubj	4	SENT_287	[p14l11t1958r189b2035],
3	also	RB	O	also	advmod	4	SENT_287	[p14l221t1958r352b2018],
4	allowed	VBD	O	allow	_	0	SENT_287	[p14l384t1958r648b2018],
5	to	TO	O	to	aux	6	SENT_287	[p14l676t1967r739b2018],
6	test	VB	O	test	xcomp	4	SENT_287	[p14l769t1967r886b2018],
7	in	IN	O	in	_	0	SENT_287	[p14l915t1958r978b2017],
8	parallel	NN	O	parallel	prep_in	6	SENT_287	[p14l1007t1958r1260b2035],
9	the	DT	O	the	det	10	SENT_287	[p14l1289t1958r1391b2018],
10	inﬂuence	NN	O	inﬂuence	dobj	6	SENT_287	[p14l1420t1958r1729b2018],
11	of	IN	O	of	_	0	SENT_287	[p14l1760t1958r1833b2018],
12	CYP450	NN	O	cyp450	nn	13	SENT_287	[p14l1857t1958r2146b2018],
13	genotypes	NNS	O	genotype	prep_of	10	SENT_287	[p14l9t2069r348b2137],
14	on	IN	O	on	_	0	SENT_287	[p14l388t2079r470b2120],
15	lipid	NN	O	lipid	nn	16	SENT_287	[p14l507t2060r661b2137],
16	responses	NNS	O	response	prep_on	13	SENT_287	[p14l696t2079r1023b2137],
17	to	TO	O	to	_	0	SENT_287	[p14l1062t2069r1125b2120],
18	statins	NNS	O	statin	prep_to	16	SENT_287	[p14l1166t2060r1395b2120],
19	.	.	O	.	_	0	SENT_287	[p14l1166t2060r1395b2120],

1	This	DT	O	this	det	2	SENT_288	[p14l1436t2060r1583b2120],
2	topic	NN	O	topic	nsubjpass	5	SENT_288	[p14l1622t2060r1788b2137],
3	is	VBZ	O	be	auxpass	5	SENT_288	[p14l1826t2060r1879b2120],
4	widely	RB	O	widely	advmod	5	SENT_288	[p14l1918t2060r2146b2137],
5	debated	VBN	O	debate	_	0	SENT_288	[p14l9t2162r288b2232],
6	,	,	O	,	_	0	SENT_288	[p14l9t2162r288b2232],
7	since	IN	O	since	mark	22	SENT_288	[p14l313t2162r482b2221],
8	initially	RB	O	initially	advmod	22	SENT_288	[p14l502t2162r763b2239],
9	Kivisto	NNP	PERSON	Kivisto	nsubj	22	SENT_288	[p14l785t2162r1028b2221],
10	et	FW	O	et	nn	12	SENT_288	[p14l1050t2171r1109b2221],
11	al.	FW	O	al.	nn	12	SENT_288	[p14l1129t2162r1203b2221],
12	[	FW	O	[	dep	9	SENT_288	[p14l1233t2162r1360b2234],
13	26	CD	NUMBER	26	num	14	SENT_288	[p14l1233t2162r1360b2234],
14	]	NN	O	]	npadvmod	12	SENT_288	[p14l1233t2162r1360b2234],
15	in	IN	O	in	_	0	SENT_288	[p14l1386t2162r1450b2221],
16	a	DT	O	a	det	17	SENT_288	[p14l1471t2180r1506b2221],
17	study	NN	O	study	prep_in	12	SENT_288	[p14l1527t2162r1705b2239],
18	on	IN	O	on	_	0	SENT_288	[p14l1726t2180r1808b2221],
19	46	CD	NUMBER	46	num	21	SENT_288	[p14l1827t2162r1908b2222],
20	hypercholesterolaemic	JJ	O	hypercholesterolaemic	amod	21	SENT_288	[p14l1929t2162r2144b2239, p14l9t2264r580b2324],
21	patients	NNS	O	patient	prep_on	17	SENT_288	[p14l597t2264r858b2341],
22	noted	VBD	O	note	advcl	5	SENT_288	[p14l877t2264r1064b2324],
23	a	DT	O	a	det	27	SENT_288	[p14l1082t2283r1118b2324],
24	higher	JJR	O	higher	amod	27	SENT_288	[p14l1132t2264r1349b2341],
25	mean	NN	O	mean	nn	27	SENT_288	[p14l1365t2283r1546b2324],
26	percent	NN	O	percent	nn	27	SENT_288	[p14l1562t2273r1812b2341],
27	reduction	NN	O	reduction	dobj	22	SENT_288	[p14l1827t2264r2147b2324],
28	of	IN	O	of	_	0	SENT_288	[p14l9t2366r82b2426],
29	total	JJ	O	total	prep_of	27	SENT_288	[p14l96t2366r244b2426],
30	and	CC	O	and	_	0	SENT_288	[p14l266t2366r385b2426],
31	LDL	NN	O	ldl	prep_of	27	SENT_288	[p14l403t2366r650b2426],
32	.	.	O	.	_	0	SENT_288	[p14l403t2366r650b2426],

1	—	NN	O	—	_	0	SENT_289	[p14l403t2366r650b2426],
2	.	.	O	.	_	0	SENT_289	[p14l403t2366r650b2426],

1	C	NN	O	c	_	0	SENT_290	[p14l403t2366r650b2426],
2	in	IN	O	in	_	0	SENT_290	[p14l671t2366r735b2425],
3	the	DT	O	the	det	5	SENT_290	[p14l754t2366r855b2426],
4	CYP3A5	NN	O	cyp3a5	nn	5	SENT_290	[p14l876t2366r1181b2426],
5	*	NN	O	*	prep_in	1	SENT_290	[p14l1208t2367r1240b2402],
6	1	CD	NUMBER	1	dep	5	SENT_290	[p14l1254t2366r1312b2426],
7	/	:	O	/	punct	1	SENT_290	[p14l1254t2366r1312b2426],
8	*	CD	NUMBER	*	number	9	SENT_290	[p14l1317t2366r1391b2426],
9	3	CD	NUMBER	3	dep	1	SENT_290	[p14l1317t2366r1391b2426],
10	genotype	NN	O	genotype	nn	11	SENT_290	[p14l1416t2375r1723b2443],
11	carriers	NNS	O	carrier	dep	9	SENT_290	[p14l1744t2366r1994b2426],
12	versus	CC	O	versus	prep	9	SENT_290	[p14l2016t2385r2144b2426, p14l11t2485r112b2526],
13	non	JJ	O	non	amod	14	SENT_290	[p14l134t2485r260b2526],
14	expressors	NNS	O	expressor	dep	12	SENT_290	[p14l280t2485r651b2544],
15	.	.	O	.	_	0	SENT_290	[p14l280t2485r651b2544],

1	This	DT	O	this	det	2	SENT_291	[p14l676t2467r822b2526],
2	ﬁnding	NN	O	ﬁnding	nsubjpass	5	SENT_291	[p14l846t2467r1082b2544],
3	was	VBD	O	be	auxpass	5	SENT_291	[p14l1104t2485r1230b2527],
4	not	RB	O	not	neg	5	SENT_291	[p14l1252t2476r1360b2526],
5	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_291	[p14l1379t2467r1721b2526],
6	in	IN	O	in	_	0	SENT_291	[p14l1741t2467r1804b2525],
7	our	PRP$	O	we	poss	8	SENT_291	[p14l1825t2485r1937b2526],
8	series	NN	O	series	prep_in	5	SENT_291	[p14l1958t2467r2145b2526],
9	of	IN	O	of	_	0	SENT_291	[p14l9t2570r82b2630],
10	100	CD	NUMBER	100	num	11	SENT_291	[p14l107t2571r224b2630],
11	individuals	NNS	O	individual	prep_of	8	SENT_291	[p14l247t2570r640b2641],
12	;	:	O	;	_	0	SENT_291	[p14l247t2570r640b2641],
13	we	PRP	O	we	nsubj	14	SENT_291	[p14l667t2589r763b2630],
14	found	VBD	O	find	parataxis	5	SENT_291	[p14l787t2570r1000b2640],
15	,	,	O	,	_	0	SENT_291	[p14l787t2570r1000b2640],
16	however	RB	O	however	advmod	14	SENT_291	[p14l1025t2570r1325b2641],
17	,	,	O	,	_	0	SENT_291	[p14l1025t2570r1325b2641],
18	that	IN	O	that	complm	24	SENT_291	[p14l1351t2570r1478b2630],
19	the	DT	O	the	det	21	SENT_291	[p14l1499t2570r1600b2630],
20	CYP2D6	NN	O	cyp2d6	nn	21	SENT_291	[p14l1625t2570r1931b2630],
21	genotype	NN	O	genotype	nsubjpass	24	SENT_291	[p14l1956t2589r2144b2647, p14l8t2681r151b2749],
22	is	VBZ	O	be	auxpass	24	SENT_291	[p14l186t2672r239b2731],
23	signiﬁcantly	RB	O	signiﬁcantly	advmod	24	SENT_291	[p14l278t2672r693b2749],
24	correlated	VBN	O	correlate	ccomp	14	SENT_291	[p14l728t2672r1066b2731],
25	with	IN	O	with	_	0	SENT_291	[p14l1100t2672r1249b2731],
26	lipid	NN	O	lipid	nn	27	SENT_291	[p14l1283t2672r1437b2749],
27	responses	NNS	O	response	prep_with	24	SENT_291	[p14l1470t2690r1797b2749],
28	to	TO	O	to	_	0	SENT_291	[p14l1833t2681r1896b2731],
29	statins	NNS	O	statin	prep_to	24	SENT_291	[p14l1935t2672r2145b2731],
30	handled	VBN	O	handle	partmod	29	SENT_291	[p14l7t2773r275b2832],
31	by	IN	O	by	_	0	SENT_291	[p14l301t2773r384b2850],
32	this	DT	O	this	det	33	SENT_291	[p14l412t2773r531b2832],
33	cytochrome	NN	O	cytochrome	agent	30	SENT_291	[p14l561t2773r975b2850],
34	.	.	O	.	_	0	SENT_291	[p14l561t2773r975b2850],

1	A	DT	O	a	det	3	SENT_292	[p14l1007t2773r1066b2831],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_292	[p14l1096t2773r1446b2850],
3	correlation	NN	O	correlation	_	0	SENT_292	[p14l1473t2773r1839b2832],
4	between	IN	O	between	_	0	SENT_292	[p14l1865t2773r2147b2832],
5	LDL	NN	O	ldl	prep_between	3	SENT_292	[p14l8t2877r254b2936],
6	.	.	O	.	_	0	SENT_292	[p14l8t2877r254b2936],

1	—	NN	O	—	_	0	SENT_293	[p14l8t2877r254b2936],
2	.	.	O	.	_	0	SENT_293	[p14l8t2877r254b2936],

1	C	NN	O	c	nn	2	SENT_294	[p14l8t2877r254b2936],
2	reduction	NN	O	reduction	nsubjpass	11	SENT_294	[p14l276t2876r596b2936],
3	and	CC	O	and	_	0	SENT_294	[p14l619t2876r738b2936],
4	reduced	VBN	O	reduce	amod	5	SENT_294	[p14l757t2876r1025b2936],
5	expression	NN	O	expression	conj_and	2	SENT_294	[p14l1047t2876r1406b2953],
6	of	IN	O	of	_	0	SENT_294	[p14l1428t2876r1501b2936],
7	CYPZD6	NN	O	cypzd6	prep_of	2	SENT_294	[p14l1517t2876r1825b2936],
8	had	VBD	O	have	aux	11	SENT_294	[p14l1846t2876r1968b2936],
9	been	VBN	O	be	auxpass	11	SENT_294	[p14l1987t2876r2147b2936],
10	earlier	RBR	O	earlier	advmod	11	SENT_294	[p14l9t2978r224b3037],
11	reported	VBN	O	report	dep	23	SENT_294	[p14l247t2978r530b3055],
12	by	IN	O	by	_	0	SENT_294	[p14l553t2978r636b3055],
13	Nordin	NNP	PERSON	Nordin	agent	11	SENT_294	[p14l662t2978r901b3038],
14	et	FW	O	et	nn	16	SENT_294	[p14l927t2987r987b3037],
15	al.	FW	O	al.	nn	16	SENT_294	[p14l1013t2978r1087b3037],
16	[	FW	O	[	dobj	11	SENT_294	[p14l1123t2978r1250b3050],
17	41	CD	NUMBER	41	num	18	SENT_294	[p14l1123t2978r1250b3050],
18	]	NN	O	]	nn	21	SENT_294	[p14l1123t2978r1250b3050],
19	and	CC	O	and	_	0	SENT_294	[p14l1283t2978r1403b3037],
20	similar	JJ	O	similar	conj_and	18	SENT_294	[p14l1430t2978r1663b3037],
21	ﬁndings	NNS	O	ﬁndings	dobj	11	SENT_294	[p14l1688t2978r1956b3055],
22	were	VBD	O	be	auxpass	23	SENT_294	[p14l1984t2996r2146b3037],
23	suggested	VBN	O	suggest	_	0	SENT_294	[p14l11t3080r341b3157],
24	by	IN	O	by	_	0	SENT_294	[p14l369t3080r452b3157],
25	Mulder	NNP	PERSON	Mulder	agent	23	SENT_294	[p14l483t3080r733b3140],
26	et	FW	O	et	nn	28	SENT_294	[p14l762t3089r821b3140],
27	al.	FW	O	al.	nn	28	SENT_294	[p14l852t3080r926b3140],
28	[	FW	O	[	dobj	23	SENT_294	[p14l967t3081r1118b3152],
29	17	CD	NUMBER	17	num	30	SENT_294	[p14l967t3081r1118b3152],
30	]	NN	O	]	nsubjpass	23	SENT_294	[p14l967t3081r1118b3152],
31	,	,	O	,	_	0	SENT_294	[p14l967t3081r1118b3152],
32	who	WP	O	who	nsubj	33	SENT_294	[p14l1151t3080r1294b3140],
33	noted	VBD	O	note	rcmod	30	SENT_294	[p14l1325t3080r1512b3140],
34	a	DT	O	a	det	36	SENT_294	[p14l1543t3099r1578b3140],
35	higher	JJR	O	higher	amod	36	SENT_294	[p14l1606t3080r1824b3157],
36	response	NN	O	response	dobj	33	SENT_294	[p14l1851t3099r2146b3157],
37	in	IN	O	in	_	0	SENT_294	[p14l8t3182r72b3241],
38	patients	NNS	O	patient	prep_in	33	SENT_294	[p14l113t3182r374b3259],
39	carrying	VBG	O	carry	partmod	38	SENT_294	[p14l419t3182r698b3259],
40	at	IN	O	at	quantmod	42	SENT_294	[p14l744t3191r802b3242],
41	least	JJS	O	least	mwe	40	SENT_294	[p14l844t3182r998b3242],
42	one	CD	NUMBER	one	dobj	39	SENT_294	[p14l1040t3201r1159b3242],
43	mutated	VBN	O	mutate	partmod	42	SENT_294	[p14l1202t3182r1475b3242],
44	allele	NN	O	allele	dobj	43	SENT_294	[p14l1518t3182r1715b3242],
45	.	.	O	.	_	0	SENT_294	[p14l1518t3182r1715b3242],

1	In	IN	O	in	_	0	SENT_295	[p14l1762t3184r1830b3241],
2	this	DT	O	this	det	7	SENT_295	[p14l1873t3182r1991b3242],
3	latter	JJ	O	latter	amod	7	SENT_295	[p14l2036t3182r2144b3242, p14l8t3292r97b3342],
4	study	NN	O	study	nn	7	SENT_295	[p14l139t3283r317b3360],
5	[	NN	O	[	nn	7	SENT_295	[p14l365t3283r517b3355],
6	17	CD	NUMBER	17	num	7	SENT_295	[p14l365t3283r517b3355],
7	]	NN	O	]	prep_in	19	SENT_295	[p14l365t3283r517b3355],
8	,	,	O	,	_	0	SENT_295	[p14l365t3283r517b3355],
9	a	DT	O	a	det	11	SENT_295	[p14l563t3301r598b3342],
10	signiﬁcant	NN	O	signiﬁcant	nn	11	SENT_295	[p14l640t3283r990b3360],
11	difference	NN	O	difference	nsubj	19	SENT_295	[p14l1031t3283r1369b3342],
12	in	IN	O	in	_	0	SENT_295	[p14l1411t3283r1475b3341],
13	the	DT	O	the	det	15	SENT_295	[p14l1516t3283r1617b3342],
14	hypolipidemic	JJ	O	hypolipidemic	amod	15	SENT_295	[p14l1658t3283r2145b3360],
15	efﬁcacy	NN	O	efﬁcacy	prep_in	11	SENT_295	[p14l9t3386r270b3463],
16	was	VBD	O	be	rcmod	15	SENT_295	[p14l315t3405r441b3446],
17	in	IN	O	in	_	0	SENT_295	[p14l487t3386r551b3445],
18	fact	NN	O	fact	prep_in	16	SENT_295	[p14l594t3386r719b3446],
19	noted	VBD	O	note	_	0	SENT_295	[p14l761t3386r948b3446],
20	particularly	RB	O	particularly	advmod	19	SENT_295	[p14l990t3386r1380b3463],
21	among	IN	O	among	_	0	SENT_295	[p14l1425t3405r1652b3463],
22	homozygotes	NNS	O	homozygote	prep_among	19	SENT_295	[p14l1695t3386r2145b3463],
23	for	IN	O	for	_	0	SENT_295	[p14l8t3488r106b3547],
24	the	DT	O	the	det	26	SENT_295	[p14l149t3488r250b3547],
25	inactivating	VBG	O	inactivate	amod	26	SENT_295	[p14l296t3488r689b3565],
26	genotype	NN	O	genotype	prep_for	19	SENT_295	[p14l736t3497r1062b3565],
27	,	,	O	,	_	0	SENT_295	[p14l736t3497r1062b3565],
28	compared	VBN	O	compare	_	0	SENT_295	[p14l1111t3488r1444b3565],
29	with	IN	O	with	prepc_compared_with	19	SENT_295	[p14l1489t3488r1637b3548],
30	the	DT	O	the	det	31	SENT_295	[p14l1681t3488r1783b3547],
31	wt	JJ	O	wt	dep	32	SENT_295	[p14l1828t3497r1912b3548],
32	*	NN	O	*	dep	36	SENT_295	[p14l1960t3488r2139b3548],
33	1	CD	NUMBER	1	num	32	SENT_295	[p14l1960t3488r2139b3548],
34	/	:	O	/	punct	36	SENT_295	[p14l1960t3488r2139b3548],
35	*	CD	NUMBER	*	num	36	SENT_295	[p14l1960t3488r2139b3548],
36	1	CD	NUMBER	1	dep	19	SENT_295	[p14l1960t3488r2139b3548],

1	316	CD	NUMBER	316	num	3	SENT_296	[p14l322t3640r370b3664],
2	P.	NNP	PERSON	P.	nn	3	SENT_296	[p14l971t3641r992b3664],
3	Zuccaro	NNP	PERSON	Zuccaro	_	0	SENT_296	[p14l1003t3641r1112b3664],
4	et	FW	O	et	nn	5	SENT_296	[p14l1122t3644r1146b3664],
5	al.	FW	O	al.	dep	3	SENT_296	[p14l1154t3640r1184b3664],
6	/	:	O	/	punct	3	SENT_296	[p14l1194t3640r1209b3664],
7	Pharmacological	JJ	O	pharmacological	amod	8	SENT_296	[p14l1213t3640r1444b3670],
8	Research	NN	O	research	dep	3	SENT_296	[p14l1452t3640r1573b3664],
9	55	CD	NUMBER	55	number	10	SENT_296	[p14l1583t3640r1615b3663],
10	(	CD	NUMBER	(	num	12	SENT_296	[p14l1625t3640r1711b3669],
11	2007	CD	DATE	2007	number	12	SENT_296	[p14l1625t3640r1711b3669],
12	)	CD	NUMBER	)	dep	8	SENT_296	[p14l1625t3640r1711b3669],
13	310-31	CD	NUMBER	310-31	number	14	SENT_296	[p14l1721t3640r1817b3663],
14	7	CD	NUMBER	7	num	12	SENT_296	[p14l1823t3640r1838b3664],

1	carriers	NNS	O	carrier	nsubj	23	SENT_297	[p15l15t59r284b128],
2	,	,	O	,	_	0	SENT_297	[p15l15t59r284b128],
3	whereas	IN	O	whereas	mark	6	SENT_297	[p15l319t59r592b118],
4	we	PRP	O	we	nsubj	6	SENT_297	[p15l625t77r721b118],
5	also	RB	O	also	advmod	6	SENT_297	[p15l754t59r885b118],
6	found	VBD	O	find	dep	1	SENT_297	[p15l918t59r1114b118],
7	some	DT	O	some	det	8	SENT_297	[p15l1147t77r1320b118],
8	differences	NNS	O	difference	dobj	6	SENT_297	[p15l1352t59r1721b118],
9	by	IN	O	by	_	0	SENT_297	[p15l1753t59r1836b135],
10	comparing	VBG	O	compare	prepc_by	6	SENT_297	[p15l1869t77r2144b135, p15l15t159r119b236],
11	heterozygotes	NNS	O	heterozygote	dobj	10	SENT_297	[p15l151t159r617b236],
12	and	CC	O	and	_	0	SENT_297	[p15l652t159r771b219],
13	wt	JJ	O	wt	amod	14	SENT_297	[p15l801t168r885b219],
14	patients	NNS	O	patient	conj_and	11	SENT_297	[p15l913t159r1195b236],
15	;	:	O	;	_	0	SENT_297	[p15l913t159r1195b236],
16	ﬁnally	RB	O	ﬁnally	advmod	18	SENT_297	[p15l1231t159r1443b236],
17	the	DT	O	the	det	18	SENT_297	[p15l1475t159r1576b219],
18	patient	NN	O	patient	dep	11	SENT_297	[p15l1606t159r1836b236],
19	with	IN	O	with	_	0	SENT_297	[p15l1866t159r2014b219],
20	the	DT	O	the	det	22	SENT_297	[p15l2045t159r2146b219],
21	ultrarapid	JJ	O	ultrarapid	amod	22	SENT_297	[p15l14t259r342b335],
22	phenotype	NN	O	phenotype	prep_with	18	SENT_297	[p15l382t259r733b335],
23	had	VBD	O	have	_	0	SENT_297	[p15l774t259r896b318],
24	the	DT	O	the	det	27	SENT_297	[p15l936t259r1037b318],
25	worst	JJS	O	worst	amod	27	SENT_297	[p15l1079t268r1265b318],
26	cholesteraemic	JJ	O	cholesteraemic	amod	27	SENT_297	[p15l1306t259r1809b318],
27	response	NN	O	response	dobj	23	SENT_297	[p15l1851t277r2146b335],
28	[	CD	NUMBER	[	number	29	SENT_297	[p15l21t359r276b430],
29	17,41	CD	NUMBER	17,41	num	30	SENT_297	[p15l21t359r276b430],
30	]	NN	O	]	dep	27	SENT_297	[p15l21t359r276b430],
31	.	.	O	.	_	0	SENT_297	[p15l21t359r276b430],

1	These	DT	O	these	det	2	SENT_298	[p15l312t359r511b418],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_298	[p15l545t359r812b435],
3	support	VBP	O	support	_	0	SENT_298	[p15l849t368r1099b435],
4	the	DT	O	the	det	5	SENT_298	[p15l1129t359r1230b418],
5	conclusion	NN	O	conclusion	dobj	3	SENT_298	[p15l1263t359r1627b418],
6	that	IN	O	that	complm	12	SENT_298	[p15l1658t359r1784b418],
7	metabolic	JJ	O	metabolic	amod	8	SENT_298	[p15l1815t359r2145b418],
8	handling	NN	O	handling	nsubj	12	SENT_298	[p15l14t461r308b538],
9	is	VBZ	O	be	cop	12	SENT_298	[p15l355t461r407b521],
10	not	RB	O	not	neg	12	SENT_298	[p15l456t470r563b521],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_298	[p15l611t461r1023b538],
12	related	JJ	O	related	ccomp	3	SENT_298	[p15l1070t461r1299b521],
13	to	TO	O	to	_	0	SENT_298	[p15l1345t470r1407b521],
14	AEs	NNS	O	ae	prep_to	12	SENT_298	[p15l1454t462r1616b532],
15	,	,	O	,	_	0	SENT_298	[p15l1454t462r1616b532],
16	since	IN	O	since	mark	24	SENT_298	[p15l1668t461r1837b521],
17	a	DT	O	a	det	20	SENT_298	[p15l1885t480r1920b521],
18	minimally	RB	O	minimally	advmod	19	SENT_298	[p15l1965t461r2144b520, p15l15t561r205b637],
19	higher	JJR	O	higher	amod	20	SENT_298	[p15l241t561r458b637],
20	incidence	NN	O	incidence	nsubjpass	24	SENT_298	[p15l493t561r814b620],
21	of	IN	O	of	_	0	SENT_298	[p15l853t561r926b620],
22	AEs	NNS	O	ae	prep_of	20	SENT_298	[p15l956t562r1098b620],
23	was	VBD	O	be	auxpass	24	SENT_298	[p15l1137t580r1264b620],
24	noted	VBN	O	note	advcl	12	SENT_298	[p15l1302t561r1489b620],
25	among	IN	O	among	_	0	SENT_298	[p15l1527t580r1752b637],
26	carriers	NNS	O	carrier	prep_among	24	SENT_298	[p15l1791t561r2039b620],
27	of	IN	O	of	_	0	SENT_298	[p15l2079t561r2152b620],
28	the	DT	O	the	det	30	SENT_298	[p15l15t662r115b721],
29	mutated	VBN	O	mutate	amod	30	SENT_298	[p15l138t662r409b721],
30	genotype	NN	O	genotype	prep_of	26	SENT_298	[p15l432t671r757b739],
31	,	,	O	,	_	0	SENT_298	[p15l432t671r757b739],
32	who	WP	O	who	nsubj	34	SENT_298	[p15l783t662r925b722],
33	should	MD	O	should	aux	34	SENT_298	[p15l951t662r1172b721],
34	have	VB	O	have	rcmod	30	SENT_298	[p15l1193t662r1348b721],
35	higher	JJR	O	higher	amod	37	SENT_298	[p15l1370t662r1586b739],
36	drug	NN	O	drug	nn	37	SENT_298	[p15l1607t662r1758b739],
37	levels	NNS	O	level	dobj	34	SENT_298	[p15l1782t662r1990b721],
38	.	.	O	.	_	0	SENT_298	[p15l1782t662r1990b721],

1	The	DT	O	the	det	2	SENT_299	[p15l2017t662r2146b721],
2	inﬂuence	NN	O	inﬂuence	nsubj	15	SENT_299	[p15l15t763r322b822],
3	of	IN	O	of	_	0	SENT_299	[p15l344t763r417b822],
4	CYP2D6	NN	O	cyp2d6	prep_of	2	SENT_299	[p15l432t763r738b822],
5	on	IN	O	on	_	0	SENT_299	[p15l761t782r843b822],
6	the	DT	O	the	det	8	SENT_299	[p15l863t763r963b822],
7	hypolipidaemic	JJ	O	hypolipidaemic	amod	8	SENT_299	[p15l984t763r1507b839],
8	activity	NN	O	activity	prep_on	4	SENT_299	[p15l1531t763r1778b839],
9	of	IN	O	of	_	0	SENT_299	[p15l1800t763r1873b822],
10	simvas	FW	O	simvas	nn	12	SENT_299	[p15l1890t763r2144b822],
11	—	FW	O	—	nn	12	SENT_299	[p15l1890t763r2144b822],
12	tatin	NN	O	tatin	prep_of	8	SENT_299	[p15l14t863r537b922],
13	/	:	O	/	punct	14	SENT_299	[p15l14t863r537b922],
14	ﬂuvastatin	NN	O	ﬂuvastatin	dep	12	SENT_299	[p15l14t863r537b922],
15	appears	VBZ	O	appear	_	0	SENT_299	[p15l557t881r809b939],
16	to	TO	O	to	aux	19	SENT_299	[p15l829t872r891b922],
17	be	VB	O	be	cop	19	SENT_299	[p15l909t863r987b922],
18	more	RBR	O	more	advmod	19	SENT_299	[p15l1005t881r1176b922],
19	signiﬁcant	JJ	O	signiﬁcant	xcomp	15	SENT_299	[p15l1198t863r1546b939],
20	than	IN	O	than	_	0	SENT_299	[p15l1563t863r1706b922],
21	that	DT	O	that	det	46	SENT_299	[p15l1724t863r1850b922],
22	reported	VBN	O	report	amod	46	SENT_299	[p15l1865t863r2147b939],
23	for	IN	O	for	_	0	SENT_299	[p15l15t965r113b1025],
24	pravastatin	NN	O	pravastatin	prep_for	22	SENT_299	[p15l127t965r494b1042],
25	(	CD	NUMBER	(	num	24	SENT_299	[p15l514t966r646b1039],
26	not	RB	O	not	neg	34	SENT_299	[p15l514t966r646b1039],
27	a	DT	O	a	det	30	SENT_299	[p15l664t984r699b1025],
28	CYP2D6	NN	O	cyp2d6	nn	30	SENT_299	[p15l716t965r1022b1025],
29	substrate	NN	O	substrate	nn	30	SENT_299	[p15l1043t965r1364b1039],
30	)	NN	O	)	pobj	26	SENT_299	[p15l1043t965r1364b1039],
31	in	IN	O	in	_	0	SENT_299	[p15l1384t965r1448b1024],
32	a	DT	O	a	det	33	SENT_299	[p15l1466t984r1501b1025],
33	study	NN	O	study	prep_in	30	SENT_299	[p15l1520t965r1698b1042],
34	investigating	VBG	O	investigate	partmod	24	SENT_299	[p15l1716t965r2145b1042],
35	mainly	RB	O	mainly	advmod	34	SENT_299	[p15l15t1065r247b1141],
36	SNPs	NNS	O	snp	dobj	34	SENT_299	[p15l268t1065r450b1124],
37	within	IN	O	within	_	0	SENT_299	[p15l471t1065r685b1124],
38	candidate	NN	O	candidate	nn	39	SENT_299	[p15l704t1065r1025b1124],
39	genes	NNS	O	gene	prep_within	34	SENT_299	[p15l1045t1083r1232b1141],
40	related	VBN	O	relate	partmod	39	SENT_299	[p15l1252t1065r1482b1124],
41	to	TO	O	to	_	0	SENT_299	[p15l1499t1074r1562b1124],
42	lipid	NN	O	lipid	nn	43	SENT_299	[p15l1582t1065r1736b1141],
43	metabolism	NN	O	metabolism	prep_to	40	SENT_299	[p15l1753t1065r2147b1124],
44	[	CD	NUMBER	[	number	45	SENT_299	[p15l21t1166r170b1237],
45	42	CD	NUMBER	42	num	46	SENT_299	[p15l21t1166r170b1237],
46	]	NN	O	]	prep_than	19	SENT_299	[p15l21t1166r170b1237],
47	.	.	O	.	_	0	SENT_299	[p15l21t1166r170b1237],

1	In	IN	O	in	_	0	SENT_300	[p15l116t1268r185b1325],
2	the	DT	O	the	det	3	SENT_300	[p15l215t1266r315b1326],
3	case	NN	O	case	prep_in	16	SENT_300	[p15l347t1285r490b1326],
4	of	IN	O	of	_	0	SENT_300	[p15l521t1266r594b1326],
5	apo	NN	O	apo	nn	7	SENT_300	[p15l620t1285r737b1343],
6	E	NN	O	e	nn	7	SENT_300	[p15l769t1268r818b1325],
7	genotypes	NNS	O	genotype	prep_of	3	SENT_300	[p15l849t1275r1208b1343],
8	,	,	O	,	_	0	SENT_300	[p15l849t1275r1208b1343],
9	correlation	NN	O	correlation	nn	10	SENT_300	[p15l1242t1266r1606b1326],
10	studies	NNS	O	study	appos	7	SENT_300	[p15l1639t1266r1867b1326],
11	investigating	VBG	O	investigate	partmod	10	SENT_300	[p15l1899t1266r2144b1326, p15l16t1366r223b1442],
12	hypolipidaemic	JJ	O	hypolipidaemic	amod	14	SENT_300	[p15l245t1366r769b1442],
13	drug	NN	O	drug	nn	14	SENT_300	[p15l794t1366r945b1442],
14	responses	NNS	O	response	dobj	11	SENT_300	[p15l967t1384r1293b1442],
15	have	VBP	O	have	aux	16	SENT_300	[p15l1316t1366r1471b1425],
16	provided	VBN	O	provide	_	0	SENT_300	[p15l1493t1366r1792b1442],
17	in	IN	O	in	_	0	SENT_300	[p15l1814t1366r1878b1424],
18	general	JJ	O	general	amod	21	SENT_300	[p15l1901t1366r2146b1442],
19	quite	RB	O	quite	advmod	20	SENT_300	[p15l15t1467r181b1544],
20	consistent	JJ	O	consistent	amod	21	SENT_300	[p15l213t1467r549b1526],
21	ﬁndings	NNS	O	ﬁndings	prep_in	16	SENT_300	[p15l579t1466r867b1544],
22	,	,	O	,	_	0	SENT_300	[p15l579t1466r867b1544],
23	as	IN	O	as	_	0	SENT_300	[p15l902t1485r966b1526],
24	reviewed	VBN	O	review	conj_as	16	SENT_300	[p15l997t1467r1303b1527],
25	by	IN	O	by	_	0	SENT_300	[p15l1331t1467r1414b1544],
26	Kajinami	NNP	PERSON	Kajinami	prep_by	24	SENT_300	[p15l1446t1466r1757b1544],
27	et	FW	O	et	nn	29	SENT_300	[p15l1788t1475r1847b1526],
28	al.	FW	O	al.	nn	29	SENT_300	[p15l1878t1467r1952b1526],
29	[	FW	O	[	dobj	16	SENT_300	[p15l1992t1467r2143b1539],
30	43	CD	NUMBER	43	num	31	SENT_300	[p15l1992t1467r2143b1539],
31	]	NN	O	]	nsubj	16	SENT_300	[p15l1992t1467r2143b1539],
32	,	,	O	,	_	0	SENT_300	[p15l1992t1467r2143b1539],
33	allowing	VBG	O	allow	partmod	31	SENT_300	[p15l16t1568r306b1644],
34	to	TO	O	to	aux	35	SENT_300	[p15l333t1577r396b1627],
35	conclude	VB	O	conclude	xcomp	33	SENT_300	[p15l424t1568r726b1627],
36	that	IN	O	that	complm	44	SENT_300	[p15l753t1568r879b1627],
37	the	DT	O	the	det	40	SENT_300	[p15l904t1568r1005b1627],
38	apo	NN	O	apo	nn	40	SENT_300	[p15l1034t1587r1151b1644],
39	E	NN	O	e	nn	40	SENT_300	[p15l1178t1570r1228b1626],
40	genotype	NN	O	genotype	nsubj	44	SENT_300	[p15l1255t1577r1562b1644],
41	is	VBZ	O	be	cop	44	SENT_300	[p15l1589t1568r1641b1627],
42	a	DT	O	a	det	44	SENT_300	[p15l1671t1587r1706b1627],
43	major	JJ	O	major	amod	44	SENT_300	[p15l1731t1568r1928b1644],
44	determinant	NN	O	determinant	ccomp	35	SENT_300	[p15l1954t1568r2144b1627, p15l15t1668r249b1727],
45	of	IN	O	of	_	0	SENT_300	[p15l282t1668r355b1727],
46	statin	NN	O	statin	nn	47	SENT_300	[p15l386t1668r564b1727],
47	response	NN	O	response	prep_of	44	SENT_300	[p15l597t1686r908b1744],
48	.	.	O	.	_	0	SENT_300	[p15l597t1686r908b1744],

1	This	DT	O	this	nsubjpass	25	SENT_301	[p15l946t1668r1092b1727],
2	was	VBD	O	be	auxpass	4	SENT_301	[p15l1129t1686r1255b1727],
3	clearly	RB	O	clearly	advmod	4	SENT_301	[p15l1291t1668r1518b1744],
4	shown	VBN	O	show	_	0	SENT_301	[p15l1555t1668r1769b1727],
5	in	IN	O	in	_	0	SENT_301	[p15l1802t1668r1866b1726],
6	clinical	JJ	O	clinical	amod	7	SENT_301	[p15l1900t1668r2146b1727],
7	studies	NNS	O	study	prep_in	4	SENT_301	[p15l18t1769r246b1828],
8	with	IN	O	with	_	0	SENT_301	[p15l285t1769r434b1828],
9	atorvastatin	NN	O	atorvastatin	prep_with	4	SENT_301	[p15l473t1769r862b1828],
10	in	IN	O	in	_	0	SENT_301	[p15l899t1769r963b1827],
11	carriers	NNS	O	carrier	prep_in	9	SENT_301	[p15l1001t1769r1250b1828],
12	of	IN	O	of	_	0	SENT_301	[p15l1291t1769r1364b1828],
13	the	DT	O	the	det	14	SENT_301	[p15l1396t1769r1496b1828],
14	.92	NN	NUMBER	.92	prep_of	11	SENT_301	[p15l1537t1770r1616b1828],
15	and	CC	O	and	_	0	SENT_301	[p15l1656t1769r1775b1828],
16	34	CD	NUMBER	34	num	17	SENT_301	[p15l1814t1770r1894b1828],
17	alleles	NNS	O	allele	prep_of	11	SENT_301	[p15l1934t1769r2144b1828],
18	with	IN	O	with	prep	4	SENT_301	[p15l15t1869r181b1938],
19	,	,	O	,	_	0	SENT_301	[p15l15t1869r181b1938],
20	respectively	RB	O	respectively	dep	18	SENT_301	[p15l216t1869r633b1945],
21	,	,	O	,	_	0	SENT_301	[p15l216t1869r633b1945],
22	signiﬁcantly	RB	O	signiﬁcantly	dep	18	SENT_301	[p15l672t1869r1084b1945],
23	higher	JJR	O	higher	advmod	4	SENT_301	[p15l1117t1869r1334b1945],
24	and	CC	O	and	_	0	SENT_301	[p15l1367t1869r1486b1928],
25	reduced	VBD	O	reduce	conj_and	4	SENT_301	[p15l1517t1869r1784b1928],
26	cholesteraemic	JJ	O	cholesteraemic	amod	27	SENT_301	[p15l1817t1869r2144b1928, p15l16t1969r213b2028],
27	responses	NNS	O	response	nsubj	28	SENT_301	[p15l232t1987r558b2045],
28	[	VBP	O	[	ccomp	25	SENT_301	[p15l584t1969r840b2040],
29	44,45	CD	NUMBER	44,45	number	30	SENT_301	[p15l584t1969r840b2040],
30	]	CD	NUMBER	]	dobj	28	SENT_301	[p15l584t1969r840b2040],
31	.	.	O	.	_	0	SENT_301	[p15l584t1969r840b2040],

1	These	DT	O	these	det	2	SENT_302	[p15l863t1969r1062b2028],
2	ﬁndings	NNS	O	ﬁndings	nsubjpass	5	SENT_302	[p15l1082t1969r1350b2045],
3	can	MD	O	can	aux	5	SENT_302	[p15l1371t1987r1486b2028],
4	be	VB	O	be	auxpass	5	SENT_302	[p15l1503t1969r1581b2028],
5	explained	VBN	O	explain	_	0	SENT_302	[p15l1601t1969r1927b2045],
6	by	IN	O	by	_	0	SENT_302	[p15l1943t1969r2026b2045],
7	the	DT	O	the	det	9	SENT_302	[p15l2045t1969r2146b2028],
8	higher	JJR	O	higher	amod	9	SENT_302	[p15l14t2071r230b2148],
9	afﬁnity	NN	O	afﬁnity	agent	5	SENT_302	[p15l249t2071r486b2148],
10	of	IN	O	of	_	0	SENT_302	[p15l506t2071r579b2131],
11	apo	FW	O	apo	prep_of	9	SENT_302	[p15l593t2090r710b2148],
12	E4	NN	O	e4	dobj	5	SENT_302	[p15l729t2072r820b2130],
13	for	IN	O	for	_	0	SENT_302	[p15l839t2071r937b2131],
14	the	DT	O	the	det	16	SENT_302	[p15l953t2071r1055b2131],
15	LDL	NN	O	ldl	nn	16	SENT_302	[p15l1072t2073r1235b2130],
16	receptor	NN	O	receptor	prep_for	12	SENT_302	[p15l1252t2080r1543b2148],
17	,	,	O	,	_	0	SENT_302	[p15l1252t2080r1543b2148],
18	resulting	VBG	O	result	partmod	12	SENT_302	[p15l1563t2071r1857b2148],
19	in	IN	O	in	_	0	SENT_302	[p15l1876t2071r1940b2130],
20	lower	JJR	O	lower	amod	22	SENT_302	[p15l1958t2071r2148b2131],
21	cholesterol	NN	O	cholesterol	nn	22	SENT_302	[p15l15t2171r384b2230],
22	synthesis	NN	O	synthesis	prep_in	18	SENT_302	[p15l415t2171r718b2247],
23	and	CC	O	and	_	0	SENT_302	[p15l751t2171r870b2230],
24	increased	VBD	O	increase	amod	25	SENT_302	[p15l897t2171r1216b2230],
25	absorption	NN	O	absorption	prep_in	18	SENT_302	[p15l1245t2171r1619b2247],
26	;	:	O	;	_	0	SENT_302	[p15l1245t2171r1619b2247],
27	conversely	RB	O	conversely	advmod	40	SENT_302	[p15l1651t2171r2023b2247],
28	,	,	O	,	_	0	SENT_302	[p15l1651t2171r2023b2247],
29	E2	NN	O	e2	nn	30	SENT_302	[p15l2054t2171r2145b2229],
30	carriers	NNS	O	carrier	nsubj	40	SENT_302	[p15l15t2272r264b2331],
31	with	IN	O	with	_	0	SENT_302	[p15l282t2272r430b2331],
32	lower	JJR	O	lower	amod	33	SENT_302	[p15l446t2272r635b2331],
33	absorption	NN	O	absorption	prep_with	30	SENT_302	[p15l651t2272r1005b2349],
34	and	CC	O	and	_	0	SENT_302	[p15l1022t2272r1141b2331],
35	higher	JJR	O	higher	amod	36	SENT_302	[p15l1155t2272r1371b2349],
36	biosynthesis	NN	O	biosynthesis	prep_with	30	SENT_302	[p15l1384t2272r1800b2349],
37	are	VBP	O	be	cop	40	SENT_302	[p15l1819t2290r1918b2331],
38	generally	RB	O	generally	advmod	40	SENT_302	[p15l1935t2290r2144b2349, p15l16t2373r139b2449],
39	more	RBR	O	more	advmod	40	SENT_302	[p15l159t2392r330b2432],
40	sensitive	JJ	O	sensitive	parataxis	5	SENT_302	[p15l354t2373r641b2432],
41	to	TO	O	to	_	0	SENT_302	[p15l661t2382r724b2432],
42	statin	NN	O	statin	nn	43	SENT_302	[p15l748t2373r926b2432],
43	treatment	NN	O	treatment	prep_to	40	SENT_302	[p15l946t2382r1265b2432],
44	[	CD	NUMBER	[	number	45	SENT_302	[p15l1289t2374r1439b2444],
45	28	CD	NUMBER	28	num	46	SENT_302	[p15l1289t2374r1439b2444],
46	]	NN	O	]	dep	43	SENT_302	[p15l1289t2374r1439b2444],
47	.	.	O	.	_	0	SENT_302	[p15l1289t2374r1439b2444],

1	In	IN	O	in	_	0	SENT_303	[p15l1463t2375r1532b2431],
2	the	DT	O	the	det	4	SENT_303	[p15l1551t2373r1652b2432],
3	present	JJ	DATE	present	amod	4	SENT_303	[p15l1671t2382r1916b2449],
4	series	NN	O	series	prep_in	9	SENT_303	[p15l1938t2373r2143b2443],
5	,	,	O	,	_	0	SENT_303	[p15l1938t2373r2143b2443],
6	apo	NN	O	apo	nn	8	SENT_303	[p15l16t2491r134b2549],
7	E2	NN	O	e2	nn	8	SENT_303	[p15l166t2473r257b2531],
8	carriers	NNS	O	carrier	nsubj	9	SENT_303	[p15l290t2473r539b2532],
9	showed	VBD	O	show	_	0	SENT_303	[p15l576t2473r828b2532],
10	both	CC	O	both	dep	16	SENT_303	[p15l858t2473r1008b2532],
11	a	DT	O	a	det	16	SENT_303	[p15l1040t2491r1075b2532],
12	non	JJ	O	non	amod	16	SENT_303	[p15l1105t2491r1230b2532],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_303	[p15l1265t2473r1678b2549],
14	higher	JJR	O	higher	amod	16	SENT_303	[p15l1709t2473r1926b2549],
15	LDLC	NN	ORGANIZATION	ldlc	nn	16	SENT_303	[p15l1955t2474r2144b2531, p15l16t2576r67b2635],
16	reduction	NN	O	reduction	nsubj	23	SENT_303	[p15l103t2575r421b2635],
17	versus	CC	O	versus	prep	16	SENT_303	[p15l457t2594r667b2635],
18	carriers	NNS	O	carrier	dep	17	SENT_303	[p15l705t2575r954b2635],
19	of	IN	O	of	_	0	SENT_303	[p15l993t2575r1066b2635],
20	the	DT	O	the	det	22	SENT_303	[p15l1095t2575r1196b2635],
21	other	JJ	O	other	amod	22	SENT_303	[p15l1233t2575r1405b2635],
22	alleles	NNS	O	allele	prep_of	18	SENT_303	[p15l1440t2575r1650b2635],
23	(	VBP	O	(	ccomp	9	SENT_303	[p15l1690t2576r1823b2649],
24	not	RB	O	not	neg	25	SENT_303	[p15l1690t2576r1823b2649],
25	reaching	VBG	O	reach	xcomp	23	SENT_303	[p15l1856t2575r2145b2652],
26	statistical	JJ	O	statistical	amod	27	SENT_303	[p15l18t2675r332b2734],
27	signiﬁcance	NN	O	signiﬁcance	dobj	25	SENT_303	[p15l351t2675r750b2751],
28	because	IN	O	because	_	0	SENT_303	[p15l765t2675r1031b2734],
29	of	IN	O	of	_	0	SENT_303	[p15l1048t2675r1121b2734],
30	the	DT	O	the	det	32	SENT_303	[p15l1131t2675r1232b2734],
31	small	JJ	O	small	amod	32	SENT_303	[p15l1251t2675r1429b2734],
32	number	NN	O	number	prep_because_of	25	SENT_303	[p15l1445t2675r1703b2734],
33	of	IN	O	of	_	0	SENT_303	[p15l1718t2675r1791b2734],
34	these	DT	O	these	det	36	SENT_303	[p15l1801t2675r1972b2734],
35	individuals	NNS	O	individual	nn	36	SENT_303	[p15l1989t2675r2144b2734, p15l15t2775r283b2847],
36	)	NN	O	)	prep_of	32	SENT_303	[p15l1989t2675r2144b2734, p15l15t2775r283b2847],
37	and	CC	O	and	dep	43	SENT_303	[p15l317t2775r453b2844],
38	,	,	O	,	_	0	SENT_303	[p15l317t2775r453b2844],
39	more	RBR	O	more	advmod	40	SENT_303	[p15l486t2793r658b2834],
40	so	RB	O	so	dep	43	SENT_303	[p15l691t2793r779b2844],
41	,	,	O	,	_	0	SENT_303	[p15l691t2793r779b2844],
42	an	DT	O	a	det	43	SENT_303	[p15l814t2793r890b2834],
43	increase	NN	O	increase	dep	25	SENT_303	[p15l920t2775r1194b2834],
44	of	IN	O	of	_	0	SENT_303	[p15l1226t2775r1299b2834],
45	HDL	NN	O	hdl	prep_of	43	SENT_303	[p15l1323t2775r1578b2834],
46	.	.	O	.	_	0	SENT_303	[p15l1323t2775r1578b2834],

1	—	NN	O	—	_	0	SENT_304	[p15l1323t2775r1578b2834],
2	.	.	O	.	_	0	SENT_304	[p15l1323t2775r1578b2834],

1	C	NN	O	c	nn	2	SENT_305	[p15l1323t2775r1578b2834],
2	levels	NNS	O	level	_	0	SENT_305	[p15l1610t2775r1818b2834],
3	.	.	O	.	_	0	SENT_305	[p15l1610t2775r1818b2834],

1	This	DT	O	this	det	4	SENT_306	[p15l1853t2775r1999b2834],
2	last	JJ	O	last	amod	4	SENT_306	[p15l2031t2775r2147b2834],
3	ﬁnding	JJ	O	ﬁnding	amod	4	SENT_306	[p15l16t2877r251b2954],
4	ﬁts	NNS	O	ﬁts	_	0	SENT_306	[p15l283t2877r381b2937],
5	well	RB	O	well	advmod	4	SENT_306	[p15l412t2877r555b2937],
6	with	IN	O	with	_	0	SENT_306	[p15l585t2877r733b2937],
7	data	NNS	O	datum	prep_with	4	SENT_306	[p15l763t2877r902b2937],
8	from	IN	O	from	_	0	SENT_306	[p15l930t2877r1093b2937],
9	a	DT	O	a	det	10	SENT_306	[p15l1123t2896r1158b2937],
10	study	NN	O	study	prep_from	7	SENT_306	[p15l1188t2877r1366b2954],
11	on	IN	O	on	_	0	SENT_306	[p15l1396t2896r1478b2937],
12	patients	NNS	O	patient	prep_on	4	SENT_306	[p15l1506t2877r1766b2954],
13	with	IN	O	with	_	0	SENT_306	[p15l1798t2877r1946b2937],
14	combined	JJ	O	combined	amod	18	SENT_306	[p15l1975t2896r2144b2937, p15l13t2977r201b3036],
15	hyperlipoproteinaemia	NN	O	hyperlipoproteinaemia	nn	18	SENT_306	[p15l235t2977r1001b3053],
16	[	NN	O	[	nn	18	SENT_306	[p15l1042t2977r1191b3048],
17	46	CD	NUMBER	46	num	18	SENT_306	[p15l1042t2977r1191b3048],
18	]	NN	O	]	prep_with	12	SENT_306	[p15l1042t2977r1191b3048],
19	.	.	O	.	_	0	SENT_306	[p15l1042t2977r1191b3048],

1	The	DT	O	the	det	4	SENT_307	[p15l1231t2977r1360b3036],
2	marked	JJ	O	marked	amod	4	SENT_307	[p15l1396t2977r1647b3036],
3	HDL	NN	O	hdl	nn	4	SENT_307	[p15l1683t2979r1854b3035],
4	rises	NNS	O	rise	nsubj	9	SENT_307	[p15l1889t2977r2041b3036],
5	of	IN	O	of	_	0	SENT_307	[p15l2079t2977r2152b3036],
6	E2/E3	NN	O	e2/e3	nn	7	SENT_307	[p15l14t3078r219b3138],
7	heterozygotes	NNS	O	heterozygote	prep_of	4	SENT_307	[p15l239t3078r706b3155],
8	is	VBZ	O	be	cop	9	SENT_307	[p15l723t3078r775b3137],
9	likely	JJ	O	likely	_	0	SENT_307	[p15l793t3078r982b3155],
10	to	TO	O	to	aux	12	SENT_307	[p15l998t3087r1061b3137],
11	be	VB	O	be	cop	12	SENT_307	[p15l1076t3078r1155b3137],
12	attributable	JJ	O	attributable	xcomp	9	SENT_307	[p15l1172t3078r1552b3137],
13	to	TO	O	to	_	0	SENT_307	[p15l1568t3086r1630b3137],
14	the	DT	O	the	det	16	SENT_307	[p15l1647t3078r1748b3137],
15	higher	JJR	O	higher	amod	16	SENT_307	[p15l1763t3078r1979b3155],
16	incidence	NN	O	incidence	prep_to	12	SENT_307	[p15l1994t3078r2144b3137, p15l15t3179r209b3238],
17	of	IN	O	of	_	0	SENT_307	[p15l245t3179r318b3238],
18	hypertriglyceridaemia	NN	O	hypertriglyceridaemia	prep_of	16	SENT_307	[p15l346t3179r1110b3255],
19	,	,	O	,	_	0	SENT_307	[p15l346t3179r1110b3255],
20	associated	VBN	O	associate	partmod	16	SENT_307	[p15l1149t3179r1493b3238],
21	with	IN	O	with	_	0	SENT_307	[p15l1528t3179r1676b3238],
22	low	JJ	O	low	amod	23	SENT_307	[p15l1710t3179r1831b3238],
23	HDL	NN	O	hdl	prep_with	20	SENT_307	[p15l1866t3180r2143b3249],
24	.	.	O	.	_	0	SENT_307	[p15l1866t3180r2143b3249],

1	—	NN	O	—	_	0	SENT_308	[p15l1866t3180r2143b3249],
2	.	.	O	.	_	0	SENT_308	[p15l1866t3180r2143b3249],

1	C	NN	O	c	_	0	SENT_309	[p15l1866t3180r2143b3249],
2	;	:	O	;	_	0	SENT_309	[p15l1866t3180r2143b3249],
3	drug	NN	O	drug	nn	4	SENT_309	[p15l15t3279r166b3355],
4	treatment	NN	O	treatment	nsubj	5	SENT_309	[p15l185t3288r504b3338],
5	led	VBD	O	lead	dep	1	SENT_309	[p15l521t3279r623b3338],
6	both	CC	O	both	advmod	5	SENT_309	[p15l638t3279r788b3338],
7	to	TO	O	to	_	0	SENT_309	[p15l805t3288r868b3338],
8	reduced	VBN	O	reduce	amod	9	SENT_309	[p15l886t3279r1154b3338],
9	triglycerides	NNS	O	triglyceride	prep_to	5	SENT_309	[p15l1171t3279r1590b3355],
10	and	CC	O	and	_	0	SENT_309	[p15l1611t3279r1730b3338],
11	to	TO	O	to	_	0	SENT_309	[p15l1747t3288r1810b3338],
12	increased	VBN	O	increase	amod	13	SENT_309	[p15l1829t3279r2147b3338],
13	HDL	NN	O	hdl	conj_and	9	SENT_309	[p15l15t3380r269b3438],
14	.	.	O	.	_	0	SENT_309	[p15l15t3380r269b3438],

1	—	NN	O	—	_	0	SENT_310	[p15l15t3380r269b3438],
2	.	.	O	.	_	0	SENT_310	[p15l15t3380r269b3438],

1	C	NN	O	c	nn	2	SENT_311	[p15l15t3380r269b3438],
2	levels	NNS	O	level	nsubj	3	SENT_311	[p15l295t3379r484b3438],
3	[	VBP	O	[	_	0	SENT_311	[p15l516t3380r665b3450],
4	47	CD	NUMBER	47	num	5	SENT_311	[p15l516t3380r665b3450],
5	]	CD	NUMBER	]	dobj	3	SENT_311	[p15l516t3380r665b3450],
6	.	.	O	.	_	0	SENT_311	[p15l516t3380r665b3450],

1	The	DT	O	the	det	2	SENT_312	[p15l116t3479r245b3538],
2	lack	NN	O	lack	nsubj	18	SENT_312	[p15l291t3479r432b3538],
3	of	IN	O	of	_	0	SENT_312	[p15l477t3479r550b3538],
4	conclusive	JJ	O	conclusive	amod	5	SENT_312	[p15l590t3479r946b3538],
5	data	NNS	O	datum	prep_of	2	SENT_312	[p15l993t3479r1132b3538],
6	on	IN	O	on	_	0	SENT_312	[p15l1178t3498r1259b3538],
7	the	DT	O	the	det	9	SENT_312	[p15l1304t3479r1405b3538],
8	genetic	JJ	O	genetic	amod	9	SENT_312	[p15l1452t3479r1692b3555],
9	associations	NNS	O	association	prep_on	5	SENT_312	[p15l1741t3479r2144b3538],
10	between	IN	O	between	_	0	SENT_312	[p15l13t3580r295b3640],
11	skeletal	JJ	O	skeletal	amod	13	SENT_312	[p15l325t3580r578b3639],
12	muscle	NN	O	muscle	nn	13	SENT_312	[p15l606t3580r843b3639],
13	toxicity	NN	O	toxicity	prep_between	9	SENT_312	[p15l872t3580r1127b3657],
14	and	CC	O	and	_	0	SENT_312	[p15l1158t3580r1277b3639],
15	CYP45O	NN	O	cyp45o	nn	16	SENT_312	[p15l1305t3579r1593b3640],
16	polymorphisms	NNS	O	polymorphism	prep_between	9	SENT_312	[p15l1620t3580r2144b3657],
17	probably	RB	O	probably	advmod	18	SENT_312	[p15l14t3683r313b3760],
18	indicates	VBZ	O	indicate	_	0	SENT_312	[p15l349t3683r646b3743],
19	that	IN	O	that	complm	30	SENT_312	[p15l684t3683r810b3743],
20	this	DT	O	this	det	26	SENT_312	[p15l844t3683r963b3743],
21	subjective	JJ	O	subjective	amod	26	SENT_312	[p15l1003t3683r1337b3760],
22	and	CC	O	and	dep	23	SENT_312	[p15l1376t3683r1494b3743],
23	at	IN	O	at	dep	21	SENT_312	[p15l1532t3692r1590b3743],
24	times	NNS	O	time	pobj	23	SENT_312	[p15l1624t3683r1803b3743],
25	objective	JJ	O	objective	amod	26	SENT_312	[p15l1843t3683r2146b3760],
26	phenomenon	NN	O	phenomenon	nsubjpass	30	SENT_312	[p16l14t18r450b94],
27	is	VBZ	O	be	auxpass	30	SENT_312	[p16l473t18r525b77],
28	not	RB	O	not	neg	30	SENT_312	[p16l551t27r658b77],
29	signiﬁcantly	RB	O	signiﬁcantly	advmod	30	SENT_312	[p16l683t18r1096b94],
30	regulated	VBN	O	regulate	ccomp	18	SENT_312	[p16l1119t18r1432b94],
31	by	IN	O	by	_	0	SENT_312	[p16l1453t18r1537b94],
32	the	DT	O	the	det	34	SENT_312	[p16l1560t18r1661b77],
33	CYP450	NN	O	cyp450	nn	34	SENT_312	[p16l1686t18r1974b77],
34	handling	NN	O	handling	agent	30	SENT_312	[p16l1998t18r2144b77, p16l15t119r186b196],
35	of	IN	O	of	_	0	SENT_312	[p16l224t119r298b178],
36	statins	NNS	O	statin	prep_of	34	SENT_312	[p16l332t119r560b178],
37	.	.	O	.	_	0	SENT_312	[p16l332t119r560b178],

1	There	EX	O	there	expl	2	SENT_313	[p16l601t119r796b178],
2	is	VBZ	O	be	_	0	SENT_313	[p16l833t119r886b178],
3	instead	RB	O	instead	advmod	2	SENT_313	[p16l925t119r1163b178],
4	deﬁnite	JJ	O	deﬁnite	amod	5	SENT_313	[p16l1200t119r1451b178],
5	evidence	NN	O	evidence	nsubj	2	SENT_313	[p16l1489t119r1785b178],
6	that	IN	O	that	complm	11	SENT_313	[p16l1822t119r1948b178],
7	most	JJS	O	most	dep	8	SENT_313	[p16l1984t127r2147b178],
8	likely	JJ	O	likely	amod	10	SENT_313	[p16l15t220r204b296],
9	CYP2D6	NN	O	cyp2d6	nn	10	SENT_313	[p16l227t220r533b279],
10	isotypes	NNS	O	isotype	nsubj	11	SENT_313	[p16l555t220r829b296],
11	inﬂuence	VBP	O	inﬂuence	ccomp	2	SENT_313	[p16l852t220r1160b279],
12	the	DT	O	the	det	14	SENT_313	[p16l1181t220r1282b279],
13	cholesteraemic	JJ	O	cholesteraemic	amod	14	SENT_313	[p16l1305t220r1808b279],
14	response	NN	O	response	dobj	11	SENT_313	[p16l1830t239r2142b296],
15	.	.	O	.	_	0	SENT_313	[p16l1830t239r2142b296],

1	Myotoxicity	NN	O	myotoxicity	nsubj	7	SENT_314	[p16l14t320r430b396],
2	would	MD	O	would	aux	7	SENT_314	[p16l455t320r663b379],
3	thus	RB	O	thus	advmod	7	SENT_314	[p16l685t320r822b379],
4	be	VB	O	be	cop	7	SENT_314	[p16l846t320r924b379],
5	an	DT	O	a	det	7	SENT_314	[p16l950t338r1026b379],
6	idiopathic	JJ	O	idiopathic	amod	7	SENT_314	[p16l1049t320r1383b396],
7	phenomenon	NN	O	phenomenon	_	0	SENT_314	[p16l1407t320r1843b396],
8	possibly	RB	O	possibly	advmod	9	SENT_314	[p16l1865t320r2145b396],
9	associated	VBN	O	associate	partmod	7	SENT_314	[p16l16t422r361b482],
10	with	IN	O	with	_	0	SENT_314	[p16l380t422r528b482],
11	individual	JJ	O	individual	amod	13	SENT_314	[p16l547t422r886b482],
12	cell	NN	O	cell	nn	13	SENT_314	[p16l907t422r1025b482],
13	changes	NNS	O	change	prep_with	9	SENT_314	[p16l1046t422r1314b499],
14	resulting	VBG	O	result	xcomp	9	SENT_314	[p16l1335t422r1628b499],
15	in	IN	O	in	_	0	SENT_314	[p16l1649t422r1712b481],
16	an	DT	O	a	det	18	SENT_314	[p16l1734t441r1809b482],
17	increased	VBN	O	increase	amod	18	SENT_314	[p16l1829t422r2147b482],
18	risk	NN	O	risk	prep_in	14	SENT_314	[p16l14t522r141b581],
19	of	IN	O	of	_	0	SENT_314	[p16l180t522r253b581],
20	apoptosis	NN	O	apoptosis	prep_of	18	SENT_314	[p16l289t522r603b598],
21	[	CD	NUMBER	[	number	22	SENT_314	[p16l651t523r970b593],
22	9	CD	NUMBER	9	dep	20	SENT_314	[p16l651t523r970b593],
23	,	,	O	,	_	0	SENT_314	[p16l651t523r970b593],
24	l2	NN	O	l2	nn	26	SENT_314	[p16l651t523r970b593],
25	,39	CD	NUMBER	,39	num	26	SENT_314	[p16l651t523r970b593],
26	]	NN	O	]	appos	20	SENT_314	[p16l651t523r970b593],
27	.	.	O	.	_	0	SENT_314	[p16l651t523r970b593],

1	Muscle	NN	O	muscle	nsubj	7	SENT_315	[p16l1014t522r1261b581],
2	from	IN	O	from	_	0	SENT_315	[p16l1302t522r1465b581],
3	subjects	NNS	O	subject	prep_from	1	SENT_315	[p16l1507t522r1773b598],
4	with	IN	O	with	_	0	SENT_315	[p16l1815t522r1963b581],
5	subjective	JJ	O	subjective	amod	6	SENT_315	[p16l2006t522r2144b581, p16l7t622r234b698],
6	myopathy	NN	O	myopathy	prep_with	3	SENT_315	[p16l266t622r602b698],
7	indicated	VBD	O	indicate	_	0	SENT_315	[p16l633t622r942b681],
8	extensive	JJ	O	extensive	amod	10	SENT_315	[p16l974t622r1285b681],
9	lipid	NN	O	lipid	nn	10	SENT_315	[p16l1317t622r1673b698],
10	—	NN	O	—	nsubj	11	SENT_315	[p16l1317t622r1673b698],
11	ﬁlled	VBD	O	ﬁlled	ccomp	7	SENT_315	[p16l1317t622r1673b698],
12	vacuoles	NNS	O	vacuole	dobj	11	SENT_315	[p16l1704t622r1993b681],
13	and	CC	O	and	_	0	SENT_315	[p16l2028t622r2147b681],
14	lipid	NN	O	lipid	nn	16	SENT_315	[p16l15t724r168b801],
15	droplet	NN	O	droplet	nn	16	SENT_315	[p16l197t724r435b801],
16	accumulation	NN	O	accumulation	conj_and	12	SENT_315	[p16l464t724r917b784],
17	after	IN	O	after	_	0	SENT_315	[p16l947t724r1100b784],
18	statins	NNS	O	statin	prep_after	11	SENT_315	[p16l1130t724r1359b795],
19	,	,	O	,	_	0	SENT_315	[p16l1130t724r1359b795],
20	most	RBS	O	most	advmod	21	SENT_315	[p16l1391t733r1555b784],
21	likely	JJ	O	likely	advmod	11	SENT_315	[p16l1582t724r1771b801],
22	associated	VBN	O	associate	dep	21	SENT_315	[p16l1802t724r2147b784],
23	to	TO	O	to	_	0	SENT_315	[p16l14t833r77b883],
24	lower	JJR	O	lower	amod	26	SENT_315	[p16l111t824r301b883],
25	respiratory	JJ	O	respiratory	amod	26	SENT_315	[p16l331t824r696b900],
26	activity	NN	O	activity	prep_to	22	SENT_315	[p16l731t824r978b900],
27	and	CC	O	and	_	0	SENT_315	[p16l1013t824r1149b893],
28	,	,	O	,	_	0	SENT_315	[p16l1013t824r1149b893],
29	as	IN	O	as	dep	26	SENT_315	[p16l1187t842r1251b883],
30	a	DT	O	a	det	31	SENT_315	[p16l1288t843r1323b883],
31	consequence	NN	O	consequence	pobj	29	SENT_315	[p16l1355t842r1802b900],
32	,	,	O	,	_	0	SENT_315	[p16l1355t842r1802b900],
33	muscular	JJ	O	muscular	amod	35	SENT_315	[p16l1838t824r2148b883],
34	lipid	NN	O	lipid	nn	35	SENT_315	[p16l15t925r168b1002],
35	metabolism	NN	O	metabolism	prep_to	22	SENT_315	[p16l191t925r601b984],
36	.	.	O	.	_	0	SENT_315	[p16l191t925r601b984],

1	A	DT	O	a	det	2	SENT_316	[p16l116t1027r175b1084],
2	limitation	NN	O	limitation	nsubj	9	SENT_316	[p16l197t1026r524b1085],
3	in	IN	O	in	_	0	SENT_316	[p16l546t1026r610b1084],
4	the	DT	O	the	det	6	SENT_316	[p16l631t1026r732b1085],
5	reported	VBN	O	report	amod	6	SENT_316	[p16l754t1026r1035b1102],
6	study	NN	O	study	prep_in	2	SENT_316	[p16l1059t1026r1237b1102],
7	is	VBZ	O	be	cop	9	SENT_316	[p16l1259t1026r1312b1085],
8	the	DT	O	the	det	9	SENT_316	[p16l1336t1026r1436b1085],
9	lack	NN	O	lack	ccomp	24	SENT_316	[p16l1459t1026r1599b1085],
10	of	IN	O	of	_	0	SENT_316	[p16l1621t1026r1693b1085],
11	evaluation	NN	O	evaluation	prep_of	9	SENT_316	[p16l1710t1026r2056b1085],
12	of	IN	O	of	_	0	SENT_316	[p16l2079t1026r2152b1085],
13	the	DT	O	the	det	17	SENT_316	[p16l14t1126r115b1185],
14	organic	JJ	O	organic	amod	17	SENT_316	[p16l148t1126r395b1202],
15	anion	NN	O	anion	nn	17	SENT_316	[p16l429t1126r613b1185],
16	transporter	NN	O	transporter	nn	17	SENT_316	[p16l643t1135r1010b1202],
17	protein	NN	O	protein	prep_of	11	SENT_316	[p16l1038t1126r1277b1202],
18	(	CD	NUMBER	(	num	21	SENT_316	[p16l1310t1126r1567b1198],
19	OATP	NN	O	oatp	nn	21	SENT_316	[p16l1310t1126r1567b1198],
20	)	CD	NUMBER	)	num	21	SENT_316	[p16l1310t1126r1567b1198],
21	polymorphisms	NNS	O	polymorphism	dep	17	SENT_316	[p16l1599t1126r2143b1202],
22	,	,	O	,	_	0	SENT_316	[p16l1599t1126r2143b1202],
23	recently	RB	DATE	recently	advmod	24	SENT_316	[p16l14t1227r284b1304],
24	indicated	VBD	O	indicate	_	0	SENT_316	[p16l333t1227r642b1286],
25	as	IN	O	as	_	0	SENT_316	[p16l690t1245r755b1286],
26	potentially	RB	O	potentially	advmod	27	SENT_316	[p16l803t1227r1164b1304],
27	regulating	VBG	O	regulate	prepc_as	24	SENT_316	[p16l1212t1227r1551b1304],
28	blood	NN	O	blood	nn	29	SENT_316	[p16l1599t1227r1791b1286],
29	levels	NNS	O	level	dobj	27	SENT_316	[p16l1839t1227r2028b1286],
30	of	IN	O	of	_	0	SENT_316	[p16l2079t1227r2152b1286],
31	pravastatin	NN	O	pravastatin	prep_of	29	SENT_316	[p16l14t1328r398b1404],
32	,	,	O	,	_	0	SENT_316	[p16l14t1328r398b1404],
33	rosuvastatin	NN	O	rosuvastatin	prep_of	29	SENT_316	[p16l424t1328r830b1387],
34	and	CC	O	and	_	0	SENT_316	[p16l855t1328r974b1387],
35	pitavastatin	NN	O	pitavastatin	prep_of	29	SENT_316	[p16l995t1328r1381b1404],
36	[	CD	NUMBER	[	tmod	24	SENT_316	[p16l1410t1328r1687b1399],
37	48	CD	NUMBER	48	num	40	SENT_316	[p16l1410t1328r1687b1399],
38	—	NN	O	—	nn	40	SENT_316	[p16l1410t1328r1687b1399],
39	50	CD	NUMBER	50	num	40	SENT_316	[p16l1410t1328r1687b1399],
40	]	NN	O	]	nsubj	24	SENT_316	[p16l1410t1328r1687b1399],
41	.	.	O	.	_	0	SENT_316	[p16l1410t1328r1687b1399],

1	We	PRP	O	we	nsubj	3	SENT_317	[p16l1713t1330r1823b1387],
2	only	RB	O	only	advmod	3	SENT_317	[p16l1848t1328r1994b1404],
3	saw	VBD	O	see	dep	16	SENT_317	[p16l2021t1347r2145b1387],
4	limited	JJ	O	limited	amod	6	SENT_317	[p16l15t1428r253b1487],
5	muscle	NN	O	muscle	nn	6	SENT_317	[p16l283t1428r520b1487],
6	toxicity	NN	O	toxicity	dobj	3	SENT_317	[p16l551t1428r807b1504],
7	with	IN	O	with	_	0	SENT_317	[p16l838t1428r986b1487],
8	both	CC	O	both	preconj	9	SENT_317	[p16l1015t1428r1165b1487],
9	pravastatin	NN	O	pravastatin	prep_with	3	SENT_317	[p16l1194t1428r1561b1504],
10	and	CC	O	and	_	0	SENT_317	[p16l1593t1428r1712b1487],
11	rosuvastatin	NN	O	rosuvastatin	prep_with	3	SENT_317	[p16l1741t1428r2146b1487],
12	(	CD	NUMBER	(	num	11	SENT_317	[p16l17t1528r161b1601],
13	this	DT	O	this	det	14	SENT_317	[p16l17t1528r161b1601],
14	latter	NN	O	latter	nsubj	16	SENT_317	[p16l201t1528r374b1587],
15	has	VBZ	O	have	aux	16	SENT_317	[p16l410t1528r519b1587],
16	entered	VBN	O	enter	_	0	SENT_317	[p16l559t1528r806b1587],
17	the	DT	O	the	det	19	SENT_317	[p16l843t1528r944b1587],
18	Italian	JJ	MISC	italian	amod	19	SENT_317	[p16l982t1528r1196b1587],
19	market	NN	O	market	dobj	16	SENT_317	[p16l1234t1528r1467b1587],
20	only	RB	O	only	advmod	21	SENT_317	[p16l1505t1529r1651b1604],
21	recently	RB	DATE	recently	advmod	16	SENT_317	[p16l1689t1528r1986b1604],
22	)	CD	NUMBER	)	nsubjpass	30	SENT_317	[p16l1689t1528r1986b1604],
23	and	CC	O	and	_	0	SENT_317	[p16l2028t1528r2147b1587],
24	pitavastatin	NN	O	pitavastatin	nsubjpass	30	SENT_317	[p16l14t1628r399b1704],
25	has	VBZ	O	have	aux	30	SENT_317	[p16l415t1628r524b1687],
26	not	RB	O	not	neg	30	SENT_317	[p16l542t1637r649b1687],
27	been	VBN	O	be	auxpass	30	SENT_317	[p16l663t1628r822b1687],
28	as	RB	O	as	advmod	29	SENT_317	[p16l839t1647r904b1687],
29	yet	RB	O	yet	advmod	30	SENT_317	[p16l922t1637r1024b1704],
30	marketed	VBN	O	market	dep	21	SENT_317	[p16l1039t1628r1352b1687],
31	in	IN	O	in	_	0	SENT_317	[p16l1368t1628r1431b1686],
32	this	DT	O	this	det	33	SENT_317	[p16l1447t1628r1565b1687],
33	part	NN	O	part	prep_in	30	SENT_317	[p16l1582t1637r1714b1704],
34	of	IN	O	of	_	0	SENT_317	[p16l1730t1628r1803b1687],
35	the	DT	O	the	det	36	SENT_317	[p16l1813t1628r1914b1687],
36	world	NN	O	world	prep_of	33	SENT_317	[p16l1931t1628r2142b1687],
37	.	.	O	.	_	0	SENT_317	[p16l1931t1628r2142b1687],

1	Of	IN	O	of	_	0	SENT_318	[p16l16t1729r107b1789],
2	course	NN	O	course	prep_of	7	SENT_318	[p16l127t1747r363b1799],
3	,	,	O	,	_	0	SENT_318	[p16l127t1747r363b1799],
4	participating	VBG	O	participate	amod	5	SENT_318	[p16l389t1729r815b1806],
5	individuals	NNS	O	individual	nsubj	7	SENT_318	[p16l841t1729r1211b1788],
6	are	VBP	O	be	cop	7	SENT_318	[p16l1239t1747r1338b1788],
7	all	DT	O	all	_	0	SENT_318	[p16l1365t1729r1445b1788],
8	of	IN	O	of	_	0	SENT_318	[p16l1471t1728r1544b1788],
9	Italian	JJ	MISC	italian	amod	10	SENT_318	[p16l1563t1729r1777b1788],
10	origin	NN	O	origin	prep_of	7	SENT_318	[p16l1803t1728r2002b1806],
11	and	CC	O	and	_	0	SENT_318	[p16l2028t1729r2147b1788],
12	it	PRP	O	it	nsubjpass	16	SENT_318	[p16l15t1830r60b1889],
13	can	MD	O	can	aux	16	SENT_318	[p16l87t1839r311b1889],
14	not	RB	O	not	neg	16	SENT_318	[p16l87t1839r311b1889],
15	be	VB	O	be	auxpass	16	SENT_318	[p16l335t1830r413b1889],
16	excluded	VBN	O	exclude	conj_and	7	SENT_318	[p16l441t1830r743b1889],
17	that	IN	O	that	complm	22	SENT_318	[p16l769t1830r895b1889],
18	metabolic	JJ	O	metabolic	amod	19	SENT_318	[p16l920t1830r1250b1889],
19	differences	NNS	O	difference	nsubjpass	22	SENT_318	[p16l1279t1830r1648b1889],
20	may	MD	O	may	aux	22	SENT_318	[p16l1677t1849r1820b1906],
21	be	VB	O	be	auxpass	22	SENT_318	[p16l1846t1830r1924b1889],
22	found	VBN	O	find	ccomp	16	SENT_318	[p16l1951t1830r2147b1889],
23	in	IN	O	in	_	0	SENT_318	[p16l15t1930r78b1988],
24	other	JJ	O	other	amod	25	SENT_318	[p16l103t1930r275b1989],
25	parts	NNS	O	part	prep_in	22	SENT_318	[p16l296t1939r457b2006],
26	of	IN	O	of	_	0	SENT_318	[p16l484t1930r557b1989],
27	the	DT	O	the	det	28	SENT_318	[p16l574t1930r675b1989],
28	world	NN	O	world	prep_of	25	SENT_318	[p16l699t1930r910b1989],
29	.	.	O	.	_	0	SENT_318	[p16l699t1930r910b1989],

1	5	CD	NUMBER	5	_	0	SENT_319	[p16l9t2037r68b2096],
2	.	.	O	.	_	0	SENT_319	[p16l9t2037r68b2096],

1	Conclusion	NN	O	conclusion	_	0	SENT_320	[p16l117t2036r518b2097],

1	This	DT	O	this	det	4	SENT_321	[p16l110t2232r257b2292],
2	large	JJ	O	large	amod	4	SENT_321	[p16l279t2232r444b2309],
3	scale	NN	O	scale	nn	4	SENT_321	[p16l468t2232r632b2292],
4	evaluation	NN	O	evaluation	nsubj	15	SENT_321	[p16l654t2232r1000b2292],
5	of	IN	O	of	_	0	SENT_321	[p16l1021t2232r1095b2292],
6	CYP450	NN	O	cyp450	nn	7	SENT_321	[p16l1110t2232r1399b2292],
7	polymorphism	NN	O	polymorphism	prep_of	4	SENT_321	[p16l1419t2232r1914b2309],
8	versus	CC	O	versus	prep	7	SENT_321	[p16l1934t2251r2145b2292],
9	myotoxic	JJ	O	myotoxic	amod	10	SENT_321	[p16l8t2333r325b2410],
10	effects	NNS	O	effect	dep	8	SENT_321	[p16l348t2332r567b2392],
11	and	CC	O	and	_	0	SENT_321	[p16l590t2333r710b2392],
12	lipid	NN	O	lipid	nn	14	SENT_321	[p16l729t2333r883b2410],
13	lowering	NN	O	lowering	nn	14	SENT_321	[p16l903t2333r1199b2410],
14	activity	NN	O	activity	conj_and	10	SENT_321	[p16l1222t2333r1470b2410],
15	provides	VBZ	O	provide	_	0	SENT_321	[p16l1490t2333r1798b2410],
16	,	,	O	,	_	0	SENT_321	[p16l1490t2333r1798b2410],
17	therefore	RB	O	therefore	dep	15	SENT_321	[p16l1821t2333r2144b2403],
18	,	,	O	,	_	0	SENT_321	[p16l1821t2333r2144b2403],
19	extensive	JJ	O	extensive	amod	20	SENT_321	[p16l9t2436r321b2496],
20	evidence	NN	O	evidence	dobj	15	SENT_321	[p16l355t2436r651b2496],
21	indicating	VBG	O	indicate	partmod	20	SENT_321	[p16l684t2436r1020b2513],
22	the	DT	O	the	det	23	SENT_321	[p16l1053t2436r1154b2496],
23	need	NN	O	need	dobj	21	SENT_321	[p16l1187t2436r1346b2496],
24	for	IN	O	for	_	0	SENT_321	[p16l1377t2436r1476b2496],
25	careful	JJ	O	careful	amod	26	SENT_321	[p16l1507t2436r1739b2496],
26	assessment	NN	O	assessment	prep_for	23	SENT_321	[p16l1773t2445r2148b2496],
27	of	IN	O	of	_	0	SENT_321	[p16l9t2538r82b2598],
28	the	DT	O	the	det	29	SENT_321	[p16l105t2538r206b2598],
29	patients	NNS	O	patient	prep_of	26	SENT_321	[p16l233t2538r494b2615],
30	without	IN	O	without	_	0	SENT_321	[p16l525t2538r783b2598],
31	the	DT	O	the	det	32	SENT_321	[p16l810t2538r911b2598],
32	need	NN	O	need	prep_without	21	SENT_321	[p16l939t2538r1098b2598],
33	for	IN	O	for	_	0	SENT_321	[p16l1126t2538r1224b2598],
34	monitoring	NN	O	monitoring	prep_for	32	SENT_321	[p16l1250t2538r1625b2615],
35	of	IN	O	of	_	0	SENT_321	[p16l1655t2538r1728b2598],
36	genetic	JJ	O	genetic	amod	38	SENT_321	[p16l1752t2538r1992b2615],
37	risk	NN	O	risk	nn	38	SENT_321	[p16l2021t2538r2149b2598],
38	factors	NNS	O	factor	prep_of	34	SENT_321	[p16l9t2639r253b2698],
39	.	.	O	.	_	0	SENT_321	[p16l9t2639r253b2698],

1	It	PRP	O	it	nsubj	3	SENT_322	[p16l275t2640r325b2698],
2	also	RB	O	also	advmod	3	SENT_322	[p16l343t2639r475b2698],
3	underlines	VBZ	O	underline	_	0	SENT_322	[p16l493t2639r843b2698],
4	the	DT	O	the	det	6	SENT_322	[p16l862t2639r963b2698],
5	potential	JJ	O	potential	amod	6	SENT_322	[p16l980t2639r1275b2716],
6	signiﬁcance	NN	O	signiﬁcance	dobj	3	SENT_322	[p16l1296t2639r1696b2716],
7	of	IN	O	of	_	0	SENT_322	[p16l1715t2639r1788b2698],
8	evaluating	VBG	O	evaluate	prepc_of	6	SENT_322	[p16l1800t2639r2146b2716],
9	CYP450	NN	O	cyp450	nn	13	SENT_322	[p16l9t2742r298b2802],
10	and	CC	O	and	_	0	SENT_322	[p16l315t2742r434b2802],
11	apo	NN	O	apo	conj_and	9	SENT_322	[p16l450t2761r567b2819],
12	E	NN	O	e	nn	13	SENT_322	[p16l582t2744r633b2801],
13	polymorphisms	NNS	O	polymorphism	dobj	8	SENT_322	[p16l646t2742r1172b2819],
14	versus	CC	O	versus	prep	8	SENT_322	[p16l1188t2761r1400b2802],
15	lipid	NN	O	lipid	nn	17	SENT_322	[p16l1416t2742r1570b2819],
16	lowering	NN	O	lowering	nn	17	SENT_322	[p16l1584t2742r1881b2819],
17	activity	NN	O	activity	dep	14	SENT_322	[p16l1898t2742r2146b2819],
18	with	IN	O	with	_	0	SENT_322	[p16l9t2843r157b2902],
19	the	DT	O	the	det	21	SENT_322	[p16l180t2843r281b2902],
20	different	JJ	O	different	amod	21	SENT_322	[p16l307t2843r595b2902],
21	statins	NNS	O	statin	prep_with	17	SENT_322	[p16l620t2843r830b2902],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_323	[p16l8t3049r707b3126],

1	This	DT	O	this	det	2	SENT_324	[p16l110t3245r257b3305],
2	research	NN	O	research	nsubjpass	4	SENT_324	[p16l367t3245r649b3305],
3	was	VBD	O	be	auxpass	4	SENT_324	[p16l757t3264r884b3305],
4	supported	VBN	O	support	_	0	SENT_324	[p16l997t3245r1328b3322],
5	by	IN	O	by	_	0	SENT_324	[p16l1435t3245r1518b3322],
6	Grants	NNPS	O	Grants	nn	7	SENT_324	[p16l1629t3245r1850b3305],
7	FIRB	NNP	O	FIRB	agent	4	SENT_324	[p16l1960t3247r2142b3304],
8	RBAUO1738C_002	NN	O	rbauo1738c_002	dep	7	SENT_324	[p16l8t3346r660b3406],
9	and	CC	O	and	_	0	SENT_324	[p16l725t3346r844b3405],
10	RBAU015E9T_OO2	NN	O	rbau015e9t_oo2	dep	7	SENT_324	[p16l905t3345r1562b3406],
11	by	IN	O	by	_	0	SENT_324	[p16l1624t3346r1707b3423],
12	the	DT	O	the	det	22	SENT_324	[p16l1769t3346r1870b3405],
13	Italian	JJ	MISC	italian	amod	22	SENT_324	[p16l1932t3346r2147b3405],
14	Ministry	NNP	ORGANIZATION	Ministry	dep	22	SENT_324	[p16l8t3448r298b3525],
15	of	IN	ORGANIZATION	of	_	0	SENT_324	[p16l323t3448r396b3508],
16	University	NNP	ORGANIZATION	University	nn	19	SENT_324	[p16l414t3448r766b3525],
17	and	CC	O	and	_	0	SENT_324	[p16l792t3448r912b3508],
18	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	19	SENT_324	[p16l937t3448r1252b3508],
19	Research	NNP	ORGANIZATION	Research	prep_of	14	SENT_324	[p16l1277t3448r1586b3508],
20	(	CD	NUMBER	(	dep	14	SENT_324	[p16l1612t3449r1902b3522],
21	MIUR	NN	O	miur	nn	22	SENT_324	[p16l1612t3449r1902b3522],
22	)	NN	O	)	agent	4	SENT_324	[p16l1612t3449r1902b3522],
23	.	.	O	.	_	0	SENT_324	[p16l1612t3449r1902b3522],

1	References	NNS	O	reference	_	0	SENT_325	[p16l9t3655r400b3715],

1	[	NN	O	[	_	0	SENT_326	[p17l43t77r111b133],
2	1	CD	NUMBER	1	num	5	SENT_326	[p17l43t77r111b133],
3	]	NNP	O	]	nn	5	SENT_326	[p17l43t77r111b133],
4	Law	NNP	O	Law	nn	5	SENT_326	[p17l145t77r262b123],
5	MR	NN	O	mr	dep	1	SENT_326	[p17l278t77r396b132],
6	,	,	O	,	_	0	SENT_326	[p17l278t77r396b132],
7	Wald	NNP	PERSON	Wald	nn	8	SENT_326	[p17l412t76r554b123],
8	NJ	NNP	O	NJ	appos	5	SENT_326	[p17l568t77r656b132],
9	,	,	O	,	_	0	SENT_326	[p17l568t77r656b132],
10	Rudnicka	NNP	PERSON	Rudnicka	nn	11	SENT_326	[p17l673t76r933b123],
11	AR	NNS	O	ar	appos	5	SENT_326	[p17l946t77r1053b123],
12	.	.	O	.	_	0	SENT_326	[p17l946t77r1053b123],

1	Quantifying	VBG	O	quantify	amod	2	SENT_327	[p17l1072t76r1397b137],
2	effect	NN	O	effect	_	0	SENT_327	[p17l1413t76r1565b123],
3	of	IN	O	of	_	0	SENT_327	[p17l1579t76r1637b123],
4	statins	NNS	O	statin	prep_of	2	SENT_327	[p17l1650t76r1818b123],
5	on	IN	O	on	_	0	SENT_327	[p17l1835t91r1900b123],
6	low	JJ	O	low	amod	9	SENT_327	[p17l1915t76r2013b123],
7	density	NN	O	density	nn	9	SENT_327	[p17l2029t76r2145b123, p17l147t159r241b220],
8	lipoprotein	NN	O	lipoprotein	nn	9	SENT_327	[p17l256t159r553b220],
9	cholesterol	NN	O	cholesterol	prep_on	4	SENT_327	[p17l568t159r878b215],
10	,	,	O	,	_	0	SENT_327	[p17l568t159r878b215],
11	ischaemic	JJ	O	ischaemic	amod	13	SENT_327	[p17l895t159r1164b207],
12	heart	NN	O	heart	nn	13	SENT_327	[p17l1179t159r1315b207],
13	disease	NN	O	disease	conj_and	9	SENT_327	[p17l1329t159r1537b215],
14	,	,	O	,	_	0	SENT_327	[p17l1329t159r1537b215],
15	and	CC	O	and	_	0	SENT_327	[p17l1555t159r1651b207],
16	stroke	NN	O	stroke	conj_and	9	SENT_327	[p17l1667t159r1843b207],
17	:	:	O	:	_	0	SENT_327	[p17l1667t159r1843b207],
18	systematic	JJ	O	systematic	amod	19	SENT_327	[p17l1864t159r2146b220],
19	review	NN	O	review	dep	2	SENT_327	[p17l144t242r324b290],
20	and	CC	O	and	_	0	SENT_327	[p17l345t242r441b290],
21	meta	NN	O	meta	nn	23	SENT_327	[p17l459t242r844b303],
22	—	NN	O	—	nn	23	SENT_327	[p17l459t242r844b303],
23	analysis	NN	O	analysis	conj_and	19	SENT_327	[p17l459t242r844b303],
24	.	.	O	.	_	0	SENT_327	[p17l459t242r844b303],

1	BMJ	NNP	O	BMJ	_	0	SENT_328	[p17l866t244r997b290],
2	2003	CD	DATE	2003	num	1	SENT_328	[p17l1017t242r1285b298],
3	;	:	O	;	_	0	SENT_328	[p17l1017t242r1285b298],
4	326	CD	NUMBER	326	num	6	SENT_328	[p17l1017t242r1285b298],
5	:	:	O	:	_	0	SENT_328	[p17l1017t242r1285b298],
6	1423-9	CD	NUMBER	1423-9	dep	1	SENT_328	[p17l1298t243r1507b290],
7	.	.	O	.	_	0	SENT_328	[p17l1298t243r1507b290],

1	[	NN	O	[	_	0	SENT_329	[p17l43t326r111b382],
2	2	CD	NUMBER	2	num	1	SENT_329	[p17l43t326r111b382],
3	]	CD	NUMBER	]	num	5	SENT_329	[p17l43t326r111b382],
4	Baigent	NN	O	baigent	nn	5	SENT_329	[p17l145t325r356b386],
5	C	NN	O	c	dep	1	SENT_329	[p17l384t326r442b381],
6	,	,	O	,	_	0	SENT_329	[p17l384t326r442b381],
7	Keech	NNP	PERSON	Keech	nn	8	SENT_329	[p17l474t325r644b373],
8	A	NNP	O	A	appos	5	SENT_329	[p17l672t326r734b381],
9	,	,	O	,	_	0	SENT_329	[p17l672t326r734b381],
10	Kearney	NNP	ORGANIZATION	Kearney	nn	11	SENT_329	[p17l766t327r991b386],
11	PM	NNP	ORGANIZATION	PM	appos	5	SENT_329	[p17l1020t327r1131b381],
12	,	,	O	,	_	0	SENT_329	[p17l1020t327r1131b381],
13	Blackwell	NNP	ORGANIZATION	Blackwell	nn	14	SENT_329	[p17l1162t325r1436b373],
14	L	NNP	ORGANIZATION	L	appos	5	SENT_329	[p17l1464t327r1519b381],
15	,	,	O	,	_	0	SENT_329	[p17l1464t327r1519b381],
16	Buck	NNP	O	Buck	nn	17	SENT_329	[p17l1550t325r1694b373],
17	G	NNP	O	G	appos	5	SENT_329	[p17l1722t326r1783b381],
18	,	,	O	,	_	0	SENT_329	[p17l1722t326r1783b381],
19	Pollicino	NNP	PERSON	Pollicino	nn	20	SENT_329	[p17l1814t325r2057b373],
20	C	NNP	O	C	appos	5	SENT_329	[p17l2087t326r2145b381],
21	,	,	O	,	_	0	SENT_329	[p17l2087t326r2145b381],
22	et	FW	O	et	nn	23	SENT_329	[p17l146t415r193b456],
23	al.	FW	O	al.	appos	5	SENT_329	[p17l217t408r276b456],
24	.	.	O	.	_	0	SENT_329	[p17l217t408r276b456],

1	Cholesterol	NNP	O	Cholesterol	nn	3	SENT_330	[p17l304t408r615b456],
2	Treatment	NN	O	treatment	nn	3	SENT_330	[p17l638t410r915b456],
3	Trialists	NNS	O	trialist	nsubj	4	SENT_330	[p17l937t408r1172b456],
4	’	VBP	O	’	_	0	SENT_330	[p17l937t408r1172b456],
5	(	CD	NUMBER	(	num	8	SENT_330	[p17l1204t409r1371b466],
6	CTT	NNP	O	CTT	nn	8	SENT_330	[p17l1204t409r1371b466],
7	)	CD	NUMBER	)	num	8	SENT_330	[p17l1204t409r1371b466],
8	Collaborators	NNS	O	collaborator	dobj	4	SENT_330	[p17l1398t408r1779b456],
9	.	.	O	.	_	0	SENT_330	[p17l1398t408r1779b456],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_331	[p17l1805t408r2027b469],
2	and	CC	O	and	_	0	SENT_331	[p17l2052t408r2148b456],
3	safety	NN	O	safety	conj_and	1	SENT_331	[p17l147t491r305b552],
4	of	IN	O	of	_	0	SENT_331	[p17l343t491r401b539],
5	cholesterol	NN	O	cholesterol	nn	8	SENT_331	[p17l434t491r992b552],
6	—	CD	NUMBER	—	num	8	SENT_331	[p17l434t491r992b552],
7	lowering	NN	O	lowering	nn	8	SENT_331	[p17l434t491r992b552],
8	treatment	NN	O	treatment	prep_of	1	SENT_331	[p17l1028t498r1298b539],
9	:	:	O	:	_	0	SENT_331	[p17l1028t498r1298b539],
10	prospective	JJ	O	prospective	amod	13	SENT_331	[p17l1338t491r1647b552],
11	meta	NN	O	meta	nn	13	SENT_331	[p17l1684t491r2054b552],
12	—	NN	O	—	nn	13	SENT_331	[p17l1684t491r2054b552],
13	analysis	NN	O	analysis	dep	1	SENT_331	[p17l1684t491r2054b552],
14	of	IN	O	of	_	0	SENT_331	[p17l2093t491r2152b539],
15	data	NNS	O	datum	prep_of	13	SENT_331	[p17l146t574r258b622],
16	from	IN	O	from	_	0	SENT_331	[p17l281t574r412b622],
17	90	CD	NUMBER	90	prep_from	15	SENT_331	[p17l437t575r516b630],
18	,	,	O	,	_	0	SENT_331	[p17l437t575r516b630],
19	056	CD	NUMBER	056	num	20	SENT_331	[p17l543t574r642b622],
20	participants	NNS	O	participant	appos	15	SENT_331	[p17l667t574r981b635],
21	in	IN	O	in	_	0	SENT_331	[p17l1007t574r1059b621],
22	14	CD	NUMBER	14	num	24	SENT_331	[p17l1089t575r1148b621],
23	randomised	JJ	O	randomised	amod	24	SENT_331	[p17l1173t574r1489b622],
24	trials	NNS	O	trial	prep_in	20	SENT_331	[p17l1513t574r1646b622],
25	of	IN	O	of	_	0	SENT_331	[p17l1672t574r1731b622],
26	statins	NNS	O	statin	prep_of	24	SENT_331	[p17l1753t574r1936b622],
27	.	.	O	.	_	0	SENT_331	[p17l1753t574r1936b622],

1	Lancet	NNP	O	Lancet	_	0	SENT_332	[p17l1963t576r2148b622],
2	2005	CD	DATE	2005	num	1	SENT_332	[p17l146t658r276b706],
3	;	:	O	;	_	0	SENT_332	[p17l285t658r414b714],
4	366	CD	NUMBER	366	num	6	SENT_332	[p17l285t658r414b714],
5	:	:	O	:	_	0	SENT_332	[p17l285t658r414b714],
6	1267-78	CD	NUMBER	1267-78	dep	1	SENT_332	[p17l427t658r670b706],
7	.	.	O	.	_	0	SENT_332	[p17l427t658r670b706],

1	[	NN	O	[	_	0	SENT_333	[p17l43t742r111b798],
2	3	CD	NUMBER	3	num	1	SENT_333	[p17l43t742r111b798],
3	]	CD	NUMBER	]	num	5	SENT_333	[p17l43t742r111b798],
4	Ucar	NNP	O	Ucar	nn	5	SENT_333	[p17l145t743r276b789],
5	M	NN	O	m	dep	1	SENT_333	[p17l303t743r377b797],
6	,	,	O	,	_	0	SENT_333	[p17l303t743r377b797],
7	Mjorndal	JJ	ORGANIZATION	mjorndal	amod	8	SENT_333	[p17l407t741r658b802],
8	T	NN	ORGANIZATION	t	dep	1	SENT_333	[p17l686t743r736b797],
9	,	,	O	,	_	0	SENT_333	[p17l686t743r736b797],
10	Dahlqvist	NNP	PERSON	Dahlqvist	nn	14	SENT_333	[p17l766t741r1030b802],
11	R.	NNP	PERSON	R.	nn	14	SENT_333	[p17l1057t743r1113b789],
12	HMG-CoA	NNP	PERSON	HMG-CoA	nn	14	SENT_333	[p17l1145t742r1453b789],
13	reductase	NN	O	reductase	nn	14	SENT_333	[p17l1480t741r1736b789],
14	inhibitors	NNS	O	inhibitor	conj_and	5	SENT_333	[p17l1764t741r2021b789],
15	and	CC	O	and	_	0	SENT_333	[p17l2052t741r2148b789],
16	myotoxicity	NN	O	myotoxicity	conj_and	5	SENT_333	[p17l145t824r481b885],
17	.	.	O	.	_	0	SENT_333	[p17l145t824r481b885],

1	Drug	NNP	O	Drug	nn	2	SENT_334	[p17l503t826r641b885],
2	Saf	NNP	O	Saf	_	0	SENT_334	[p17l662t824r753b872],
3	2000	CD	DATE	2000	num	2	SENT_334	[p17l768t824r1225b880],
4	;	:	O	;	_	0	SENT_334	[p17l768t824r1225b880],
5	22:441	CD	NUMBER	22:441	number	6	SENT_334	[p17l768t824r1225b880],
6	-57	CD	NUMBER	-57	dep	2	SENT_334	[p17l768t824r1225b880],
7	.	.	O	.	_	0	SENT_334	[p17l768t824r1225b880],

1	[	NN	O	[	nn	5	SENT_335	[p17l43t908r111b965],
2	4	CD	NUMBER	4	num	5	SENT_335	[p17l43t908r111b965],
3	]	CD	NUMBER	]	num	5	SENT_335	[p17l43t908r111b965],
4	Farmer	NNP	O	Farmer	nn	5	SENT_335	[p17l145t909r340b955],
5	JA	NNP	O	JA	_	0	SENT_335	[p17l361t908r446b963],
6	,	,	O	,	_	0	SENT_335	[p17l361t908r446b963],
7	Torre-Amione	NNP	O	Torre-Amione	nn	8	SENT_335	[p17l471t907r857b955],
8	G.	NNP	O	G.	appos	5	SENT_335	[p17l881t908r941b955],
9	Comparative	JJ	O	comparative	amod	10	SENT_335	[p17l968t908r1314b969],
10	tolerability	NN	O	tolerability	dep	5	SENT_335	[p17l1337t908r1633b969],
11	of	IN	O	of	_	0	SENT_335	[p17l1658t907r1716b955],
12	the	DT	O	the	det	13	SENT_335	[p17l1735t908r1816b955],
13	HMG-CoA	NN	O	hmg-coa	prep_of	10	SENT_335	[p17l1839t908r2147b955],

1	reductase	NN	O	reductase	nn	2	SENT_336	[p17l144t990r399b1038],
2	inhibitors	NNS	O	inhibitor	_	0	SENT_336	[p17l419t990r691b1038],
3	.	.	O	.	_	0	SENT_336	[p17l419t990r691b1038],

1	Drug	NNP	O	Drug	nn	2	SENT_337	[p17l713t992r850b1052],
2	Saf	NNP	O	Saf	_	0	SENT_337	[p17l872t990r964b1038],
3	2000	CD	DATE	2000	num	2	SENT_337	[p17l978t991r1469b1046],
4	;	:	O	;	_	0	SENT_337	[p17l978t991r1469b1046],
5	23:197	CD	NUMBER	23:197	number	6	SENT_337	[p17l978t991r1469b1046],
6	-213	CD	NUMBER	-213	dep	2	SENT_337	[p17l978t991r1469b1046],
7	.	.	O	.	_	0	SENT_337	[p17l978t991r1469b1046],

1	[	NN	O	[	_	0	SENT_338	[p17l43t1073r111b1131],
2	5	CD	NUMBER	5	number	3	SENT_338	[p17l43t1073r111b1131],
3	]	CD	NUMBER	]	dep	1	SENT_338	[p17l43t1073r111b1131],
4	Grundy	NNP	O	Grundy	nn	5	SENT_338	[p17l146t1074r350b1135],
5	SM	NNP	O	SM	dep	3	SENT_338	[p17l377t1074r485b1121],
6	.	.	O	.	_	0	SENT_338	[p17l377t1074r485b1121],

1	The	DT	O	the	det	2	SENT_339	[p17l514t1074r617b1121],
2	issue	NN	O	issue	_	0	SENT_339	[p17l642t1074r776b1121],
3	of	IN	O	of	_	0	SENT_339	[p17l802t1073r861b1121],
4	statin	NN	O	statin	nn	5	SENT_339	[p17l883t1074r1027b1121],
5	safety	NN	O	safety	prep_of	2	SENT_339	[p17l1054t1073r1221b1135],
6	.	.	O	.	_	0	SENT_339	[p17l1054t1073r1221b1135],

1	Where	WRB	O	where	advmod	4	SENT_340	[p17l1248t1073r1428b1121],
2	do	VBP	O	do	aux	4	SENT_340	[p17l1454t1074r1519b1121],
3	we	PRP	O	we	nsubj	4	SENT_340	[p17l1544t1088r1621b1121],
4	stand	VB	O	stand	_	0	SENT_340	[p17l1649t1074r1818b1121],
5	?	.	O	?	_	0	SENT_340	[p17l1649t1074r1818b1121],

1	Circulation	NN	O	circulation	_	0	SENT_341	[p17l1844t1074r2147b1121],

1	[	NN	O	[	nsubj	27	SENT_342	[p17l43t1240r111b1298],
2	6	CD	NUMBER	6	num	1	SENT_342	[p17l43t1240r111b1298],
3	]	CD	NUMBER	]	num	5	SENT_342	[p17l43t1240r111b1298],
4	Franc	NN	O	franc	nn	5	SENT_342	[p17l145t1242r297b1288],
5	S	NN	O	s	rcmod	1	SENT_342	[p17l320t1241r369b1296],
6	,	,	O	,	_	0	SENT_342	[p17l320t1241r369b1296],
7	Dejager	NNP	PERSON	Dejager	nn	8	SENT_342	[p17l391t1240r606b1302],
8	S	NNP	O	S	appos	5	SENT_342	[p17l627t1241r675b1296],
9	,	,	O	,	_	0	SENT_342	[p17l627t1241r675b1296],
10	Bruckert	NNP	O	Bruckert	nn	11	SENT_342	[p17l698t1240r934b1288],
11	E	NNP	O	E	appos	5	SENT_342	[p17l953t1242r1007b1296],
12	,	,	O	,	_	0	SENT_342	[p17l953t1242r1007b1296],
13	Chauvenet	NNP	O	Chauvenet	nn	14	SENT_342	[p17l1031t1241r1319b1288],
14	M	NNP	O	M	appos	5	SENT_342	[p17l1338t1242r1411b1296],
15	,	,	O	,	_	0	SENT_342	[p17l1338t1242r1411b1296],
16	Giral	NNP	PERSON	Giral	nn	17	SENT_342	[p17l1435t1240r1572b1288],
17	P	NN	PERSON	p	appos	5	SENT_342	[p17l1591t1242r1634b1296],
18	,	,	O	,	_	0	SENT_342	[p17l1591t1242r1634b1296],
19	Turpin	NNP	PERSON	Turpin	nn	23	SENT_342	[p17l1657t1241r1838b1302],
20	G.	NNP	O	G.	nn	23	SENT_342	[p17l1858t1241r1918b1288],
21	A	NNP	O	A	nn	23	SENT_342	[p17l1942t1241r1989b1287],
22	comprehensive	JJ	O	comprehensive	amod	23	SENT_342	[p17l2010t1255r2145b1288, p17l144t1323r435b1385],
23	description	NN	O	description	appos	5	SENT_342	[p17l451t1324r751b1385],
24	of	IN	O	of	dep	5	SENT_342	[p17l767t1323r825b1371],
25	muscle	NN	O	muscle	nn	26	SENT_342	[p17l836t1324r1026b1371],
26	symptoms	NNS	O	symptom	pobj	24	SENT_342	[p17l1044t1331r1318b1385],
27	associated	VBN	O	associate	_	0	SENT_342	[p17l1336t1324r1613b1371],
28	with	IN	O	with	_	0	SENT_342	[p17l1628t1324r1747b1371],
29	lipid-lowering	JJ	O	lipid-lowering	amod	30	SENT_342	[p17l1762t1323r2146b1385],
30	drugs	NNS	O	drug	prep_with	27	SENT_342	[p17l146t1407r308b1468],
31	.	.	O	.	_	0	SENT_342	[p17l146t1407r308b1468],

1	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_343	[p17l331t1407r630b1454],
2	Drugs	NNPS	O	Drugs	nn	3	SENT_343	[p17l650t1408r813b1468],
3	T	NN	O	t	_	0	SENT_343	[p17l833t1408r873b1453],
4	her	PRP$	O	she	poss	7	SENT_343	[p17l874t1407r961b1454],
5	2003	CD	DATE	2003	num	7	SENT_343	[p17l979t1406r1436b1462],
6	;	:	O	;	_	0	SENT_343	[p17l979t1406r1436b1462],
7	17:459	CD	NUMBER	17:459	dep	3	SENT_343	[p17l979t1406r1436b1462],
8	—	CD	NUMBER	—	number	9	SENT_343	[p17l979t1406r1436b1462],
9	65	CD	NUMBER	65	dep	7	SENT_343	[p17l979t1406r1436b1462],
10	.	.	O	.	_	0	SENT_343	[p17l979t1406r1436b1462],

1	[	NN	O	[	_	0	SENT_344	[p17l43t1491r111b1547],
2	7	CD	NUMBER	7	number	3	SENT_344	[p17l43t1491r111b1547],
3	]	CD	NUMBER	]	dep	1	SENT_344	[p17l43t1491r111b1547],
4	Moore	NNP	PERSON	Moore	nn	5	SENT_344	[p17l145t1491r324b1537],
5	JD	NNP	O	JD	dep	3	SENT_344	[p17l345t1491r432b1537],
6	.	.	O	.	_	0	SENT_344	[p17l345t1491r432b1537],

1	Successful	JJ	O	successful	amod	2	SENT_345	[p17l458t1489r745b1537],
2	treatment	NN	O	treatment	_	0	SENT_345	[p17l766t1497r1022b1537],
3	with	IN	O	with	_	0	SENT_345	[p17l1042t1489r1161b1537],
4	colesevelam	NN	O	colesevelam	nn	5	SENT_345	[p17l1182t1490r1514b1537],
5	HCl	NN	O	hcl	prep_with	2	SENT_345	[p17l1533t1490r1645b1537],
6	and	CC	O	and	_	0	SENT_345	[p17l1667t1490r1762b1537],
7	pravastatin	NN	O	pravastatin	conj_and	5	SENT_345	[p17l1781t1490r2075b1551],
8	in	IN	O	in	_	0	SENT_345	[p17l2096t1490r2147b1536],
9	a	DT	O	a	det	10	SENT_345	[p17l147t1587r175b1620],
10	patient	NN	O	patient	prep_in	2	SENT_345	[p17l199t1573r384b1634],
11	previously	RB	DATE	previously	advmod	12	SENT_345	[p17l409t1572r693b1634],
12	hospitalised	VBN	O	hospitalise	partmod	2	SENT_345	[p17l719t1573r1043b1634],
13	with	IN	O	with	_	0	SENT_345	[p17l1069t1573r1188b1620],
14	severe	JJ	O	severe	amod	17	SENT_345	[p17l1217t1587r1384b1620],
15	normal	JJ	O	normal	amod	17	SENT_345	[p17l1410t1573r1601b1620],
16	CPK	NN	O	cpk	nn	17	SENT_345	[p17l1628t1573r1759b1620],
17	myopathy	NN	O	myopathy	prep_with	12	SENT_345	[p17l1784t1573r2054b1634],
18	on	IN	O	on	_	0	SENT_345	[p17l2082t1587r2147b1620],
19	introduction	NN	O	introduction	prep_on	17	SENT_345	[p17l145t1656r476b1703],
20	of	IN	O	of	_	0	SENT_345	[p17l495t1656r554b1703],
21	simvastatin	NN	O	simvastatin	prep_of	19	SENT_345	[p17l571t1656r888b1703],
22	.	.	O	.	_	0	SENT_345	[p17l571t1656r888b1703],

1	Clin	NNP	O	Clin	nn	3	SENT_346	[p17l911t1656r1025b1703],
2	Drug	NNP	O	Drug	nn	3	SENT_346	[p17l1044t1657r1181b1717],
3	Invest	NNP	O	Invest	_	0	SENT_346	[p17l1201t1657r1362b1703],
4	2005	CD	DATE	2005	num	3	SENT_346	[p17l1381t1656r1837b1711],
5	;	:	O	;	_	0	SENT_346	[p17l1381t1656r1837b1711],
6	25:417	CD	NUMBER	25:417	number	7	SENT_346	[p17l1381t1656r1837b1711],
7	-20	CD	NUMBER	-20	dep	3	SENT_346	[p17l1381t1656r1837b1711],
8	.	.	O	.	_	0	SENT_346	[p17l1381t1656r1837b1711],

1	[	NN	O	[	nn	5	SENT_347	[p17l43t1739r111b1796],
2	8	CD	NUMBER	8	num	5	SENT_347	[p17l43t1739r111b1796],
3	]	CD	NUMBER	]	num	5	SENT_347	[p17l43t1739r111b1796],
4	Hansen	NNP	PERSON	Hansen	nn	5	SENT_347	[p17l145t1740r348b1786],
5	KE	NNP	PERSON	KE	_	0	SENT_347	[p17l363t1740r466b1794],
6	,	,	O	,	_	0	SENT_347	[p17l363t1740r466b1794],
7	Hildebrand	NNP	PERSON	Hildebrand	nn	8	SENT_347	[p17l484t1739r788b1786],
8	JP	NNP	O	JP	appos	5	SENT_347	[p17l802t1740r872b1794],
9	,	,	O	,	_	0	SENT_347	[p17l802t1740r872b1794],
10	Ferguson	NNP	PERSON	Ferguson	nn	11	SENT_347	[p17l889t1740r1140b1800],
11	EE	NNP	O	EE	appos	5	SENT_347	[p17l1154t1740r1250b1794],
12	,	,	O	,	_	0	SENT_347	[p17l1154t1740r1250b1794],
13	Stein	NNP	PERSON	Stein	nn	16	SENT_347	[p17l1270t1739r1406b1786],
14	J	NNP	O	J	nn	16	SENT_347	[p17l1421t1740r1446b1786],
15	H.	NNP	O	H.	nn	16	SENT_347	[p17l1448t1740r1508b1786],
16	Outcome	NNP	O	Outcome	appos	5	SENT_347	[p17l1528t1739r1774b1786],
17	in	IN	O	in	_	0	SENT_347	[p17l1790t1739r1841b1785],
18	45	CD	NUMBER	45	num	19	SENT_347	[p17l1856t1739r1919b1786],
19	patients	NNS	O	patient	prep_in	16	SENT_347	[p17l1937t1739r2145b1800],
20	with	IN	O	with	_	0	SENT_347	[p17l146t1822r265b1869],
21	statin-associated	JJ	O	statin-associated	amod	22	SENT_347	[p17l285t1822r731b1869],
22	myopathy	NN	O	myopathy	prep_with	19	SENT_347	[p17l749t1822r1028b1883],
23	.	.	O	.	_	0	SENT_347	[p17l749t1822r1028b1883],

1	Arch	NNP	O	Arch	nn	3	SENT_348	[p17l1050t1822r1185b1869],
2	Intern	NNP	O	Intern	nn	3	SENT_348	[p17l1203t1823r1364b1869],
3	Med	NNP	O	Med	_	0	SENT_348	[p17l1382t1822r1506b1869],
4	2000	CD	DATE	2000	num	3	SENT_348	[p17l1525t1822r2015b1877],
5	;	:	O	;	_	0	SENT_348	[p17l1525t1822r2015b1877],
6	165:2671	CD	NUMBER	165:2671	number	7	SENT_348	[p17l1525t1822r2015b1877],
7	—	CD	NUMBER	—	dep	3	SENT_348	[p17l1525t1822r2015b1877],
8	6	CD	NUMBER	6	dep	7	SENT_348	[p17l1525t1822r2015b1877],
9	.	.	O	.	_	0	SENT_348	[p17l1525t1822r2015b1877],

1	[	NN	O	[	nn	3	SENT_349	[p17l43t1905r111b1962],
2	9	CD	NUMBER	9	num	3	SENT_349	[p17l43t1905r111b1962],
3	]	NN	O	]	_	0	SENT_349	[p17l43t1905r111b1962],
4	Phillips	NNP	ORGANIZATION	Phillips	nn	5	SENT_349	[p17l145t1905r350b1966],
5	PS	NNP	ORGANIZATION	PS	dep	3	SENT_349	[p17l366t1905r454b1961],
6	,	,	O	,	_	0	SENT_349	[p17l366t1905r454b1961],
7	Haas	NNP	PERSON	Haas	nn	8	SENT_349	[p17l472t1906r605b1952],
8	RH	NNP	O	RH	appos	5	SENT_349	[p17l621t1906r729b1960],
9	,	,	O	,	_	0	SENT_349	[p17l621t1906r729b1960],
10	Bannykh	NNP	PERSON	Bannykh	nn	11	SENT_349	[p17l746t1905r989b1966],
11	S	NNP	O	S	appos	5	SENT_349	[p17l1006t1905r1054b1960],
12	,	,	O	,	_	0	SENT_349	[p17l1006t1905r1054b1960],
13	Hathaway	NNP	PERSON	Hathaway	nn	14	SENT_349	[p17l1072t1905r1344b1966],
14	S	NNP	O	S	appos	5	SENT_349	[p17l1361t1905r1410b1960],
15	,	,	O	,	_	0	SENT_349	[p17l1361t1905r1410b1960],
16	Gray	NNP	ORGANIZATION	Gray	nn	17	SENT_349	[p17l1428t1905r1561b1966],
17	NL	NNP	ORGANIZATION	NL	appos	5	SENT_349	[p17l1576t1906r1679b1960],
18	,	,	O	,	_	0	SENT_349	[p17l1576t1906r1679b1960],
19	Kimura	NNP	ORGANIZATION	Kimura	nn	20	SENT_349	[p17l1699t1905r1904b1952],
20	BJ	NNP	ORGANIZATION	BJ	appos	5	SENT_349	[p17l1918t1906r2003b1960],
21	,	,	O	,	_	0	SENT_349	[p17l1918t1906r2003b1960],
22	et	FW	O	et	nn	23	SENT_349	[p17l2021t1912r2069b1952],
23	al.	FW	O	al.	appos	5	SENT_349	[p17l2084t1905r2144b1952],
24	.	.	O	.	_	0	SENT_349	[p17l2084t1905r2144b1952],

1	Statin	NN	O	statin	nn	2	SENT_350	[p17l147t1988r605b2035],
2	—	NN	O	—	nsubj	3	SENT_350	[p17l147t1988r605b2035],
3	associated	VBN	O	associate	_	0	SENT_350	[p17l147t1988r605b2035],
4	myopathy	NN	O	myopathy	dobj	3	SENT_350	[p17l620t1988r890b2049],
5	with	IN	O	with	_	0	SENT_350	[p17l907t1988r1026b2035],
6	normal	JJ	O	normal	amod	9	SENT_350	[p17l1042t1988r1233b2035],
7	creatine	NN	O	creatine	nn	9	SENT_350	[p17l1250t1988r1462b2035],
8	kinase	NN	O	kinase	nn	9	SENT_350	[p17l1478t1988r1651b2035],
9	levels	NNS	O	level	prep_with	3	SENT_350	[p17l1668t1988r1835b2035],
10	.	.	O	.	_	0	SENT_350	[p17l1668t1988r1835b2035],

1	Ann	NNP	O	Ann	nn	3	SENT_351	[p17l1855t1988r1970b2034],
2	Intern	NNP	O	Intern	nn	3	SENT_351	[p17l1987t1989r2147b2035],
3	Med	NNP	O	Med	_	0	SENT_351	[p17l145t2071r268b2118],
4	2002	CD	DATE	2002	num	3	SENT_351	[p17l287t2071r744b2126],
5	;	:	O	;	_	0	SENT_351	[p17l287t2071r744b2126],
6	137:581	CD	NUMBER	137:581	number	7	SENT_351	[p17l287t2071r744b2126],
7	—	CD	NUMBER	—	dep	3	SENT_351	[p17l287t2071r744b2126],
8	5	CD	NUMBER	5	dep	7	SENT_351	[p17l287t2071r744b2126],
9	.	.	O	.	_	0	SENT_351	[p17l287t2071r744b2126],

1	[	NN	O	[	_	0	SENT_352	[p17l9t2154r111b2211],
2	10	CD	NUMBER	10	num	1	SENT_352	[p17l9t2154r111b2211],
3	]	CD	NUMBER	]	num	5	SENT_352	[p17l9t2154r111b2211],
4	Gambelli	NNP	PERSON	Gambelli	nn	5	SENT_352	[p17l146t2154r396b2201],
5	S	NN	PERSON	s	dep	1	SENT_352	[p17l411t2154r459b2210],
6	,	,	O	,	_	0	SENT_352	[p17l411t2154r459b2210],
7	Dotti	NNP	PERSON	Dotti	nn	8	SENT_352	[p17l474t2154r612b2201],
8	MT	NNP	O	MT	appos	5	SENT_352	[p17l625t2155r735b2209],
9	,	,	O	,	_	0	SENT_352	[p17l625t2155r735b2209],
10	Malandrini	NNP	O	Malandrini	nn	11	SENT_352	[p17l749t2154r1049b2201],
11	A	NNP	O	A	appos	5	SENT_352	[p17l1062t2154r1124b2209],
12	,	,	O	,	_	0	SENT_352	[p17l1062t2154r1124b2209],
13	Mondelli	NNP	O	Mondelli	nn	14	SENT_352	[p17l1139t2154r1386b2201],
14	M	NNP	O	M	appos	5	SENT_352	[p17l1399t2155r1472b2209],
15	,	,	O	,	_	0	SENT_352	[p17l1399t2155r1472b2209],
16	Strornillo	NNP	O	Strornillo	nn	17	SENT_352	[p17l1489t2154r1742b2201],
17	ML	NNP	O	ML	appos	5	SENT_352	[p17l1755t2155r1870b2209],
18	,	,	O	,	_	0	SENT_352	[p17l1755t2155r1870b2209],
19	Gaudiano	NNP	O	Gaudiano	nn	20	SENT_352	[p17l1886t2154r2146b2201],
20	C	NNP	O	C	appos	5	SENT_352	[p17l146t2237r203b2292],
21	,	,	O	,	_	0	SENT_352	[p17l146t2237r203b2292],
22	et	FW	O	et	nn	23	SENT_352	[p17l226t2244r274b2284],
23	al.	FW	O	al.	appos	5	SENT_352	[p17l295t2237r354b2284],
24	.	.	O	.	_	0	SENT_352	[p17l295t2237r354b2284],

1	Mitochondrial	JJ	O	mitochondrial	amod	2	SENT_353	[p17l377t2237r765b2284],
2	alterations	NNS	O	alteration	_	0	SENT_353	[p17l787t2237r1065b2284],
3	in	IN	O	in	_	0	SENT_353	[p17l1087t2237r1138b2283],
4	muscle	NN	O	muscle	nn	5	SENT_353	[p17l1158t2237r1348b2284],
5	biopsies	NNS	O	biopsy	prep_in	2	SENT_353	[p17l1368t2237r1588b2298],
6	of	IN	O	of	_	0	SENT_353	[p17l1611t2237r1670b2284],
7	patients	NNS	O	patient	prep_of	2	SENT_353	[p17l1685t2237r1893b2298],
8	on	IN	O	on	_	0	SENT_353	[p17l1916t2252r1981b2284],
9	statin	NN	O	statin	nn	10	SENT_353	[p17l2004t2237r2147b2284],
10	therapy	NN	O	therapy	prep_on	7	SENT_353	[p17l145t2320r355b2381],
11	.	.	O	.	_	0	SENT_353	[p17l145t2320r355b2381],

1	J	NNP	O	J	nn	4	SENT_354	[p17l377t2321r402b2367],
2	Submicrosc	NNP	O	Submicrosc	nn	4	SENT_354	[p17l423t2320r739b2367],
3	Cytol	NNP	O	Cytol	nn	4	SENT_354	[p17l760t2320r908b2381],
4	Pathol	NNP	O	Pathol	_	0	SENT_354	[p17l927t2320r1098b2367],
5	2004	CD	DATE	2004	num	4	SENT_354	[p17l1118t2320r1506b2375],
6	;	:	O	;	_	0	SENT_354	[p17l1118t2320r1506b2375],
7	36:85	CD	NUMBER	36:85	number	8	SENT_354	[p17l1118t2320r1506b2375],
8	—	CD	NUMBER	—	dep	4	SENT_354	[p17l1118t2320r1506b2375],
9	9	CD	NUMBER	9	dep	8	SENT_354	[p17l1118t2320r1506b2375],
10	.	.	O	.	_	0	SENT_354	[p17l1118t2320r1506b2375],

1	[	NN	O	[	_	0	SENT_355	[p17l9t2402r111b2459],
2	11	CD	NUMBER	11	num	1	SENT_355	[p17l9t2402r111b2459],
3	]	CD	NUMBER	]	num	5	SENT_355	[p17l9t2402r111b2459],
4	Paiva	NN	PERSON	paiva	nn	5	SENT_355	[p17l145t2402r294b2449],
5	H	NN	PERSON	h	dep	1	SENT_355	[p17l319t2403r381b2458],
6	,	,	O	,	_	0	SENT_355	[p17l319t2403r381b2458],
7	Thelen	NNP	ORGANIZATION	Thelen	nn	8	SENT_355	[p17l410t2402r597b2449],
8	KM	NNP	ORGANIZATION	KM	appos	5	SENT_355	[p17l624t2403r745b2458],
9	,	,	O	,	_	0	SENT_355	[p17l624t2403r745b2458],
10	Van	NNP	PERSON	Van	nn	12	SENT_355	[p17l774t2403r878b2449],
11	Coster	NNP	PERSON	Coster	nn	12	SENT_355	[p17l905t2402r1081b2449],
12	R	NNP	PERSON	R	appos	5	SENT_355	[p17l1106t2403r1164b2458],
13	,	,	O	,	_	0	SENT_355	[p17l1106t2403r1164b2458],
14	Smet	NNP	PERSON	Smet	nn	15	SENT_355	[p17l1195t2402r1332b2449],
15	J	NNP	PERSON	J	appos	5	SENT_355	[p17l1357t2403r1382b2449],
16	,	,	O	,	_	0	SENT_355	[p17l1386t2441r1396b2458],
17	De	NNP	PERSON	De	nn	19	SENT_355	[p17l1425t2403r1502b2449],
18	Paepe	NNP	PERSON	Paepe	nn	19	SENT_355	[p17l1529t2403r1688b2463],
19	B	NNP	O	B	appos	5	SENT_355	[p17l1715t2403r1773b2458],
20	,	,	O	,	_	0	SENT_355	[p17l1715t2403r1773b2458],
21	Mattila	NNP	PERSON	Mattila	nn	22	SENT_355	[p17l1801t2402r1997b2449],
22	KM	NNP	O	KM	appos	5	SENT_355	[p17l2024t2403r2145b2458],
23	,	,	O	,	_	0	SENT_355	[p17l2024t2403r2145b2458],
24	et	FW	O	et	nn	25	SENT_355	[p17l146t2492r193b2532],
25	al.	FW	O	al.	appos	5	SENT_355	[p17l226t2485r285b2532],
26	.	.	O	.	_	0	SENT_355	[p17l226t2485r285b2532],

1	High	JJ	O	high	amod	4	SENT_356	[p17l321t2485r602b2546],
2	—	NN	O	—	nn	4	SENT_356	[p17l321t2485r602b2546],
3	dose	NN	O	dose	nn	4	SENT_356	[p17l321t2485r602b2546],
4	statins	NNS	O	statin	_	0	SENT_356	[p17l637t2485r805b2532],
5	and	CC	O	and	_	0	SENT_356	[p17l840t2485r935b2532],
6	skeletal	JJ	O	skeletal	amod	8	SENT_356	[p17l969t2485r1172b2532],
7	muscle	NN	O	muscle	nn	8	SENT_356	[p17l1204t2485r1395b2532],
8	metabolism	NN	O	metabolism	conj_and	4	SENT_356	[p17l1427t2485r1744b2532],
9	in	IN	O	in	_	0	SENT_356	[p17l1775t2485r1826b2532],
10	humans	NNS	O	human	prep_in	8	SENT_356	[p17l1857t2485r2082b2532],
11	:	:	O	:	_	0	SENT_356	[p17l1857t2485r2082b2532],
12	a	DT	O	a	dep	4	SENT_356	[p17l2120t2500r2148b2532],
13	randomized	VBN	O	randomize	partmod	12	SENT_356	[p17l144t2569r479b2625],
14	,	,	O	,	_	0	SENT_356	[p17l144t2569r479b2625],
15	controlled	VBN	O	control	dep	13	SENT_356	[p17l501t2569r774b2616],
16	trials	NNS	O	trial	dobj	13	SENT_356	[p17l793t2569r940b2616],
17	.	.	O	.	_	0	SENT_356	[p17l793t2569r940b2616],

1	Clin	NNP	O	Clin	nn	3	SENT_357	[p17l963t2569r1078b2616],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_357	[p17l1097t2569r1385b2616],
3	Ther	NNP	O	Ther	_	0	SENT_357	[p17l1405t2569r1532b2616],
4	2005	CD	DATE	2005	num	3	SENT_357	[p17l1551t2569r1939b2625],
5	;	:	O	;	_	0	SENT_357	[p17l1551t2569r1939b2625],
6	78:60	CD	NUMBER	78:60	number	7	SENT_357	[p17l1551t2569r1939b2625],
7	—	CD	NUMBER	—	dep	3	SENT_357	[p17l1551t2569r1939b2625],
8	8	CD	NUMBER	8	dep	7	SENT_357	[p17l1551t2569r1939b2625],
9	.	.	O	.	_	0	SENT_357	[p17l1551t2569r1939b2625],

1	[	NN	O	[	nn	5	SENT_358	[p17l9t2652r111b2709],
2	12	CD	NUMBER	12	num	5	SENT_358	[p17l9t2652r111b2709],
3	]	CD	NUMBER	]	num	5	SENT_358	[p17l9t2652r111b2709],
4	Phillips	NNP	O	Phillips	nn	5	SENT_358	[p17l145t2652r350b2713],
5	PS	NNP	O	PS	_	0	SENT_358	[p17l385t2652r474b2708],
6	,	,	O	,	_	0	SENT_358	[p17l385t2652r474b2708],
7	Phillips	NNP	PERSON	Phillips	nn	8	SENT_358	[p17l510t2652r714b2713],
8	CT	NNP	O	CT	appos	5	SENT_358	[p17l751t2652r845b2708],
9	,	,	O	,	_	0	SENT_358	[p17l751t2652r845b2708],
10	Sullivan	NNP	PERSON	Sullivan	nn	11	SENT_358	[p17l883t2652r1103b2699],
11	MJ	NNP	PERSON	MJ	appos	5	SENT_358	[p17l1137t2653r1236b2708],
12	,	,	O	,	_	0	SENT_358	[p17l1137t2653r1236b2708],
13	Naviaux	NNP	O	Naviaux	nn	14	SENT_358	[p17l1273t2652r1500b2699],
14	RK	NNP	O	RK	appos	5	SENT_358	[p17l1535t2653r1642b2708],
15	,	,	O	,	_	0	SENT_358	[p17l1535t2653r1642b2708],
16	Haas	NNP	PERSON	Haas	nn	17	SENT_358	[p17l1678t2653r1811b2699],
17	RH	NNP	O	RH	appos	5	SENT_358	[p17l1847t2653r1953b2699],
18	.	.	O	.	_	0	SENT_358	[p17l1847t2653r1953b2699],

1	Statin	NN	O	statin	nn	2	SENT_359	[p17l1992t2652r2147b2699],
2	myotoxicity	NN	O	myotoxicity	nsubjpass	4	SENT_359	[p17l145t2735r471b2796],
3	is	VBZ	O	be	auxpass	4	SENT_359	[p17l495t2735r536b2782],
4	associated	VBN	O	associate	_	0	SENT_359	[p17l562t2735r839b2782],
5	with	IN	O	with	_	0	SENT_359	[p17l861t2735r980b2782],
6	changes	NNS	O	change	prep_with	4	SENT_359	[p17l1003t2735r1218b2796],
7	in	IN	O	in	_	0	SENT_359	[p17l1242t2735r1294b2782],
8	the	DT	O	the	det	10	SENT_359	[p17l1316t2735r1397b2782],
9	cardiopulmonary	JJ	O	cardiopulmonary	amod	10	SENT_359	[p17l1421t2735r1882b2796],
10	function	NN	O	function	prep_in	6	SENT_359	[p17l1906t2735r2144b2782],
11	.	.	O	.	_	0	SENT_359	[p17l1906t2735r2144b2782],

1	Atherosclerosis	NNP	O	Atherosclerosis	_	0	SENT_360	[p17l145t2819r565b2866],
2	2004	CD	DATE	2004	num	1	SENT_360	[p17l586t2819r735b2875],
3	;	:	O	;	_	0	SENT_360	[p17l586t2819r735b2875],
4	177	CD	NUMBER	177	num	6	SENT_360	[p17l746t2819r854b2866],
5	:	:	O	:	_	0	SENT_360	[p17l746t2819r854b2866],
6	183-8	CD	NUMBER	183-8	dep	1	SENT_360	[p17l867t2819r1042b2866],
7	.	.	O	.	_	0	SENT_360	[p17l867t2819r1042b2866],

1	[	RB	O	[	advmod	10	SENT_361	[p17l9t2902r111b2959],
2	13	CD	NUMBER	13	num	10	SENT_361	[p17l9t2902r111b2959],
3	]	CD	NUMBER	]	num	10	SENT_361	[p17l9t2902r111b2959],
4	Desager	NNP	O	Desager	nn	10	SENT_361	[p17l145t2903r367b2963],
5	JP	NNP	O	JP	nn	10	SENT_361	[p17l413t2903r482b2958],
6	,	,	O	,	_	0	SENT_361	[p17l413t2903r482b2958],
7	Horsmans	NNP	O	Horsmans	appos	10	SENT_361	[p17l532t2903r804b2949],
8	Y.	NNP	O	Y.	nn	10	SENT_361	[p17l853t2903r905b2949],
9	Clinical	JJ	O	clinical	amod	10	SENT_361	[p17l957t2902r1169b2949],
10	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_361	[p17l1215t2902r1693b2963],
11	of	IN	O	of	_	0	SENT_361	[p17l1742t2902r1801b2949],
12	3hydroXy3	NN	O	3hydroxy3	nn	15	SENT_361	[p17l1845t2902r2145b2963, p17l147t2985r864b3046],
13	—	CD	NUMBER	—	num	15	SENT_361	[p17l1845t2902r2145b2963, p17l147t2985r864b3046],
14	metylglutaryl	NN	O	metylglutaryl	nn	15	SENT_361	[p17l1845t2902r2145b2963, p17l147t2985r864b3046],
15	—	NN	O	—	prep_of	10	SENT_361	[p17l1845t2902r2145b2963, p17l147t2985r864b3046],
16	coenzyme	NN	O	coenzyme	nn	17	SENT_361	[p17l1845t2902r2145b2963, p17l147t2985r864b3046],
17	A	NN	O	a	dep	10	SENT_361	[p17l901t2985r949b3032],
18	reductase	NN	O	reductase	nn	19	SENT_361	[p17l984t2985r1239b3032],
19	inhibitors	NNS	O	inhibitor	dep	17	SENT_361	[p17l1277t2985r1549b3032],
20	.	.	O	.	_	0	SENT_361	[p17l1277t2985r1549b3032],

1	Clin	NNP	O	Clin	nn	2	SENT_362	[p17l1590t2985r1705b3032],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_362	[p17l1741t2985r2148b3032],
3	1996	CD	DATE	1996	num	2	SENT_362	[p17l152t3069r603b3125],
4	;	:	O	;	_	0	SENT_362	[p17l152t3069r603b3125],
5	31:348	CD	NUMBER	31:348	number	6	SENT_362	[p17l152t3069r603b3125],
6	—	CD	NUMBER	—	num	7	SENT_362	[p17l152t3069r603b3125],
7	7l	NN	O	7l	dep	2	SENT_362	[p17l152t3069r603b3125],
8	.	.	O	.	_	0	SENT_362	[p17l152t3069r603b3125],

1	[	RB	O	[	dep	2	SENT_363	[p17l9t3152r111b3209],
2	14	CD	NUMBER	14	dep	5	SENT_363	[p17l9t3152r111b3209],
3	]	CD	NUMBER	]	num	5	SENT_363	[p17l9t3152r111b3209],
4	Lennernéis	NN	O	lennernéis	nn	5	SENT_363	[p17l145t3153r425b3199],
5	H	NN	O	h	_	0	SENT_363	[p17l451t3153r513b3208],
6	,	,	O	,	_	0	SENT_363	[p17l451t3153r513b3208],
7	Fager	NNP	PERSON	Fager	nn	9	SENT_363	[p17l540t3153r694b3213],
8	G.	NNP	PERSON	G.	nn	9	SENT_363	[p17l718t3153r778b3200],
9	Pharmacodynamics	NNPS	PERSON	Pharmacodynamics	conj_and	5	SENT_363	[p17l806t3152r1336b3213],
10	and	CC	O	and	_	0	SENT_363	[p17l1364t3152r1459b3199],
11	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	5	SENT_363	[p17l1482t3152r1960b3213],
12	of	IN	O	of	_	0	SENT_363	[p17l1987t3152r2046b3199],
13	the	DT	O	the	prep_of	5	SENT_363	[p17l2066t3152r2147b3199],

1	HMGCoA	NN	O	hmgcoa	_	0	SENT_364	[p17l145t3236r431b3284],
2	reductase	NN	O	reductase	nn	3	SENT_364	[p17l449t3236r703b3283],
3	inhibitors	NNS	O	inhibitor	dep	1	SENT_364	[p17l723t3236r995b3283],
4	.	.	O	.	_	0	SENT_364	[p17l723t3236r995b3283],

1	Clin	NNP	O	Clin	nn	2	SENT_365	[p17l1018t3236r1133b3284],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_365	[p17l1151t3236r1558b3283],
3	1997	CD	DATE	1997	num	2	SENT_365	[p17l1583t3236r2033b3292],
4	;	:	O	;	_	0	SENT_365	[p17l1583t3236r2033b3292],
5	32:403	CD	NUMBER	32:403	number	6	SENT_365	[p17l1583t3236r2033b3292],
6	—	CD	NUMBER	—	dep	2	SENT_365	[p17l1583t3236r2033b3292],
7	25	CD	NUMBER	25	dep	6	SENT_365	[p17l1583t3236r2033b3292],
8	.	.	O	.	_	0	SENT_365	[p17l1583t3236r2033b3292],

1	[	RB	O	[	dep	2	SENT_366	[p17l9t3319r111b3376],
2	15	CD	NUMBER	15	dep	3	SENT_366	[p17l9t3319r111b3376],
3	]	CD	NUMBER	]	_	0	SENT_366	[p17l9t3319r111b3376],
4	Schachter	NNP	PERSON	Schachter	nn	6	SENT_366	[p17l147t3319r413b3367],
5	M.	NNP	PERSON	M.	nn	6	SENT_366	[p17l434t3320r507b3366],
6	Chemical	NNP	PERSON	Chemical	dep	3	SENT_366	[p17l534t3319r807b3375],
7	,	,	O	,	_	0	SENT_366	[p17l534t3319r807b3375],
8	pharmacokinetic	JJ	O	pharmacokinetic	amod	11	SENT_366	[p17l832t3319r1282b3380],
9	and	CC	O	and	_	0	SENT_366	[p17l1308t3319r1404b3366],
10	pharmacodynamic	JJ	O	pharmacodynamic	amod	11	SENT_366	[p17l1426t3319r1926b3380],
11	properties	NNS	O	property	appos	6	SENT_366	[p17l1949t3334r2145b3380, p17l145t3402r236b3449],

1	of	IN	O	of	_	0	SENT_367	[p17l257t3402r316b3449],
2	statins	NNS	O	statin	prep_of	5	SENT_367	[p17l332t3402r516b3449],
3	:	:	O	:	_	0	SENT_367	[p17l332t3402r516b3449],
4	an	DT	O	a	nsubj	5	SENT_367	[p17l541t3417r602b3449],
5	update	VBP	O	update	_	0	SENT_367	[p17l620t3402r814b3463],
6	.	.	O	.	_	0	SENT_367	[p17l620t3402r814b3463],

1	Fundam	NNP	O	Fundam	nn	3	SENT_368	[p17l836t3402r1058b3449],
2	Clin	NNP	O	Clin	nn	3	SENT_368	[p17l1076t3402r1191b3450],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_368	[p17l1210t3402r1499b3449],
4	2005	CD	DATE	2005	num	3	SENT_368	[p17l1519t3402r1975b3458],
5	;	:	O	;	_	0	SENT_368	[p17l1519t3402r1975b3458],
6	19:117	CD	NUMBER	19:117	number	7	SENT_368	[p17l1519t3402r1975b3458],
7	-25	CD	NUMBER	-25	dep	3	SENT_368	[p17l1519t3402r1975b3458],
8	.	.	O	.	_	0	SENT_368	[p17l1519t3402r1975b3458],

1	[	RB	O	[	advmod	5	SENT_369	[p17l9t3485r111b3542],
2	16	CD	NUMBER	16	number	3	SENT_369	[p17l9t3485r111b3542],
3	]	CD	NUMBER	]	num	5	SENT_369	[p17l9t3485r111b3542],
4	Kirchheiner	NN	PERSON	kirchheiner	nn	5	SENT_369	[p17l146t3485r469b3532],
5	J	NN	PERSON	j	_	0	SENT_369	[p17l487t3486r512b3533],
6	,	,	O	,	_	0	SENT_369	[p17l517t3524r527b3541],
7	Fuhr	NNP	PERSON	Fuhr	nn	8	SENT_369	[p17l548t3485r677b3532],
8	U	NNP	O	U	appos	5	SENT_369	[p17l695t3486r757b3541],
9	,	,	O	,	_	0	SENT_369	[p17l695t3486r757b3541],
10	Brockmoller	NNP	O	Brockmoller	nn	11	SENT_369	[p17l779t3485r1123b3532],
11	J	NNP	O	J	appos	8	SENT_369	[p17l1141t3486r1166b3533],
12	.	.	O	.	_	0	SENT_369	[p17l1171t3524r1179b3532],

1	Pharmacogenetics-based	JJ	O	pharmacogenetics-based	amod	3	SENT_370	[p17l1202t3485r1873b3546],
2	therapeutic	JJ	O	therapeutic	amod	3	SENT_370	[p17l1892t3485r2145b3546, p17l145t3568r210b3615],
3	recommendations	NNS	O	recommendation	nsubj	4	SENT_370	[p17l234t3568r934b3629],
4	—	VBP	O	—	_	0	SENT_370	[p17l234t3568r934b3629],
5	ready	JJ	O	ready	acomp	4	SENT_370	[p17l234t3568r934b3629],
6	for	IN	O	for	_	0	SENT_370	[p17l959t3568r1037b3615],
7	clinical	JJ	O	clinical	amod	8	SENT_370	[p17l1059t3568r1257b3615],
8	practice	NN	O	practice	prep_for	4	SENT_370	[p17l1280t3568r1523b3629],
9	?	.	O	?	_	0	SENT_370	[p17l1280t3568r1523b3629],

1	Nat	NNP	MISC	Nat	nn	3	SENT_371	[p17l1547t3569r1645b3615],
2	Rev	NN	MISC	rev	nn	3	SENT_371	[p17l1667t3569r1772b3616],
3	Drug	NN	MISC	drug	_	0	SENT_371	[p17l1796t3569r1933b3629],
4	Discov	NNP	MISC	Discov	dep	3	SENT_371	[p17l1957t3568r2147b3615],
5	2005	CD	DATE	2005	num	4	SENT_371	[p17l146t3652r568b3708],
6	;	:	O	;	_	0	SENT_371	[p17l146t3652r568b3708],
7	4:639	CD	NUMBER	4:639	number	8	SENT_371	[p17l146t3652r568b3708],
8	—	CD	NUMBER	—	dep	3	SENT_371	[p17l146t3652r568b3708],
9	47	CD	NUMBER	47	dep	8	SENT_371	[p17l146t3652r568b3708],
10	.	.	O	.	_	0	SENT_371	[p17l146t3652r568b3708],

1	[	NN	O	[	nn	5	SENT_372	[p17l9t3736r111b3792],
2	17	CD	NUMBER	17	num	5	SENT_372	[p17l9t3736r111b3792],
3	]	CD	NUMBER	]	num	5	SENT_372	[p17l9t3736r111b3792],
4	Mulder	NNP	ORGANIZATION	Mulder	nn	5	SENT_372	[p17l145t3735r345b3782],
5	AB	NNP	ORGANIZATION	AB	_	0	SENT_372	[p17l358t3736r465b3791],
6	,	,	O	,	_	0	SENT_372	[p17l358t3736r465b3791],
7	Van	NNP	PERSON	Van	nn	9	SENT_372	[p17l483t3736r586b3782],
8	Lijf	NNP	PERSON	Lijf	nn	9	SENT_372	[p17l601t3735r706b3796],
9	HJ	NNP	O	HJ	appos	5	SENT_372	[p17l716t3736r804b3791],
10	,	,	O	,	_	0	SENT_372	[p17l716t3736r804b3791],
11	Bon	NNP	LOCATION	Bon	nn	12	SENT_372	[p17l822t3736r933b3782],
12	MA	NNP	LOCATION	MA	appos	9	SENT_372	[p17l948t3736r1070b3791],
13	,	,	O	,	_	0	SENT_372	[p17l948t3736r1070b3791],
14	Van	NNP	PERSON	Van	nn	17	SENT_372	[p17l1088t3736r1192b3782],
15	den	NN	O	den	nn	17	SENT_372	[p17l1207t3735r1303b3782],
16	Bergh	NNP	ORGANIZATION	Bergh	nn	17	SENT_372	[p17l1318t3735r1481b3796],
17	FA	NNP	ORGANIZATION	FA	appos	9	SENT_372	[p17l1495t3736r1590b3791],
18	,	,	O	,	_	0	SENT_372	[p17l1495t3736r1590b3791],
19	Touw	NNP	PERSON	Touw	nn	20	SENT_372	[p17l1607t3736r1758b3782],
20	DJ	NNP	O	DJ	appos	9	SENT_372	[p17l1774t3736r1862b3791],
21	,	,	O	,	_	0	SENT_372	[p17l1774t3736r1862b3791],
22	Neef	NNP	PERSON	Neef	nn	23	SENT_372	[p17l1879t3735r2014b3782],
23	C	NNP	O	C	appos	9	SENT_372	[p17l2025t3735r2083b3791],
24	,	,	O	,	_	0	SENT_372	[p17l2025t3735r2083b3791],
25	et	FW	O	et	nn	26	SENT_372	[p17l2101t3742r2148b3782],
26	al.	FW	O	al.	appos	9	SENT_372	[p18l147t18r206b65],
27	.	.	O	.	_	0	SENT_372	[p18l147t18r206b65],

1	Association	NNP	O	Association	_	0	SENT_373	[p18l228t18r547b65],
2	of	IN	O	of	_	0	SENT_373	[p18l566t18r625b65],
3	polymorphism	NN	O	polymorphism	prep_of	1	SENT_373	[p18l637t18r1034b79],
4	in	IN	O	in	_	0	SENT_373	[p18l1052t18r1103b65],
5	the	DT	O	the	det	7	SENT_373	[p18l1121t18r1202b65],
6	cytochrome	NN	O	cytochrome	nn	7	SENT_373	[p18l1221t18r1538b79],
7	CYP2D6	NN	O	cyp2d6	prep_in	1	SENT_373	[p18l1558t18r1803b66],
8	and	CC	O	and	_	0	SENT_373	[p18l1824t18r1920b65],
9	the	DT	O	the	det	10	SENT_373	[p18l1938t18r2018b65],
10	efﬁcacy	NN	O	efﬁcacy	prep_in	1	SENT_373	[p18l2038t18r2145b65, p18l146t116r266b162],
11	and	CC	O	and	_	0	SENT_373	[p18l283t101r379b149],
12	tolerability	NN	O	tolerability	conj_and	10	SENT_373	[p18l393t101r689b162],
13	of	IN	O	of	_	0	SENT_373	[p18l705t101r763b149],
14	simvastatin	NN	O	simvastatin	prep_of	1	SENT_373	[p18l776t101r1093b149],
15	.	.	O	.	_	0	SENT_373	[p18l776t101r1093b149],

1	Clin	NNP	O	Clin	nn	3	SENT_374	[p18l1112t101r1227b149],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_374	[p18l1241t101r1530b149],
3	Ther	NNP	O	Ther	_	0	SENT_374	[p18l1545t101r1673b149],
4	2001	CD	DATE	2001	num	3	SENT_374	[p18l1687t102r1814b149],
5	;	:	O	;	_	0	SENT_374	[p18l1827t101r2143b157],
6	70:546	CD	NUMBER	70:546	number	7	SENT_374	[p18l1827t101r2143b157],
7	-51	CD	NUMBER	-51	dep	3	SENT_374	[p18l1827t101r2143b157],
8	.	.	O	.	_	0	SENT_374	[p18l1827t101r2143b157],

1	P.	FW	PERSON	p.	nn	4	SENT_375	[p18l321t238r342b261],
2	Zuccaro	FW	PERSON	zuccaro	nn	4	SENT_375	[p18l353t238r462b261],
3	er	FW	O	er	nn	4	SENT_375	[p18l472t241r496b261],
4	al.	FW	O	al.	_	0	SENT_375	[p18l504t237r534b261],
5	/	:	O	/	punct	7	SENT_375	[p18l544t237r559b261],
6	Pharmacological	JJ	O	pharmacological	amod	7	SENT_375	[p18l563t237r794b267],
7	Research	NN	O	research	dep	4	SENT_375	[p18l801t237r923b261],
8	55	CD	NUMBER	55	number	9	SENT_375	[p18l933t237r965b260],
9	(	CD	NUMBER	(	num	10	SENT_375	[p18l975t237r1061b266],
10	2007	CD	DATE	2007	dep	7	SENT_375	[p18l975t237r1061b266],
11	)	CD	NUMBER	)	num	12	SENT_375	[p18l975t237r1061b266],
12	310-31	CD	NUMBER	310-31	dep	10	SENT_375	[p18l1071t237r1167b260],
13	7	CD	NUMBER	7	num	14	SENT_375	[p18l1173t237r1188b261],
14	317	CD	NUMBER	317	dep	4	SENT_375	[p18l1791t237r1838b261],

1	[	NN	O	[	nn	6	SENT_376	[p18l7t384r109b440],
2	18	CD	NUMBER	18	num	6	SENT_376	[p18l7t384r109b440],
3	]	CD	NUMBER	]	num	6	SENT_376	[p18l7t384r109b440],
4	Van	NNP	PERSON	Van	nn	6	SENT_376	[p18l143t384r248b430],
5	Schaik	NNP	PERSON	Schaik	nn	6	SENT_376	[p18l285t383r468b431],
6	RH	NNP	O	RH	_	0	SENT_376	[p18l503t384r610b439],
7	,	,	O	,	_	0	SENT_376	[p18l503t384r610b439],
8	Van	NNP	PERSON	Van	nn	11	SENT_376	[p18l648t384r753b431],
9	der	NNP	PERSON	der	nn	11	SENT_376	[p18l790t383r875b430],
10	Heiden	NNP	PERSON	Heiden	nn	11	SENT_376	[p18l910t383r1105b430],
11	IP	NNP	O	IP	appos	6	SENT_376	[p18l1140t384r1206b439],
12	,	,	O	,	_	0	SENT_376	[p18l1140t384r1206b439],
13	Van	NNP	PERSON	Van	nn	15	SENT_376	[p18l1245t384r1349b430],
14	den	NN	PERSON	den	nn	15	SENT_376	[p18l1385t383r1481b430],
15	Anker	NNP	PERSON	Anker	appos	6	SENT_376	[p18l1517t383r1686b430],
16	JN	NN	O	jn	dep	15	SENT_376	[p18l1720t384r1809b439],
17	,	,	O	,	_	0	SENT_376	[p18l1720t384r1809b439],
18	Lindemans	NNPS	O	Lindemans	nn	19	SENT_376	[p18l1847t383r2147b430],
19	J	NNP	O	J	appos	6	SENT_376	[p18l143t467r168b514],
20	.	.	O	.	_	0	SENT_376	[p18l174t505r182b513],

1	CYP3A5	NN	O	cyp3a5	_	0	SENT_377	[p18l215t466r459b514],
2	Variant	JJ	O	variant	amod	4	SENT_377	[p18l491t466r677b513],
3	allele	NN	O	allele	nn	4	SENT_377	[p18l706t466r850b513],
4	frequencies	NNS	O	frequency	dep	1	SENT_377	[p18l879t466r1190b527],
5	in	IN	O	in	_	0	SENT_377	[p18l1220t466r1271b513],
6	Dutch	JJ	MISC	dutch	amod	7	SENT_377	[p18l1299t466r1464b513],
7	Caucasians	NNPS	MISC	Caucasians	prep_in	4	SENT_377	[p18l1494t466r1811b514],
8	.	.	O	.	_	0	SENT_377	[p18l1494t466r1811b514],

1	Clin	NNP	ORGANIZATION	Clin	nn	2	SENT_378	[p18l1844t466r1959b514],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_378	[p18l1988t466r2149b514],
3	2002	CD	DATE	2002	num	2	SENT_378	[p18l144t550r379b606],
4	;	:	O	;	_	0	SENT_378	[p18l144t550r379b606],
5	48	CD	NUMBER	48	num	7	SENT_378	[p18l144t550r379b606],
6	:	:	O	:	_	0	SENT_378	[p18l144t550r379b606],
7	1668-71	CD	NUMBER	1668-71	dep	2	SENT_378	[p18l392t550r635b598],
8	.	.	O	.	_	0	SENT_378	[p18l392t550r635b598],

1	[	NN	O	[	nn	5	SENT_379	[p18l7t634r109b690],
2	19	CD	NUMBER	19	num	5	SENT_379	[p18l7t634r109b690],
3	]	CD	NUMBER	]	num	5	SENT_379	[p18l7t634r109b690],
4	Nasu	NNP	PERSON	Nasu	nn	5	SENT_379	[p18l143t634r281b680],
5	K	NNP	PERSON	K	_	0	SENT_379	[p18l299t634r360b689],
6	,	,	O	,	_	0	SENT_379	[p18l299t634r360b689],
7	Kubota	NNP	ORGANIZATION	Kubota	nn	8	SENT_379	[p18l380t633r578b680],
8	T	NN	ORGANIZATION	t	appos	5	SENT_379	[p18l593t634r642b689],
9	,	,	O	,	_	0	SENT_379	[p18l593t634r642b689],
10	Ishizaki	NNP	PERSON	Ishizaki	nn	13	SENT_379	[p18l662t633r875b680],
11	T.	NNP	PERSON	T.	nn	13	SENT_379	[p18l892t634r940b680],
12	Genetic	NNP	PERSON	Genetic	nn	13	SENT_379	[p18l961t633r1169b681],
13	analysis	NN	O	analysis	appos	5	SENT_379	[p18l1188t633r1403b694],
14	of	IN	O	of	_	0	SENT_379	[p18l1422t633r1480b680],
15	CYP2C9	NN	O	cyp2c9	nn	16	SENT_379	[p18l1493t633r1735b681],
16	polymorphism	NN	O	polymorphism	prep_of	13	SENT_379	[p18l1752t633r2149b694],
17	in	IN	O	in	_	0	SENT_379	[p18l144t718r195b766],
18	a	DT	O	a	det	20	SENT_379	[p18l215t733r243b766],
19	Japanese	JJ	MISC	japanese	amod	20	SENT_379	[p18l260t720r500b780],
20	population	NN	O	population	prep_in	16	SENT_379	[p18l519t718r822b780],
21	.	.	O	.	_	0	SENT_379	[p18l519t718r822b780],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_380	[p18l844t718r1337b780],
2	1997	CD	DATE	1997	num	1	SENT_380	[p18l1364t718r1747b775],
3	;	:	O	;	_	0	SENT_380	[p18l1364t718r1747b775],
4	7:405	CD	NUMBER	7:405	number	5	SENT_380	[p18l1364t718r1747b775],
5	—	CD	NUMBER	—	dep	1	SENT_380	[p18l1364t718r1747b775],
6	9	CD	NUMBER	9	dep	5	SENT_380	[p18l1364t718r1747b775],
7	.	.	O	.	_	0	SENT_380	[p18l1364t718r1747b775],

1	[	RB	O	[	advmod	4	SENT_381	[p18l7t804r109b861],
2	20	CD	NUMBER	20	number	3	SENT_381	[p18l7t804r109b861],
3	]	CD	NUMBER	]	num	4	SENT_381	[p18l7t804r109b861],
4	Sullivan	NNP	PERSON	Sullivan	_	0	SENT_381	[p18l145t803r546b852],
5	.	.	O	.	_	0	SENT_381	[p18l145t803r546b852],

1	—	NN	O	—	_	0	SENT_382	[p18l145t803r546b852],
2	.	.	O	.	_	0	SENT_382	[p18l145t803r546b852],

1	Klose	NNP	PERSON	Klose	nn	2	SENT_383	[p18l145t803r546b852],
2	TH	NN	O	th	_	0	SENT_383	[p18l575t805r678b860],
3	,	,	O	,	_	0	SENT_383	[p18l575t805r678b860],
4	Ghanayem	NNP	O	Ghanayem	nn	5	SENT_383	[p18l711t803r1003b865],
5	BI	NNP	O	BI	appos	2	SENT_383	[p18l1031t805r1112b860],
6	,	,	O	,	_	0	SENT_383	[p18l1031t805r1112b860],
7	Bell	NNP	ORGANIZATION	Bell	nn	8	SENT_383	[p18l1142t803r1254b851],
8	DA	NNP	ORGANIZATION	DA	appos	5	SENT_383	[p18l1283t804r1391b860],
9	,	,	O	,	_	0	SENT_383	[p18l1283t804r1391b860],
10	Zhang	NNP	PERSON	Zhang	nn	11	SENT_383	[p18l1422t803r1594b865],
11	ZY	NNP	O	ZY	appos	5	SENT_383	[p18l1622t805r1717b860],
12	,	,	O	,	_	0	SENT_383	[p18l1622t805r1717b860],
13	Kaminsky	NNP	PERSON	Kaminsky	nn	14	SENT_383	[p18l1749t803r2025b865],
14	LS	NN	O	l	appos	5	SENT_383	[p18l2053t804r2146b860],
15	,	,	O	,	_	0	SENT_383	[p18l2053t804r2146b860],
16	Shenﬁeld	NNP	ORGANIZATION	Shenﬁeld	nn	17	SENT_383	[p18l145t887r400b935],
17	GM	NNP	ORGANIZATION	GM	appos	5	SENT_383	[p18l418t888r539b943],
18	,	,	O	,	_	0	SENT_383	[p18l418t888r539b943],
19	et	FW	O	et	nn	20	SENT_383	[p18l559t895r607b935],
20	al.	FW	O	al.	appos	5	SENT_383	[p18l625t887r685b935],
21	.	.	O	.	_	0	SENT_383	[p18l625t887r685b935],

1	The	DT	O	the	det	2	SENT_384	[p18l706t887r810b935],
2	role	NN	O	role	_	0	SENT_384	[p18l827t887r931b935],
3	of	IN	O	of	_	0	SENT_384	[p18l950t887r1008b935],
4	the	DT	O	the	det	5	SENT_384	[p18l1021t887r1103b935],
5	CYP2C9	NN	O	cyp2c9	prep_of	2	SENT_384	[p18l1121t887r1594b935],
6	.	.	O	.	_	0	SENT_384	[p18l1121t887r1594b935],

1	—	NN	O	—	_	0	SENT_385	[p18l1121t887r1594b935],
2	.	.	O	.	_	0	SENT_385	[p18l1121t887r1594b935],

1	Leu359	NN	O	leu359	_	0	SENT_386	[p18l1121t887r1594b935],
2	allelic	JJ	O	allelic	amod	3	SENT_386	[p18l1614t887r1776b935],
3	Variant	JJ	O	variant	dep	1	SENT_386	[p18l1795t887r1982b935],
4	in	IN	O	in	_	0	SENT_386	[p18l1998t887r2049b934],
5	the	DT	O	the	det	7	SENT_386	[p18l2067t887r2148b935],
6	tolbutamide	NN	O	tolbutamide	nn	7	SENT_386	[p18l143t972r465b1020],
7	polymorphism	NN	O	polymorphism	prep_in	3	SENT_386	[p18l483t972r893b1034],
8	.	.	O	.	_	0	SENT_386	[p18l483t972r893b1034],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_387	[p18l915t972r1407b1034],
2	1996	CD	DATE	1996	num	1	SENT_387	[p18l1434t972r1818b1029],
3	;	:	O	;	_	0	SENT_387	[p18l1434t972r1818b1029],
4	6:341	CD	NUMBER	6:341	number	5	SENT_387	[p18l1434t972r1818b1029],
5	—	CD	NUMBER	—	dep	1	SENT_387	[p18l1434t972r1818b1029],
6	9	CD	NUMBER	9	dep	5	SENT_387	[p18l1434t972r1818b1029],
7	.	.	O	.	_	0	SENT_387	[p18l1434t972r1818b1029],

1	[	NN	O	[	nn	5	SENT_388	[p18l7t1058r109b1115],
2	21	CD	NUMBER	21	num	5	SENT_388	[p18l7t1058r109b1115],
3	]	CD	NUMBER	]	num	5	SENT_388	[p18l7t1058r109b1115],
4	Yasar	NNP	PERSON	Yasar	nn	5	SENT_388	[p18l144t1059r295b1105],
5	U	NNP	PERSON	U	_	0	SENT_388	[p18l315t1059r377b1114],
6	,	,	O	,	_	0	SENT_388	[p18l315t1059r377b1114],
7	Eliasson	NNP	PERSON	Eliasson	nn	8	SENT_388	[p18l401t1057r630b1105],
8	E	NNP	PERSON	E	appos	5	SENT_388	[p18l651t1059r706b1114],
9	,	,	O	,	_	0	SENT_388	[p18l651t1059r706b1114],
10	Dahl	NNP	PERSON	Dahl	nn	11	SENT_388	[p18l730t1057r860b1105],
11	ML	NNP	O	ML	appos	5	SENT_388	[p18l882t1059r997b1114],
12	,	,	O	,	_	0	SENT_388	[p18l882t1059r997b1114],
13	Johansson	NNP	PERSON	Johansson	appos	5	SENT_388	[p18l1021t1057r1299b1106],
14	1	CD	NUMBER	1	num	13	SENT_388	[p18l1321t1059r1356b1114],
15	,	,	O	,	_	0	SENT_388	[p18l1321t1059r1356b1114],
16	Ingelman-Sundberg	NNP	O	Ingelman-Sundberg	nn	17	SENT_388	[p18l1380t1057r1917b1119],
17	M	NNP	O	M	appos	5	SENT_388	[p18l1939t1059r2013b1114],
18	,	,	O	,	_	0	SENT_388	[p18l1939t1059r2013b1114],
19	Sjoqvist	NNP	O	Sjoqvist	nn	21	SENT_388	[p18l2038t1057r2146b1119, p18l144t1142r275b1204],
20	F.	NNP	O	F.	nn	21	SENT_388	[p18l302t1144r346b1190],
21	Validation	NNP	O	Validation	appos	5	SENT_388	[p18l378t1142r656b1190],
22	of	IN	O	of	_	0	SENT_388	[p18l685t1142r744b1190],
23	methods	NNS	O	method	prep_of	21	SENT_388	[p18l767t1142r994b1190],
24	for	IN	O	for	_	0	SENT_388	[p18l1024t1142r1103b1190],
25	CYP2C9	NN	O	cyp2c9	nn	26	SENT_388	[p18l1130t1143r1372b1191],
26	genotyping	NN	O	genotyping	prep_for	23	SENT_388	[p18l1403t1142r1721b1204],
27	:	:	O	:	_	0	SENT_388	[p18l1403t1142r1721b1204],
28	frequencies	NNS	O	frequency	dep	5	SENT_388	[p18l1753t1142r2064b1204],
29	of	IN	O	of	_	0	SENT_388	[p18l2094t1142r2153b1190],
30	mutant	JJ	O	mutant	amod	31	SENT_388	[p18l143t1233r332b1273],
31	alleles	NNS	O	allele	prep_of	28	SENT_388	[p18l355t1225r525b1273],
32	in	IN	O	in	_	0	SENT_388	[p18l549t1225r601b1272],
33	a	DT	O	a	det	35	SENT_388	[p18l625t1240r654b1273],
34	Swedish	JJ	MISC	swedish	amod	35	SENT_388	[p18l677t1225r905b1273],
35	population	NN	O	population	prep_in	31	SENT_388	[p18l927t1225r1231b1286],
36	.	.	O	.	_	0	SENT_388	[p18l927t1225r1231b1286],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	4	SENT_389	[p18l1257t1225r1502b1273],
2	Biophys	NNP	ORGANIZATION	Biophys	nn	4	SENT_389	[p18l1525t1225r1748b1286],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_389	[p18l1773t1227r1872b1273],
4	Commun	NNP	ORGANIZATION	Commun	_	0	SENT_389	[p18l1898t1226r2149b1273],
5	1999	CD	DATE	1999	num	4	SENT_389	[p18l150t1309r635b1365],
6	;	:	O	;	_	0	SENT_389	[p18l150t1309r635b1365],
7	254:628	CD	NUMBER	254:628	number	8	SENT_389	[p18l150t1309r635b1365],
8	-31	CD	NUMBER	-31	dep	4	SENT_389	[p18l150t1309r635b1365],
9	.	.	O	.	_	0	SENT_389	[p18l150t1309r635b1365],

1	[	NN	O	[	nn	4	SENT_390	[p18l7t1395r109b1452],
2	22	CD	NUMBER	22	num	4	SENT_390	[p18l7t1395r109b1452],
3	]	NN	O	]	nn	4	SENT_390	[p18l7t1395r109b1452],
4	Hersberger	NN	O	hersberger	_	0	SENT_390	[p18l143t1394r444b1456],
5	M	NN	O	m	dep	4	SENT_390	[p18l458t1396r531b1451],
6	,	,	O	,	_	0	SENT_390	[p18l458t1396r531b1451],
7	Marti	NNP	PERSON	Marti	appos	5	SENT_390	[p18l549t1394r846b1443],
8	.	.	O	.	_	0	SENT_390	[p18l549t1394r846b1443],

1	—	NN	O	—	_	0	SENT_391	[p18l549t1394r846b1443],
2	.	.	O	.	_	0	SENT_391	[p18l549t1394r846b1443],

1	Jaun	NNP	PERSON	Jaun	nn	2	SENT_392	[p18l549t1394r846b1443],
2	J	NNP	PERSON	J	_	0	SENT_392	[p18l861t1396r886b1443],
3	,	,	O	,	_	0	SENT_392	[p18l890t1434r900b1451],
4	Rentsch	NNP	PERSON	Rentsch	nn	5	SENT_392	[p18l918t1394r1136b1442],
5	K	NNP	PERSON	K	appos	2	SENT_392	[p18l1152t1396r1212b1451],
6	,	,	O	,	_	0	SENT_392	[p18l1152t1396r1212b1451],
7	Hanseler	NNP	PERSON	Hanseler	nn	10	SENT_392	[p18l1230t1394r1472b1442],
8	E.	NNP	PERSON	E.	nn	10	SENT_392	[p18l1485t1396r1539b1442],
9	Rapid	NNP	PERSON	Rapid	nn	10	SENT_392	[p18l1558t1394r1719b1456],
10	detection	NN	O	detection	appos	2	SENT_392	[p18l1735t1394r1982b1442],
11	of	IN	O	of	_	0	SENT_392	[p18l1997t1394r2056b1442],
12	the	DT	O	the	det	14	SENT_392	[p18l2067t1394r2148b1442],
13	CYP2D6	NN	O	cyp2d6	nn	14	SENT_392	[p18l144t1479r474b1536],
14	*	NN	O	*	prep_of	10	SENT_392	[p18l144t1479r474b1536],
15	3	CD	NUMBER	3	dep	2	SENT_392	[p18l144t1479r474b1536],
16	,	,	O	,	_	0	SENT_392	[p18l144t1479r474b1536],
17	CYP2D6	NN	O	cyp2d6	nn	18	SENT_392	[p18l500t1479r829b1536],
18	*	NN	O	*	appos	15	SENT_392	[p18l500t1479r829b1536],
19	4	CD	NUMBER	4	dep	2	SENT_392	[p18l500t1479r829b1536],
20	,	,	O	,	_	0	SENT_392	[p18l500t1479r829b1536],
21	CYP2D6	NN	O	cyp2d6	nn	22	SENT_392	[p18l856t1479r1170b1528],
22	*	NN	O	*	appos	19	SENT_392	[p18l856t1479r1170b1528],
23	6	CD	NUMBER	6	num	24	SENT_392	[p18l856t1479r1170b1528],
24	alleles	NNS	O	allele	conj_and	24	SENT_392	[p18l1195t1480r1364b1528],
25	by	IN	O	by	_	0	SENT_392	[p18l1388t1480r1454b1542],
26	tetra	NN	O	tetra	nn	29	SENT_392	[p18l1478t1480r1803b1542],
27	—	CD	NUMBER	—	num	29	SENT_392	[p18l1478t1480r1803b1542],
28	primer	NN	O	primer	nn	29	SENT_392	[p18l1478t1480r1803b1542],
29	PCR	NN	O	pcr	prep_by	24	SENT_392	[p18l1824t1480r1952b1528],
30	and	CC	O	and	_	0	SENT_392	[p18l1975t1480r2071b1528],
31	of	IN	O	of	_	0	SENT_392	[p18l2094t1479r2153b1528],
32	the	DT	O	the	det	34	SENT_392	[p18l143t1564r224b1613],
33	CYP2D6	NN	O	cyp2d6	nn	34	SENT_392	[p18l241t1564r553b1613],
34	*	NN	O	*	prep_of	24	SENT_392	[p18l241t1564r553b1613],
35	5	CD	NUMBER	5	num	36	SENT_392	[p18l241t1564r553b1613],
36	allele	NN	O	allele	dep	2	SENT_392	[p18l573t1565r716b1613],
37	by	IN	O	by	_	0	SENT_392	[p18l731t1565r798b1627],
38	multiplex	JJ	O	multiplex	amod	40	SENT_392	[p18l813t1564r1071b1627],
39	long	JJ	O	long	amod	40	SENT_392	[p18l1087t1565r1205b1627],
40	PCR	NN	O	pcr	prep_by	36	SENT_392	[p18l1221t1565r1361b1613],
41	.	.	O	.	_	0	SENT_392	[p18l1221t1565r1361b1613],

1	Clin	NNP	ORGANIZATION	Clin	nn	2	SENT_393	[p18l1381t1564r1496b1613],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_393	[p18l1511t1565r1672b1613],
3	2000	CD	DATE	2000	num	2	SENT_393	[p18l1688t1564r1922b1621],
4	;	:	O	;	_	0	SENT_393	[p18l1688t1564r1922b1621],
5	46	CD	NUMBER	46	num	7	SENT_393	[p18l1688t1564r1922b1621],
6	:	:	O	:	_	0	SENT_393	[p18l1688t1564r1922b1621],
7	1072-7	CD	NUMBER	1072-7	dep	2	SENT_393	[p18l1935t1565r2145b1613],
8	.	.	O	.	_	0	SENT_393	[p18l1935t1565r2145b1613],

1	[	NN	O	[	_	0	SENT_394	[p18l7t1650r109b1708],
2	23	CD	NUMBER	23	num	1	SENT_394	[p18l7t1650r109b1708],
3	]	CD	NUMBER	]	num	5	SENT_394	[p18l7t1650r109b1708],
4	Steijns	NNP	O	Steijns	nn	5	SENT_394	[p18l145t1650r326b1712],
5	LS	NN	O	l	dep	1	SENT_394	[p18l358t1650r451b1706],
6	,	,	O	,	_	0	SENT_394	[p18l358t1650r451b1706],
7	Van	NNP	PERSON	Van	nn	10	SENT_394	[p18l485t1651r589b1698],
8	der	NNP	PERSON	der	nn	10	SENT_394	[p18l622t1650r707b1698],
9	Weide	NNP	PERSON	Weide	nn	10	SENT_394	[p18l737t1649r908b1698],
10	J	NNP	O	J	appos	5	SENT_394	[p18l939t1651r964b1698],
11	.	.	O	.	_	0	SENT_394	[p18l970t1689r978b1698],

1	Ultrarapid	JJ	O	ultrarapid	amod	3	SENT_395	[p18l1013t1649r1291b1712],
2	drug	NN	O	drug	nn	3	SENT_395	[p18l1324t1650r1445b1712],
3	metabolism	NN	O	metabolism	_	0	SENT_395	[p18l1477t1649r1808b1698],
4	:	:	O	:	_	0	SENT_395	[p18l1477t1649r1808b1698],
5	PCR	NN	O	pcr	nn	6	SENT_395	[p18l1843t1650r2149b1698],
6	—	NN	O	—	dep	3	SENT_395	[p18l1843t1650r2149b1698],
7	based	VBN	O	base	partmod	6	SENT_395	[p18l1843t1650r2149b1698],
8	detection	NN	O	detection	dobj	7	SENT_395	[p18l144t1735r391b1783],
9	of	IN	O	of	_	0	SENT_395	[p18l411t1734r469b1783],
10	CYP2D6	NN	O	cyp2d6	nn	12	SENT_395	[p18l484t1734r731b1783],
11	gene	NN	O	gene	nn	12	SENT_395	[p18l751t1750r877b1797],
12	duplication	NN	O	duplication	prep_of	8	SENT_395	[p18l897t1734r1214b1797],
13	.	.	O	.	_	0	SENT_395	[p18l897t1734r1214b1797],

1	Clin	NNP	ORGANIZATION	Clin	nn	2	SENT_396	[p18l1237t1735r1352b1783],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_396	[p18l1371t1735r1532b1783],
3	1998	CD	DATE	1998	num	2	SENT_396	[p18l1556t1735r1974b1791],
4	;	:	O	;	_	0	SENT_396	[p18l1556t1735r1974b1791],
5	44:914	CD	NUMBER	44:914	num	6	SENT_396	[p18l1556t1735r1974b1791],
6	—	NN	O	—	dep	2	SENT_396	[p18l1556t1735r1974b1791],
7	7	CD	NUMBER	7	dep	6	SENT_396	[p18l1556t1735r1974b1791],
8	.	.	O	.	_	0	SENT_396	[p18l1556t1735r1974b1791],

1	[	NN	O	[	nn	4	SENT_397	[p18l7t1820r109b1878],
2	24	CD	NUMBER	24	num	4	SENT_397	[p18l7t1820r109b1878],
3	]	NN	O	]	nn	4	SENT_397	[p18l7t1820r109b1878],
4	Aozaki	NN	PERSON	aozakus	_	0	SENT_397	[p18l143t1820r337b1868],
5	R	NN	PERSON	r	dep	4	SENT_397	[p18l364t1821r422b1876],
6	,	,	O	,	_	0	SENT_397	[p18l364t1821r422b1876],
7	Kawaguchi	NNP	PERSON	Kawaguchi	nn	8	SENT_397	[p18l451t1819r756b1882],
8	R	NNP	PERSON	R	appos	5	SENT_397	[p18l782t1821r840b1876],
9	,	,	O	,	_	0	SENT_397	[p18l782t1821r840b1876],
10	Ogasa	NNP	ORGANIZATION	Ogasa	nn	11	SENT_397	[p18l870t1820r1038b1882],
11	U	NNP	ORGANIZATION	U	appos	5	SENT_397	[p18l1062t1821r1124b1876],
12	,	,	O	,	_	0	SENT_397	[p18l1062t1821r1124b1876],
13	Hikiji	NNP	PERSON	Hikiji	nn	14	SENT_397	[p18l1153t1819r1309b1882],
14	K	NNP	PERSON	K	appos	5	SENT_397	[p18l1336t1821r1397b1876],
15	,	,	O	,	_	0	SENT_397	[p18l1336t1821r1397b1876],
16	Kubo	NNP	PERSON	Kubo	nn	17	SENT_397	[p18l1427t1820r1573b1868],
17	N	NNP	O	N	appos	5	SENT_397	[p18l1599t1821r1661b1876],
18	,	,	O	,	_	0	SENT_397	[p18l1599t1821r1661b1876],
19	Sakurabayashi	NNP	ORGANIZATION	Sakurabayashi	appos	5	SENT_397	[p18l1692t1819r2084b1882],
20	1	CD	NUMBER	1	num	19	SENT_397	[p18l2111t1821r2145b1868],
21	.	.	O	.	_	0	SENT_397	[p18l2111t1821r2145b1868],

1	Rapid	JJ	O	rapid	amod	2	SENT_398	[p18l143t1904r305b1967],
2	identiﬁcation	NN	O	identiﬁcation	_	0	SENT_398	[p18l333t1904r690b1953],
3	of	IN	O	of	_	0	SENT_398	[p18l720t1904r778b1953],
4	the	DT	O	the	det	6	SENT_398	[p18l802t1905r883b1953],
5	common	JJ	O	common	amod	6	SENT_398	[p18l913t1919r1149b1953],
6	Apo	NN	O	apo	prep_of	2	SENT_398	[p18l1177t1905r1357b1967],
7	.	.	O	.	_	0	SENT_398	[p18l1177t1905r1357b1967],

1	—	NN	O	—	_	0	SENT_399	[p18l1177t1905r1357b1967],
2	.	.	O	.	_	0	SENT_399	[p18l1177t1905r1357b1967],

1	E	NN	O	e	nn	2	SENT_400	[p18l1177t1905r1357b1967],
2	genotype	NN	O	genotype	_	0	SENT_400	[p18l1386t1912r1633b1967],
3	using	VBG	O	use	partmod	2	SENT_400	[p18l1662t1905r1807b1967],
4	polymerase	NN	O	polymerase	nn	5	SENT_400	[p18l1835t1905r2148b1967],
5	chein	NN	O	chein	dobj	3	SENT_400	[p18l144t1990r289b2038],
6	reaction-single	JJ	O	reaction-single	amod	9	SENT_400	[p18l321t1989r724b2052],
7	strand	NN	O	strand	nn	9	SENT_400	[p18l758t1990r921b2038],
8	conformation	NN	O	conformation	nn	9	SENT_400	[p18l954t1989r1318b2038],
9	polymorphism	NN	O	polymorphism	tmod	3	SENT_400	[p18l1349t1989r1746b2052],
10	(	CD	NUMBER	(	num	11	SENT_400	[p18l1780t1990r2145b2049],
11	PCR	NN	O	pcr	dep	9	SENT_400	[p18l1780t1990r2145b2049],
12	.	.	O	.	_	0	SENT_400	[p18l1780t1990r2145b2049],

1	—	NN	O	—	_	0	SENT_401	[p18l1780t1990r2145b2049],
2	.	.	O	.	_	0	SENT_401	[p18l1780t1990r2145b2049],

1	SSCP	NN	O	sscp	_	0	SENT_402	[p18l1780t1990r2145b2049],
2	)	NN	O	)	dep	1	SENT_402	[p18l1780t1990r2145b2049],
3	.	.	O	.	_	0	SENT_402	[p18l1780t1990r2145b2049],

1	Mol	NNP	O	Mol	nn	3	SENT_403	[p18l143t2074r255b2121],
2	Cell	NNP	O	Cell	nn	3	SENT_403	[p18l275t2073r385b2121],
3	Probes	NNP	O	Probes	_	0	SENT_403	[p18l404t2074r586b2121],
4	1994	CD	DATE	1994	num	3	SENT_403	[p18l613t2073r962b2129],
5	;	:	O	;	_	0	SENT_403	[p18l613t2073r962b2129],
6	8:51	CD	TIME	8:51	number	7	SENT_403	[p18l613t2073r962b2129],
7	—	CD	NUMBER	—	dep	3	SENT_403	[p18l613t2073r962b2129],
8	4	CD	NUMBER	4	dep	7	SENT_403	[p18l613t2073r962b2129],
9	.	.	O	.	_	0	SENT_403	[p18l613t2073r962b2129],

1	[	NN	O	[	_	0	SENT_404	[p18l7t2158r109b2217],
2	25	CD	NUMBER	25	num	1	SENT_404	[p18l7t2158r109b2217],
3	]	CD	NUMBER	]	num	5	SENT_404	[p18l7t2158r109b2217],
4	Fiegenbaum	NN	O	fiegenbaum	nn	5	SENT_404	[p18l143t2159r478b2221],
5	M	NN	O	m	dep	1	SENT_404	[p18l489t2160r563b2215],
6	,	,	O	,	_	0	SENT_404	[p18l489t2160r563b2215],
7	da	NN	PERSON	da	nn	9	SENT_404	[p18l578t2159r641b2207],
8	Silveira	NNP	PERSON	Silveira	nn	9	SENT_404	[p18l653t2158r862b2207],
9	FR	NN	O	fr	appos	5	SENT_404	[p18l872t2160r968b2215],
10	,	,	O	,	_	0	SENT_404	[p18l872t2160r968b2215],
11	Van	NNP	PERSON	Van	nn	14	SENT_404	[p18l983t2160r1087b2207],
12	der	NNP	O	der	nn	14	SENT_404	[p18l1100t2159r1186b2207],
13	Sand	NNP	O	Sand	nn	14	SENT_404	[p18l1198t2159r1331b2207],
14	CR	NN	O	cr	appos	5	SENT_404	[p18l1343t2159r1446b2215],
15	,	,	O	,	_	0	SENT_404	[p18l1343t2159r1446b2215],
16	Van	NNP	PERSON	Van	nn	19	SENT_404	[p18l1460t2160r1565b2207],
17	der	NNP	O	der	nn	19	SENT_404	[p18l1578t2159r1663b2207],
18	Sand	NNP	O	Sand	nn	19	SENT_404	[p18l1676t2159r1809b2207],
19	LC	NNP	O	LC	appos	5	SENT_404	[p18l1820t2159r1920b2215],
20	,	,	O	,	_	0	SENT_404	[p18l1820t2159r1920b2215],
21	Ferreira	NNP	PERSON	Ferreira	nn	22	SENT_404	[p18l1934t2159r2149b2207],
22	ME	NNP	O	ME	appos	5	SENT_404	[p18l143t2244r258b2299],
23	,	,	O	,	_	0	SENT_404	[p18l143t2244r258b2299],
24	Pires	NNP	PERSON	Pires	nn	25	SENT_404	[p18l283t2243r416b2290],
25	RC	NNP	O	RC	appos	5	SENT_404	[p18l440t2243r544b2298],
26	,	,	O	,	_	0	SENT_404	[p18l440t2243r544b2298],
27	et	FW	O	et	nn	28	SENT_404	[p18l569t2250r617b2290],
28	al.	FW	O	al.	appos	5	SENT_404	[p18l640t2243r699b2290],
29	.	.	O	.	_	0	SENT_404	[p18l640t2243r699b2290],

1	The	DT	O	the	det	2	SENT_405	[p18l725t2243r829b2290],
2	role	NN	O	role	_	0	SENT_405	[p18l851t2243r955b2290],
3	of	IN	O	of	_	0	SENT_405	[p18l979t2243r1038b2290],
4	common	JJ	O	common	amod	5	SENT_405	[p18l1056t2258r1292b2290],
5	Variants	NNS	O	variant	prep_of	2	SENT_405	[p18l1315t2243r1525b2290],
6	of	IN	O	of	_	0	SENT_405	[p18l1550t2243r1609b2290],
7	ABCB1	NN	O	abcb1	nn	9	SENT_405	[p18l1626t2243r1858b2298],
8	,	,	O	,	_	0	SENT_405	[p18l1626t2243r1858b2298],
9	CYP3A4	NN	O	cyp3a4	prep_of	5	SENT_405	[p18l1884t2243r2146b2298],
10	,	,	O	,	_	0	SENT_405	[p18l1884t2243r2146b2298],
11	and	CC	O	and	_	0	SENT_405	[p18l145t2328r241b2376],
12	CYP3A5	NN	O	cyp3a5	nn	13	SENT_405	[p18l267t2327r511b2376],
13	genes	NNS	O	gene	prep_of	5	SENT_405	[p18l542t2343r693b2390],
14	in	IN	O	in	_	0	SENT_405	[p18l721t2328r772b2375],
15	lipid-lowering	JJ	O	lipid-lowering	amod	16	SENT_405	[p18l799t2328r1184b2390],
16	efﬁcacy	NN	O	efﬁcacy	prep_in	2	SENT_405	[p18l1212t2328r1422b2390],
17	and	CC	O	and	_	0	SENT_405	[p18l1451t2328r1546b2376],
18	safety	NN	O	safety	conj_and	16	SENT_405	[p18l1575t2328r1733b2390],
19	of	IN	O	of	_	0	SENT_405	[p18l1761t2328r1820b2376],
20	simvastatin	NN	O	simvastatin	nn	21	SENT_405	[p18l1844t2328r2148b2376],
21	treatment	NN	O	treatment	prep_of	2	SENT_405	[p18l143t2418r412b2458],
22	.	.	O	.	_	0	SENT_405	[p18l143t2418r412b2458],

1	Clin	NNP	O	Clin	nn	3	SENT_406	[p18l435t2411r550b2458],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_406	[p18l569t2411r858b2458],
3	Ther	NNP	O	Ther	_	0	SENT_406	[p18l877t2411r1005b2458],
4	2005	CD	DATE	2005	num	3	SENT_406	[p18l1023t2410r1446b2467],
5	;	:	O	;	_	0	SENT_406	[p18l1023t2410r1446b2467],
6	78:551	CD	NUMBER	78:551	number	7	SENT_406	[p18l1023t2410r1446b2467],
7	-8	CD	NUMBER	-8	dep	3	SENT_406	[p18l1023t2410r1446b2467],
8	.	.	O	.	_	0	SENT_406	[p18l1023t2410r1446b2467],

1	[	NN	O	[	nn	5	SENT_407	[p18l7t2494r109b2551],
2	26	CD	NUMBER	26	num	5	SENT_407	[p18l7t2494r109b2551],
3	]	CD	NUMBER	]	num	5	SENT_407	[p18l7t2494r109b2551],
4	Kivisto	NNP	ORGANIZATION	Kivisto	nn	5	SENT_407	[p18l145t2494r339b2541],
5	KT	NNP	ORGANIZATION	KT	_	0	SENT_407	[p18l358t2495r455b2549],
6	,	,	O	,	_	0	SENT_407	[p18l358t2495r455b2549],
7	Niemi	NNP	PERSON	Niemi	nn	8	SENT_407	[p18l474t2494r642b2541],
8	M	NNP	O	M	appos	5	SENT_407	[p18l659t2495r733b2549],
9	,	,	O	,	_	0	SENT_407	[p18l659t2495r733b2549],
10	Schaeffeler	NNP	O	Schaeffeler	nn	11	SENT_407	[p18l753t2494r1059b2541],
11	E	NNP	O	E	appos	8	SENT_407	[p18l1074t2495r1128b2550],
12	,	,	O	,	_	0	SENT_407	[p18l1074t2495r1128b2550],
13	Pitkéila	NNP	LOCATION	Pitkéila	nn	14	SENT_407	[p18l1147t2494r1336b2541],
14	K	NNP	LOCATION	K	appos	8	SENT_407	[p18l1352t2495r1413b2550],
15	,	,	O	,	_	0	SENT_407	[p18l1352t2495r1413b2550],
16	Tilvis	NNP	PERSON	Tilvis	nn	17	SENT_407	[p18l1432t2494r1585b2541],
17	R	NNP	PERSON	R	appos	8	SENT_407	[p18l1603t2495r1661b2550],
18	,	,	O	,	_	0	SENT_407	[p18l1603t2495r1661b2550],
19	Fromm	NNP	PERSON	Fromm	nn	20	SENT_407	[p18l1680t2495r1880b2541],
20	MF	NN	O	mf	appos	8	SENT_407	[p18l1895t2495r2001b2550],
21	,	,	O	,	_	0	SENT_407	[p18l1895t2495r2001b2550],
22	et	FW	O	et	nn	23	SENT_407	[p18l2021t2501r2068b2541],
23	al.	FW	O	al.	appos	8	SENT_407	[p18l2085t2494r2145b2541],
24	.	.	O	.	_	0	SENT_407	[p18l2085t2494r2145b2541],

1	Lipid	NN	O	lipid	nn	3	SENT_408	[p18l143t2579r290b2641],
2	lowering	NN	O	lowering	nn	3	SENT_408	[p18l309t2579r546b2641],
3	response	NN	O	response	nsubjpass	7	SENT_408	[p18l566t2594r803b2641],
4	to	TO	O	to	_	0	SENT_408	[p18l822t2586r873b2627],
5	statins	NNS	O	statin	prep_to	3	SENT_408	[p18l895t2579r1064b2627],
6	is	VBZ	O	be	auxpass	7	SENT_408	[p18l1085t2579r1127b2627],
7	affected	VBN	O	affect	_	0	SENT_408	[p18l1149t2579r1364b2627],
8	by	IN	O	by	_	0	SENT_408	[p18l1382t2579r1449b2641],
9	CYP3A5	NN	O	cyp3a5	nn	10	SENT_408	[p18l1469t2579r1713b2627],
10	polymorphism	NN	O	polymorphism	agent	7	SENT_408	[p18l1735t2579r2145b2641],
11	.	.	O	.	_	0	SENT_408	[p18l1735t2579r2145b2641],

1	Pharmaco	NNP	ORGANIZATION	Pharmaco	nn	2	SENT_409	[p18l143t2662r413b2709],
2	genetics	NNS	O	genetics	_	0	SENT_409	[p18l417t2662r635b2723],
3	2004	CD	DATE	2004	num	5	SENT_409	[p18l657t2662r806b2718],
4	;	:	O	;	_	0	SENT_409	[p18l657t2662r806b2718],
5	14523-5	CD	NUMBER	14523-5	dep	2	SENT_409	[p18l817t2662r1080b2709],
6	.	.	O	.	_	0	SENT_409	[p18l817t2662r1080b2709],

1	[	NN	O	[	nn	4	SENT_410	[p18l7t2747r109b2805],
2	27	CD	NUMBER	27	num	4	SENT_410	[p18l7t2747r109b2805],
3	]	NN	O	]	nn	4	SENT_410	[p18l7t2747r109b2805],
4	Kirchheiner	NN	O	kirchheiner	_	0	SENT_410	[p18l145t2747r468b2795],
5	J	NN	O	j	dep	4	SENT_410	[p18l486t2748r511b2795],
6	,	,	O	,	_	0	SENT_410	[p18l516t2786r526b2803],
7	Brockmoller	NN	O	brockmoller	nn	8	SENT_410	[p18l548t2747r892b2795],
8	J	NN	O	j	appos	5	SENT_410	[p18l910t2748r935b2795],
9	.	.	O	.	_	0	SENT_410	[p18l940t2787r948b2795],

1	Clinical	JJ	O	clinical	amod	2	SENT_411	[p18l972t2747r1185b2795],
2	consequences	NNS	O	consequence	_	0	SENT_411	[p18l1206t2762r1576b2809],
3	of	IN	O	of	_	0	SENT_411	[p18l1598t2747r1657b2795],
4	cytochrome	NN	O	cytochrome	nn	5	SENT_411	[p18l1672t2747r1990b2809],
5	P450	NN	O	p450	prep_of	2	SENT_411	[p18l2010t2746r2148b2795],

1	2C9	CD	NUMBER	2c9	num	2	SENT_412	[p18l144t2830r253b2878],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_412	[p18l273t2830r709b2891],
3	.	.	O	.	_	0	SENT_412	[p18l273t2830r709b2891],

1	Clin	NNP	O	Clin	nn	3	SENT_413	[p18l732t2830r847b2877],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_413	[p18l866t2830r1155b2877],
3	Ther	NNP	O	Ther	_	0	SENT_413	[p18l1174t2830r1302b2877],
4	2005	CD	DATE	2005	num	3	SENT_413	[p18l1320t2830r1555b2885],
5	;	:	O	;	_	0	SENT_413	[p18l1320t2830r1555b2885],
6	77	CD	NUMBER	77	num	8	SENT_413	[p18l1320t2830r1555b2885],
7	:	:	O	:	_	0	SENT_413	[p18l1320t2830r1555b2885],
8	1-16	CD	NUMBER	1-16	dep	3	SENT_413	[p18l1568t2830r1709b2877],
9	.	.	O	.	_	0	SENT_413	[p18l1568t2830r1709b2877],

1	[	NN	O	[	_	0	SENT_414	[p18l7t2915r109b2973],
2	28	CD	NUMBER	28	number	3	SENT_414	[p18l7t2915r109b2973],
3	]	CD	NUMBER	]	dep	1	SENT_414	[p18l7t2915r109b2973],
4	Roberts	NNP	PERSON	Roberts	nn	5	SENT_414	[p18l143t2915r352b2963],
5	WC	NNP	O	WC	dep	3	SENT_414	[p18l378t2915r500b2963],
6	.	.	O	.	_	0	SENT_414	[p18l378t2915r500b2963],

1	The	DT	O	the	det	2	SENT_415	[p18l529t2915r633b2963],
2	rule	NN	O	rule	_	0	SENT_415	[p18l658t2915r762b2963],
3	of	IN	O	of	_	0	SENT_415	[p18l789t2915r848b2963],
4	5	CD	NUMBER	5	prep_of	2	SENT_415	[p18l870t2915r898b2963],
5	and	CC	O	and	_	0	SENT_415	[p18l928t2915r1023b2963],
6	the	DT	O	the	det	7	SENT_415	[p18l1048t2915r1129b2963],
7	rule	NN	O	rule	conj_and	4	SENT_415	[p18l1155t2915r1259b2963],
8	of	IN	O	of	_	0	SENT_415	[p18l1286t2915r1344b2963],
9	7	CD	NUMBER	7	prep_of	2	SENT_415	[p18l1366t2916r1395b2963],
10	in	IN	O	in	_	0	SENT_415	[p18l1423t2915r1474b2962],
11	lipid-lowering	JJ	O	lipid-lowering	prep_in	2	SENT_415	[p18l1499t2915r1885b2977],
12	by	IN	O	by	_	0	SENT_415	[p18l1910t2915r1977b2977],
13	statin	NN	O	statin	nn	14	SENT_415	[p18l2005t2915r2148b2963],
14	drugs	NNS	O	drug	prep_by	11	SENT_415	[p18l144t2997r306b3058],
15	.	.	O	.	_	0	SENT_415	[p18l144t2997r306b3058],

1	Am	NNP	O	Am	nn	3	SENT_416	[p18l329t2998r430b3044],
2	J	NNP	O	J	nn	3	SENT_416	[p18l448t2998r472b3044],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_416	[p18l492t2997r694b3044],
4	1997	CD	DATE	1997	num	3	SENT_416	[p18l719t2997r1136b3053],
5	;	:	O	;	_	0	SENT_416	[p18l719t2997r1136b3053],
6	80:106	CD	NUMBER	80:106	number	7	SENT_416	[p18l719t2997r1136b3053],
7	-7	CD	NUMBER	-7	dep	3	SENT_416	[p18l719t2997r1136b3053],
8	.	.	O	.	_	0	SENT_416	[p18l719t2997r1136b3053],

1	[	NN	O	[	nn	5	SENT_417	[p18l7t3080r109b3137],
2	29	CD	NUMBER	29	num	5	SENT_417	[p18l7t3080r109b3137],
3	]	CD	NUMBER	]	num	5	SENT_417	[p18l7t3080r109b3137],
4	Ordovas	NNP	O	Ordovas	nn	5	SENT_417	[p18l145t3080r368b3127],
5	J	NNP	O	J	_	0	SENT_417	[p18l386t3081r411b3127],
6	M	NN	O	m	dep	5	SENT_417	[p18l413t3081r486b3136],
7	,	,	O	,	_	0	SENT_417	[p18l413t3081r486b3136],
8	Mooser	NNP	O	Mooser	nn	9	SENT_417	[p18l505t3081r713b3127],
9	V.	NNP	O	V.	appos	6	SENT_417	[p18l728t3081r781b3127],
10	The	DT	O	the	det	12	SENT_417	[p18l801t3080r905b3127],
11	apoE	NN	O	apoe	nn	12	SENT_417	[p18l923t3081r1060b3141],
12	locus	NN	O	locus	dep	5	SENT_417	[p18l1077t3080r1217b3127],
13	and	CC	O	and	_	0	SENT_417	[p18l1237t3080r1332b3127],
14	the	DT	O	the	det	15	SENT_417	[p18l1349t3080r1430b3127],
15	pharmacogenetics	NNS	O	pharmacogenetic	dep	5	SENT_417	[p18l1446t3080r1935b3141],
16	of	IN	O	of	_	0	SENT_417	[p18l1954t3080r2013b3127],
17	lipid	NN	O	lipid	nn	18	SENT_417	[p18l2026t3080r2149b3141],
18	response	NN	O	response	prep_of	15	SENT_417	[p18l143t3178r393b3224],
19	.	.	O	.	_	0	SENT_417	[p18l143t3178r393b3224],

1	Curr	NNP	O	Curr	nn	3	SENT_418	[p18l417t3163r540b3210],
2	Opin	NNP	O	Opin	nn	3	SENT_418	[p18l558t3163r692b3224],
3	Lipidol	NNP	O	Lipidol	_	0	SENT_418	[p18l710t3163r909b3224],
4	2002	CD	DATE	2002	num	3	SENT_418	[p18l929t3163r1352b3219],
5	;	:	O	;	_	0	SENT_418	[p18l929t3163r1352b3219],
6	13:113	CD	NUMBER	13:113	number	7	SENT_418	[p18l929t3163r1352b3219],
7	-7	CD	NUMBER	-7	dep	3	SENT_418	[p18l929t3163r1352b3219],
8	.	.	O	.	_	0	SENT_418	[p18l929t3163r1352b3219],

1	[	RB	O	[	advmod	5	SENT_419	[p18l7t3246r109b3303],
2	30	CD	NUMBER	30	num	5	SENT_419	[p18l7t3246r109b3303],
3	]	CD	NUMBER	]	num	5	SENT_419	[p18l7t3246r109b3303],
4	Mukhtar	NNP	PERSON	Mukhtar	nn	5	SENT_419	[p18l143t3246r377b3293],
5	RY	NNP	O	RY	_	0	SENT_419	[p18l399t3247r493b3302],
6	,	,	O	,	_	0	SENT_419	[p18l399t3247r493b3302],
7	Reckless	JJ	O	reckless	amod	8	SENT_419	[p18l519t3246r757b3293],
8	JP	NNP	O	JP	appos	5	SENT_419	[p18l782t3247r851b3293],
9	.	.	O	.	_	0	SENT_419	[p18l782t3247r851b3293],

1	Statin-induced	JJ	O	statin-induced	amod	2	SENT_420	[p18l879t3246r1273b3293],
2	myositis	NN	O	myositis	_	0	SENT_420	[p18l1296t3246r1539b3307],
3	:	:	O	:	_	0	SENT_420	[p18l1296t3246r1539b3307],
4	a	DT	O	a	det	6	SENT_420	[p18l1568t3261r1596b3293],
5	commonly	RB	O	commonly	advmod	6	SENT_420	[p18l1619t3246r1907b3307],
6	encountered	VBN	O	encounter	dep	2	SENT_420	[p18l1931t3261r2146b3293, p18l143t3329r278b3376],

1	or	CC	O	or	_	0	SENT_421	[p18l298t3344r353b3376],
2	rare	JJ	O	rare	amod	4	SENT_421	[p18l370t3344r474b3376],
3	side	NN	O	side	nn	4	SENT_421	[p18l495t3329r601b3376],
4	effect	NN	O	effect	dep	1	SENT_421	[p18l620t3329r800b3376],
5	?	.	O	?	_	0	SENT_421	[p18l620t3329r800b3376],

1	Curr	NNP	O	Curr	nn	3	SENT_422	[p18l821t3329r944b3376],
2	Opinion	NNP	O	Opinion	nn	3	SENT_422	[p18l963t3329r1184b3390],
3	Lipidol	NNP	O	Lipidol	_	0	SENT_422	[p18l1202t3329r1400b3390],
4	2005	CD	DATE	2005	num	3	SENT_422	[p18l1421t3329r1844b3385],
5	;	:	O	;	_	0	SENT_422	[p18l1421t3329r1844b3385],
6	16:640	CD	NUMBER	16:640	number	7	SENT_422	[p18l1421t3329r1844b3385],
7	-7	CD	NUMBER	-7	dep	3	SENT_422	[p18l1421t3329r1844b3385],
8	.	.	O	.	_	0	SENT_422	[p18l1421t3329r1844b3385],

1	[	NN	O	[	nn	6	SENT_423	[p18l7t3412r109b3469],
2	31	CD	NUMBER	31	num	6	SENT_423	[p18l7t3412r109b3469],
3	]	CD	NUMBER	]	num	6	SENT_423	[p18l7t3412r109b3469],
4	Ingelman-Sundberg	NNP	O	Ingelman-Sundberg	nn	6	SENT_423	[p18l143t3412r680b3473],
5	M.	NNP	O	M.	nn	6	SENT_423	[p18l713t3413r786b3459],
6	Pharmacogenetics	NNP	O	Pharmacogenetics	_	0	SENT_423	[p18l822t3412r1314b3473],
7	of	IN	O	of	_	0	SENT_423	[p18l1348t3412r1407b3459],
8	cytochrome	NN	O	cytochrome	nn	9	SENT_423	[p18l1436t3412r1753b3473],
9	P450	NN	O	p450	prep_of	6	SENT_423	[p18l1786t3412r1924b3459],
10	and	CC	O	and	_	0	SENT_423	[p18l1958t3412r2054b3459],
11	its	PRP$	O	its	poss	12	SENT_423	[p18l2086t3412r2147b3459],
12	applications	NNS	O	application	conj_and	6	SENT_423	[p18l145t3495r469b3556],
13	in	IN	O	in	_	0	SENT_423	[p18l484t3495r535b3542],
14	drug	NN	O	drug	nn	15	SENT_423	[p18l549t3495r670b3556],
15	therapy	NN	O	therapy	prep_in	12	SENT_423	[p18l685t3495r901b3556],
16	:	:	O	:	_	0	SENT_423	[p18l685t3495r901b3556],
17	the	DT	DATE	the	det	18	SENT_423	[p18l919t3495r999b3542],
18	past	NN	DATE	past	dep	6	SENT_423	[p18l1012t3502r1136b3556],
19	,	,	DATE	,	_	0	SENT_423	[p18l1012t3502r1136b3556],
20	present	JJ	DATE	present	conj_and	18	SENT_423	[p18l1151t3502r1347b3556],
21	and	CC	O	and	_	0	SENT_423	[p18l1361t3495r1457b3542],
22	future	JJ	DATE	future	dep	6	SENT_423	[p18l1470t3495r1644b3542],
23	.	.	O	.	_	0	SENT_423	[p18l1470t3495r1644b3542],

1	Trends	NNS	O	trend	_	0	SENT_424	[p18l1661t3495r1844b3542],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_424	[p18l1859t3495r2148b3542],
3	Sci	NNP	O	Sci	dep	1	SENT_424	[p18l145t3579r228b3626],
4	2004	CD	DATE	2004	num	3	SENT_424	[p18l249t3579r739b3635],
5	;	:	O	;	_	0	SENT_424	[p18l249t3579r739b3635],
6	25:193	CD	NUMBER	25:193	num	7	SENT_424	[p18l249t3579r739b3635],
7	-200	CD	NUMBER	-200	dep	1	SENT_424	[p18l249t3579r739b3635],
8	.	.	O	.	_	0	SENT_424	[p18l249t3579r739b3635],

1	[	NN	O	[	nn	5	SENT_425	[p18l7t3662r109b3719],
2	32	CD	NUMBER	32	num	5	SENT_425	[p18l7t3662r109b3719],
3	]	CD	NUMBER	]	num	5	SENT_425	[p18l7t3662r109b3719],
4	Charles	NNP	PERSON	Charles	nn	5	SENT_425	[p18l144t3662r348b3709],
5	EC	NNP	PERSON	EC	_	0	SENT_425	[p18l373t3662r473b3718],
6	,	,	O	,	_	0	SENT_425	[p18l373t3662r473b3718],
7	Olson	NNP	ORGANIZATION	Olson	nn	8	SENT_425	[p18l501t3662r660b3709],
8	KL	NNP	ORGANIZATION	KL	appos	5	SENT_425	[p18l685t3663r787b3718],
9	,	,	O	,	_	0	SENT_425	[p18l685t3663r787b3718],
10	Sandhoff	NNP	ORGANIZATION	Sandhoff	nn	11	SENT_425	[p18l815t3662r1065b3709],
11	BG	NNP	ORGANIZATION	BG	appos	5	SENT_425	[p18l1084t3662r1191b3718],
12	,	,	O	,	_	0	SENT_425	[p18l1084t3662r1191b3718],
13	McClure	NNP	PERSON	McClure	nn	14	SENT_425	[p18l1217t3662r1457b3709],
14	DL	NNP	O	DL	appos	5	SENT_425	[p18l1481t3663r1584b3718],
15	,	,	O	,	_	0	SENT_425	[p18l1481t3663r1584b3718],
16	Merenich	NNP	O	Merenich	nn	17	SENT_425	[p18l1611t3662r1870b3709],
17	JA	NNP	O	JA	appos	5	SENT_425	[p18l1893t3662r1977b3709],
18	.	.	O	.	_	0	SENT_425	[p18l1893t3662r1977b3709],

1	Evaluation	NN	O	evaluation	_	0	SENT_426	[p18l2004t3662r2146b3709, p18l143t3745r312b3792],
2	of	IN	O	of	_	0	SENT_426	[p18l334t3745r393b3792],
3	cases	NNS	O	case	prep_of	1	SENT_426	[p18l410t3760r550b3792],
4	of	IN	O	of	_	0	SENT_426	[p18l574t3745r632b3792],
5	severe	JJ	O	severe	amod	7	SENT_426	[p18l651t3760r818b3792],
6	statin-related	JJ	O	statin-related	amod	7	SENT_426	[p18l842t3745r1194b3792],
7	transaminitis	NN	O	transaminitis	prep_of	3	SENT_426	[p18l1215t3745r1563b3792],
8	within	IN	O	within	_	0	SENT_426	[p18l1586t3745r1758b3792],
9	a	DT	O	a	det	13	SENT_426	[p18l1781t3760r1809b3792],
10	large	JJ	O	large	amod	13	SENT_426	[p18l1829t3745r1962b3806],
11	health	NN	O	health	nn	13	SENT_426	[p18l1983t3745r2149b3792],
12	maintenance	NN	O	maintenance	nn	13	SENT_426	[p19l144t18r485b65],
13	organization	NN	O	organization	prep_within	1	SENT_426	[p19l505t18r855b79],
14	.	.	O	.	_	0	SENT_426	[p19l505t18r855b79],

1	Am	VBP	O	be	_	0	SENT_427	[p19l877t19r979b65],
2	J	NN	O	j	nsubj	3	SENT_427	[p19l996t19r1021b66],
3	Med	VBD	O	med	ccomp	1	SENT_427	[p19l1040t18r1163b65],
4	2005	CD	DATE	2005	dobj	3	SENT_427	[p19l1183t18r1363b74],
5	;	:	O	;	_	0	SENT_427	[p19l1183t18r1363b74],
6	1	CD	NUMBER	1	num	7	SENT_427	[p19l1183t18r1363b74],
7	182618-24	CD	NUMBER	182618-24	dep	4	SENT_427	[p19l1377t18r1674b66],
8	.	.	O	.	_	0	SENT_427	[p19l1377t18r1674b66],

1	[	NN	O	[	nn	5	SENT_428	[p19l7t102r109b158],
2	33	CD	NUMBER	33	num	5	SENT_428	[p19l7t102r109b158],
3	]	CD	NUMBER	]	num	5	SENT_428	[p19l7t102r109b158],
4	Graham	NNP	PERSON	Graham	nn	5	SENT_428	[p19l144t101r362b149],
5	DJ	NNP	O	DJ	_	0	SENT_428	[p19l387t102r476b157],
6	,	,	O	,	_	0	SENT_428	[p19l387t102r476b157],
7	Staffa	NNP	O	Staffa	nn	8	SENT_428	[p19l507t101r664b149],
8	JA	NNP	O	JA	appos	5	SENT_428	[p19l689t102r774b157],
9	,	,	O	,	_	0	SENT_428	[p19l689t102r774b157],
10	Shatin	NNP	ORGANIZATION	Shatin	nn	11	SENT_428	[p19l805t101r975b149],
11	D	NNP	ORGANIZATION	D	appos	8	SENT_428	[p19l1002t102r1064b157],
12	,	,	O	,	_	0	SENT_428	[p19l1002t102r1064b157],
13	Andrade	NNP	PERSON	Andrade	nn	14	SENT_428	[p19l1092t101r1325b148],
14	SE	NN	PERSON	se	appos	8	SENT_428	[p19l1354t101r1444b157],
15	,	,	O	,	_	0	SENT_428	[p19l1354t101r1444b157],
16	Schech	NNP	O	Schech	nn	17	SENT_428	[p19l1475t101r1668b149],
17	SD	NN	O	sd	appos	8	SENT_428	[p19l1696t102r1794b157],
18	,	,	O	,	_	0	SENT_428	[p19l1696t102r1794b157],
19	La	NNP	O	La	nn	21	SENT_428	[p19l1823t102r1894b148],
20	Grenade	NNP	O	Grenade	nn	21	SENT_428	[p19l1921t101r2148b149],
21	L	NNP	O	L	appos	8	SENT_428	[p19l143t185r198b240],
22	,	,	O	,	_	0	SENT_428	[p19l143t185r198b240],
23	et	FW	O	et	nn	24	SENT_428	[p19l220t191r268b231],
24	al.	FW	O	al.	appos	8	SENT_428	[p19l288t184r347b231],
25	.	.	O	.	_	0	SENT_428	[p19l288t184r347b231],

1	Incidence	NN	O	incidence	_	0	SENT_429	[p19l371t184r633b231],
2	of	IN	O	of	_	0	SENT_429	[p19l653t184r712b231],
3	hospitalized	VBN	O	hospitalize	amod	4	SENT_429	[p19l726t184r1055b245],
4	rhabdomyolysis	NN	O	rhabdomyolysis	prep_of	1	SENT_429	[p19l1073t184r1505b245],
5	in	IN	O	in	_	0	SENT_429	[p19l1527t184r1577b231],
6	patients	NNS	O	patient	prep_in	1	SENT_429	[p19l1596t184r1805b245],
7	treated	VBN	O	treat	partmod	1	SENT_429	[p19l1826t184r2010b231],
8	with	IN	O	with	_	0	SENT_429	[p19l2029t184r2149b232],
9	lipid-lowering	JJ	O	lipid-lowering	amod	10	SENT_429	[p19l143t267r529b328],
10	drugs	NNS	O	drug	prep_with	7	SENT_429	[p19l549t267r711b328],
11	.	.	O	.	_	0	SENT_429	[p19l549t267r711b328],

1	JAMA	NNP	O	JAMA	_	0	SENT_430	[p19l733t268r913b315],
2	2004	CD	DATE	2004	num	1	SENT_430	[p19l933t267r1271b323],
3	;	:	O	;	_	0	SENT_430	[p19l933t267r1271b323],
4	292:25	CD	NUMBER	292:25	number	5	SENT_430	[p19l933t267r1271b323],
5	85-90	CD	NUMBER	85-90	dep	1	SENT_430	[p19l1279t267r1458b315],
6	.	.	O	.	_	0	SENT_430	[p19l1279t267r1458b315],

1	[	NN	O	[	_	0	SENT_431	[p19l7t350r109b407],
2	34	CD	NUMBER	34	num	1	SENT_431	[p19l7t350r109b407],
3	]	CD	NUMBER	]	num	5	SENT_431	[p19l7t350r109b407],
4	Zhou	NNP	PERSON	Zhou	nn	5	SENT_431	[p19l143t350r285b397],
5	S	NN	PERSON	s	dep	1	SENT_431	[p19l319t350r368b406],
6	,	,	O	,	_	0	SENT_431	[p19l319t350r368b406],
7	Yung	NNP	PERSON	Yung	nn	9	SENT_431	[p19l402t351r543b411],
8	Chan	NNP	PERSON	Chan	nn	9	SENT_431	[p19l577t350r718b398],
9	S	NN	PERSON	s	appos	5	SENT_431	[p19l752t351r800b406],
10	,	,	O	,	_	0	SENT_431	[p19l752t351r800b406],
11	Cher	NNP	PERSON	Cher	nn	13	SENT_431	[p19l835t350r966b398],
12	Goh	NNP	PERSON	Goh	nn	13	SENT_431	[p19l998t350r1113b398],
13	B	NNP	PERSON	B	appos	5	SENT_431	[p19l1144t351r1202b406],
14	,	,	O	,	_	0	SENT_431	[p19l1144t351r1202b406],
15	Chan	NNP	PERSON	Chan	nn	16	SENT_431	[p19l1238t350r1379b398],
16	E	NNP	PERSON	E	appos	5	SENT_431	[p19l1410t351r1465b406],
17	,	,	O	,	_	0	SENT_431	[p19l1410t351r1465b406],
18	Duan	NNP	PERSON	Duan	nn	19	SENT_431	[p19l1499t351r1645b397],
19	W	NNP	PERSON	W	appos	5	SENT_431	[p19l1676t351r1747b406],
20	,	,	O	,	_	0	SENT_431	[p19l1676t351r1747b406],
21	Huang	NNP	PERSON	Huang	nn	22	SENT_431	[p19l1782t351r1961b411],
22	M	NNP	PERSON	M	appos	5	SENT_431	[p19l1993t351r2066b406],
23	,	,	O	,	_	0	SENT_431	[p19l1993t351r2066b406],
24	et	FW	O	et	nn	25	SENT_431	[p19l2102t357r2149b397],
25	al.	FW	O	al.	appos	5	SENT_431	[p19l145t433r204b480],
26	.	.	O	.	_	0	SENT_431	[p19l145t433r204b480],

1	Mechanism-based	JJ	O	mechanism-based	amod	2	SENT_432	[p19l231t433r726b480],
2	inhibition	NN	O	inhibition	_	0	SENT_432	[p19l749t433r1012b480],
3	of	IN	O	of	_	0	SENT_432	[p19l1037t433r1095b480],
4	cytochrome	NN	O	cytochrome	nn	6	SENT_432	[p19l1115t433r1432b494],
5	P450	NN	O	p450	nn	6	SENT_432	[p19l1456t433r1594b481],
6	3A4	NN	O	3a4	prep_of	2	SENT_432	[p19l1620t433r1733b481],
7	by	IN	O	by	_	0	SENT_432	[p19l1756t433r1823b494],
8	therapeutic	JJ	O	therapeutic	amod	9	SENT_432	[p19l1847t433r2147b494],
9	drugs	NNS	O	drug	prep_by	2	SENT_432	[p19l144t516r306b577],
10	.	.	O	.	_	0	SENT_432	[p19l144t516r306b577],

1	Clin	NNP	O	Clin	nn	2	SENT_433	[p19l330t516r444b564],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_433	[p19l463t516r871b563],
3	2005	CD	DATE	2005	num	2	SENT_433	[p19l889t516r1380b572],
4	;	:	O	;	_	0	SENT_433	[p19l889t516r1380b572],
5	44:279	CD	NUMBER	44:279	number	6	SENT_433	[p19l889t516r1380b572],
6	-304	CD	NUMBER	-304	dep	2	SENT_433	[p19l889t516r1380b572],
7	.	.	O	.	_	0	SENT_433	[p19l889t516r1380b572],

1	[	NN	O	[	nn	5	SENT_434	[p19l7t599r109b656],
2	35	CD	NUMBER	35	num	5	SENT_434	[p19l7t599r109b656],
3	]	CD	NUMBER	]	num	5	SENT_434	[p19l7t599r109b656],
4	Owczarek	NNP	PERSON	Owczarek	nn	5	SENT_434	[p19l145t599r419b647],
5	J	NNP	PERSON	J	_	0	SENT_434	[p19l431t600r456b647],
6	,	,	O	,	_	0	SENT_434	[p19l460t638r470b655],
7	J	NNP	O	J	appos	5	SENT_434	[p19l486t600r511b647],
8	asinska	FW	O	asinska	dep	9	SENT_434	[p19l514t599r712b646],
9	M	NN	O	m	rcmod	7	SENT_434	[p19l725t600r798b655],
10	,	,	O	,	_	0	SENT_434	[p19l725t600r798b655],
11	Orszulak-Michalak	NNP	O	Orszulak-Michalak	nn	12	SENT_434	[p19l815t599r1339b647],
12	D.	NNP	O	D.	appos	5	SENT_434	[p19l1351t600r1412b646],
13	Drug-induced	JJ	O	drug-induced	amod	14	SENT_434	[p19l1429t599r1806b660],
14	myopathies	NNS	O	myopathy	dep	12	SENT_434	[p19l1819t599r2145b660],
15	.	.	O	.	_	0	SENT_434	[p19l1819t599r2145b660],

1	An	DT	O	a	det	2	SENT_435	[p19l143t683r225b729],
2	overview	NN	O	overview	_	0	SENT_435	[p19l243t682r490b730],
3	of	IN	O	of	_	0	SENT_435	[p19l509t682r568b730],
4	the	DT	O	the	det	6	SENT_435	[p19l581t682r662b730],
5	possible	JJ	O	possible	amod	6	SENT_435	[p19l679t682r901b743],
6	mechanisms	NNS	O	mechanism	prep_of	2	SENT_435	[p19l919t682r1267b730],
7	.	.	O	.	_	0	SENT_435	[p19l919t682r1267b730],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_436	[p19l1288t682r1577b730],
2	Rep	NNP	O	Rep	_	0	SENT_436	[p19l1595t684r1702b743],
3	2005	CD	DATE	2005	num	2	SENT_436	[p19l1722t682r2145b738],
4	;	:	O	;	_	0	SENT_436	[p19l1722t682r2145b738],
5	57:23	CD	NUMBER	57:23	number	6	SENT_436	[p19l1722t682r2145b738],
6	—	CD	NUMBER	—	dep	2	SENT_436	[p19l1722t682r2145b738],
7	34	CD	NUMBER	34	dep	6	SENT_436	[p19l1722t682r2145b738],
8	.	.	O	.	_	0	SENT_436	[p19l1722t682r2145b738],

1	[	NN	O	[	_	0	SENT_437	[p19l7t767r109b825],
2	36	CD	NUMBER	36	number	3	SENT_437	[p19l7t767r109b825],
3	]	CD	NUMBER	]	num	5	SENT_437	[p19l7t767r109b825],
4	Sinzinger	NN	O	sinzinger	nn	5	SENT_437	[p19l145t767r404b829],
5	H	NN	O	h	dep	1	SENT_437	[p19l437t769r499b824],
6	,	,	O	,	_	0	SENT_437	[p19l437t769r499b824],
7	O’Grady	JJ	O	o’grady	amod	8	SENT_437	[p19l537t767r776b829],
8	J	NN	O	j	appos	5	SENT_437	[p19l810t769r835b816],
9	.	.	O	.	_	0	SENT_437	[p19l841t807r849b815],

1	Professional	JJ	O	professional	amod	2	SENT_438	[p19l887t767r1221b815],
2	athletes	NNS	O	athlete	nsubj	8	SENT_438	[p19l1258t767r1461b815],
3	suffering	VBG	O	suffer	partmod	2	SENT_438	[p19l1499t767r1738b829],
4	from	IN	O	from	_	0	SENT_438	[p19l1774t767r1905b815],
5	familial	JJ	O	familial	amod	6	SENT_438	[p19l1939t767r2148b815],
6	hypercholesterolaemia	NN	O	hypercholesterolaemia	prep_from	3	SENT_438	[p19l143t850r759b911],
7	rarely	RB	O	rarely	advmod	8	SENT_438	[p19l773t850r930b911],
8	tolerate	VBP	O	tolerate	_	0	SENT_438	[p19l947t850r1149b898],
9	statin	NN	O	statin	nn	10	SENT_438	[p19l1168t850r1312b898],
10	treatment	NN	O	treatment	dobj	8	SENT_438	[p19l1328t857r1584b898],
11	because	IN	O	because	_	0	SENT_438	[p19l1598t850r1813b898],
12	of	IN	O	of	prepc_because_of	8	SENT_438	[p19l1830t850r1889b898],
13	muscular	JJ	O	muscular	amod	14	SENT_438	[p19l1901t850r2150b898],
14	problems	NNS	O	problem	pobj	8	SENT_438	[p19l142t933r409b994],
15	.	.	O	.	_	0	SENT_438	[p19l142t933r409b994],

1	Br	NN	O	br	nn	3	SENT_439	[p19l431t935r498b980],
2	J	NN	O	j	nn	3	SENT_439	[p19l515t935r541b981],
3	Clin	NN	O	clin	_	0	SENT_439	[p19l560t933r675b981],
4	Pharmacol	NNP	O	Pharmacol	dep	3	SENT_439	[p19l693t933r983b981],
5	2004	CD	DATE	2004	num	4	SENT_439	[p19l1003t933r1426b989],
6	;	:	O	;	_	0	SENT_439	[p19l1003t933r1426b989],
7	57:525	CD	NUMBER	57:525	number	8	SENT_439	[p19l1003t933r1426b989],
8	—	CD	NUMBER	—	dep	3	SENT_439	[p19l1003t933r1426b989],
9	8	CD	NUMBER	8	dep	8	SENT_439	[p19l1003t933r1426b989],
10	.	.	O	.	_	0	SENT_439	[p19l1003t933r1426b989],

1	[	NN	O	[	_	0	SENT_440	[p19l7t1017r110b1073],
2	37	CD	NUMBER	37	num	1	SENT_440	[p19l7t1017r110b1073],
3	]	CD	NUMBER	]	num	5	SENT_440	[p19l7t1017r110b1073],
4	Pierno	NNP	O	Pierno	nn	5	SENT_440	[p19l144t1016r319b1063],
5	S	NN	O	s	dep	1	SENT_440	[p19l336t1017r384b1072],
6	,	,	O	,	_	0	SENT_440	[p19l336t1017r384b1072],
7	De	NNP	PERSON	De	nn	9	SENT_440	[p19l400t1017r478b1063],
8	Luca	NNP	PERSON	Luca	nn	9	SENT_440	[p19l491t1017r627b1063],
9	A	NNP	PERSON	A	appos	5	SENT_440	[p19l639t1017r701b1072],
10	,	,	O	,	_	0	SENT_440	[p19l639t1017r701b1072],
11	Liantonio	NNP	O	Liantonio	nn	12	SENT_440	[p19l717t1016r980b1063],
12	A	NNP	O	A	appos	5	SENT_440	[p19l994t1017r1056b1072],
13	,	,	O	,	_	0	SENT_440	[p19l994t1017r1056b1072],
14	Camerino	NNP	ORGANIZATION	Camerino	nn	15	SENT_440	[p19l1073t1016r1338b1064],
15	C	NNP	ORGANIZATION	C	appos	5	SENT_440	[p19l1353t1017r1411b1072],
16	,	,	O	,	_	0	SENT_440	[p19l1353t1017r1411b1072],
17	Conte	NNP	ORGANIZATION	Conte	nn	20	SENT_440	[p19l1427t1017r1587b1064],
18	Camerino	NNP	ORGANIZATION	Camerino	nn	20	SENT_440	[p19l1602t1016r1867b1064],
19	D.	NNP	O	D.	nn	20	SENT_440	[p19l1881t1017r1942b1063],
20	Effects	NNS	O	effect	appos	5	SENT_440	[p19l1959t1016r2147b1063],
21	of	IN	O	of	_	0	SENT_440	[p19l145t1099r204b1146],
22	HMG-CoA	NN	O	hmg-coa	nn	24	SENT_440	[p19l212t1100r520b1147],
23	reductase	NN	O	reductase	nn	24	SENT_440	[p19l533t1099r788b1146],
24	inhibitors	NNS	O	inhibitor	prep_of	20	SENT_440	[p19l802t1099r1060b1146],
25	on	IN	O	on	_	0	SENT_440	[p19l1075t1114r1140b1146],
26	excitation-contraction	JJ	O	excitation-contraction	amod	27	SENT_440	[p19l1154t1099r1748b1146],
27	coupling	NN	O	coupling	prep_on	5	SENT_440	[p19l1762t1099r1997b1160],
28	of	IN	O	of	_	0	SENT_440	[p19l2011t1099r2070b1146],
29	rat	NN	O	rat	nn	31	SENT_440	[p19l2078t1106r2150b1146],
30	skeletal	JJ	O	skeletal	amod	31	SENT_440	[p19l146t1183r349b1230],
31	muscle	NN	O	muscle	prep_of	27	SENT_440	[p19l369t1183r573b1230],
32	.	.	O	.	_	0	SENT_440	[p19l369t1183r573b1230],

1	Eur	NNP	O	Eur	nn	4	SENT_441	[p19l595t1184r693b1230],
2	J	NNP	O	J	nn	4	SENT_441	[p19l710t1184r735b1231],
3	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_441	[p19l754t1183r1043b1230],
4	l999	NN	O	l999	_	0	SENT_441	[p19l1069t1183r1486b1239],
5	;	:	O	;	_	0	SENT_441	[p19l1069t1183r1486b1239],
6	364:43	CD	NUMBER	364:43	number	7	SENT_441	[p19l1069t1183r1486b1239],
7	—	CD	NUMBER	—	dep	4	SENT_441	[p19l1069t1183r1486b1239],
8	8	CD	NUMBER	8	dep	7	SENT_441	[p19l1069t1183r1486b1239],
9	.	.	O	.	_	0	SENT_441	[p19l1069t1183r1486b1239],

1	[	NN	O	[	_	0	SENT_442	[p19l7t1267r110b1323],
2	38	CD	NUMBER	38	num	1	SENT_442	[p19l7t1267r110b1323],
3	]	CD	NUMBER	]	num	5	SENT_442	[p19l7t1267r110b1323],
4	Maeda	NNP	PERSON	Maeda	nn	5	SENT_442	[p19l144t1266r329b1313],
5	S	NN	PERSON	s	dep	1	SENT_442	[p19l350t1267r399b1322],
6	,	,	O	,	_	0	SENT_442	[p19l350t1267r399b1322],
7	Matsuoka	NNP	PERSON	Matsuoka	nn	8	SENT_442	[p19l421t1266r690b1313],
8	I	NNP	O	I	appos	5	SENT_442	[p19l709t1267r744b1322],
9	,	,	O	,	_	0	SENT_442	[p19l709t1267r744b1322],
10	Iwamoto	NNP	PERSON	Iwamoto	nn	11	SENT_442	[p19l767t1267r1006b1314],
11	T	NN	O	t	appos	5	SENT_442	[p19l1028t1267r1077b1322],
12	,	,	O	,	_	0	SENT_442	[p19l1028t1267r1077b1322],
13	Kurose	NN	PERSON	kurose	nn	14	SENT_442	[p19l1101t1267r1293b1313],
14	H	NN	O	h	appos	5	SENT_442	[p19l1314t1267r1376b1322],
15	,	,	O	,	_	0	SENT_442	[p19l1314t1267r1376b1322],
16	Kimura	NNP	PERSON	Kimura	nn	17	SENT_442	[p19l1401t1266r1607b1313],
17	J	NNP	PERSON	J	appos	5	SENT_442	[p19l1626t1267r1651b1314],
18	.	.	O	.	_	0	SENT_442	[p19l1656t1305r1664b1313],

1	Down-regulation	NN	O	down-regulation	_	0	SENT_443	[p19l1688t1266r2149b1327],
2	of	IN	O	of	_	0	SENT_443	[p19l145t1349r204b1397],
3	Na	NN	O	na	prep_of	1	SENT_443	[p19l225t1337r485b1398],
4	+	CC	O	+	_	0	SENT_443	[p19l225t1337r485b1398],
5	/	:	O	/	punct	6	SENT_443	[p19l225t1337r485b1398],
6	Ca2	NN	O	ca2	dep	15	SENT_443	[p19l225t1337r485b1398],
7	+	CC	O	+	_	0	SENT_443	[p19l225t1337r485b1398],
8	exchanger	NN	O	exchanger	dep	15	SENT_443	[p19l516t1350r793b1411],
9	by	IN	O	by	dep	6	SENT_443	[p19l818t1349r884b1411],
10	ﬂuvastatin	NN	O	ﬂuvastatin	pobj	9	SENT_443	[p19l912t1349r1191b1398],
11	in	IN	O	in	_	0	SENT_443	[p19l1217t1349r1269b1397],
12	rat	NN	O	rat	nn	14	SENT_443	[p19l1294t1357r1366b1397],
13	cardiomyoblast	NN	O	cardiomyoblast	nn	14	SENT_443	[p19l1391t1349r1810b1411],
14	H9c2	NN	O	h9c2	prep_in	10	SENT_443	[p19l1835t1350r1980b1398],
15	cells	NNS	O	cell	conj_+	1	SENT_443	[p19l2007t1350r2144b1397],
16	:	:	O	:	_	0	SENT_443	[p19l2007t1350r2144b1397],
17	involvment	NN	O	involvment	dep	22	SENT_443	[p19l144t1433r449b1482],
18	of	IN	O	of	_	0	SENT_443	[p19l473t1433r532b1481],
19	RhoB	NN	O	rhob	prep_of	17	SENT_443	[p19l552t1434r705b1481],
20	in	IN	O	in	_	0	SENT_443	[p19l733t1433r784b1481],
21	Na	NN	O	na	prep_in	19	SENT_443	[p19l808t1421r1068b1482],
22	+	CC	O	+	dep	15	SENT_443	[p19l808t1421r1068b1482],
23	/	:	O	/	punct	22	SENT_443	[p19l808t1421r1068b1482],
24	Ca2	NN	O	ca2	dep	1	SENT_443	[p19l808t1421r1068b1482],
25	+	CC	O	+	_	0	SENT_443	[p19l808t1421r1068b1482],
26	exchanger	NN	O	exchanger	nn	28	SENT_443	[p19l1097t1433r1374b1495],
27	mRNA	NN	O	mrna	nn	28	SENT_443	[p19l1398t1434r1590b1481],
28	stability	NN	O	stability	conj_+	24	SENT_443	[p19l1617t1433r1841b1495],
29	.	.	O	.	_	0	SENT_443	[p19l1617t1433r1841b1495],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_444	[p19l1869t1434r1980b1481],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_444	[p19l2004t1434r2147b1481, p19l144t1518r308b1566],
3	2005	CD	DATE	2005	num	2	SENT_444	[p19l328t1518r459b1566],
4	;	:	O	;	_	0	SENT_444	[p19l468t1518r785b1574],
5	68:414	CD	NUMBER	68:414	number	6	SENT_444	[p19l468t1518r785b1574],
6	—	CD	NUMBER	—	dep	2	SENT_444	[p19l468t1518r785b1574],
7	20	CD	NUMBER	20	dep	6	SENT_444	[p19l468t1518r785b1574],
8	.	.	O	.	_	0	SENT_444	[p19l468t1518r785b1574],

1	[	NN	O	[	nn	5	SENT_445	[p19l7t1604r110b1661],
2	39	CD	NUMBER	39	num	5	SENT_445	[p19l7t1604r110b1661],
3	]	CD	NUMBER	]	num	5	SENT_445	[p19l7t1604r110b1661],
4	Urso	NNP	O	Urso	nn	5	SENT_445	[p19l144t1605r274b1652],
5	ML	NNP	O	ML	_	0	SENT_445	[p19l297t1605r412b1660],
6	,	,	O	,	_	0	SENT_445	[p19l297t1605r412b1660],
7	Clarkson	NNP	PERSON	Clarkson	nn	8	SENT_445	[p19l438t1603r682b1652],
8	PM	NNP	O	PM	appos	5	SENT_445	[p19l704t1605r816b1660],
9	,	,	O	,	_	0	SENT_445	[p19l704t1605r816b1660],
10	Hittel	NNP	PERSON	Hittel	nn	11	SENT_445	[p19l841t1603r994b1651],
11	D	NNP	PERSON	D	appos	5	SENT_445	[p19l1017t1605r1079b1660],
12	,	,	O	,	_	0	SENT_445	[p19l1017t1605r1079b1660],
13	Hoffman	NNP	PERSON	Hoffman	nn	14	SENT_445	[p19l1104t1603r1346b1651],
14	EP	NNP	O	EP	appos	5	SENT_445	[p19l1369t1605r1454b1660],
15	,	,	O	,	_	0	SENT_445	[p19l1369t1605r1454b1660],
16	Thompson	NNP	PERSON	Thompson	nn	17	SENT_445	[p19l1479t1603r1769b1665],
17	PD	NN	O	pd	appos	5	SENT_445	[p19l1791t1605r1890b1651],
18	.	.	O	.	_	0	SENT_445	[p19l1791t1605r1890b1651],

1	Changes	NNS	O	change	_	0	SENT_446	[p19l1917t1603r2147b1665],
2	in	IN	O	in	_	0	SENT_446	[p19l144t1688r195b1736],
3	ubiquitin	NN	O	ubiquitin	nn	7	SENT_446	[p19l233t1688r478b1750],
4	proteasome	NN	O	proteasome	nn	7	SENT_446	[p19l515t1696r828b1750],
5	pathway	NN	O	pathway	nn	7	SENT_446	[p19l865t1688r1094b1750],
6	gene	NN	O	gene	nn	7	SENT_446	[p19l1134t1703r1259b1750],
7	expression	NN	O	expression	prep_in	1	SENT_446	[p19l1298t1688r1586b1750],
8	in	IN	O	in	_	0	SENT_446	[p19l1625t1688r1676b1736],
9	skeletal	JJ	O	skeletal	amod	10	SENT_446	[p19l1716t1688r1919b1736],
10	muscle	NN	O	muscle	prep_in	7	SENT_446	[p19l1958t1688r2149b1736],
11	with	IN	O	with	_	0	SENT_446	[p19l144t1772r264b1820],
12	exercise	NN	O	exercise	prep_with	1	SENT_446	[p19l308t1772r527b1820],
13	and	CC	O	and	_	0	SENT_446	[p19l573t1772r669b1820],
14	statins	NNS	O	statin	conj_and	12	SENT_446	[p19l715t1772r899b1820],
15	.	.	O	.	_	0	SENT_446	[p19l715t1772r899b1820],

1	Arterioscler	NNP	MISC	Arterioscler	nn	4	SENT_447	[p19l947t1772r1272b1820],
2	Thromb	NNP	MISC	Thromb	nn	4	SENT_447	[p19l1315t1772r1531b1820],
3	Vasc	NNP	MISC	Vasc	nn	4	SENT_447	[p19l1577t1774r1702b1820],
4	Biol	NNP	MISC	Biol	_	0	SENT_447	[p19l1748t1772r1864b1820],
5	2005	CD	DATE	2005	num	4	SENT_447	[p19l1910t1772r2144b1828],
6	;	:	O	;	_	0	SENT_447	[p19l1910t1772r2144b1828],
7	25	CD	NUMBER	25	num	9	SENT_447	[p19l1910t1772r2144b1828],
8	:	:	O	:	_	0	SENT_447	[p19l1910t1772r2144b1828],
9	2560-6	CD	NUMBER	2560-6	dep	4	SENT_447	[p19l145t1856r360b1904],
10	.	.	O	.	_	0	SENT_447	[p19l145t1856r360b1904],

1	[	RB	O	[	advmod	4	SENT_448	[p19l7t1942r110b1999],
2	40	CD	NUMBER	40	number	3	SENT_448	[p19l7t1942r110b1999],
3	]	CD	NUMBER	]	num	4	SENT_448	[p19l7t1942r110b1999],
4	Hermann	NNP	PERSON	Hermann	_	0	SENT_448	[p19l144t1943r395b1989],
5	M	NN	PERSON	m	dep	4	SENT_448	[p19l420t1943r493b1998],
6	,	,	O	,	_	0	SENT_448	[p19l420t1943r493b1998],
7	Bogsrud	NNP	O	Bogsrud	nn	8	SENT_448	[p19l520t1941r749b2003],
8	MP	NNP	O	MP	appos	5	SENT_448	[p19l772t1943r876b1998],
9	,	,	O	,	_	0	SENT_448	[p19l772t1943r876b1998],
10	Molden	NNP	PERSON	Molden	nn	11	SENT_448	[p19l903t1941r1113b1989],
11	E	NNP	O	E	appos	5	SENT_448	[p19l1137t1943r1192b1998],
12	,	,	O	,	_	0	SENT_448	[p19l1137t1943r1192b1998],
13	Asberg	NNP	O	Asberg	nn	14	SENT_448	[p19l1218t1941r1411b2003],
14	A	NNP	O	A	appos	5	SENT_448	[p19l1436t1942r1498b1998],
15	,	,	O	,	_	0	SENT_448	[p19l1436t1942r1498b1998],
16	Mohebi	NNP	ORGANIZATION	Mohebi	nn	17	SENT_448	[p19l1525t1941r1734b1989],
17	BU	NNP	ORGANIZATION	BU	appos	5	SENT_448	[p19l1759t1943r1865b1998],
18	,	,	O	,	_	0	SENT_448	[p19l1759t1943r1865b1998],
19	Ose	NNP	O	Ose	nn	20	SENT_448	[p19l1894t1942r1996b1990],
20	L	NNP	O	L	appos	5	SENT_448	[p19l2020t1943r2075b1998],
21	,	,	O	,	_	0	SENT_448	[p19l2020t1943r2075b1998],
22	et	FW	O	et	nn	23	SENT_448	[p19l2102t1949r2150b1989],
23	al.	FW	O	al.	appos	5	SENT_448	[p19l145t2026r205b2074],
24	.	.	O	.	_	0	SENT_448	[p19l145t2026r205b2074],

1	Exposure	NN	O	exposure	nsubj	5	SENT_449	[p19l228t2028r484b2088],
2	of	IN	O	of	_	0	SENT_449	[p19l506t2026r565b2074],
3	atorvastatin	NN	O	atorvastatin	prep_of	1	SENT_449	[p19l582t2026r895b2074],
4	is	VBZ	O	be	cop	5	SENT_449	[p19l915t2026r957b2074],
5	unchanged	JJ	O	unchanged	_	0	SENT_449	[p19l979t2026r1273b2088],
6	while	IN	O	while	mark	13	SENT_449	[p19l1293t2026r1442b2075],
7	lactone	NN	O	lactone	nn	10	SENT_449	[p19l1463t2026r1657b2074],
8	and	CC	O	and	_	0	SENT_449	[p19l1680t2026r1776b2074],
9	acid	NN	O	acid	nn	10	SENT_449	[p19l1797t2026r1908b2074],
10	metabolites	NNS	O	metabolite	nsubj	13	SENT_449	[p19l1928t2026r2147b2074, p19l144t2112r254b2160],
11	are	VBP	O	be	cop	13	SENT_449	[p19l289t2127r368b2160],
12	several	JJ	O	several	amod	13	SENT_449	[p19l402t2111r721b2160],
13	—	NNS	O	—	advcl	5	SENT_449	[p19l402t2111r721b2160],
14	fold	VBP	O	fold	rcmod	13	SENT_449	[p19l402t2111r721b2160],
15	increased	VBN	O	increase	csubj	22	SENT_449	[p19l752t2112r1008b2160],
16	in	IN	O	in	_	0	SENT_449	[p19l1039t2112r1090b2159],
17	patients	NNS	O	patient	prep_in	15	SENT_449	[p19l1121t2112r1330b2174],
18	in	IN	O	in	prep	15	SENT_449	[p19l1363t2112r1414b2159],
19	with	IN	O	with	pcomp	18	SENT_449	[p19l1446t2112r1565b2160],
20	atorvastatin	NN	O	atorvastatin	nn	21	SENT_449	[p19l1598t2111r2149b2160],
21	—	NN	O	—	pobj	19	SENT_449	[p19l1598t2111r2149b2160],
22	induced	VBD	O	induce	ccomp	14	SENT_449	[p19l1598t2111r2149b2160],
23	myopathy	NN	O	myopathy	dobj	22	SENT_449	[p19l144t2197r423b2259],
24	.	.	O	.	_	0	SENT_449	[p19l144t2197r423b2259],

1	Clin	NNP	O	Clin	nn	3	SENT_450	[p19l447t2196r561b2245],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_450	[p19l580t2196r869b2245],
3	Ther	NNP	O	Ther	_	0	SENT_450	[p19l888t2197r1016b2245],
4	2006:7925	CD	NUMBER	2006:7925	number	5	SENT_450	[p19l1035t2196r1305b2253],
5	32-9	CD	NUMBER	32-9	num	3	SENT_450	[p19l1312t2197r1457b2245],
6	.	.	O	.	_	0	SENT_450	[p19l1312t2197r1457b2245],

1	[	NN	O	[	dep	5	SENT_451	[p19l7t2282r110b2340],
2	41	CD	NUMBER	41	dep	1	SENT_451	[p19l7t2282r110b2340],
3	]	CD	NUMBER	]	num	4	SENT_451	[p19l7t2282r110b2340],
4	Nordin	NN	PERSON	nordin	dep	5	SENT_451	[p19l144t2282r335b2330],
5	C	NN	PERSON	c	dep	23	SENT_451	[p19l360t2282r417b2338],
6	,	,	O	,	_	0	SENT_451	[p19l360t2282r417b2338],
7	Dahl	NNP	PERSON	Dahl	nn	8	SENT_451	[p19l444t2282r575b2330],
8	ML	NNP	O	ML	appos	5	SENT_451	[p19l599t2283r714b2338],
9	,	,	O	,	_	0	SENT_451	[p19l599t2283r714b2338],
10	Eriksson	NNP	PERSON	Eriksson	nn	11	SENT_451	[p19l740t2282r977b2330],
11	M	NNP	O	M	appos	5	SENT_451	[p19l1001t2283r1075b2338],
12	,	,	O	,	_	0	SENT_451	[p19l1001t2283r1075b2338],
13	Sjoberg	NNP	PERSON	Sjoberg	nn	14	SENT_451	[p19l1103t2282r1310b2344],
14	S.	NNP	O	S.	appos	5	SENT_451	[p19l1336t2282r1384b2330],
15	Is	VBZ	O	be	auxpass	23	SENT_451	[p19l1412t2283r1457b2330],
16	the	DT	O	the	det	20	SENT_451	[p19l1483t2282r1564b2330],
17	cholesterol	NN	O	cholesterol	nn	20	SENT_451	[p19l1590t2281r2148b2344],
18	—	CD	NUMBER	—	num	20	SENT_451	[p19l1590t2281r2148b2344],
19	lowering	NN	O	lowering	nn	20	SENT_451	[p19l1590t2281r2148b2344],
20	effect	NN	O	effect	attr	23	SENT_451	[p19l145t2366r296b2415],
21	of	IN	O	of	_	0	SENT_451	[p19l337t2366r396b2415],
22	simvastatin	NN	O	simvastatin	prep_of	20	SENT_451	[p19l435t2367r739b2415],
23	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_451	[p19l780t2366r1062b2415],
24	by	IN	O	by	_	0	SENT_451	[p19l1102t2367r1168b2429],
25	CYP2D6	NN	O	cyp2d6	nn	26	SENT_451	[p19l1211t2366r1457b2415],
26	polymorphism	NN	O	polymorphism	agent	23	SENT_451	[p19l1498t2367r1924b2429],
27	?	.	O	?	_	0	SENT_451	[p19l1498t2367r1924b2429],

1	Lancet	NNP	O	Lancet	nn	2	SENT_452	[p19l1965t2368r2150b2415],
2	l997	NN	O	l997	_	0	SENT_452	[p19l150t2450r602b2506],
3	;	:	O	;	_	0	SENT_452	[p19l150t2450r602b2506],
4	350:29	CD	NUMBER	350:29	number	5	SENT_452	[p19l150t2450r602b2506],
5	—	CD	NUMBER	—	dep	2	SENT_452	[p19l150t2450r602b2506],
6	30	CD	NUMBER	30	dep	5	SENT_452	[p19l150t2450r602b2506],
7	.	.	O	.	_	0	SENT_452	[p19l150t2450r602b2506],

1	[	NN	O	[	nn	5	SENT_453	[p19l7t2536r110b2594],
2	42	CD	NUMBER	42	num	5	SENT_453	[p19l7t2536r110b2594],
3	]	CD	NUMBER	]	num	5	SENT_453	[p19l7t2536r110b2594],
4	Chasman	NNP	PERSON	Chasman	nn	5	SENT_453	[p19l145t2536r396b2584],
5	DI	NNP	O	DI	_	0	SENT_453	[p19l417t2537r501b2592],
6	,	,	O	,	_	0	SENT_453	[p19l417t2537r501b2592],
7	Posada	NNP	PERSON	Posada	nn	8	SENT_453	[p19l524t2536r716b2584],
8	D	NNP	PERSON	D	appos	5	SENT_453	[p19l736t2537r798b2592],
9	,	,	O	,	_	0	SENT_453	[p19l736t2537r798b2592],
10	Subrahmanyan	NNP	PERSON	Subrahmanyan	nn	11	SENT_453	[p19l824t2536r1227b2598],
11	L	NNP	PERSON	L	appos	8	SENT_453	[p19l1248t2537r1303b2592],
12	,	,	O	,	_	0	SENT_453	[p19l1248t2537r1303b2592],
13	Cook	NNP	ORGANIZATION	Cook	nn	14	SENT_453	[p19l1327t2535r1473b2584],
14	NR	NNP	ORGANIZATION	NR	appos	8	SENT_453	[p19l1492t2537r1600b2592],
15	,	,	O	,	_	0	SENT_453	[p19l1492t2537r1600b2592],
16	Stanton	NNP	PERSON	Stanton	nn	17	SENT_453	[p19l1625t2536r1830b2584],
17	VP	NNP	O	VP	appos	8	SENT_453	[p19l1850t2537r1943b2592],
18	,	,	O	,	_	0	SENT_453	[p19l1850t2537r1943b2592],
19	Ridker	NNP	PERSON	Ridker	nn	20	SENT_453	[p19l1966t2536r2150b2584],
20	PM	NNP	O	PM	appos	8	SENT_453	[p19l144t2622r254b2669],
21	.	.	O	.	_	0	SENT_453	[p19l144t2622r254b2669],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_454	[p19l284t2620r750b2683],
2	study	NN	O	study	_	0	SENT_454	[p19l780t2621r922b2683],
3	of	IN	O	of	_	0	SENT_454	[p19l950t2620r1009b2669],
4	statin	NN	O	statin	nn	5	SENT_454	[p19l1033t2621r1176b2669],
5	therapy	NN	O	therapy	prep_of	2	SENT_454	[p19l1203t2621r1404b2683],
6	and	CC	O	and	_	0	SENT_454	[p19l1432t2621r1528b2669],
7	cholesterol	NN	O	cholesterol	nn	8	SENT_454	[p19l1554t2621r1850b2669],
8	reduction	NN	O	reduction	conj_and	5	SENT_454	[p19l1876t2621r2145b2669],
9	.	.	O	.	_	0	SENT_454	[p19l1876t2621r2145b2669],

1	JAMA	NNP	O	JAMA	_	0	SENT_455	[p19l144t2705r324b2752],
2	2004	CD	DATE	2004	num	1	SENT_455	[p19l343t2705r834b2760],
3	;	:	O	;	_	0	SENT_455	[p19l343t2705r834b2760],
4	291:2821	CD	NUMBER	291:2821	num	5	SENT_455	[p19l343t2705r834b2760],
5	—	NN	O	—	dep	1	SENT_455	[p19l343t2705r834b2760],
6	7	CD	NUMBER	7	dep	5	SENT_455	[p19l343t2705r834b2760],
7	.	.	O	.	_	0	SENT_455	[p19l343t2705r834b2760],

1	[	NN	O	[	nn	5	SENT_456	[p19l7t2790r110b2848],
2	43	CD	NUMBER	43	num	5	SENT_456	[p19l7t2790r110b2848],
3	]	CD	NUMBER	]	num	5	SENT_456	[p19l7t2790r110b2848],
4	Kajinami	NNP	PERSON	Kajinami	nn	5	SENT_456	[p19l145t2789r395b2852],
5	K	NNP	PERSON	K	_	0	SENT_456	[p19l431t2791r492b2846],
6	,	,	O	,	_	0	SENT_456	[p19l431t2791r492b2846],
7	Takekoshi	NNP	PERSON	Takekoshi	nn	8	SENT_456	[p19l528t2789r803b2838],
8	N	NNP	PERSON	N	appos	5	SENT_456	[p19l837t2791r900b2846],
9	,	,	O	,	_	0	SENT_456	[p19l837t2791r900b2846],
10	Brousseau	NNP	PERSON	Brousseau	nn	11	SENT_456	[p19l936t2791r1217b2838],
11	ME	NNP	O	ME	appos	5	SENT_456	[p19l1252t2791r1367b2846],
12	,	,	O	,	_	0	SENT_456	[p19l1252t2791r1367b2846],
13	Schaefer	NNP	PERSON	Schaefer	nn	14	SENT_456	[p19l1406t2789r1641b2838],
14	EJ	NNP	O	EJ	appos	5	SENT_456	[p19l1673t2791r1754b2838],
15	.	.	O	.	_	0	SENT_456	[p19l1673t2791r1754b2838],

1	Phar1nacoge	NN	O	phar1nacoge	_	0	SENT_457	[p19l1791t2790r2147b2852],
2	—	CD	NUMBER	—	num	3	SENT_457	[p19l1791t2790r2147b2852],
3	netics	NNS	O	netic	dep	1	SENT_457	[p19l144t2873r299b2920],
4	of	IN	O	of	_	0	SENT_457	[p19l339t2873r398b2920],
5	HMG-CoA	NN	O	hmg-coa	nn	7	SENT_457	[p19l431t2873r739b2920],
6	reductase	NN	O	reductase	nn	7	SENT_457	[p19l775t2873r1031b2920],
7	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_457	[p19l1068t2873r1342b2920],
8	:	:	O	:	_	0	SENT_457	[p19l1068t2873r1342b2920],
9	exploring	VBG	O	explore	dep	1	SENT_457	[p19l1384t2873r1641b2934],
10	the	DT	O	the	det	11	SENT_457	[p19l1679t2873r1760b2920],
11	potential	NN	O	potential	dobj	9	SENT_457	[p19l1797t2873r2034b2934],
12	for	IN	O	for	_	0	SENT_457	[p19l2072t2873r2150b2920],
13	genotype-based	JJ	O	genotype-based	amod	14	SENT_457	[p19l145t2956r570b3017],
14	individualization	NN	O	individualization	prep_for	9	SENT_457	[p19l592t2956r1050b3003],
15	of	IN	O	of	_	0	SENT_457	[p19l1073t2956r1132b3003],
16	coronary	JJ	O	coronary	amod	19	SENT_457	[p19l1150t2971r1389b3017],
17	heart	NN	O	heart	nn	19	SENT_457	[p19l1411t2956r1547b3003],
18	disease	NN	O	disease	nn	19	SENT_457	[p19l1570t2956r1763b3003],
19	management	NN	O	management	prep_of	14	SENT_457	[p19l1786t2963r2145b3017],
20	.	.	O	.	_	0	SENT_457	[p19l1786t2963r2145b3017],

1	Atherosclerosis	NNP	O	Atherosclerosis	_	0	SENT_458	[p19l144t3040r564b3087],
2	2004	CD	DATE	2004	num	1	SENT_458	[p19l586t3040r1076b3095],
3	;	:	O	;	_	0	SENT_458	[p19l586t3040r1076b3095],
4	l77	CD	NUMBER	l77	num	6	SENT_458	[p19l586t3040r1076b3095],
5	:2	CD	NUMBER	:2	num	6	SENT_458	[p19l586t3040r1076b3095],
6	l9	NN	O	l9	dep	1	SENT_458	[p19l586t3040r1076b3095],
7	—	CD	NUMBER	—	number	8	SENT_458	[p19l586t3040r1076b3095],
8	34	CD	NUMBER	34	dep	6	SENT_458	[p19l586t3040r1076b3095],
9	.	.	O	.	_	0	SENT_458	[p19l586t3040r1076b3095],

1	[	NN	O	[	nn	5	SENT_459	[p19l7t3123r110b3180],
2	44	CD	NUMBER	44	num	5	SENT_459	[p19l7t3123r110b3180],
3	]	CD	NUMBER	]	num	5	SENT_459	[p19l7t3123r110b3180],
4	Pedro-Botet	NNP	O	Pedro-Botet	nn	5	SENT_459	[p19l144t3123r472b3170],
5	J	NNP	O	J	nsubj	24	SENT_459	[p19l497t3124r522b3170],
6	,	,	O	,	_	0	SENT_459	[p19l527t3162r537b3178],
7	Schaefer	NNP	PERSON	Schaefer	nn	8	SENT_459	[p19l567t3123r803b3170],
8	EJ	NNP	O	EJ	appos	5	SENT_459	[p19l827t3124r908b3178],
9	,	,	O	,	_	0	SENT_459	[p19l827t3124r908b3178],
10	Bakker-Arkema	NNP	PERSON	Bakker-Arkema	nn	11	SENT_459	[p19l937t3123r1372b3170],
11	RG	NNP	O	RG	appos	5	SENT_459	[p19l1397t3123r1504b3179],
12	,	,	O	,	_	0	SENT_459	[p19l1397t3123r1504b3179],
13	Black	NNP	ORGANIZATION	Black	nn	14	SENT_459	[p19l1533t3123r1692b3170],
14	DM	NN	ORGANIZATION	dm	appos	5	SENT_459	[p19l1716t3124r1839b3178],
15	,	,	O	,	_	0	SENT_459	[p19l1716t3124r1839b3178],
16	Stein	NNP	ORGANIZATION	Stein	nn	17	SENT_459	[p19l1869t3123r2006b3170],
17	EM	NNP	ORGANIZATION	EM	appos	5	SENT_459	[p19l2031t3124r2146b3178],
18	,	,	O	,	_	0	SENT_459	[p19l2031t3124r2146b3178],
19	Corella	NNP	PERSON	Corella	nn	23	SENT_459	[p19l145t3206r344b3253],
20	D.	NNP	PERSON	D.	nn	23	SENT_459	[p19l372t3207r432b3253],
21	Apolipoprotein	NNP	PERSON	Apolipoprotein	nn	23	SENT_459	[p19l465t3206r879b3267],
22	E	NNP	O	E	nn	23	SENT_459	[p19l908t3207r948b3252],
23	genotype	NN	O	genotype	appos	5	SENT_459	[p19l977t3213r1224b3267],
24	affects	VBZ	O	affect	_	0	SENT_459	[p19l1255t3206r1430b3253],
25	plasma	NN	O	plasma	nn	27	SENT_459	[p19l1460t3206r1653b3267],
26	lipid	NN	O	lipid	nn	27	SENT_459	[p19l1680t3206r1804b3267],
27	response	NN	O	response	dobj	24	SENT_459	[p19l1832t3221r2068b3267],
28	to	TO	O	to	_	0	SENT_459	[p19l2098t3213r2148b3253],
29	atorvastatin	NN	O	atorvastatin	prep_to	27	SENT_459	[p19l145t3289r458b3336],
30	in	IN	O	in	_	0	SENT_459	[p19l483t3289r534b3335],
31	a	DT	O	a	det	34	SENT_459	[p19l560t3304r588b3336],
32	gender	NN	O	gender	nn	34	SENT_459	[p19l613t3289r797b3350],
33	speciﬁc	NN	O	speciﬁc	nn	34	SENT_459	[p19l823t3289r1026b3350],
34	manner	NN	O	manner	prep_in	29	SENT_459	[p19l1051t3304r1264b3336],
35	.	.	O	.	_	0	SENT_459	[p19l1051t3304r1264b3336],

1	Atherosclerosis	NNP	MISC	Atherosclerosis	_	0	SENT_460	[p19l1292t3289r1712b3336],
2	2001	CD	DATE	2001	num	1	SENT_460	[p19l1739t3289r2150b3344, p19l145t3372r224b3420],
3	;	:	O	;	_	0	SENT_460	[p19l1739t3289r2150b3344, p19l145t3372r224b3420],
4	158:18393	CD	NUMBER	158:18393	dep	1	SENT_460	[p19l1739t3289r2150b3344, p19l145t3372r224b3420],
5	.	.	O	.	_	0	SENT_460	[p19l1739t3289r2150b3344, p19l145t3372r224b3420],

1	[	NN	O	[	nn	5	SENT_461	[p19l7t3456r110b3513],
2	45	CD	NUMBER	45	num	5	SENT_461	[p19l7t3456r110b3513],
3	]	CD	NUMBER	]	num	5	SENT_461	[p19l7t3456r110b3513],
4	Kajinami	NNP	PERSON	Kajinami	nn	5	SENT_461	[p19l145t3456r395b3517],
5	K	NNP	PERSON	K	_	0	SENT_461	[p19l417t3457r478b3511],
6	,	,	O	,	_	0	SENT_461	[p19l417t3457r478b3511],
7	Brousseau	NNP	PERSON	Brousseau	nn	8	SENT_461	[p19l501t3457r782b3503],
8	ME	NNP	O	ME	appos	5	SENT_461	[p19l803t3457r918b3512],
9	,	,	O	,	_	0	SENT_461	[p19l803t3457r918b3512],
10	Ordovas	NNP	O	Ordovas	nn	11	SENT_461	[p19l942t3456r1165b3503],
11	JM	NN	O	jm	appos	5	SENT_461	[p19l1187t3457r1287b3511],
12	,	,	O	,	_	0	SENT_461	[p19l1187t3457r1287b3511],
13	Schaefer	NNP	PERSON	Schaefer	nn	14	SENT_461	[p19l1312t3456r1548b3503],
14	EJ	NNP	O	EJ	appos	5	SENT_461	[p19l1567t3457r1647b3503],
15	.	.	O	.	_	0	SENT_461	[p19l1567t3457r1647b3503],

1	A	DT	O	a	det	3	SENT_462	[p19l1671t3456r1719b3502],
2	promoter	NN	O	promoter	nn	3	SENT_462	[p19l1738t3463r1988b3517],
3	polymorphism	NN	O	polymorphism	nsubj	9	SENT_462	[p19l2006t3456r2147b3517, p19l144t3539r419b3600],
4	in	IN	O	in	_	0	SENT_462	[p19l436t3539r487b3585],
5	cholesterol	NN	O	cholesterol	nn	6	SENT_462	[p19l505t3539r801b3586],
6	7alpha	NN	O	7alpha	prep_in	3	SENT_462	[p19l819t3539r1353b3600],
7	—	CD	NUMBER	—	num	8	SENT_462	[p19l819t3539r1353b3600],
8	hydroxylase	NN	O	hydroxylase	dep	6	SENT_462	[p19l819t3539r1353b3600],
9	interacts	VBZ	O	interact	_	0	SENT_462	[p19l1371t3539r1598b3586],
10	with	IN	O	with	_	0	SENT_462	[p19l1617t3539r1736b3586],
11	apolipoprotein	NN	O	apolipoprotein	nn	13	SENT_462	[p19l1755t3539r2149b3600],
12	E	NN	O	e	nn	13	SENT_462	[p19l144t3622r184b3668],
13	genotype	NN	O	genotype	prep_with	9	SENT_462	[p19l204t3628r450b3682],
14	in	IN	O	in	_	0	SENT_462	[p19l469t3621r521b3668],
15	the	DT	O	the	det	19	SENT_462	[p19l539t3621r620b3668],
16	LDL	NN	O	ldl	nn	19	SENT_462	[p19l639t3621r1032b3682],
17	—	CD	NUMBER	—	num	19	SENT_462	[p19l639t3621r1032b3682],
18	1owering	NN	O	1owering	nn	19	SENT_462	[p19l639t3621r1032b3682],
19	response	NN	O	response	prep_in	13	SENT_462	[p19l1051t3636r1288b3682],
20	to	TO	O	to	_	0	SENT_462	[p19l1307t3628r1358b3668],
21	atorvastatin	NN	O	atorvastatin	prep_to	19	SENT_462	[p19l1379t3621r1705b3668],
22	.	.	O	.	_	0	SENT_462	[p19l1379t3621r1705b3668],

1	Atherosclerosis	NNP	O	Atherosclerosis	_	0	SENT_463	[p19l1727t3621r2147b3668],
2	2005	CD	DATE	2005	num	1	SENT_463	[p19l145t3705r636b3761],
3	;	:	O	;	_	0	SENT_463	[p19l145t3705r636b3761],
4	l80	CD	NUMBER	l80	number	5	SENT_463	[p19l145t3705r636b3761],
5	:407	CD	NUMBER	:407	num	7	SENT_463	[p19l145t3705r636b3761],
6	—	NN	O	—	nn	7	SENT_463	[p19l145t3705r636b3761],
7	l5	NN	O	l5	dep	1	SENT_463	[p19l145t3705r636b3761],
8	.	.	O	.	_	0	SENT_463	[p19l145t3705r636b3761],

1	[	RB	O	[	advmod	2	SENT_464	[p20l7t20r110b77],
2	46	CD	NUMBER	46	_	0	SENT_464	[p20l7t20r110b77],
3	]	CD	NUMBER	]	num	5	SENT_464	[p20l7t20r110b77],
4	Nestel	NNP	ORGANIZATION	Nestel	nn	5	SENT_464	[p20l144t20r316b67],
5	P	NN	ORGANIZATION	p	dep	2	SENT_464	[p20l344t21r387b76],
6	,	,	O	,	_	0	SENT_464	[p20l344t21r387b76],
7	Simons	NNP	ORGANIZATION	Simons	nn	8	SENT_464	[p20l420t20r619b67],
8	L	NNP	ORGANIZATION	L	appos	5	SENT_464	[p20l649t21r703b76],
9	,	,	O	,	_	0	SENT_464	[p20l649t21r703b76],
10	Barter	NNP	O	Barter	nn	11	SENT_464	[p20l734t21r904b67],
11	P	NN	O	p	appos	5	SENT_464	[p20l931t21r974b76],
12	,	,	O	,	_	0	SENT_464	[p20l931t21r974b76],
13	Clifton	NNP	PERSON	Clifton	nn	14	SENT_464	[p20l1005t20r1196b67],
14	P	NN	PERSON	p	appos	5	SENT_464	[p20l1224t21r1267b76],
15	,	,	O	,	_	0	SENT_464	[p20l1224t21r1267b76],
16	Colquhoun	NNP	PERSON	Colquhoun	nn	17	SENT_464	[p20l1299t20r1599b81],
17	D	NNP	PERSON	D	appos	5	SENT_464	[p20l1627t21r1689b76],
18	,	,	O	,	_	0	SENT_464	[p20l1627t21r1689b76],
19	Hamilton-Craig	NNP	O	Hamilton-Craig	appos	5	SENT_464	[p20l1720t20r2148b81],
20	I	PRP	O	I	dep	19	SENT_464	[p20l144t104r179b159],
21	,	,	O	,	_	0	SENT_464	[p20l144t104r179b159],
22	et	FW	O	et	nn	23	SENT_464	[p20l215t110r262b150],
23	al.	FW	O	al.	appos	5	SENT_464	[p20l295t103r355b150],
24	.	.	O	.	_	0	SENT_464	[p20l295t103r355b150],

1	A	DT	O	a	det	3	SENT_465	[p20l390t103r438b150],
2	comparative	JJ	O	comparative	amod	3	SENT_465	[p20l471t103r801b164],
3	study	NN	O	study	_	0	SENT_465	[p20l836t103r979b164],
4	of	IN	O	of	_	0	SENT_465	[p20l1013t103r1072b150],
5	the	DT	O	the	det	6	SENT_465	[p20l1099t103r1180b150],
6	efﬁcacy	NN	O	efﬁcacy	prep_of	3	SENT_465	[p20l1213t103r1423b164],
7	of	IN	O	of	_	0	SENT_465	[p20l1457t103r1516b150],
8	simvastatin	NN	O	simvastatin	prep_of	6	SENT_465	[p20l1545t103r1850b150],
9	and	CC	O	and	_	0	SENT_465	[p20l1883t103r1979b150],
10	gemﬁbrozil	NN	O	gemﬁbrozil	prep_of	6	SENT_465	[p20l2011t118r2147b164, p20l145t186r339b233],
11	in	IN	O	in	_	0	SENT_465	[p20l376t186r427b233],
12	combined	JJ	O	combined	amod	14	SENT_465	[p20l464t186r731b233],
13	hyperlipoproteinemiaz	NN	O	hyperlipoproteinemiaz	nn	14	SENT_465	[p20l766t186r1365b247],
14	prediction	NN	O	prediction	prep_in	8	SENT_465	[p20l1406t186r1681b247],
15	of	IN	O	of	_	0	SENT_465	[p20l1719t186r1777b233],
16	response	NN	O	response	prep_of	14	SENT_465	[p20l1809t201r2045b247],
17	by	IN	O	by	_	0	SENT_465	[p20l2081t186r2148b247],
18	baseline	NN	O	baseline	nn	19	SENT_465	[p20l143t269r365b316],
19	lipids	NNS	O	lipid	prep_by	16	SENT_465	[p20l380t269r544b330],
20	,	,	O	,	_	0	SENT_465	[p20l380t269r544b330],
21	apo-E	JJ	O	apo-e	amod	22	SENT_465	[p20l562t270r721b330],
22	genotype	NN	O	genotype	appos	3	SENT_465	[p20l736t276r998b330],
23	,	,	O	,	_	0	SENT_465	[p20l736t276r998b330],
24	1ipoprotein	NN	O	1ipoprotein	appos	3	SENT_465	[p20l1015t269r1385b330],
25	(	CD	NUMBER	(	num	24	SENT_465	[p20l1015t269r1385b330],
26	a	DT	O	a	det	27	SENT_465	[p20l1015t269r1385b330],
27	)	NN	O	)	dep	24	SENT_465	[p20l1015t269r1385b330],
28	and	CC	O	and	_	0	SENT_465	[p20l1403t269r1498b316],
29	insulin	NN	O	insulin	conj_and	27	SENT_465	[p20l1512t269r1709b316],
30	.	.	O	.	_	0	SENT_465	[p20l1512t269r1709b316],

1	Atherosclerosis	NNP	O	Atherosclerosis	_	0	SENT_466	[p20l1727t269r2147b316],
2	1997	CD	DATE	1997	num	1	SENT_466	[p20l151t353r602b409],
3	;	:	O	;	_	0	SENT_466	[p20l151t353r602b409],
4	129:231	CD	NUMBER	129:231	number	5	SENT_466	[p20l151t353r602b409],
5	—	CD	NUMBER	—	dep	1	SENT_466	[p20l151t353r602b409],
6	9	CD	NUMBER	9	dep	5	SENT_466	[p20l151t353r602b409],
7	.	.	O	.	_	0	SENT_466	[p20l151t353r602b409],

1	[	NN	O	[	_	0	SENT_467	[p20l7t436r110b493],
2	47	CD	NUMBER	47	number	3	SENT_467	[p20l7t436r110b493],
3	]	CD	NUMBER	]	num	6	SENT_467	[p20l7t436r110b493],
4	Gaw	NNP	PERSON	Gaw	nn	6	SENT_467	[p20l145t436r269b483],
5	A.	NN	O	a.	nn	6	SENT_467	[p20l301t436r362b483],
6	HDL-C	NN	O	hdl-c	dep	1	SENT_467	[p20l397t436r602b483],
7	and	CC	O	and	_	0	SENT_467	[p20l636t436r731b483],
8	triglyceride	NN	O	triglyceride	nn	9	SENT_467	[p20l762t436r1074b497],
9	levels	NNS	O	level	dep	1	SENT_467	[p20l1105t436r1274b483],
10	:	:	O	:	_	0	SENT_467	[p20l1105t436r1274b483],
11	relationship	NN	O	relationship	dep	1	SENT_467	[p20l1309t436r1628b497],
12	to	TO	O	to	_	0	SENT_467	[p20l1661t443r1711b483],
13	coronary	JJ	O	coronary	amod	15	SENT_467	[p20l1744t451r1983b497],
14	heart	NN	O	heart	nn	15	SENT_467	[p20l2014t436r2150b483],
15	disease	NN	O	disease	prep_to	11	SENT_467	[p20l145t519r338b566],
16	and	CC	O	and	_	0	SENT_467	[p20l367t519r462b566],
17	treatment	NN	O	treatment	conj_and	11	SENT_467	[p20l489t526r745b566],
18	with	IN	O	with	_	0	SENT_467	[p20l772t519r891b566],
19	statins	NNS	O	statin	prep_with	17	SENT_467	[p20l919t519r1103b566],
20	.	.	O	.	_	0	SENT_467	[p20l919t519r1103b566],

1	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_468	[p20l1134t519r1434b566],
2	Drugs	NNPS	O	Drugs	nn	3	SENT_468	[p20l1462t520r1624b580],
3	Ther	NNP	O	Ther	_	0	SENT_468	[p20l1653t519r1781b566],
4	2003	CD	DATE	2003	num	6	SENT_468	[p20l1808t519r2150b575, p20l145t603r224b651],
5	;	:	O	;	_	0	SENT_468	[p20l1808t519r2150b575, p20l145t603r224b651],
6	17:5362	CD	NUMBER	17:5362	dep	3	SENT_468	[p20l1808t519r2150b575, p20l145t603r224b651],
7	.	.	O	.	_	0	SENT_468	[p20l1808t519r2150b575, p20l145t603r224b651],

1	[	NN	O	[	nn	5	SENT_469	[p20l7t686r110b743],
2	48	CD	NUMBER	48	num	5	SENT_469	[p20l7t686r110b743],
3	]	CD	NUMBER	]	num	5	SENT_469	[p20l7t686r110b743],
4	Konig	NNP	PERSON	Konig	nn	5	SENT_469	[p20l145t686r309b747],
5	J	NNP	PERSON	J	_	0	SENT_469	[p20l345t687r385b742],
6	,	,	O	,	_	0	SENT_469	[p20l345t687r385b742],
7	Seithel	NNP	O	Seithel	nn	8	SENT_469	[p20l425t686r610b734],
8	A	NNP	O	A	appos	5	SENT_469	[p20l646t687r708b742],
9	,	,	O	,	_	0	SENT_469	[p20l646t687r708b742],
10	Gradhand	NNP	O	Gradhand	nn	11	SENT_469	[p20l748t686r1013b734],
11	U	NNP	O	U	appos	5	SENT_469	[p20l1048t687r1111b742],
12	,	,	O	,	_	0	SENT_469	[p20l1048t687r1111b742],
13	Fromm	NNP	PERSON	Fromm	nn	14	SENT_469	[p20l1148t687r1348b733],
14	MF	NN	O	mf	appos	5	SENT_469	[p20l1383t687r1488b733],
15	.	.	O	.	_	0	SENT_469	[p20l1383t687r1488b733],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_470	[p20l1527t686r2057b747],
2	of	IN	O	of	_	0	SENT_470	[p20l2095t686r2153b733],
3	human	JJ	O	human	amod	5	SENT_470	[p20l143t769r328b816],
4	OATP	NN	O	oatp	nn	5	SENT_470	[p20l374t770r539b817],
5	transporters	NNS	O	transporter	prep_of	1	SENT_470	[p20l583t776r916b830],
6	.	.	O	.	_	0	SENT_470	[p20l583t776r916b830],

1	Naunyn	NNP	O	Naunyn	nn	4	SENT_471	[p20l964t770r1178b830],
2	Schmiedebergs	NNP	O	Schmiedebergs	nn	4	SENT_471	[p20l1224t769r1634b830],
3	Arch	NNP	O	Arch	nn	4	SENT_471	[p20l1680t769r1815b816],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_471	[p20l1860t769r2148b816],
5	2006	CD	DATE	2006	num	4	SENT_471	[p20l145t853r636b909],
6	;	:	O	;	_	0	SENT_471	[p20l145t853r636b909],
7	372:432	CD	NUMBER	372:432	number	8	SENT_471	[p20l145t853r636b909],
8	—	CD	NUMBER	—	dep	4	SENT_471	[p20l145t853r636b909],
9	43	CD	NUMBER	43	dep	8	SENT_471	[p20l145t853r636b909],
10	.	.	O	.	_	0	SENT_471	[p20l145t853r636b909],

1	[	NN	O	[	_	0	SENT_472	[p20l7t936r110b993],
2	49	CD	NUMBER	49	num	1	SENT_472	[p20l7t936r110b993],
3	]	CD	NUMBER	]	num	5	SENT_472	[p20l7t936r110b993],
4	Hedman	NNP	O	Hedman	nn	5	SENT_472	[p20l144t936r373b983],
5	M	NN	O	m	dep	1	SENT_472	[p20l399t937r473b992],
6	,	,	O	,	_	0	SENT_472	[p20l399t937r473b992],
7	Antikainen	NN	O	antikainen	nn	8	SENT_472	[p20l502t936r802b983],
8	M	NN	O	m	appos	5	SENT_472	[p20l829t937r902b992],
9	,	,	O	,	_	0	SENT_472	[p20l829t937r902b992],
10	Holmberg	NNP	ORGANIZATION	Holmberg	nn	11	SENT_472	[p20l931t936r1203b997],
11	C	NNP	ORGANIZATION	C	appos	5	SENT_472	[p20l1231t937r1289b992],
12	,	,	O	,	_	0	SENT_472	[p20l1231t937r1289b992],
13	Neuvonen	NNP	O	Neuvonen	nn	14	SENT_472	[p20l1317t937r1595b983],
14	M	NNP	O	M	appos	5	SENT_472	[p20l1621t937r1694b992],
15	,	,	O	,	_	0	SENT_472	[p20l1621t937r1694b992],
16	Eichelbaum	NNP	PERSON	Eichelbaum	nn	17	SENT_472	[p20l1723t936r2047b983],
17	M	NNP	O	M	appos	5	SENT_472	[p20l2073t937r2146b992],
18	,	,	O	,	_	0	SENT_472	[p20l2073t937r2146b992],
19	Kivisto	NNP	PERSON	Kivisto	nn	20	SENT_472	[p20l145t1019r340b1066],
20	KT	NNP	O	KT	appos	5	SENT_472	[p20l364t1020r461b1075],
21	,	,	O	,	_	0	SENT_472	[p20l364t1020r461b1075],
22	et	FW	O	et	nn	23	SENT_472	[p20l485t1026r534b1066],
23	al.	FW	O	al.	appos	5	SENT_472	[p20l555t1019r615b1066],
24	.	.	O	.	_	0	SENT_472	[p20l555t1019r615b1066],

1	Pharmacokinetics	NNS	O	pharmacokinetic	conj_and	1	SENT_473	[p20l640t1019r1120b1066],
2	and	CC	O	and	_	0	SENT_473	[p20l1145t1019r1241b1066],
3	response	NN	O	response	conj_and	1	SENT_473	[p20l1261t1034r1498b1080],
4	to	TO	O	to	_	0	SENT_473	[p20l1520t1026r1570b1066],
5	pravastatin	NN	O	pravastatin	prep_to	1	SENT_473	[p20l1591t1019r1886b1080],
6	in	IN	O	in	_	0	SENT_473	[p20l1908t1019r1959b1066],
7	paediatric	JJ	O	paediatric	amod	8	SENT_473	[p20l1980t1019r2147b1080, p20l145t1102r262b1149],
8	patients	NNS	O	patient	prep_in	5	SENT_473	[p20l278t1102r487b1163],
9	with	IN	O	with	_	0	SENT_473	[p20l504t1102r624b1150],
10	familial	JJ	O	familial	amod	11	SENT_473	[p20l639t1102r848b1149],
11	hypercholesterolaemia	NN	O	hypercholesterolaemia	prep_with	8	SENT_473	[p20l863t1102r1479b1163],
12	and	CC	O	and	_	0	SENT_473	[p20l1495t1102r1590b1149],
13	in	IN	O	in	_	0	SENT_473	[p20l1606t1102r1657b1149],
14	paediatric	JJ	O	paediatric	amod	17	SENT_473	[p20l1671t1102r1937b1163],
15	cardiac	JJ	O	cardiac	amod	17	SENT_473	[p20l1955t1102r2148b1149],
16	transplant	NN	O	transplant	nn	17	SENT_473	[p20l144t1185r412b1246],
17	recipients	NNS	O	recipient	prep_in	1	SENT_473	[p20l435t1185r697b1246],
18	in	IN	O	in	_	0	SENT_473	[p20l724t1185r775b1232],
19	relation	NN	O	relation	prep_in	17	SENT_473	[p20l800t1185r1006b1232],
20	to	TO	O	to	_	0	SENT_473	[p20l1032t1192r1082b1232],
21	polymorphisms	NNS	O	polymorphism	prep_to	1	SENT_473	[p20l1107t1185r1528b1246],
22	of	IN	O	of	_	0	SENT_473	[p20l1556t1185r1614b1232],
23	the	DT	O	the	det	27	SENT_473	[p20l1635t1185r1716b1232],
24	SLCOIBI	NNP	O	SLCOIBI	nn	27	SENT_473	[p20l1743t1185r2021b1233],
25	and	CC	O	and	_	0	SENT_473	[p20l2054t1185r2149b1232],
26	ABCBI	NNP	O	ABCBI	nn	27	SENT_473	[p20l144t1269r355b1316],
27	genes	NNS	O	gene	prep_of	21	SENT_473	[p20l381t1283r547b1329],
28	.	.	O	.	_	0	SENT_473	[p20l381t1283r547b1329],

1	Br	NN	O	br	nn	3	SENT_474	[p20l569t1269r637b1315],
2	J	NN	O	j	nn	3	SENT_474	[p20l654t1269r679b1316],
3	Clin	NN	O	clin	_	0	SENT_474	[p20l699t1268r814b1316],
4	Pharmacol	NNP	O	Pharmacol	dep	3	SENT_474	[p20l832t1268r1121b1315],
5	2006	CD	DATE	2006	num	4	SENT_474	[p20l1141t1268r1599b1324],
6	;	:	O	;	_	0	SENT_474	[p20l1141t1268r1599b1324],
7	6l	CD	NUMBER	6l	dep	3	SENT_474	[p20l1141t1268r1599b1324],
8	:706	CD	NUMBER	:706	num	10	SENT_474	[p20l1141t1268r1599b1324],
9	—	NN	O	—	nn	10	SENT_474	[p20l1141t1268r1599b1324],
10	l5	NN	O	l5	dep	7	SENT_474	[p20l1141t1268r1599b1324],
11	.	.	O	.	_	0	SENT_474	[p20l1141t1268r1599b1324],

1	[	RB	O	[	advmod	2	SENT_475	[p20l7t1351r110b1408],
2	50	CD	NUMBER	50	_	0	SENT_475	[p20l7t1351r110b1408],
3	]	CD	NUMBER	]	num	5	SENT_475	[p20l7t1351r110b1408],
4	Niemi	NNP	O	Niemi	nn	5	SENT_475	[p20l144t1351r312b1399],
5	M	NN	O	m	dep	2	SENT_475	[p20l329t1353r402b1407],
6	,	,	O	,	_	0	SENT_475	[p20l329t1353r402b1407],
7	Neuvonen	NNP	LOCATION	Neuvonen	nn	8	SENT_475	[p20l421t1353r698b1399],
8	PJ	NNP	LOCATION	PJ	appos	5	SENT_475	[p20l714t1353r791b1407],
9	,	,	O	,	_	0	SENT_475	[p20l714t1353r791b1407],
10	Hoffmann	NNP	ORGANIZATION	Hoffmann	nn	11	SENT_475	[p20l810t1351r1086b1399],
11	U	NNP	ORGANIZATION	U	appos	5	SENT_475	[p20l1102t1353r1164b1407],
12	,	,	O	,	_	0	SENT_475	[p20l1102t1353r1164b1407],
13	Backman	NNP	PERSON	Backman	nn	15	SENT_475	[p20l1183t1351r1439b1399],
14	J	NNP	PERSON	J	nn	15	SENT_475	[p20l1454t1353r1480b1399],
15	T	NN	PERSON	t	appos	5	SENT_475	[p20l1481t1353r1530b1407],
16	,	,	O	,	_	0	SENT_475	[p20l1481t1353r1530b1407],
17	Schwab	NNP	PERSON	Schwab	nn	18	SENT_475	[p20l1551t1351r1762b1399],
18	M	NNP	O	M	appos	5	SENT_475	[p20l1779t1353r1852b1407],
19	,	,	O	,	_	0	SENT_475	[p20l1779t1353r1852b1407],
20	Lutjohann	NNP	PERSON	Lutjohann	nn	21	SENT_475	[p20l1870t1351r2149b1412],
21	D	NNP	PERSON	D	appos	5	SENT_475	[p20l144t1436r206b1490],
22	,	,	O	,	_	0	SENT_475	[p20l144t1436r206b1490],
23	et	FW	O	et	nn	24	SENT_475	[p20l233t1442r281b1482],
24	al.	FW	O	al.	appos	5	SENT_475	[p20l305t1434r364b1482],
25	.	.	O	.	_	0	SENT_475	[p20l305t1434r364b1482],

1	Acute	JJ	O	acute	amod	2	SENT_476	[p20l391t1435r552b1482],
2	effects	NNS	O	effect	nsubjpass	9	SENT_476	[p20l577t1434r752b1482],
3	of	IN	O	of	_	0	SENT_476	[p20l779t1434r837b1482],
4	pravastatin	NN	O	pravastatin	prep_of	2	SENT_476	[p20l855t1434r1151b1495],
5	on	IN	O	on	_	0	SENT_476	[p20l1175t1449r1240b1482],
6	cholesterol	NN	O	cholesterol	nn	7	SENT_476	[p20l1265t1434r1561b1482],
7	synthesis	NN	O	synthesis	prep_on	4	SENT_476	[p20l1587t1434r1831b1495],
8	are	VBP	O	be	auxpass	9	SENT_476	[p20l1858t1449r1937b1482],
9	associated	VBN	O	associate	_	0	SENT_476	[p20l1963t1434r2147b1482, p20l145t1519r256b1567],
10	with	IN	O	with	_	0	SENT_476	[p20l268t1519r387b1568],
11	SLCO1Bl	NN	O	slco1bl	prep_with	9	SENT_476	[p20l400t1520r678b1568],
12	(	CD	NUMBER	(	num	11	SENT_476	[p20l698t1519r965b1581],
13	encoding	VBG	O	encode	xcomp	9	SENT_476	[p20l698t1519r965b1581],
14	OATPB	NN	O	oatpb	dobj	13	SENT_476	[p20l979t1520r1186b1568],
15	1	CD	NUMBER	1	number	16	SENT_476	[p20l1198t1520r1244b1578],
16	)	CD	NUMBER	)	num	18	SENT_476	[p20l1198t1520r1244b1578],
17	haplotype	NN	O	haplotype	nn	18	SENT_476	[p20l1257t1519r1555b1581],
18	*	NN	O	*	dep	14	SENT_476	[p20l1257t1519r1555b1581],
19	17	CD	NUMBER	17	dep	18	SENT_476	[p20l1567t1520r1640b1567],
20	.	.	O	.	_	0	SENT_476	[p20l1567t1520r1640b1567],

1	Pharmacogenetics	NNS	O	pharmacogenetic	nn	2	SENT_477	[p20l1655t1519r2147b1581],
2	Genomics	NNS	O	genomic	_	0	SENT_477	[p20l145t1603r417b1651],
3	2005	CD	DATE	2005	dep	2	SENT_477	[p20l438t1603r861b1658],
4	;	:	O	;	_	0	SENT_477	[p20l438t1603r861b1658],
5	15:303	CD	NUMBER	15:303	number	6	SENT_477	[p20l438t1603r861b1658],
6	—	CD	NUMBER	—	dep	2	SENT_477	[p20l438t1603r861b1658],
7	9	CD	NUMBER	9	dep	6	SENT_477	[p20l438t1603r861b1658],
8	.	.	O	.	_	0	SENT_477	[p20l438t1603r861b1658],

